MRC Centre for Global Infectious Disease Analysis
Lead Research Organisation:
Imperial College London
Department Name: School of Public Health
Abstract
The continuing threat from new infectious diseases has been highlighted in recent years by the emergence of MERS-coronavirus in the Middle East, Ebola in West Africa and Zika in Latin America. Preparing for and responding to such threats is a priority for public health agencies and governments worldwide. Equally importantly, as scientific research delivers new approaches to controlling existing infectious diseases such as malaria, HIV, tuberculosis and polio, there is a need to determine what interventions are likely to work best to limit the disease and illness caused by a specific disease in a particular setting.
In this context, computer modelling of the spread of diseases in populations coupled with scientifically rigorous data analysis have proven themselves as powerful tools for giving insight into how diseases spread and what can be done to limit that control that spread. The Centre for Global Infectious Disease Analysis undertakes research on these scientific methods and applies them to disease threats of concern.
A key feature of the Centre is the close links it has made with with public health agencies - such as the Public Health England, the Centers for Disease Control and Prevention in the US (CDC), and the World Health Organization (WHO) - organisations which have to formulate and implement strategies to control infectious diseases.
Senior scientists in the Centre are world-leaders in infectious disease modelling and analysis. They have broad experience in responding to real epidemics, and undertaking epidemiological research on endemic diseases (such as malaria, HIV, tuberculosis and polio). Their work directly influences disease control policy through the many interactions the Centre has with public health organisations and governments.
Funding provided by MRC and Imperial College has allowed dedicated investment into the development of close collaborative partnerships with PHE, CDC and WHO and governments and research centres in many low and middle income countries (LMICs). We also work closely with other important organisations who work on improving health in LMICs (notably the Bill and Melinda Gates Foundation, The Global Fund and Gavi). With each, our collaborative research has both scientific interest to Centre researchers and contributes to the evidence base for public health decisions. Centre funding supports a core technical capacity available to all projects and pays for dedicated liaison staff who facilitate and enhance our partnerships with major global health organisations and LMICs.
MRC funding has also facilitated a greater focus on collaboration, training and career development within the Centre - training the next generation of quantitative infectious disease epidemiologists. We are also involved in increasing knowledge of advanced modelling methods in public health institutions and the wider infectious disease research community, and so have run a large number of introductory short-courses and workshops (in 13 countries in the last 5 years)
This applied activity depends on more fundamental research undertaken in the Centre on the transmission dynamics of different diseases, how diseases evolve genetically over time, and on analysing new approaches to control or treat diseases. This research is interdisciplinary, with Centre researchers working with leading clinical and experimental scientists around the world.
Continued Centre funding will allow existing partnerships to be sustained and enhanced, and new collaborations with researchers and health agencies in LMICs to be developed. By supporting PhD training and postdoctoral career development, it will also continue to expand the UK skill base in mathematical modelling and advanced analysis applied to health problems. Last, continued MRC support will pump-prime new priority research areas, including work on improving the development of new vaccines and on tackling the global challenge posed by antimicrobial resistance.
In this context, computer modelling of the spread of diseases in populations coupled with scientifically rigorous data analysis have proven themselves as powerful tools for giving insight into how diseases spread and what can be done to limit that control that spread. The Centre for Global Infectious Disease Analysis undertakes research on these scientific methods and applies them to disease threats of concern.
A key feature of the Centre is the close links it has made with with public health agencies - such as the Public Health England, the Centers for Disease Control and Prevention in the US (CDC), and the World Health Organization (WHO) - organisations which have to formulate and implement strategies to control infectious diseases.
Senior scientists in the Centre are world-leaders in infectious disease modelling and analysis. They have broad experience in responding to real epidemics, and undertaking epidemiological research on endemic diseases (such as malaria, HIV, tuberculosis and polio). Their work directly influences disease control policy through the many interactions the Centre has with public health organisations and governments.
Funding provided by MRC and Imperial College has allowed dedicated investment into the development of close collaborative partnerships with PHE, CDC and WHO and governments and research centres in many low and middle income countries (LMICs). We also work closely with other important organisations who work on improving health in LMICs (notably the Bill and Melinda Gates Foundation, The Global Fund and Gavi). With each, our collaborative research has both scientific interest to Centre researchers and contributes to the evidence base for public health decisions. Centre funding supports a core technical capacity available to all projects and pays for dedicated liaison staff who facilitate and enhance our partnerships with major global health organisations and LMICs.
MRC funding has also facilitated a greater focus on collaboration, training and career development within the Centre - training the next generation of quantitative infectious disease epidemiologists. We are also involved in increasing knowledge of advanced modelling methods in public health institutions and the wider infectious disease research community, and so have run a large number of introductory short-courses and workshops (in 13 countries in the last 5 years)
This applied activity depends on more fundamental research undertaken in the Centre on the transmission dynamics of different diseases, how diseases evolve genetically over time, and on analysing new approaches to control or treat diseases. This research is interdisciplinary, with Centre researchers working with leading clinical and experimental scientists around the world.
Continued Centre funding will allow existing partnerships to be sustained and enhanced, and new collaborations with researchers and health agencies in LMICs to be developed. By supporting PhD training and postdoctoral career development, it will also continue to expand the UK skill base in mathematical modelling and advanced analysis applied to health problems. Last, continued MRC support will pump-prime new priority research areas, including work on improving the development of new vaccines and on tackling the global challenge posed by antimicrobial resistance.
Technical Summary
The continued threat posed by emerging infectious diseases has been highlighted in recent years by the emergence of MERS-coronavirus in the Middle East, Ebola in West Africa and Zika in Latin America. Preparedness therefore remains a policy priority for public health agencies and governments worldwide. In addition, as new vaccines, drugs and other interventions are developed for endemic diseases such as malaria, HIV and TB, there is a need to extrapolate from clinical trial results to determine which combination of interventions gives the optimal (or most cost-effective) control strategy for a specific disease in a particular setting.
In this context, modern epidemiological modelling and analysis methods have proven themselves increasingly powerful tools for giving insight into the patterns of emergence of novel outbreaks, the transmission dynamics of endemic diseases and the options available for the control of both. The Centre for Global Infectious Disease Analysis is a world leader in research in this area, and in translating our research into improved public-health decision-making. Since it was founded, MRC funding has supported this translation by facilitating the forging of close partnerships with all major global health organisations (e.g. WHO, PHE, CDC, BMGF, The Global Fund, Gavi) and research centres and public health agencies in many low and middle income countries (LMICs).
Continued funding for the Centre will allow existing partnerships to be sustained and enhanced, and new collaborations with researchers and health agencies in LMICs to be developed. By supporting PhD training and postdoctoral career development, it will also continue to expand the UK skill base in mathematical modelling and advanced analysis applied to health problems. Last, continued MRC support will pump-prime new priority research areas, including work on improving the development of new vaccines and on tackling the global challenge posed by antimicrobial resistance.
In this context, modern epidemiological modelling and analysis methods have proven themselves increasingly powerful tools for giving insight into the patterns of emergence of novel outbreaks, the transmission dynamics of endemic diseases and the options available for the control of both. The Centre for Global Infectious Disease Analysis is a world leader in research in this area, and in translating our research into improved public-health decision-making. Since it was founded, MRC funding has supported this translation by facilitating the forging of close partnerships with all major global health organisations (e.g. WHO, PHE, CDC, BMGF, The Global Fund, Gavi) and research centres and public health agencies in many low and middle income countries (LMICs).
Continued funding for the Centre will allow existing partnerships to be sustained and enhanced, and new collaborations with researchers and health agencies in LMICs to be developed. By supporting PhD training and postdoctoral career development, it will also continue to expand the UK skill base in mathematical modelling and advanced analysis applied to health problems. Last, continued MRC support will pump-prime new priority research areas, including work on improving the development of new vaccines and on tackling the global challenge posed by antimicrobial resistance.
Planned Impact
A primary aim of the MRC Centre for Global Infectious Disease Analysis is to have societal as well as academic impact - both in the UK and across the world. Our goal is to improve public and global health decision making in relation to infectious disease control through the use of advanced statistical and mathematical modelling methods, whether in emergencies like the West African Ebola epidemic in 2014, or in improving control of major infectious disease killers like HIV, malaria and Tuberculosis. We believe the only effective way of delivering on this goal is to form long-term collaborative partnerships with the leading public and global health organisations world-wide, providing analytical support and capacity building for those partners.
Since the Centre was founded in 2008, we have worked on dozens of policy-relevant problems with decision-makers around the world. We provided real-time support to the World Health Organization (WHO), the governments of the UK, and many other international partners during the 2001 H1N1 influenza pandemic, in relation to continued outbreaks of MERS coronavirus in the Middle East, during the 2014-15 West African Ebola epidemic, and, most recently, during the Latin American Zika epidemic. In addition, we have worked closely with WHO and the major international organisations (e.g. The Global Fund, Gavi and the Bill and Melinda Gates Foundation [BMGF]) that fund infectious disease control efforts in low income countries on HIV, malaria, tuberculosis, polio, influenza and a wide range of other diseases. Our relationship with BMGF is of particular strategic importance - it is both the largest funder of Centre research, but more importantly is a key stakeholder in global health decision-making.
These interactions, and our consequent impact on policy, is facilitated by staff dedicated to acting as liaisons between the scientists working in the Centre and the staff of the global and public health agencies we work with. Indeed, in times of crisis, we embed our staff in some of those key organisations. Recently, one of our researchers joined a WHO field mission to the Democratic Republic of Congo to help that country respond to an outbreak of Ebola.
In addition to formal research outputs, often the most important value we give to these organisations is advice provided from a dynamical modelling perspective. This analytical advisory role is multifaceted: from improving situational awareness in crises, advising on likely impact of interventions for endemic diseases, undertaking rapid analyses of priority questions, and advising on improving surveillance and data capture systems.
Capacity building within our partners is another priority, through informal skills transfer and formal training. The former occurs as a natural result of the degree of interaction, and for the latter we run short-courses, both in the Centre and at our partners' sites. Increasingly, we have also been undertaking capacity-building in low and middle income countries [LMIC], either by running disease-specific workshops with local ministries of health, or by training able local scientists. This activity will be further emphasised in the future.
In addition to impact on public health, we have also been increasing our collaborations with the pharmaceutical industry, most notably with vaccine manufacturers. In the last 5 years we have worked closely with GSK and Sanofi Pasteur, helping to characterise the effectiveness of their malaria and dengue vaccines, respectively. Our work involved analysing the data those companies collected on their products during clinical trials and advising them, WHO and regulatory agencies on how their vaccines might best be used. We also work with a wide range of public-private product development partnerships developing new vaccines, drugs and vector control measures.
Attached letters of support from UK DoH, GoS, PHE, US CDC, WHO and BMGF highlight the public health impact of the Centre.
Since the Centre was founded in 2008, we have worked on dozens of policy-relevant problems with decision-makers around the world. We provided real-time support to the World Health Organization (WHO), the governments of the UK, and many other international partners during the 2001 H1N1 influenza pandemic, in relation to continued outbreaks of MERS coronavirus in the Middle East, during the 2014-15 West African Ebola epidemic, and, most recently, during the Latin American Zika epidemic. In addition, we have worked closely with WHO and the major international organisations (e.g. The Global Fund, Gavi and the Bill and Melinda Gates Foundation [BMGF]) that fund infectious disease control efforts in low income countries on HIV, malaria, tuberculosis, polio, influenza and a wide range of other diseases. Our relationship with BMGF is of particular strategic importance - it is both the largest funder of Centre research, but more importantly is a key stakeholder in global health decision-making.
These interactions, and our consequent impact on policy, is facilitated by staff dedicated to acting as liaisons between the scientists working in the Centre and the staff of the global and public health agencies we work with. Indeed, in times of crisis, we embed our staff in some of those key organisations. Recently, one of our researchers joined a WHO field mission to the Democratic Republic of Congo to help that country respond to an outbreak of Ebola.
In addition to formal research outputs, often the most important value we give to these organisations is advice provided from a dynamical modelling perspective. This analytical advisory role is multifaceted: from improving situational awareness in crises, advising on likely impact of interventions for endemic diseases, undertaking rapid analyses of priority questions, and advising on improving surveillance and data capture systems.
Capacity building within our partners is another priority, through informal skills transfer and formal training. The former occurs as a natural result of the degree of interaction, and for the latter we run short-courses, both in the Centre and at our partners' sites. Increasingly, we have also been undertaking capacity-building in low and middle income countries [LMIC], either by running disease-specific workshops with local ministries of health, or by training able local scientists. This activity will be further emphasised in the future.
In addition to impact on public health, we have also been increasing our collaborations with the pharmaceutical industry, most notably with vaccine manufacturers. In the last 5 years we have worked closely with GSK and Sanofi Pasteur, helping to characterise the effectiveness of their malaria and dengue vaccines, respectively. Our work involved analysing the data those companies collected on their products during clinical trials and advising them, WHO and regulatory agencies on how their vaccines might best be used. We also work with a wide range of public-private product development partnerships developing new vaccines, drugs and vector control measures.
Attached letters of support from UK DoH, GoS, PHE, US CDC, WHO and BMGF highlight the public health impact of the Centre.
Organisations
- Imperial College London (Lead Research Organisation)
- University of Milan (Collaboration)
- Medical Research Council of South Africa (MRC) (Collaboration)
- University of KwaZulu-Natal (Collaboration)
- World Bank Group (Collaboration)
- PATH (Collaboration)
- MM Global Health Consulting (Collaboration)
- University of California, Berkeley (Collaboration)
- University of Antwerp (Collaboration)
- Botswana Harvard AIDS Institute Partnership (Collaboration)
- Government of India (Collaboration)
- Program for Appropriate Technology in Health (PATH) (Collaboration)
- Pancasila University (Collaboration)
- Centre for Research in Infectious Diseases (CRID) (Collaboration)
- Charles University (Collaboration)
- Department of Health (DH) (Collaboration)
- Center for Infectious Disease Research (Collaboration)
- Population Services International (Collaboration)
- East Central and Southern Africa Health Community (Collaboration)
- Baylor School (Collaboration)
- The National Institute of Public Health of Mexico (INSP) (Collaboration)
- UNIVERSITY OF OXFORD (Collaboration)
- Google (Collaboration)
- Imperial College Healthcare NHS Trust (Collaboration)
- Mahidol University (Collaboration)
- International Agency for Research on Cancer (IARC) (Collaboration)
- Princeton University (Collaboration)
- Drugs for Neglected Diseases initiative (DNDi) (Collaboration)
- Yale University (Collaboration)
- UNIVERSITY OF EDINBURGH (Collaboration)
- Edmund Mach Foundation (Collaboration)
- European Centre for Disease Prevention and Control (ECDC) (Collaboration)
- Medicines for Malaria Venture (MMV) (Collaboration)
- Programme PAC-CI (Collaboration)
- Flu Lab (Collaboration)
- Umea University (Collaboration)
- Penn State University (Collaboration)
- ST GEORGE'S UNIVERSITY OF LONDON (Collaboration)
- Medical Research Council of Zimbabwe (Collaboration)
- Global Fund to Fight AIDS, Tuberculosis and Malaria (Collaboration)
- Tel Aviv University (Collaboration)
- The Global Health Network (Collaboration)
- International Society for Infectious Diseases (ISID) (Collaboration)
- Gavi (Collaboration)
- UNIVERSITY OF LIVERPOOL (Collaboration)
- National University of Río Negro (Collaboration)
- Herbert Smith Freehills (Collaboration)
- Makerere University (Collaboration)
- Sixth Framework Programme (FP6) (Collaboration)
- Health Intervention and Technology Assessment Program (Collaboration)
- Institute of Development Research (IRD) (Collaboration)
- UNIVERSITY OF ENERGY AND NATURAL RESOURCES (Collaboration)
- Universitas Indonesia (Collaboration)
- Infectious Diseases Data Observatory (Collaboration)
- Centers for Disease Control and Prevention (CDC) (Collaboration)
- National Institute for Biological Standards and Control (NIBSC) (Collaboration)
- Institute of Tropical Medicine Antwerp (Collaboration)
- IMPERIAL COLLEGE LONDON (Collaboration)
- Aurum Institute (Collaboration)
- Neglected Tropical Diseases Modelling Consortium (Collaboration)
- World Vision Ethiopia (Collaboration)
- University of Malawi (Collaboration)
- UNIVERSITY OF YORK (Collaboration)
- QIMR Berghofer Medical Research Institute (Collaboration)
- Christian Medical College, Vellore (Collaboration)
- Government of Thailand (Collaboration)
- Zoological Society of London (Collaboration)
- Healthsites.io (Collaboration)
- Karolinska Institute (Collaboration)
- University of California, San Francisco (Collaboration)
- National Conservatory of Arts and Crafts (Collaboration)
- University of Warwick (Collaboration)
- Centro de Investigação em Saúde de Manhiça (Collaboration)
- Oriole Global Health (Collaboration)
- University of Bamako (Collaboration)
- Leiden University Medical Center (Collaboration)
- EMBL European Bioinformatics Institute (EMBL - EBI) (Collaboration)
- University of Bath (Collaboration)
- Natural History Museum (Collaboration)
- Central University of Venezuela (Collaboration)
- HARVARD UNIVERSITY (Collaboration)
- University of Wisconsin-Madison (Collaboration)
- Academic Medical Center (Collaboration)
- Fundação Pró-Sangue Hemocentro de São Paulo (Collaboration)
- Oswaldo Cruz Foundation (Fiocruz) (Collaboration)
- Global Solutions for Infectious Disease (Collaboration)
- Hannover Medical School (Collaboration)
- Kaiser Permanente (Collaboration)
- Telethon Kids Institute (Collaboration)
- DeepBlue Technology (Shanghai) Co., Ltd. (Collaboration)
- University of Toronto (Collaboration)
- Rakai Health Sciences Program (Collaboration)
- University of Oslo (Collaboration)
- Ministry of Health (Collaboration)
- UNICEF (Collaboration)
- State of New York (Collaboration)
- United States Department of State (Collaboration)
- Centre for Infectious Disease Research in Zambia (Collaboration)
- Utrecht University (Collaboration)
- University of Texas at Galveston (Collaboration)
- Jinan University (Collaboration)
- Roehampton University (Collaboration)
- Stellenbosch University (Collaboration)
- University of the Witwatersrand (Collaboration)
- Maestral International (Collaboration)
- Ifakara Health Institute (Collaboration)
- African Institute for Mathematical Sciences (Collaboration)
- Bill & Melinda Gates Foundation (Collaboration)
- Sanofi (Collaboration)
- United States President's Emergency Plan for AIDS Relief (Collaboration)
- Chinese University of Hong Kong (Collaboration)
- World Health Organization (WHO) (Collaboration)
- University College London (Collaboration)
- Avenir Health (Collaboration)
- University of Bergen (Collaboration)
- Government of Madagascar (Collaboration)
- University of Montpellier (Collaboration)
- University of North Carolina at Chapel Hill (Collaboration)
- Center for Global Development (Collaboration)
- Ministry of Health and Social Welfare (Collaboration)
- Ministry of Health and Child Welfare of the Republic of Zimbabwe (Collaboration)
- Institute for Disease Modeling (Collaboration)
- Liverpool School of Tropical Medicine (Collaboration)
- National Centre for Infectious Diseases (Collaboration)
- Africa Health Research Institute (Collaboration)
- National Institute of Health (Collaboration)
- University of Washington (Collaboration)
- Congo National Institute of Biomedical Research (Collaboration)
- Simon Fraser University (Collaboration)
- Foreign Commonwealth and Development Office (FCDO) (Collaboration)
- Kwame Nkrumah University of Science and Technology (KNUST) (Collaboration)
- Pan American Health Organization (Collaboration)
- Technical University of Munich (Collaboration)
- Government of Brazil (Collaboration)
- University of Surrey (Collaboration)
- World Without Orphans (Collaboration)
- University of Notre Dame (Collaboration)
- National Institute for Medical Research, Tanzania (Collaboration)
- Government of Swaziland (Collaboration)
- Royal Veterinary College (RVC) (Collaboration)
- Johns Hopkins University (Collaboration)
- Pasteur Institute, Paris (Collaboration)
- National University of San Marcos (Collaboration)
- MRC/UVRI Uganda Research Unit on AIDS (Collaboration)
- New York University (Collaboration)
- Medical Research Council (MRC) (Collaboration)
- University of Zambia (Collaboration)
- The African Institute of Biomedical Science and Technology (Collaboration)
- University of Malaya (Collaboration)
- University of Copenhagen (Collaboration)
- UNIVERSITY OF THE WESTERN CAPE (Collaboration)
- United States Agency for International Development (Collaboration)
- Simprints (Collaboration)
- University of the Philippines (Collaboration)
- UNIVERSITY OF CAMBRIDGE (Collaboration)
- UNIVERSITY OF EXETER (Collaboration)
- Government of Colombia (Collaboration)
- McGill University (Collaboration)
- UNIVERSITY OF GLASGOW (Collaboration)
- UNIVERSITY OF PRETORIA (Collaboration)
- University of California, San Diego (UCSD) (Collaboration)
- Indian Ministry of Health (Collaboration)
- London School of Hygiene and Tropical Medicine (LSHTM) (Collaboration)
- FONDAZIONE BRUNO KESSLER (Collaboration)
- Johnson & Johnson (Collaboration)
- National Institutes of Health (NIH) (Collaboration)
- Stop TB Partnership (Collaboration)
- Canadian Institute for Advanced Research (CIFAR) (Collaboration)
- KING'S COLLEGE LONDON (Collaboration)
- Worldwide Antimalarial Resistance Network (Collaboration)
- Sorbonne University (Collaboration)
- Ministry of Health Malawi (Collaboration)
- University of Padova (Collaboration)
- Indian Council of Medical Research (ICMR) (Collaboration)
- International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) (Collaboration)
- Broad Institute (Collaboration)
- National Institute of Health Research (Collaboration)
- Kenyan Institute for Medical Research (KEMRI) (Collaboration)
- The Statens Serum Institute (SSI) (Collaboration)
- UNIVERSITY OF WESTMINSTER (Collaboration)
- Ministry of Health, Kenya (Collaboration)
- University of Ghent (Collaboration)
- Zambart (Collaboration)
- GlaxoSmithKline (GSK) (Collaboration)
- University of Bristol (Collaboration)
- London School of Economics and Political Science (University of London) (Collaboration)
- UNIVERSITY OF LEICESTER (Collaboration)
- Upstate Medical University (Collaboration)
- University of Virginia (UVa) (Collaboration)
- University of Gothenburg (Collaboration)
- Joint United Nations Programme on HIV/AIDS (UNAIDS) (Collaboration)
- U.S. President's Malaria Initiative (Collaboration)
- Georgetown University (Collaboration)
- Kenya National Malaria Control Programme (Collaboration)
- University of Sussex (Collaboration)
- Malawi Government (Collaboration)
- Lund University (Collaboration)
- University of Queensland (Collaboration)
- Diocese of Mutare Community Care Programme (Collaboration)
- BioFire Diagnostics, LLC (Collaboration)
- Government of South Africa (Collaboration)
- HealthMap (Collaboration)
- Center for Disease Analysis (Collaboration)
- University of Colorado Boulder (Collaboration)
- Government of the UK (Collaboration)
- The Wellcome Trust Sanger Institute (Collaboration)
- Institut Pierre Richet (IPR) (Collaboration)
- University of Geneva (Collaboration)
- University Hospital of Laval University (Collaboration)
- Cooper Smith (Collaboration)
- University of Hong Kong (Collaboration)
- Ethiopian Public Health Institute (Collaboration)
- Malaria Consortium (Collaboration)
- Getulio Vargas Foundation (Collaboration)
- Foundation for Innovative New Diagnostics (FIND) (Collaboration)
- University of Florida (Collaboration)
- Department for Education (Collaboration)
- PUBLIC HEALTH ENGLAND (Collaboration)
- United Nations (UN) (Collaboration)
- International Epidemiologic Databases to Evaluate AIDS (IeDEA) (Collaboration)
- Wellcome Trust (Collaboration)
- Pontifical Xavierian University (Collaboration)
- The Health Foundation (Collaboration)
- National Blood Service Zimbabwe (Collaboration)
- Human Sciences Research Council (HSRC) (Collaboration)
- Defence Science & Technology Laboratory (DSTL) (Collaboration)
- National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS) (Collaboration)
- Biomedical Research and Training Institute (BRTI) (Collaboration)
- National Institute of Health, Pakistan (Collaboration)
- University of Bern (Collaboration)
- Antigen Discovery Inc (Collaboration)
- Chinese Center for Disease Control and Prevention (China CDC) (Collaboration)
- Erasmus University Rotterdam (Collaboration)
- MRC Dementias Platform UK (Collaboration)
- Government of the United States of America (Collaboration)
- University of Yaoundé (Collaboration)
- Wits Health Consortium (Collaboration)
- CLINTON HEALTH ACCESS INITIATIVE (Collaboration)
- Lombardy and Emilia Romagna Experimental Zootechnic Institute (IZSLER) (Collaboration)
- National Center for Scientific and Technological Research (CNRST) (Collaboration)
- Teralytics (Collaboration)
- Aix-Marseille University (Collaboration)
- French National Institute of Agricultural Research (Collaboration)
- Janssen Pharmaceutica NV (Collaboration)
- U.S. Department of Agriculture USDA (Collaboration)
- Ohio State University (Collaboration)
- Malawi Epidemiology & Intervention Research Unit (Collaboration)
- Global Health Asia Institute (Collaboration)
- University of Grenoble (Collaboration)
- Cardiff University (Collaboration)
- Ministry of Health, Ethiopia (Collaboration)
- University of Helsinki (Collaboration)
- Public Health Institute of Malawi (Collaboration)
- International Vaccine Institute (IVI) (Collaboration)
- University of Cape Town (Collaboration)
- Burnt Orange Theatre Company (Collaboration)
- Universidade de São Paulo (Collaboration)
- University of Manchester (Collaboration)
- Phramongkutklao College of Medicine (Collaboration)
- Takeda Pharmaceutical Company (Collaboration)
- University of Trento (Collaboration)
- Medicines Development for Global Health (Collaboration)
- Institute for Health Metrics and Evaluation (IHME) (Collaboration)
- Imperial College School of Medicine (Collaboration)
- Colorado State University (Collaboration)
- Statistics Denmark (Collaboration)
- Fred Hutchinson Cancer Research Center (FHCRC) (Collaboration)
- Government of Mozambique (Collaboration)
People |
ORCID iD |
| Neil Ferguson (Principal Investigator) |
Publications
Vöhringer H
(2022)
Publisher Correction: Genomic reconstruction of the SARS CoV-2 epidemic in England
in Nature
Volz EM
(2020)
Identification of Hidden Population Structure in Time-Scaled Phylogenies.
in Systematic biology
Volz EM
(2018)
Molecular Epidemiology of HIV-1 Subtype B Reveals Heterogeneous Transmission Risk: Implications for Intervention and Control.
in The Journal of infectious diseases
Volz EM
(2018)
Bayesian phylodynamic inference with complex models.
in PLoS computational biology
Volz E
(2021)
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
in Nature
| Title | Compiling all publicly available genotype-phenotype data on AMR |
| Description | Lecture delivered at CMO workshop 2022 |
| Type Of Art | Film/Video/Animation |
| Year Produced | 2022 |
| Impact | Received many views |
| URL | https://www.birs.ca/events/2022/5-day-workshops/22w5186/videos/watch/202211101000-Chindelevitch.html |
| Title | Interpretable machine learning methods for predicting drug resistance |
| Description | Presentation of my group's work on interpretable ML for drug resistance |
| Type Of Art | Film/Video/Animation |
| Year Produced | 2020 |
| Impact | Many views received |
| URL | https://www.birs.ca/events/2020/5-day-workshops/20w5222/videos/watch/202011121320-Chindelevitch.html |
| Title | Knowledge |
| Description | Picture of an antenna radio that has been placed in the ground in front of the fundament to a clay house in Zimbabwe. Using a disposable camera, a young man who calls himself Knowledge took the picture, which was part of a response to potential solution models for the prevention of HIV among young people in Zimbabwe. |
| Type Of Art | Image |
| Year Produced | 2021 |
| Impact | Winner of the Danish National Research Foundation's Photo Competition 2021 |
| URL | https://dg.dk/en/the-picture-of-a-radio-photographed-with-a-disposable-camera-wins-1st-prize-in-the-... |
| Description | The COVID-19 Response Team at Imperial College London have been at the forefront globally in providing analytical capacity and modelling to support government responses to the COVID-19 pandemic worldwide. During the first quarter of 2020 the team provided regular epidemiological and modelling updates to UK government via its scientific committee SAGE, including key evidence in March 2020 demonstrating the need to move to a suppression strategy to avoid the NHS becoming overwhelmed that led to the first UK national lockdown. Weekly estimates of the reproduction number R, the epidemic growth rate and medium-term projections have been used to support UK government and NHS planning. Analysis of the novel variant in December 2020 demonstrated its increased transmissibility leading directly to the tightening of restrictions. Internationally, the team's work has supported WHO policy development and other country responses to the pandemic. |
| First Year Of Impact | 2020 |
| Sector | Education,Healthcare,Government, Democracy and Justice |
| Impact Types | Societal,Economic,Policy & public services |
| Description | ASCEND Programme - UK AID programme funded by FCDO |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | Advice to individual governments in Africa and South East Asia on how to manage COVID-19 in the context of other disease programmes. |
| Description | Academy of Medical Science reports |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | Professor Azra Ghani led the modelling inputs for both reports. The reports were utilised across government departments for planning for healthcare in UK. |
| Description | Active case finding in South India |
| Geographic Reach | Asia |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| Impact | Modelling analysis helped local authorities in their decision making for how to implement a highly resource intensive activity (active case finding) in a more efficient way. Guidance allowed a 20% increase in numbers of x-rays being diagnosed for TB. Awaiting further data to assess further impact on patient outcomes. Update 2021: Paper under preparation |
| Description | Adoption and Impact of Non-Pharmaceutical Interventions for COVID-19 (03-03-2020). Considered at SAGE 12 on 3 March 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/891850/S0035_SAGE12_Current_Data_on_COVID-19_Interventions_Annex_1_to_Potential_impact_of_behavioural_and_social_interventions_on_an_epidemic_of_Covid19_in_the_UK.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8918... |
| Description | Advice given to UK government on Brazil variant (Nuno Faria) |
| Geographic Reach | National |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| Impact | Advice given to UK govt on potential for increased transmissibility and/or immune escape of Brazil variant. Advice given led to ban on all flights from South America and Portugal and led to the introduction of mandatory hotel quarantine upon arrival in the UK. Widely discussed in media - policy change had a considerable impact on the UK aerospace industry and has been an effective measure to control the spread of COVID-19 in the UK. |
| Description | Advice given to WHO and Public Health England on P1 variant lineage (Nuno Faria) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| Impact | Presented evidence to WHO and advice given to Public Health England on P1 variant and how guidelines should be amended to adapt COVID-19 response to changing variants. Advice given and awareness raised will lead to a decrease in COVID-19 transmission globally and will contribute to decreasing case and death rates, and increased control measures within the UK to ensure the success of COVID-19 restrictions |
| Description | Advise to Chinese government to set up national procurement |
| Geographic Reach | Asia |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Centralized national procurement process for pharmaceuticals was established in China based on this advise, launched in 2018. |
| Description | Advising on global polio policy to the Global Polio Eradication Initiative |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Guidance on vaccine choice during polio eradication endgame, release of global stockpile, development of a new oral poliovirus vaccine 2009-2020 WHO SAGE polio vaccine working group 2016 onwards - participation in CRTT - modelling committee for polio eradication |
| Description | Advisory Board of Parasites & Vectors |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Shaping up the scope of the journal; engagement with contributors; advising the Editor-in-Chief |
| Description | Advisory research support to the Center for Global Development on the Return on Investment of Pandemic Preparedness |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | a report was prepared for the G20 panel, see https://pandemic-financing.org/report/foreword/ |
| URL | https://pandemic-financing.org/wp-content/uploads/2021/07/G20-HLIP-Report.pdf |
| Description | Analysis of Transmissibility Based on Genomics (15-12-2020). Considered at SAGE 74 on 22 December 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/954930/s0996-analysis-of-transmissibility-genomics.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9549... |
| Description | Areas of Intervention ('Local Lockdown') Measures to Control Outbreaks of COVID during the National Release Phase (30-07-2020). Considered at SAGE 49 on 30 July 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/909388/s0660-spi-b-areas-of-intervention-measures-outbreaks-300720-sage-49.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9093... |
| Description | Autumn and Winter 2021 to 2022 - Potential COVID-19 Epidemic Trajectories - PART 1 (13-10-2021). Considered at SAGE 96 on 14 October 2021; 2021:1-22. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1027920/S1386_SPI-M_potential_winter_trajectories_Imperial_College.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1027... |
| Description | Autumn and Winter 2021 to 2022 - Potential COVID-19 Epidemic Trajectories - PART 2 (13-10-2021). Considered at SAGE 96 on 14 October 2021; 2021:1-22. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1029646/S1391_Imperial_College_London_autumn_and_winter_2021_to_2022___potential_COVID-19_epidemic_trajectories___Part_2.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1029... |
| Description | Awarded role of Co-convenor for the National Infected Blood Enquiry (Katharina Hauck) |
| Geographic Reach | Europe |
| Policy Influence Type | Contribution to a national consultation/review |
| Description | Bogota Secretary of Health Mathematical Modelling Course Delivery |
| Geographic Reach | South America |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Guideline Title | 2018 BASHH UK national guideline for the management of infection with Mycoplasma genitalium |
| Description | British Association for Sexual Health and HIV guidelines on public health management of Mycoplasma genitalium and antimicrobial resistance |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| URL | https://www.bashh.org/news/news/bashh-launches-new-nice-accredited-guidelines-to-help-prevent-mycopl... |
| Description | CAB-LA mathematical modelling working group |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | COVID-19 variants advisory board with Moderna |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Providing epidemiological background on variants of concern which supports Moderna's strategy for vaccine development for COVID-19 |
| Description | Chair of Oriole Global Health Limited |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Chair of OGH Limited which is helping UK Aid and DFID deliver the ASCEND project for the control of NTDs in resource poor settings. |
| URL | https://orioleglobalhealth.com |
| Description | Chair of UNAIDs reference group on estimates modelling projections |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Improvements to global data on HIV/AIDs which are used for advocacy for resources for HIV treatments an interventions to monitor progress and accountability toward global HIV strategies. Data used to allocate budgets by national govts, PEPFAR and Global Fund |
| Description | Chair of the COVID-19 modelling guidance group for the Global Fund (Tim Hallett) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Led analytical work of the Global Fund to quantify the impact that COVID-19 has had on the portfolio of countries in 2020 and the following 2 years Analytical work has contributed to acute awareness of potential impact of COVID-19 on other disease (HIV, TB, Malaria) and a recognition of how the impact would extend to post pandemic years. |
| Description | Citation in Blackett review |
| Geographic Reach | National |
| Policy Influence Type | Citation in other policy documents |
| URL | https://www.gov.uk/government/publications/computational-modelling-blackett-review |
| Description | Citation in GAVI decision to support HBV birth dose |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| URL | https://www.gavi.org/our-alliance/strategy/vaccine-investment-strategy |
| Description | Citation in SAGE document (NERVTAG) 27 Jan 2021 |
| Geographic Reach | National |
| Policy Influence Type | Citation in other policy documents |
| Impact | There is currently insufficient evidence to assess whether variant P.1 is associated with any change in disease severity, but the information provided in this document has been used to guide policy and decision-making for international leaders. |
| URL | https://www.bbc.co.uk/news/uk-politics-55655388 |
| Description | Citation in WHO Policy Document - COVID-19 variants |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| URL | https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---23-march-2021 |
| Description | Citation in WHO consolidated guidelines in HIV testing |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Impact | Modelling expertise has contributed to guideline development and publication in WHO guidelines and policy briefs. Guidelines have led to changes in services - diagnosis of HIV. Presentations on work have been given to multiple countries (Cameroon, Kenya and Malawi) https://www.who.int/publications/i/item/978-92-4-155058-1 https://www.who.int/publications/i/item/WHO-CDS-HIV-19.31 https://www.who.int/publications/i/item/WHO-CDS-HIV-19.34 |
| URL | https://www.who.int/publications/i/item/978-92-4-155058-1 |
| Description | Citation in WHO policy document 'Considerations for implementing and adjusting public health and social measures in the context of COVID-19: interim guidance, 4 November 2020' |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Impact | Citation in WHO policy document. Implementation of guidance has resulted in decisions made at country levels to assist in response to COVID-19 pandemic - actions taken by countries include implementation of non-pharmaceutical interventions |
| URL | https://apps.who.int/iris/handle/10665/336374 |
| Description | Citation in WHO report: Genomic sequencing of SARS-CoV-2 (Erik Volz) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Impact | Has impacted the ways in which nations are responding to COVID-19 (setting up of surveillance systems) |
| URL | https://apps.who.int/iris/bitstream/handle/10665/338480/9789240018440-eng.pdf |
| Description | Citation in WHO weekly epidemiological records |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| URL | https://www.who.int/publications/i/item/WER9647 |
| Description | Citation in recommendations to African Union Member States on the epidemic modelling of the COVID-19 pandemic |
| Geographic Reach | Africa |
| Policy Influence Type | Citation in other policy documents |
| URL | https://africacdc.org/download/statement-of-guidance-and-recommendations-to-african-union-member-sta... |
| Description | Citation of and use of R Package EpiEstim by multiple governments to support tracking of COVID-19 pandemic and support decision making |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Impact | Improved hospital management during COVID-19 pandemic (assisted in management of human resources) |
| Description | Co-wrote a WHO protocol for assessing non-inferiority of bednets and indoor residual sprays |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Impact | We have devised a protocol to enable novel vector control products that are part of an existing intervention class to be recommended by the WHO (and therefore purchased by the Global Fund) without the need to go through expensive randomised control trials. Update 2020 - The policy was refined and accepted by the Malaria Programme Advisory Comittee at the WHO. New bednets are currently being distributed across Africa which are predicted to have a significant public health benefit to the people using them. |
| Description | Coalition for Epidemic Preparedness |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Creation of vaccines for COVID-19 and Ebola |
| Description | Collaboration with WHO Global Malaria Programme |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Impact | This publication was cited in new policy guidance for the use of current rapid diagnostic tests for malaria, including guidance on when to switch test type if resistance mutations are present. |
| URL | https://www.who.int/malaria/mpac/en/ |
| Description | Commonwealth Heads of Government Malaria Committment |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| URL | https://www.malariasummit.com/ |
| Description | Comparison of different brands of bed nets |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Determine methods to ensure that bed nets procured by governments and charitable organisations are of an efficient standard |
| Description | Confidential report to Ministry of Health Singapore regarding number if imported cases from China |
| Geographic Reach | Asia |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| Impact | Estimates produced were used to support COVID-19 response in Singapore and used to evaluate the decision to impose travel restrictions in Singapore. |
| Description | Confidential reports to Ministry of Health and National Institutes of Health Italy |
| Geographic Reach | Europe |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| Impact | Confidential advice given to Italian Ministry of Health and Italian National Institute of Health which has led to implementation of non-pharmaceutical interventions and closure of schools and businesses |
| Description | Confidential reports to support COVID-19 response in Philippines |
| Geographic Reach | Asia |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| Impact | Contribution to tracking of reproductive number of COVID-19 in the Philippines |
| Description | Consensus Statement on COVID-19 (02-06-2021). Considered at SAGE 91 on 3 June 2021; 2021:1-12. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/993321/S1267_SPI-M-O_Consensus_Statement.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9933... |
| Description | Consensus Statement on COVID-19 (03-02-2021). Considered at SAGE 79 on 4 February 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/962824/s1073-spi-m-o-consensus-statement-030221.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9628... |
| Description | Consensus Statement on COVID-19 (03-06-2020). Considered at SAGE 40 on 4 June 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/897526/S0471_SAGE_40_200603_SPI-M-O_Consensus_Statement.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8975... |
| Description | Consensus Statement on COVID-19 (08-09-2021). Considered at SAGE 95 on 9 September 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1017129/S1376_SPI-M-O_Consensus_Statement.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1017... |
| Description | Consensus Statement on COVID-19 (10-02-2021). Considered at SAGE 80 on 4 February 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/963368/S1096_SPI-M-O_Consensus_Statement_on_COVID-19.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9633... |
| Description | Consensus Statement on COVID-19 (19-05-2021). Considered by CSA and DCMO on 20 May 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/993315/S1248_SPI-M-O_Consensus_Statement.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9933... |
| Description | Consensus Statement on COVID-19 (21-04-2021). Considered at SAGE 87 on 22 April 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/984091/S1205_SPI-M-O_Consensus_Statement.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9840... |
| Description | Consensus Statement on COVID-19 (22-12-2021). Considered at SAGE 101 on 23 December 2021; 2021:1-8. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1053755/SAGE101_S1460_SPI-M_O_consensus_statement.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1053... |
| Description | Consensus Statement on COVID-19 (24-03-2021). Considered at SAGE 84 on 25 March 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/976328/S1164_SPI-M-O_Consensus_Statement.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9763... |
| Description | Consensus Statement on COVID-19 (30-06-2021). Considered by CSA and CMO on 1 July 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1000410/S1298_SPI-M-O_Consensus_Statement.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1000... |
| Description | Consensus Statment - Housing, Household Transmission and Ethnicity: For SAGE Meeting (26-11-2020). Considered at SAGE 70 on 26 November 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/943178/S0923_housing_household_transmission_and_ethnicity.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9431... |
| Description | Consensus View on COVID-19 (25-03-2020). Considered at SAGE 19 on 26 March 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/887470/26-spi-m-o-working-group-scenario-planning-consensus-view-25032020.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8874... |
| Description | Consensus View on Potential Relaxing of Social Distancing Measures (04-05-2020). Considered at SAGE 33 on 5 May 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/888759/S0313_SAGE33_Consensus_for_SPI-M_on_transition_strategies.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8887... |
| Description | Consensus View on the Potential Relaxing of Social Distancing Measures (04-05-2020). Considered at SAGE 33 on 5 May 2020; 2020:1-4. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/888759/S0313_SAGE33_Consensus_for_SPI-M_on_transition_strategies.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8887... |
| Description | Consensus View: 13th April Review of Social Distancing Measures (01-04-2020). Considered at SAGE 22 on 2 April 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/888761/S0406_SAGE22_200401_SPI-M_consensus_view_on_social_distancing_options_for_SAGE.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8887... |
| Description | Considerations for Potential Impact of Plan B Measures (13-10-2021). Considered at SAGE 96 on 14 October 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1027586/S1393_SPI-B_SPI-M_EMG_Considerations_for_potential_impact_of_Plan_B_measures_13_October_2021.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1027... |
| Description | Consultation on Zimbabwe COVID-19 response |
| Geographic Reach | Africa |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | Modelling support to Zimbabwe Ministry of Health led to implementation on national lockdown and introduction of non pharmaceutical interventions to reduce the transmission of COVID-19 in Zimbabwe |
| Description | Contribution to Kenya's National Strategic Plan for TB control |
| Geographic Reach | National |
| Policy Influence Type | Citation in other policy documents |
| Description | Contribution to UNAIDs guidelines on HIV prevention cascades |
| Geographic Reach | Africa |
| Policy Influence Type | Citation in other policy documents |
| Impact | Not yet recognised but will provide a framework for improved implementation of HIV prevention methods |
| URL | https://www.unaids.org/sites/default/files/media_asset/JC3038_creating-hiv-prevention-cascades_en.pd... |
| Guideline Title | HBV prevention of mother-child transmission |
| Description | Contribution to and citation in WHO guideline for HBV prevention of mother-child transmission |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Description | Coronavirus Disease 2019 (COVID19) Intervention Strategies (16-03-2020). Considered at SAGE 16 on 16 March 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/893632/S0103_SAGE22_20200401_Imperial_Effect_of_Relaxing_Current_Measures.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8936... |
| Description | Current Research in Parasitology and Vector borne diseases |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Published peer reviewed journal contributes to the advancement of scientific knowledge |
| Description | Delta (B.1.617.2) Transmission in England - Risk Factors and Transmission Advantage (01-06-2021). Considered at SAGE 91 on 3 June 2021; 2021:1-14. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/993159/S1270_IMPERIAL_B.1.617.2.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9931... |
| Description | Design and teaching on Global Master in Public Health |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Impact | The Global Master in Public Health attracts postgraduate students across from health care, public and private health organization, etc. I have led the design and taught with fellow academics the policy impact evaluation modules of the master program. In doing so, the knowledge and skills of the students, mostly from the active workforce, will have improved, i.e. an impact is knowledge transfer. |
| URL | https://www.coursera.org/degrees/global-mph-imperial |
| Description | Directing London Centre for NTD research - Helping deliver impact in the control of infectious diseases in resource poor settings |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | Creation of an evidence base of how best to control NTDs. Influence on WHO guidelines for disease control and funding by philanthropic organisations, (GATES and CIFF). Guidelines hope to improve health in resource poor settings. |
| URL | https://www.lshtm.ac.uk/newsevents/news/2013/ntd_research_launch.html |
| Description | EU policy on banning trade in vector species infected with Batrachochytrium salamandrivorans fungus |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in other policy documents |
| Impact | Biosecurity-relevant policy on banning the import of vector species with a view to stopping the introduction of Batrachochytrium salamandrivorans into the EU |
| URL | https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32018D0320&from=EN |
| Description | Effect of Relaxing Current Measures (02-04-2020). Considered at SAGE 22 on 2 April 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/893632/S0103_SAGE22_20200401_Imperial_Effect_of_Relaxing_Current_Measures.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8936... |
| Description | Elimination Scenario Planning Exercise with Senegal & The Gambia |
| Geographic Reach | Africa |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| Impact | Supported by The Global Fund, in 2016-2017 we undertook three workshops to support malaria country programme planning with The Gambia and Senegal. The last of these, in March 2017, was a joint workshop between the two programmes in which we coordinated discussions surrounding cross-border collaboration between the two countries. Our role in supporting the establishment of this new collaboration was acknowledged at the Malaria Summit held ahead of the Commonwealth Heads of Government meeting by the President of The Gambia (see URL below - we are mentioned in the film). A formal collaboration between the two countries was signed in January 2019. |
| URL | https://www.malariasummit.com/ |
| Description | Epidemics Analysis, Modelling and Response Short Course, Bogota, 11-15 December 2017 |
| Geographic Reach | South America |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Impact | This short course has been the first of a series of capacity building activities in Latin America about mathematical modelling for infectious disease analysis. The course was done in collaboration between Imperial College London, R Epidemics Consortium and Universidad Nacional de Colombia. The course received abot 620 applications from which we selected 45 participants. The course provided capacity building and skills improvement for analysing data of infectious diseases. |
| URL | https://epicoursebogota.netlify.app/ |
| Description | Epidemiology Modelling Review Group: Consensus Statement on COVID-19 (01-09-2021). Considered at SAGE 95 on 9 September 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1017244/S1361_EMRG_Consensus_Statement.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1017... |
| Description | Evaluating England's Roadmap out of Lockdown (18-02-2021). Considered at SAGE 81 on 18 February 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/963440/S1129__Unlocking__Roadmap_Scenarios_for_England_.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9634... |
| Description | Evaluating England's Roadmap out of Lockdown (30-03-2021). Considered at SAGE 85 on 31 March 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1000511/S1183_SPI-M_Imperial.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1000... |
| Description | Evaluating the Roadmap out of Lockdown - Modelling Step 4 of the Roadmap in the Context of B.1.617.2 (Delta) (09-06-2021). Considered at SAGE 92 on 9 June 2021; 2021:1-41. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/993427/S1289_Imperial_Roadmap_Step_4.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9934... |
| Description | Evaluating the Roadmap out of Lockdown for England: Modelling the Delayed Step 4 of the Roadmap in the Context of the Delta Variant (07-07-2021). Considered at SAGE 93 on 7 July 2021; 2021:1-33. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1001177/S1303_Imperial_College_London_Evaluating_the_Roadmap_out_of_Lockdown_for_England_modelling_the_delayed_step_4.2_of_the_roadmap_in_the_context_of_the_Delta_variant__7_July_2021__1_.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1001... |
| Description | Evaluating the Roadmap out of Lockdown: Step 3 (05-05-2021). Considered at SAGE 88 on 5 May 2021; 2021:1-27. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/984688/S1228_Imperial_Evaluating_the_Roadmap_out_of_Lockdown_Step_3.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9846... |
| Description | Evidence to UK government to support COVID-19 response (genomics) |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | Senior advisory group at MRC-GIDA have presented to UK government on multiple occasions to assist COVID-19 efforts nationally. Evidence provided has included: Modelling of worst case scenarios (led to introduction of national NPIs and lockdown measures) Assessed the effectiveness of COVID-19 interventions internationally Assessed the international research evidence Report submitted: https://www.cogconsortium.uk/wp-content/uploads/2020/05/16th-April-2020-Report-Covid-19-Genomics-Consortium-UK-COG-UK.pdf https://www.cogconsortium.uk/wp-content/uploads/2020/07/25th-June-2020-Report-COVID-19-Genomics-UK-COG-UK-Consortium.pdf |
| Description | Evidence to UK government to support Covid-19 response (epidemiology and modelling): UK response December 2020 - Phylodynamic analysis of new variants |
| Geographic Reach | National |
| Policy Influence Type | Citation in other policy documents |
| Impact | Towards the end of 2020 rapid research was undertaken to evaluate the significance of a new variant of SARS-Cov-2 that had emerged in the UK, with phylodynamic analysis coupled with epidemiological analysis demonstrating significantly increased transmissibility of the new variant of concern. Submitted for publication: Volz et al. (2021) Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data. medRxiv https://doi.org/10.1101/2020.12.30.20249034. In December 2020, phylodynamic analysis provided the first estimates of increased transmissibility of the new Variant of Concern 202012/01 (VOC) of up to 70%, the figure cited by the Prime Minister in his statement on 19th December that led to the decision to put more regions of the UK into Tier 4 restriction and eventually the 3rd UK national lockdown in January 2021. |
| URL | https://www.gov.uk/government/speeches/prime-ministers-statement-on-coronavirus-covid-19-19-december... |
| Description | Evidence to UK government to support Covid-19 response: AMS Report - RWC projections (UK response May - December 2020) |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | The Imperial team have developed Reasonable Worst-Case (RWC) outputs for an independent report commissioned by the Chief Scientific Advisor and produced by the Academy of Medical Sciences, highlighting the need to prepare for a challenging winter period. |
| URL | https://acmedsci.ac.uk/more/news/prepare-now-for-a-winter-covid-19-peak-warns-academy-of-medical-sci... |
| Description | Evidence to UK government to support Covid-19 response: Reasonable worst case (RWC) projections (UK response May - December 2020) |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | The Imperial team have provided medium-term projections of the UK COVID-19 epidemic released by UK government and to support government departments in the form of "Reasonable Worst-Case (RWC)" projections. |
| URL | https://www.gov.uk/government/publications/spi-m-o-covid-19-preparatory-analysis-long-term-scenarios... |
| Description | Evidence to UK government to support Covid-19 response: Report 9 (UK early response Jan-Apr 2020) |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | Whilst multiple UK teams contributed to the modelling evidence underpinning the UK lockdown that occurred in March 2020, "Report 9" [Ferguson NM et al. (2020) Report 9 - Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. https://doi.org/10.25561/77482] was one of the most globally influential with the highest ever global score for impact in the Altmetric database (63,840 mentions as of January 1st 2021). The policy report summarised scenarios for NPIs developed in close collaboration with SAGE and the Government Office for Science - including case isolation in the home, household quarantine, isolation of the elderly and closure of schools and universities. The results demonstrated that mitigation (slowing but not interrupting epidemic spread) would result in the UK health service being over-whelmed and that to suppress transmission would require social distancing to be implemented across the population alongside isolation of cases and household quarantine. Results contained in this report were shared with SAGE, the CSA, CMO, the NHS executive and Downing Street in the days preceding the first announcement from the UK government of a move to a suppression strategy on 16 March 2020 [D] that subsequently led to the first UK lockdown on 23 March 2020. The widespread global media coverage of Report 9 generated considerable global impact as evidenced by a drop in mobility from 17th March determined using Google mobility data (https://www.google.com/covid19/mobility/). |
| URL | http://www.gov.uk/government/collections/scientific-evidence-supporting-the-government-response-to-c... |
| Description | Evidence to UK government to support Covid-19 response: Report 9 - SAGE Meeting 16 (1) (UK early response Jan-Apr 2020) |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | "Report 9" [Ferguson NM et al. (2020) Report 9 - Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. https://doi.org/10.25561/77482]. Results contained in this report were shared with SAGE, the CSA, CMO, the NHS executive and Downing Street in the days preceding the first announcement from the UK government of a move to a suppression strategy on 16 March 2020 [D] that subsequently led to the first UK lockdown on 23 March 2020. Key government and SAGE documents informing the move to a suppression strategy, including Meeting 16, 16th March 2020. |
| URL | https://www.gov.uk/government/publications/impact-of-non-pharmaceutical-interventions-npis-to-reduce... |
| Description | Evidence to UK government to support Covid-19 response: Report 9 - SAGE Meeting 16 (2) (UK early response Jan-Apr 2020) |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | "Report 9" [Ferguson NM et al. (2020) Report 9 - Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. https://doi.org/10.25561/77482]. Results contained in this report were shared with SAGE, the CSA, CMO, the NHS executive and Downing Street in the days preceding the first announcement from the UK government of a move to a suppression strategy on 16 March 2020 [D] that subsequently led to the first UK lockdown on 23 March 2020. Key government and SAGE documents informing the move to a suppression strategy, including Meeting 16, 16th March 2020. |
| URL | https://www.gov.uk/government/publications/coronavirus-disease-2019-covid19-intervention-strategies |
| Description | Evidence to UK government to support Covid-19 response: Report 9 - SAGE Meeting 17 (UK early response Jan-Apr 2020) |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | "Report 9" [Ferguson NM et al. (2020) Report 9 - Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. https://doi.org/10.25561/77482]. Results contained in this report were shared with SAGE, the CSA, CMO, the NHS executive and Downing Street in the days preceding the first announcement from the UK government of a move to a suppression strategy on 16 March 2020 [D] that subsequently led to the first UK lockdown on 23 March 2020. Key government and SAGE documents informing the move to a suppression strategy, including Meeting 17, 18th March 2020. |
| URL | https://www.gov.uk/government/publications/timing-of-the-introduction-of-school-closure-for-covid-19... |
| Description | Evidence to UK government to support Covid-19 response: SAGE Meeting 10 (UK early response Jan-April 2020). |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | During February 2020, several Imperial College COVID-19 reports submitted to SAGE (meetings 9, 10, 12 and 13 directly informed SAGE advice to government. These include evidence of the potential impact of a range of NPIs - including banning of large gatherings, school closures and isolation of the elderly. |
| URL | https://www.gov.uk/government/publications/potential-effect-of-non-pharmaceutical-interventions-on-a... |
| Description | Evidence to UK government to support Covid-19 response: SAGE Meeting 12 (UK early response Jan-April 2020). |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | During February 2020, several Imperial College COVID-19 reports submitted to SAGE (meetings 9, 10, 12 and 13 directly informed SAGE advice to government. These include evidence of the potential impact of a range of NPIs - including banning of large gatherings, school closures and isolation of the elderly. |
| URL | https://www.gov.uk/government/publications/adoption-and-impact-of-non-pharmaceutical-interventions-f... |
| Description | Evidence to UK government to support Covid-19 response: SAGE Meeting 13 (UK early response Jan-April 2020). |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | During February 2020, several Imperial College COVID-19 reports submitted to SAGE (meetings 9, 10, 12 and 13 directly informed SAGE advice to government. These include evidence of the potential impact of a range of NPIs - including banning of large gatherings, school closures and isolation of the elderly. |
| URL | https://www.gov.uk/government/publications/timing-local-triggering-of-non-pharmaceutical-interventio... |
| Description | Evidence to UK government to support Covid-19 response: SAGE Meeting 9 (UK early response Jan-April 2020). |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | During February 2020, several Imperial College COVID-19 reports submitted to SAGE (meetings 9, 10, 12 and 13 directly informed SAGE advice to government. These include evidence of the potential impact of a range of NPIs - including banning of large gatherings, school closures and isolation of the elderly. |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8917... |
| Description | Evidence to UK government to support Covid-19 response: Summary of scientific evidence supporting the UK government response (UK early response Jan-April 2020). |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | Imperial College research on the epidemiology of SARS-CoV-2 and modelling of potential mitigation options in a UK context formed a central piece of evidence underpinning the UK government response during the first 4 months of the pandemic. The Imperial team was cited in a summary of scientific evidence supporting the response to coronavirus published on 26th June 2020 which includes a unique section on "Imperial College Reports" [https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/covid-19-reports/] including the first 8 online reports (including estimates of the early-scale of the potential scale of the epidemic in Wuhan, and the first estimates of transmissibility and severity) and reference [Verity R et al. (2020) Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 20(6):669-677. doi: 10.1016/S1473-3099(20)30243-7] which provided the most robust estimates of the infection fatality ratio (IFR). These latter estimates were critical during the early stages of the response in determining, alongside estimates of the reproduction number made in earlier reports, the potential magnitude of an unmitigated epidemic (~500,000 deaths) and therefore the need to act to contain transmission of the virus. |
| URL | http://www.gov.uk/government/collections/scientific-evidence-supporting-the-government-response-to-c... |
| Description | Evidence to UK government to support Covid-19 response: UK Government Consensus Statement on Mass Testing (UK response May - December 2020) |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | As testing capacity increased in the UK and NHS Test and Trace was established, Imperial research [Grassly NC, Pons-Salort M, Parker EPK et al. (2020) Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study. Lancet Infect Dis. 2020 20(12):1381-1389. doi: 10.1016/S1473-3099(20)30630-7] directly informed the policy and UK Government Consensus Statement on Mass Testing. |
| URL | https://www.gov.uk/government/publications/tfms-consensus-statement-on-mass-testing-27-august-2020 |
| Description | Evidence to UK government to support Covid-19 response: UK Government Coronavirus Action Plan (UK early response Jan-April 2020). |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | Imperial College research on the epidemiology of SARS-CoV-2 and modelling of potential mitigation options in a UK context formed a central piece of evidence underpinning the UK government response during the first 4 months of the pandemic. The Imperial team was cited in the UK Government Coronavirus Action Plan published on 3 March 2020. |
| URL | http://www.gov.uk/government/publications/coronavirus-action-plan; |
| Description | Evidence to UK government to support Covid-19 response: Weekly R estimates to SPI-M-O (UK response May - December 2020) |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | From May 2020 onwards, the UK government, via SAGE, has published weekly estimates of the reproduction number, R, and associated growth rates [ https://www.gov.uk/guidance/the-r-number-in-the-uk], of which the Imperial team is one of four contributing modelling groups. These estimates, provided as part of a SPI-M-O "consensus statement", are shared across government departments, the NHS and local resilience forums and are used widely for planning purposes and to support local and national responses, thereby directly impacting the course of the UK epidemic. |
| URL | https://www.gov.uk/government/publications/scientific-advisory-group-for-emergencies-sage-coronaviru... |
| Description | FDA approval of moxidectin to treat human onchocerciasis |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | Work is ongoing to allow moxidectin to be rolled out as a mass drug administration strategy in Africa |
| Description | GAVI Vaccine Investment Strategy |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Membership of the GAVI Vaccine Investment Strategy Committee which provided the scientific input for the recommendation of new vaccines to be supported by GAVI in the upcoming replenishment. This has a direct impact on worldwide childhood vaccination strategies. |
| URL | https://www.gavi.org/about/strategy/vaccine-investment-strategy/ |
| Description | Growth, population distribution and immune escape of Omicron in England, 15 December 2021 |
| Geographic Reach | National |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Part of the data that is considered by the UK govt when making decisions in response to the rise of new variants and the impacts this will have on public well being |
| URL | https://www.gov.uk/government/publications/imperial-college-london-report-49-growth-population-distr... |
| Description | HPCs-UNAIDS |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Contribution to a national consultation/review |
| Description | HPCs-Zimbabwe |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Description | Health system strategic plan in Malawi |
| Geographic Reach | Africa |
| Policy Influence Type | Membership of a guideline committee |
| Description | How Do Contact Patterns Affect VOC Transmission Advantage? (14-01-2021). Available at SAGE 76 on 14 January 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1067152/S1036_Imperial_-_B117_-_NPIs_and_transmission_advantage__1_.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1067... |
| Description | Impact of Non-Pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand (03-03-2020). Considered at SAGE 12 on 3 March 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/891862/S0057_SAGE16_Imperial_Impact_of_NPIs_to_reduce_Mortality_and_Healthcare_Demand.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8918... |
| Description | Impact of Non-Pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand (16-03-2020). Considered at SAGE 16 on 16 March 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/891862/S0057_SAGE16_Imperial_Impact_of_NPIs_to_reduce_Mortality_and_Healthcare_Demand.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8918... |
| Description | Informing strategic priorities for TB elimination in Mumbai, India |
| Geographic Reach | Local/Municipal/Regional |
| Policy Influence Type | Citation in other policy documents |
| Description | Insights from Early Vaccination Modelling (09-12-2020). Considered at SAGE 72 on 10 December 2020; 2020:1-8. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/954908/s0959-spi-m-o-early-insights-vaccines.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9549... |
| Description | Interagency Liaison Group on Biodiversity and Health |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| URL | https://www.cbd.int/health/ilg-health/ |
| Description | Internaional Response: Country level support |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | The team directly supported control efforts in 10 countries (Columbia, India, Indonesia, Italy, Malawi, Nigeria, Senegal, Sudan, the United States and Zimbabwe) providing local model reports through academic and public health partners to support government responses. Example: Announcement by New York Governor's Office of Research Partnership with Imperial College London. |
| URL | https://www.governor.ny.gov/news/amid-ongoing-covid-19-pandemic-governor-cuomo-announces-state-bring... |
| Description | International Course - Outbreak Analysis and Modelling for Public Health June 2019 |
| Geographic Reach | South America |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Impact | This was the second version of a course on mathematical modelling applied to infectious diseases in Latin America. The course reached 498 person interested from wich we selected 45 participants from 4 countries in Latin America: Colombia, Panamá, Peru, and Venezuela. The course was co-organised by Imperial College London, R Epidemics Consortium, Universidad Javeriana and National Institute of Health in Colombia. The course provided capacity building and skills improvement for analysing data of infectious diseases. |
| URL | https://www.ins.gov.co/modelamiento/modelamiento.html |
| Description | International response: Vaccine modelling |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Impact | The team has developed models to explore the impact of vaccination in the UK and globally, demonstrating that even partially effective vaccines can have a significant public health impact and that global allocation of limited vaccine supply according to population size is near-optimal to equitably reduce the impact of the pandemic. Research has contributed to the WHO SAGE Roadmap for Prioritizing Uses of COVID-19 vaccines in the context of limited supply. Submitted for publication: Hogan et al. (2020) Report 33 - Modelling the allocation and impact of a COVID-19 vaccine. doi: https://doi.org/10.25561/82822 [https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-33-vaccine/]. |
| URL | https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-33-vaccine/ |
| Description | Intervention Options and Testing Needs for Long-Term Suppression of COVID-19 Transmission (28-04-2020). |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1067140/S0249_Imperial_Exit_strategies_incl_age.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1067... |
| Description | Investigation of Novel SARS-COV-2 Variant Variant of Concern 202012/01. Available at SAGE 74 on 22 December 2020; 2020:1-11. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/959438/Technical_Briefing_VOC_SH_NJL2_SH2.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9594... |
| Description | Invited participation in European Commission & Joint Research Centre teleconferences |
| Geographic Reach | Europe |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Local Interventions and Spatial Scales. Considered at SAGE 50 on 6 August 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/926927/S0677_SPI-M-O_Local_interventions_and_spatial_scales.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9269... |
| Description | Long Term Winter Scenarios Preparatory Working Analysis (31-10-2020). Available to CSA on 31 October 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/938967/201031_SPI-M_preparatory_analysis_long_term_scenarios.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9389... |
| Description | Low Critical Care Capacity and High Severity of COVID-19 Mean There Is Little Functional Difference between Successful "Flattening the Curve" and Ongoing Containment (16-03-2020). Considered at SAGE 16 on 16 March 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/891912/S0054_SAGE16_Imperial_Mitigation_Strategies.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8919... |
| Description | MRC Centre for Global Infectious Disease Analsysis. Age Dependence in Infection and Fatality Risk (11-02-2020). Available at SAGE 6 on 11 February 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1067136/S0177.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1067... |
| Description | Malaria Policy Advisory Committee |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Impact | This committee provides advice directly to the WHO Global Malaria Programme on all topics relevant to malaria control and elimination. WHO guidance has direct impact on the policies adopted by national government, which over the past year has included amendment of treatment protocols, advice on current and new prevention interventions, allocation of global donor funding and certification of malaria elimination. UPDATE 2022 - still active member of advisory committee, including work supporting recent recommendations for first malaria vaccine |
| URL | https://www.who.int/malaria/mpac/en/ |
| Description | Medium-Term Projections (01-09-2021). Considered by CSA and CMO on 2 September 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1016438/S1358_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1016... |
| Description | Medium-Term Projections (01-12-2021). Considered by dCSA on 2 December 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1039426/S1428_SPI-M-O_Medium_Term_Projections_1_.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1039... |
| Description | Medium-Term Projections (02-06-2021). Considered at SAGE 91 on 3 June 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/994670/S1268_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9946... |
| Description | Medium-Term Projections (03-03-2021). Considered by CSA and CMO on 4 March 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/970807/S1140_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9708... |
| Description | Medium-Term Projections (04-08-2021). Considered by CSA and CMO on 5 August 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1010616/S1352_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1010... |
| Description | Medium-Term Projections (05-05-2021). Considered at SAGE 88 on 5 May 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/988229/S1225_SPI-M-O_MediumTermProjections__1_.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9882... |
| Description | Medium-Term Projections (07-04-2021). Considered at SAGE 86 on 8 April 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/979869/S1188_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9798... |
| Description | Medium-Term Projections (08-09-2021). Considered at SAGE 95 on 9 September 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1017130/S1377_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1017... |
| Description | Medium-Term Projections (09-03-2022). Considered by dCSA on 10 March 2022; 2022. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1064591/SAGE105e_9_March_2022_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1064... |
| Description | Medium-Term Projections (11-08-2021). Considered by CSA and CMO on 12 August 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1012425/S1353_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1012... |
| Description | Medium-Term Projections (12-05-2021). Considered at SAGE 89 on 13 May 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/989812/S1238_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9898... |
| Description | Medium-Term Projections (14-04-2021). Considered by CSA and CMO on 15 April 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/982495/S1203_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9824... |
| Description | Medium-Term Projections (14-07-2021). Considered by CSA and CMO on 15 July 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1005158/S1320_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1005... |
| Description | Medium-Term Projections (15-09-2021). Considered by CSA and CMO on 16 September 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1022466/SAGE95b_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1022... |
| Description | Medium-Term Projections (17-03-2021). Considered by CSA and CMO on 18 March 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/977250/S1178_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9772... |
| Description | Medium-Term Projections (17-11-2021). Considered by dCSA and CMO on 18 November 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | ttps://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1035667/S1421_SPI-M-O_MediumTermProjections_SAGE.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1035... |
| Description | Medium-Term Projections (19-05-2021). Considered by CSA and CMO on 20 May 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/991211/S1249_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9912... |
| Description | Medium-Term Projections (21-04-2021). Considered at SAGE 87 on 22 April 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/984019/S1206_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9840... |
| Description | Medium-Term Projections (22-09-2021). Considered by CSA and CMO on 23 September 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1022230/SAGE95c_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1022... |
| Description | Medium-Term Projections (23-02-2022). Considered by dCSA on 25 February 2022; 2022. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1064588/SAGE105c_23_Feb_2022_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1064... |
| Description | Medium-Term Projections (23-06-2021). Considered by CSA and CMO on 23 June 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1000611/S1297_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1000... |
| Description | Medium-Term Projections (24-03-2021). Considered at SAGE 84 on 25 March 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/976329/S1165_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9763... |
| Description | Medium-Term Projections (24-11-2021). Considered by dCSA on 25 November 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1038077/S1426_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1038... |
| Description | Medium-Term Projections (25-08-2021). Considered by CSA and CMO on 26 August 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1016434/S1357_SAGE94f_SPI-M-O_MediumTermProjections__1_.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1016... |
| Description | Medium-Term Projections (26-05-2021). Considered at SAGE 90 on 27 May 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/992320/S1252_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9923... |
| Description | Medium-Term Projections (28-07-2021). Considered by CSA and CMO on 29 July 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1010603/S1346_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1010... |
| Description | Medium-Term Projections (29-09-2021). Considered by CSA and CMO on 30 September 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1025239/SAGE95d_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1025... |
| Description | Medium-Term Projections (30-06-2021). Considered by CSA and CMO on 1 July 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1000488/S1299_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1000... |
| Description | Medium-Term Projections and Model Descriptions (31-10-2020). Available evidence to SAGE; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/938965/201031_SPI-M-O_medium_term_projections_explainer.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9389... |
| Description | Member IVAG (in vitro advisory group)- NICE |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | This working group advised on development of a framework for evaluation of effectiveness of monoclonal antibody therapies. |
| Description | Member of Executive Management of Neglected Tropical Disease Modelling Consortium |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Description | Member of Global Polio Eradication Initiative (GPEI) bOPV Cessation Planning Team |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Member of Global Polio Eradication Initiative - Environmental Surveillance Implementation working group |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Member of Global Polio Eradication Initiative - Environmental Surveillance Implementation working group Contributed analysis of surveillance data Recommendations were made by the group based on results of analysis of data. Recommendations led to changes in best practice for environmental surveillance |
| Description | Member of Global Polio Eradication Initiative - nOPV2 genetic characterisation sub-group |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Member of Global Polio Eradication Initiative - nOPV2 genetic characterisation sub-group Contributed analysis of data to inform surveillance during vaccine roll out |
| Description | Member of Global Polio Eradication Initiative cessation risk task team |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Member of Global Polio Eradication Initiative cessation risk task team Contributed analysis of surveillance data Recommendations made based on results of data analysis to improve best practice of outbreak response |
| Description | Member of Influenza Incidence Analytics Group |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Member of SPI-M - Series of reports for SPI-M on vaccination roll-out and restriction lifting and their impact on COVID-19 in the UK |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Reports submitted to SPI-M were used by SAGE to support evidence-based decision making for UK government for Roadmap out of lockdown |
| URL | http://tinyurl.com/2bed8uur |
| Description | Member of Scientific Advisory Group for Emergencies (SAGE), COVID-19 |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Presented multiple reports on modelling COVID-19 to SAGE. Reports have led to implementation of social distancing, changes to NHS services and business operations nationally and have averted COVID cases and death numbers. Reports available: https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/ |
| URL | https://www.gov.uk/government/organisations/scientific-advisory-group-for-emergencies |
| Description | Member of Scientific Pandemic Influenza Group on Modelling (SPI-M), COVID-19 |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Membership of SPI-M ( Professors Peter White, Neil Ferguson, Steven Riley, Nick Grassly and Drs Samir Bhatt and Marc Baguelin) Presented multiple reports on modelling COVID-19 to SPI-M. Reports have contributed to implementation of social distancing, changes to NHS services and business operations nationally and have averted COVID cases and death numbers. Reports have aldo contributed to the planning and successful roll out of the COVID-19 vaccination programme. Reports available: https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/ |
| URL | https://www.gov.uk/government/groups/scientific-pandemic-influenza-subgroup-on-modelling |
| Description | Member of WHO Strategic and Technical Advisory Group for Tuberculosis |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Membership of guidance committee - have contributed mathematical modelling expertise Recommendations have informed WHO policy on mitigating COVID disruptions on TB and on strategies for 'building back stronger'. |
| URL | https://www.who.int/publications/m/item/report-of-the-20th-meetingwho-strategic-and-technical-adviso... |
| Description | Member of WHO committee for recommendation for screening and treatment for cervical cancer |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Involvement in WHO committee. Have informed WHO guidelines on cervical cancer screening. Publications ongoing. Update 2022: New guidelines: Publication: https://www.who.int/publications/i/item/9789240030824 |
| URL | https://www.who.int/publications/i/item/9789240014107 |
| Description | Member of WHO guideline development group |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | The results from this GDG will be completed and published later in 2023. They will form part of official WHO guidelines for the use of new diagnostic tools, and will be adopted worldwide. |
| Description | Member of WHO-SAGE COVID-19 vaccines working group |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Professor Nick Grassly is a member of the WHO SAGE COVID-19 vaccine working group. The group approves and make recommendations for COVID-19 vaccines. These recommendations are used by countries to support their immunisation policies |
| Description | Member of a guidance committee - Gavi Vaccine Investment Strategy 2023 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Member of expert group for MoD (Confidential) - ongoing as of 2021 |
| Geographic Reach | National |
| Policy Influence Type | Membership of a guideline committee |
| Description | Member of the Onchocerciasis and Lymphatic Filariasis elimination committee in Cameroon and providing advice to the PNLO (National programme for Ochocerciasis and LF control) |
| Geographic Reach | Africa |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Committee has directly advised the national programme who have made recommendations for onchocerciasis and LF control |
| Description | Member, COVID Infection Survey Advisory Board subgroup on medium-term scenarios, Office for National Statistics, 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Improving the design of ongoing surveys |
| Description | Membership of Data Debrief Group (JBC) |
| Geographic Reach | National |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Improved situational awareness for secretary of state and prime minister to assist in evidence based decision making during COVID-19 peaks. |
| Description | Membership of Pandemic Preparedness Committee of the National Science Foundation USA - Professor Sir Roy Anderson |
| Geographic Reach | North America |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Membership of committee which advises USA government on pandemic preparedness and lessons learnt from COVID-19. Advise given in confidence |
| Description | Membership of SET-C committee - guidance to Chief Scientist Officer (Professor Sir Roy Anderson) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Membership of Royal Society SET-C committee which provides advice in confidence to the Chief Scientists Office continuously throughout the COVID-19 pandemic. Professor Anderson has contributed extensively to multiple reports and has been lead author on multiple papers: 14 December 2020: SARS-CoV-2: Where do people acquire infection and 'who infects whom'? (PDF) - 30 November 2020: Appendix (PDF) 24 August 2020: Reproduction number (R) and growth rate (r) of the COVID-19 epidemic in the UK (PDF) |
| URL | https://royalsociety.org/topics-policy/projects/set-c-science-in-emergencies-tasking-covid/ |
| Description | Membership of WHO SE Asian regional green light committee for TB |
| Geographic Reach | Asia |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Membership of WHO guidance committee. Provided 11 countries of SE Asian region with technical assistance in management of drug resistant TB. Activities have already influence strategic planning for several countries within the region. |
| Description | Membership of WHO Technical Advisory Group on Health benefit packages |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Issue WHO guidance on how to design healthcare packages eg Universal Healthcare Coverage |
| Description | Membership of regional WHO advisory committee on multi-drug-resistant TB in South East Asian Region |
| Geographic Reach | Asia |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Methods development for global HIV estimates and projections |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Impact | We developed new mathematical models used to estimate and project trends in the global HIV epidemic. These models are used by all countries in sub-Saharan Africa and over 150 countries globally to develop official national estimates of their HIV epidemic and plan, budget, and allocate resources to the HIV response. Estimates are reported by UNAIDS as official global HIV estimates and projection, and they form consensus estimates underpinning resource allocation by the US President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to fight HIV, TB, and Malaria. 2021 - still ongoing |
| URL | http://aidsinfo.unaids.org |
| Description | Modelling Proposed GB Exit Strategies (05-05-2020). Available at SAGE 33 on 5 May 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1067184/S0323_SPI-M-UK_Exit_strategies.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1067... |
| Description | Modelling for estimating global burden of TB |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Contribution to new or Improved professional practice |
| Impact | This exercise represents the first time that model based approaches have been used by WHO for estimating global TB burden. The advantage of using model based approaches is that WHO can systematically take account of evidence for the degree to which TB services have been disrupted by COVID. After the first year, WHO is now arranging for this approach to become established as a formal part of their methodology. |
| Description | Modelling impact of COVID disruptions on TB |
| Geographic Reach | Asia |
| Policy Influence Type | Citation in other policy documents |
| Impact | Modelling paper was used to influence in country discussions regarding domestic financing for TB control. Contribution was especially important in the Phillipines where public finances were under severe strain and in Tajekistan where modelling shaped strategy for international donors (USAID). |
| Description | Modelling in support of the Global Plan to end TB |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Contribution to new or Improved professional practice |
| Description | Modelling to support the WHO reccommendation decision for the RTS,S malaria vaccine. |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| URL | https://www.nitag-resource.org/sites/default/files/2022-05/Full-evidence-report-on-the-rtss-as01-mal... |
| Description | NERVTAG (New and Emerging Respiratory Virus Threats Advisory Group) - Since 2015 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| URL | https://www.gov.uk/government/groups/new-and-emerging-respiratory-virus-threats-advisory-group |
| Description | NERVTAG Paper on COVID-19 Variant of Concern B.1.1.7 (21-01-2021). Considered at SAGE 77 on 21 January 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/961037/NERVTAG_note_on_B.1.1.7_severity_for_SAGE_77__1_.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9610... |
| Description | NERVTAG Update Note on B.1.1.7 Severity (11-02-2021). Considered at SAGE 80 on 11 February 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/982640/Feb_NERVTAG_update_note_on_B.1.1.7_severity.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9826... |
| Description | National Studies, Covid-19 Surveillance and Immunity Data Debrief Group |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Non-Pharmaceutical Interventions (NPIs) Table (17-09-2020). Considered at SAGE 58 on 21 September 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/925856/S0770_NPIs_table__pivot_.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9258... |
| Description | Omicron Severity and Vaccine Effectiveness (05-01-2022). Considered at SAGE 102 on 7 January 2022; 2022. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1046479/S1479_Imperial_Severity.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1046... |
| Description | Omicron severity and vaccine effectiveness, 5 January 2022 |
| Geographic Reach | National |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Part of the data that is considered by the UK govt when making decisions in response to the rise of new variants and the impacts this will have on public well being |
| URL | https://www.gov.uk/government/publications/imperial-college-london-omicron-severity-and-vaccine-effe... |
| Description | Ongoing Disease Control Priorities 4 Chapter Authorship With World Health Organization |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Pandemic influenza preparedness - advice to government |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Effective preparedness and response to pandemics, which are the highest category of risk identified on the National Risk Register of Civil Emergencies. This is an ongoing activity, supported by multiple relevant grants spanning different time-periods. Updated 2020: Involvement in coronavirus real time analysis and advice |
| Description | Participation in GONE meetings: Global Onchocerciasis Network for Elimination |
| Geographic Reach | Africa |
| Policy Influence Type | Contribution to a national consultation/review |
| URL | https://www.who.int/news-room/events/detail/2023/01/30/default-calendar/act-now-act-together.-invest... |
| Description | Participation in Global COVID steering group - GSK |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Contribution to new or Improved professional practice |
| Description | Participation in International Best Practice Advisory Group to Cabinet Office UK (Katharina Hauck) |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Involvement led to greater awareness of looking at the combined economic/health impacts of the COVID-19 pandemic to UK policy makers |
| Description | Participation in NHRDP - national health research and development programme - committee to decide on grant allocations for COVID-19 networks |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Participation in WHO consultation process for setting the 2030 Roadmap on Neglected Tropical Diseases |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Report of the consultation meeting by the WHO - Neglected Tropical Disease Modelling Consortium Report Open Letter for Gates Open Research on Onchocerciasis, Chagas Disease and Taeniasis/Cysticercosis - contribution by ICL by highlighting insights from mathematical modelling in these 3 disciplines for the achievement of the 2030 NTD goals. Will result in increases in survival. improved quality of life for patients, decrease in disease burden and infection. This modelling can be used with economic modelling to assess the cost effectiveness of the interventions modelled. |
| URL | https://www.who.int/neglected_diseases/news/WHO-launches-global-consultations-for-new-NTD-Roadmap/en... |
| Description | Participation in advisory committee - [15:20] Turner, Hugo C Wolbachia Evidence Review Group (Guideline development) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Participation in expert scientific advisory committee (New Paradigms in Vector Control) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Investment in most appropriate tools for killing mosquitoes |
| URL | http://www.ivcc.com |
| Description | Participation in the Royal Statistical society COVID-19 task force |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| URL | https://rss.org.uk/policy-campaigns/policy-groups/covid-19-task-force/ |
| Description | PhD Co-supervision |
| Geographic Reach | Local/Municipal/Regional |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Impact | Co-supervision of a PhD student. Providing inputs on a weekly basis. Inputs are reading material, help with shaping the analysis, interpretation of findings, writing up of the final results and overall progress of the PhD. The PhD focuses on HIV and economic productivity in Sub-Saharan Africa, a topic closely related to my funded research. My support helped the student to improve the output and to progress in her PhD. |
| Description | Planning Assumptions for the UK Reasonable Worst Case Scenario (25-03-2020). Considered at SAGE 19 on 26 March 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/904543/S0083_Planning_assumptions_for_the_UK_RWC_scenario.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9045... |
| Description | Planning Scenarios for the next 6 Months (25-03-2020). Considered at SAGE 19 on 26 March 2020; 2020:1-6. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/893527/S0084_SAGE19_20200325_MRC_Imperial_COVID-19_Response_Team_Planning_Scenarios.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8935... |
| Description | Planning and Reasonable Worst-Case Scenarios (20-05-2020). Considered at SAGE 38 on 21 May 202; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/926903/S0414_SPI-M-O_Planning_and_reasonable_worst-case_scenarios.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9269... |
| Description | Population wide mass testing campaign conducted in Vo, Italy |
| Geographic Reach | Europe |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| Impact | Support to population testing campaign in Vo, Italy in early stages of COVID-19 pandemic led to increased testing in the region. Early testing identified asymptomatic infection and led to a lower number of cases in the region compared to other regions in Italy. |
| Description | Post-discharge malaria chemoprevention |
| Geographic Reach | Africa |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Children under 5 years of age recovering from severe anaemia are now recommended to receive malaria chemoprevention. |
| Description | Potential Effect of Non-Pharmaceutical Interventions on a COVID-19 Epidemic (25-02-2020). Considered at SAGE 10 on 25 February 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/891785/S0025_SAGE10_Effect_of_NPIs.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8917... |
| Description | Potential Effect of School Closure on a UK COVID-19 Epidemic: Annex to SPI-M-O Consensus View (20-02-2020). Considered at SAGE 9 on 20 February 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/891780/S0019_SAGE9_Effect_of_School_Closure_Annex_to_SPIMO_Consensus_view_on_the_impact_of_mass_school_closures.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8917... |
| Description | Potential Impact of Face Covering on the Transmissibility of SARS-CoV-2 in the UK (20-04-2020). Considered at SAGE 27 on 21 April 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/893648/S0207_Imperial_face_covering_plausible.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8936... |
| Description | Potential Profile of the COVID-19 Epidemic in the UK under Different Vaccination Roll out Strategies (14-01-2021). Considered at SAGE 76 on 14 January 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/958913/S1024_SPI-M_vaccination_ask_Imperial_College.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9589... |
| Description | Presentation and participation in WHO Technical Consultation in Research priorities for the use of more highly sensitive diagnostics during pregnancy |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| URL | https://www.who.int/malaria/mpac/mpac-april2018-hi-sensitive-tests-session5.pdf?ua=1 |
| Description | Presentation to JCVI subcommittee on pneumococcal vaccination |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Production of estimates of travel data to/from China globally for Office for National Statistics and Department for International Development |
| Geographic Reach | National |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| Description | Provided evidence to government reviews on phylogenetics of COVID-19 (Erik Volz) |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | Provided evidence to govt to inform policies relating to transmission of COVID-19 in UK |
| Description | Publication 'Evolution and epidemic spread of SARS-CoV-2 in Brazil' - Citation in three WHO Policy Documents, and by The Inter-American Development Bank. |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| URL | https://science.altmetric.com/details/86328003/policy-documents |
| Description | Publication of work about Evidence Synthesis for Policy |
| Geographic Reach | National |
| Policy Influence Type | Influenced training of practitioners or researchers |
| URL | https://royalsociety.org/topics-policy/projects/evidence-synthesis/ |
| Description | Published estimates of Impact of President's Malaria Initiative used in 12th annual report to congress |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Impact | Our estimates, published in PLoS Medicine, of the impact of the PMI since it's conception were used by PMI in it's report to congress. This report is used to advocate for resources for malaria prevention across 19 focus countries, amid a time when the US' contribution to foreign aid was being questioned. |
| URL | https://www.pmi.gov/docs/default-source/default-document-library/pmi-reports/2018-pmi-twelfth-annual... |
| Description | RDTs-WHO |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | Evidence generated on the cost-effectiveness of repeat HIV testing prior to initiation on antiretroviral treatment contributed to a decision in Zimbabwe (and possibly elsewhere) to adopt a World Health Organisation recommendation to implement repeat HIV testing prior to initiating people onto antiretroviral treatment. This change in policy will reduce the numbers of HIV-negative people put on potentially life-long treatment, will reduce the occurrence of unnecessary side effects, and will reduce unnecessary expenditure. |
| Description | REACT study - national study led by Professor Steven Riley |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | REACT (REal-time Assessment of Community Transmission) is a series studies that are using home testing to improve our understanding of how the COVID-19 pandemic is progressing across England. This major research programme was commissioned by the Department of Health and Social Care (DHSC) and is being carried out by Imperial College London in partnership with Ipsos MORI and Imperial College Healthcare NHS Trust. Here's our announcement from when the study first launched in April 2020. Results from the REACT study have been reported extensively in the media and have shaped public attitudes to non-pharmaceutical interventions, whilst providing both public and government with high level estimates of community transmission. Results from REACT have been used to shape public policy decisions regarding interventions and have been used to directly inform the Secretary of State Matt Hancock: Results from the REACT study have contributed to the implementation of the 'Rule of 6' to assist with the COVI-19 response https://www.imperial.ac.uk/medicine/research-and-impact/groups/react-study/ Multiple reports have been published |
| URL | https://www.gov.uk/government/news/february-interim-findings-from-covid-19-react-1-study-published |
| Description | Raising awareness on the pros and cons of measures of epidemic spread |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| URL | https://rss.onlinelibrary.wiley.com/toc/1467985x/2022/185/S1 |
| Description | Reasonable Worst-Case Planning Scenario (29-03-2020). Considered at SAGE 21 on 31 March 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/897509/S0089_Reasonable_Worst-Case_Planning_Scenario_-_29.03.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8975... |
| Description | Recommendation of second dose of inactivated polio vaccine into routine immunisation |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Impact | Recommendations made have contributed to decision to include second dose of inactivated polio vaccine into routine immunisation Policy decision will lead to decrease number of polio cases |
| URL | https://www.who.int/immunization/sage/meetings/2020/october/SAGE_eYB_Oct2020final.pdf?ua=1 |
| Description | Report 1: Estimating the Potential Total Number of Novel Coronavirus Cases in Wuhan City, China. Available evidence to SAGE; 2020:1-5. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Imai N, Dorigatti I, Cori A, Riley S, Ferguson N. Report 1: Estimating the Potential Total Number of Novel Coronavirus Cases in Wuhan City, China. Available evidence to SAGE; 2020:1-5. doi:10.25561/77149 |
| Description | Report 2: Estimating the Potential Total Number of Novel Coronavirus s (2019-NCoV) Cases in Wuhan City, China. Available evidence to SAGE; 2020:1-7. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Imai N, Dorigatti I, Cori A, Donnelly C, Riley S, Ferguson N. Report 2: Estimating the Potential Total Number of Novel Coronavirus s (2019-NCoV) Cases in Wuhan City, China. Available evidence to SAGE; 2020:1-7. doi:10.25561/77150 |
| Description | Report 3: Transmissibility of 2019-NCoV. Available evidence to SAGE; 2020:1-6. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Imai N, Cori A, Dorigatti I, et al. Report 3: Transmissibility of 2019-NCoV. Available evidence to SAGE; 2020:1-6. doi:10.25561/77148 |
| Description | Report 4: Severity of 2019-Novel Coronavirus (NCoV). Available evidence to SAGE; 2020:1-14. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Dorigatti I, Okell L, Cori A, et al. Report 4: Severity of 2019-Novel Coronavirus (NCoV). Available evidence to SAGE; 2020:1-14. doi:10.25561/77154 |
| Description | Report 50 - Hospitalisation risk for Omicron cases in England |
| Geographic Reach | National |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Part of the data that is considered by the UK govt when making decisions in response to the rise of new variants and the impacts this will have on public well being |
| URL | https://www.gov.uk/government/publications/imperial-college-london-report-50-hospitalisation-risk-fo... |
| Description | Report 5: Phylogenetic Analysis of SARS-CoV-2. Available evidence to SAGE; 2020:1-8. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Volz E, Baguelin M, Bhatia S, et al. Report 5: Phylogenetic Analysis of SARS-CoV-2. Available evidence to SAGE; 2020:1-8. doi:10.25561/77169 |
| Description | Report 6: Relative Sensitivity of International Surveillance. Available evidence to SAGE; 2020:1-6. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Bhatia S, Imai N, Cuomo-Dannenburg G, et al. Report 6: Relative Sensitivity of International Surveillance. Available evidence to SAGE; 2020:1-6. doi:10.25561/77168 |
| Description | Report 7: Estimating Infection Prevalence in Wuhan City from Repatriation Flights. Available evidence to SAGE; 2020:1-9. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | doi:10.25561/77295 |
| Description | Report 8: Symptom Progression of COVID-19. Available evidence to SAGE; 2020:1-11. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | doi: |
| Description | Report 9: Impact of Non-Pharmaceutical Interventions (NPIs) to Reduce COVID19 Mortality and Healthcare Demand. Available evidence to SAGE; 2020:1-20. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | doi: |
| Description | Response to COVID-19 in South Korea and Implications for UK Exit Strategies (03-05-2020). Available at SAGE 33 on 5 May 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1067172/S0322_south_korea_short_report_2020_05_03.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1067... |
| Description | Return on Investment of Pandemic preparedness - contribution to report for G20 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | Report objective was to determine the societal benefits of pandemic preparedness (policy impacts confidential) There is very little quantitative evidence on the role of pandemic preparedness (P2) in reducing the health and economic losses associated with pandemics. Here, we use a previously developed epidemiological-economic model to project the deaths and short-term GDP loss associated with potential future pandemics for four countries (USA, UK, China, India) and four respiratory pathogens (COVID-like, Spanish flu-like, SARS-like and Swine flu-like). |
| URL | https://www.mef.gov.it/en/ufficio-stampa/comunicati/2021/The-G20-establishes-a-High-Level-Independen... |
| Description | SPI-M-O. Consensus Statement on COVID-19 (01-10-2020). |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://www.gov.uk/government/publications/spi-m-o-consensus-statement-on-covid-19-1-october-2020 |
| URL | https://www.gov.uk/government/publications/spi-m-o-consensus-statement-on-covid-19-1-october-2020 |
| Description | SPI-M-O. Consensus Statement on COVID-19 (10-09-2020). |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://www.gov.uk/government/publications/spi-m-o-consensus-statement-on-covid-19-10-september-2020 |
| URL | https://www.gov.uk/government/publications/spi-m-o-consensus-statement-on-covid-19-10-september-2020 |
| Description | SPI-M-O. Consensus View on the Impact of Mass School Closures (17-03-2020). Considered at SAGE 17 on 18 March 2020; 2020:1-4. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/888390/s0063-spi-m-o-consensus-view-school-closures-170320-sage17.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8883... |
| Description | SPI-M-O. Consensus View on the Impact of Mass School Closures on 2019 Novel Coronavirus (2019-NCoV) (10-02-2020). Considered at SAGE 6 on 11 February 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/888389/s0010-spi-m-o-consensus-view-school-closures-100220-sage6.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8883... |
| Description | SPI-M-O. Medium-Term Projections (19-01-2022). Considered by dCSA on 28 January 2022; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1052427/S1499_220119_SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1052... |
| Description | SPI-M-O. Medium-Term Projections (27-10-2021). Considered by dCSA on 28 October 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1031219/SPI-M-O_MediumTermProjections.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1031... |
| Description | Scientific Advisory Group for Emergencies (SAGE) - Covid-19 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Report submitted to SAGE: https://www.cogconsortium.uk/wp-content/uploads/2020/05/16th-April-2020-Report-Covid-19-Genomics-Consortium-UK-COG-UK.pdf |
| Description | Scientific Pandemic Influenza Group on Modelling (SPI-M-O) (since 2009) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| URL | https://www.gov.uk/government/publications/spi-m-publish-updated-modelling-summary |
| Description | Scientific committee for Pandemic Influenza - Modelling (SPI-M) |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Evidence given to SPI_M committee directly influenced early messaging about the severity of COVID-19. |
| URL | https://www.gov.uk/government/groups/scientific-pandemic-influenza-subgroup-on-modelling |
| Description | Seconded to the UK Health Security Agency as Director General for Data, Analytics and Surveillance |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | I have directly informed a numebr of government policies, including the respoinse to Omicron, living with COVID and others. |
| Description | Selected to participate in BBSRC pool of experts |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Sensitivity of Proposed UK Sentinel GP COVID-19 Surveillance (25-02-2020). Considered at SAGE 10 on 25 February 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/891888/S0024_SAGE10_Sensitivity_of_GP_Surveillance.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8918... |
| Description | Sensitivity of Proposed UK Sentinel ICU Pneumonia Surveillance (25-02-2020). Considered at SAGE 10 on 25th February 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/891878/S0023_SAGE10_Sensitivity_of_ICU_Surveillance.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8918... |
| Description | Short-Term Forecasting: Academic Summary Positions (02-04-2020). Considered at SAGE 22 on 2 April 2020; 2020:1. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/917022/SAGE22_20200401_Summary_of_Warwick__Imperial__LSHTM_and_PHE_Forecasting_Models_S0106.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9170... |
| Description | Short-Term Forecasting: Proposed Process for Discussion (02-04-2020). Considered at SAGE 22 on 2 April 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/916915/SAGE22_20200401_SAGE_Short-term_forecasting_-_proposed_process_for_discussion_S0104_for_release_v2.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9169... |
| Description | Short-Term Forecasting: Proposed Process for Discussion (06-04-2020). Considered at SAGE 23 on 7 April 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/916917/SAGE23_20200406_SPI-M_Short-Term_Forecasting_S0110_for_release_v2.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9169... |
| Description | Short-Term Forecasts from SPI-M-O (07-07-2020). Considered at SAGE 46 on 9 July 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/917069/SAGE46_20200708_forecasts_equal_weight_for_SAGE_S0598_for_release_v2.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9170... |
| Description | Short-Term Forecasts from SPI-M-O (08-06-2020). Considered at SAGE 41 on 11 June 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/917043/SAGE41_2b._20200609_forecasts_equal_weight_SAGE_S0516_for_release_v2.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9170... |
| Description | Short-Term Forecasts from SPI-M-O (10-05-2020). Considered at SAGE 35 on 12 May 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://www.gov.uk/government/publications/spi-m-o-covid-19-short-term-forecasts-10-may-2020 |
| URL | https://www.gov.uk/government/publications/spi-m-o-covid-19-short-term-forecasts-10-may-2020 |
| Description | Short-Term Forecasts from SPI-M-O (11-08-2020). Considered at SAGE 51 on 13 August 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/917253/SAGE51_20200811_forecast_equal_weight_for_SAGE_S0694_for_release.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9172... |
| Description | Short-Term Forecasts from SPI-M-O (16-06-2020). Considered at SAGE 42 on 18 June 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/917045/SAGE42_2b._20200616_forecasts_equal_weight_for_SAGE_S0542_for_release_v2.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9170... |
| Description | Short-Term Forecasts from SPI-M-O (17-05-2020). Considered at SAGE 37 on 19 May 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/917036/SAGE37_2a._20200518_forecasts_equal_weight_SAGE_S0408_for_release_v2.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9170... |
| Description | Short-Term Forecasts from SPI-M-O (21-07-2020). Considered at SAGE 48 on 23 July 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/917048/SAGE48_20200721_forecasts_equal_weight_for_SAGE_S0645_for_release.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9170... |
| Description | Short-Term Forecasts from SPI-M-O (24-06-2020). Considered at SAGE 44 on 25 June 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/917046/SAGE44_20200623_forecasts_equal_weight_for_SAGE_S0563_for_release_v2.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9170... |
| Description | Short-Term Forecasts from SPI-M-O (25-05-2020). Considered at SAGE 39 on 28 May 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/917040/SAGE39_2a._SPI-M_Short-term_Forecasts_20200526_S0443_for_release_v2.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9170... |
| Description | Short-Term Forecasts from SPI-M-O (30-06-2020). Considered at SAGE 45 on 2 July 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/917066/SAGE45_20200630_forecasts_equal_weight_for_SAGE_S0576_for_release_v2.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9170... |
| Description | Short-Term Forecasts from SPI-M-O - PILOT (03-05-2020). Considered at SAGE 33 on 5 May 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/917031/SAGE33_2b._20200504_forecasts_SAGE_S0311_for_release_v2.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9170... |
| Description | Short-Term Forecasts from SPI-M-O - PILOT (07-04-2020). Considered at SAGE 24 on 9 April 2020; 2020. h |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/917244/SAGE24_SPI-M_20200407_forecasts_S0119_for_release.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9172... |
| Description | Short-Term Forecasts from SPI-M-O - PILOT (12-04-2020). Considered at SAGE 25 on 14 April 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/917245/SAGE25_20200412_forecasts_S0125_for_release.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9172... |
| Description | Special Adviser to Governor of New York State Andrew Cuomo |
| Geographic Reach | North America |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Special adviser to NY state government to provide modelling and information regarding easing of control measures. Advice given has led to reduction in number of COVID cases and deaths and led to slowing of reopening of retail and hospitality sectors. Quoted in Andrew Cuomo's book 'American crisis' |
| Description | Strategic Technical Advisory Group for Infectious Hazards at WHO |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Influence on continued operational response for Ebola outbreak in DRC - has led to increased situational awareness of epidemiological trends. HAs led to improved service provision from international organisations. |
| URL | https://www.who.int/emergencies/diseases/strategic-and-technical-advisory-group-for-infectious-hazar... |
| Description | Strategies for Gradually Lifting NPIs in Parallel to COVID-19 Vaccine Roll-out in the UK (03-02-2021). Considered at SAGE 79 on 4 February 2021; 2021:1-17. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/963364/S1078_SPI-M_vaccination_ask_Imperial_College_.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9633... |
| Description | Strategies for Long-Term Management of COVID-19 Transmission (21-04-2020). Considered at SAGE 27 on 21 April 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/943099/S0211_Imperial_Strategies_for_long-term_management_of_COVID-19_transmission.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9430... |
| Description | Summary Indicative Effects of Non-Pharmaceutical Interventions (NPIs) to Reduce COVID-19 Transmission & Mortality (02-03-2020). Considered at SAGE 12 on 3 March 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/891845/S0029_NPIs_summary_Imperial_Annex_3_to_Potential_impact_of_behavioural_and_social_interventions_on_an_epidemic_of_Covid19_in_the_UK.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8918... |
| Description | Summary of Further Modelling of Easing Restrictions - Roadmap Step 2 (31-03-2021). Considered at SAGE 85 on 31 March 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/975909/S1182_SPI-M-O_Summary_of_modelling_of_easing_roadmap_step_2_restrictions.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9759... |
| Description | Summary of Further Modelling of Easing Restrictions - Roadmap Step 3 (05-05-2021). Considered at SAGE 88 on 5 May 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/984521/S1227_SPI-M-O_Summary_of_further_modelling_of_easing_restrictions_Roadmap_Step_3__2_.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9845... |
| Description | Summary of Further Modelling of Easing Restrictions - Roadmap Step 4 (07-07-2021). Considered at SAGE 93 on 7 July 2021; 2021:1-17. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1075065/S1301_SPI-M-O_Summary_Roadmap_second_Step_4.2_1_.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1075... |
| Description | Summary of Further Modelling of Easing Restrictions - Roadmap Step 4 (09-06-2020). Considered at SAGE 92 on 9 June 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://www.gov.uk/government/publications/spi-m-o-summary-of-further-modelling-of-easing-restrictions-roadmap-step-4-9-june-2021/spi-m-o-summary-of-further-modelling-of-easing-restrictions-roadmap-step-4 |
| URL | https://www.gov.uk/government/publications/spi-m-o-summary-of-further-modelling-of-easing-restrictio... |
| Description | Summary of Modelling Considerations for the Reimposition of Measures (13-10-2021). Considered at SAGE 96 on 14 October 2021; 2021:1-4. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1029670/S1389_SPI-M-O_Summary_reimposition.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1029... |
| Description | Summary of Modelling for Scenarios for COVID-19 Autumn and Winter 2021 to 2022 (13-10-2021). Considered at SAGE 96 on 14 October 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1027851/S1383_SPI-M-O_Summary_autumn_winter_scenarios.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1027... |
| Description | Summary of Modelling on Easing Restrictions (03-02-2021). Considered at SAGE 79 4 February 2021; 2021:1-5. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/963504/S1075_SPI-M-O_summary_of_modelling_on_easing_restrictions__1_.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9635... |
| Description | Summary of Modelling on Roadmap Scenarios (17-02-2021). Considered at SAGE 81 on 18 February 2021; 2021:1-13. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1075032/S1130_SPI-M-O_Summary_of_further_modelling_of_easing_restrictions__1_.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1075... |
| Description | Summary of Modelling on Scenarios for Easing Restrictions (07-02-2021). Considered at SAGE 80 on 11 February 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://www.gov.uk/government/publications/spi-m-o-summary-of-modelling-on-scenario-for-easing-restrictions-6-february-2021/spi-m-o-summary-of-modelling-on-scenario-for-easing-restrictions-7-february-2021 |
| URL | https://www.gov.uk/government/publications/spi-m-o-summary-of-modelling-on-scenario-for-easing-restr... |
| Description | Support MSF surveillance of malaria policy |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Provided evidence to allow MSF to monitor malaria severity using antinatal clinic data |
| URL | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114784 |
| Description | Support the development of guidelines for malaria surveillance in near-elimination settings. We have outlined a set of questions that should be asked to estimate whether an identified case of malaria was acquired locally or imported from abroad. These include statements on the time and location of travel, duration of stay and date of arrival of symptoms. Questions trailed in regions of South Africa. |
| Geographic Reach | Africa |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Description | TB control priorities in India |
| Geographic Reach | Asia |
| Policy Influence Type | Contribution to a national consultation/review |
| Description | Talk given to All Party PArliamentary Group on Biosecurity re COVID-19 |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| URL | https://www.parliament.uk/mps-lords-and-offices/offices/bicameral/post/post-events/future-biosecurit... |
| Description | Talk given to Zimbabwe MoH on 'Misclassification errors in routine HIV testing' |
| Geographic Reach | Africa |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | Led to changes in decisions to the national HIV testing algorithm. |
| Description | Technical advisory committee for the development of GOData2 - WHO Software for contact tracing |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Development of software used in contact tracing for various diseases including Ebola and COVID-19 |
| URL | https://www.who.int/godata |
| Description | Technical assistance to inform the COVID-19 policy response (Sri Lanka) |
| Geographic Reach | National |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| Impact | The findings contributed to Sri Lanka's decision to extend the lockdown by two further weeks |
| Description | Technical assistance to inform the second SARS-CoV-2 booster vaccination (Indonesia) |
| Geographic Reach | National |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| Impact | Informing the Ministry of Health on the value of a second booster |
| Description | Technical consultation on the use of economics in insecticide resistance management for malaria vector control |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Impact | Online tool to help national malaria control programmes to choose the most appropriate vector control tool for their setting and budget. This will lead to lives saved. |
| URL | https://www.who.int/publications/i/item/9789240042049 |
| Description | The Role of Children in Transmission (16-04-2020). Considered at SAGE 26 on 16 April 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/894616/s0141-sage-sub-group-role-children-transmission-160420-sage26.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8946... |
| Description | Timing & Local Triggering of Non-Pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demands (05-03-2020). Considered at SAGE 12 on 3 March 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/891855/S0039_SAGE13_MRC_Imperial_Timing_and_Triggering_of_NPIs.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8918... |
| Description | Timing of the Introduction of School Closure for COVID-19 Epidemic Suppression (18-03-2020). Considered at SAGE 17 on 18 March 2020; 2020. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/893515/S0067_SAGE17_20200318_Imperial_School_Closure_Timing.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/8935... |
| Description | Travel Ban to the UK from South America, Cape Verde and Portugal. |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | PI Nuno Faria presented work to the UK Government on a new variant of SARS-CoV-2 (P1) discovered in Manaus, Brazil. As a consequence of the findings, the UK Prime Minister Boris Johnson issued a travel ban from several Latin American countries, Portugal, Panama and Cape Verde. |
| URL | https://www.bbc.co.uk/news/uk-55671656#:~:text=Covid%3A%20UK's%20ban%20on%20South%20America%20and%20... |
| Description | Typhoid environmental surveillance advisory group for the Gates Foundation |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | UK Academy of Sciences |
| Geographic Reach | South America |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | UKHSA mpox technical group |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Our modelling informed situational awareness related to the mpox epidemic, providing insights into the relative effect of vaccination and behaviour change in decreasing mpox cases. |
| URL | https://www.gov.uk/government/publications/monkeypox-outbreak-technical-briefings/investigation-into... |
| Description | UNAIDS reference group |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Impact | From 2015 to 2018, I co-chaired the UNAIDS Reference Group on Estimates, Modelling and Projections. This group advises UNAIDS and WHO on the methods used to generate international estimates of HIV infection and it's demographic impact. During this period, significant progress was made in improving these estimates - for example, for children infected with HIV, by incorporating age-structure into the models, and in producing local estimates of levels of HIV infection - that can be used to strengthen national HIV control programmes and, thereby, to further reduce levels of new infections and mortality. |
| URL | http://www.epidem.org/ |
| Description | US National Academy of Science committee on pandemic preparedness |
| Geographic Reach | North America |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Decisions made regarding future pandemic responses (metrics to consider). |
| Description | Unlocking Roadmap Scenarios for England (05-02-2021). Considered at SAGE 80 on 11 February 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/963445/S1117_Unlocking_roadmap_scenarios_for_England.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9634... |
| Description | Unlocking Roadmap Scenarios for England v2 (18-02-2021). Considered at SAGE 81 on 18 February 2021; 2021. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/963440/S1129__Unlocking__Roadmap_Scenarios_for_England_.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/9634... |
| Description | Update from Regional Variation Group (02-06-2021). Available at SAGE 91 on 3 June 2021; 2021:1-4. |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1067099/S1277_Local_Variation_Space_SPI-M_subgroup.pdf |
| URL | https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1067... |
| Description | WHO - Technical Advisory Group (TAG) on Arbovirus |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| URL | https://www.who.int/news-room/articles-detail/public-notice-of-proposed-new-technical-advisory-group... |
| Description | WHO Advisory Group for the HPV therapeutic vaccines modelling and preferred product characteristics |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | WHO Cervical Cancer Elimination Modelling Consortium (CCEMC) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Publication of report - |
| Guideline Title | WHO Dengue Vaccination recommendation |
| Description | WHO Dengue Vaccination recommendation |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Impact | Recommendations on optimal vaccine use has led to changes in the delivery of vaccines in relevant populations |
| URL | https://www.who.int/wer/2016/wer9130.pdf?ua=1 |
| Description | WHO Flu Burden |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Description | WHO Technical Consultation on the Validation of elimination of HBV mother-to-child transmission. |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | WHO UNAIDs recent infection Consultation on Using HIV recency testing for surveillance |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | WHO consultation to review interim results of the multi-centre laboratory study for determining insecticide discriminating concentrations monitoring of resistance in multiple vector species |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | Using a standard conc of insecticide will allow more sensitive detection of resistance and the sue of the most appropriate insecticide |
| URL | https://www.who.int/publications/i/item/9789240045200 |
| Description | WHO guidelines for prevention of mother to child transmission of HBV |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Impact | Contribution to the goal of elimination of HBV for new technologies for mother to child transmission |
| Description | WHO mpox data and analytics |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | These meetings provided clarity about the drivers of mpox cases in developed countries and possible mechanisms for the decline in mpox cases. Our modelling effort was the first to indicate changing risk behaviour as a likely driver behind decreasing mpox cases in Summer 2022. |
| Description | WHO policy of recommending the use of second-in-class bednets against malaria |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Impacts not yet recognised |
| Description | WHO spread of pyrethroid resistant mosquitoes across Africa. |
| Geographic Reach | Africa |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Collaboration with the World Health Organisation (WHO) Global Malaria Programme to understand the spread of pyrethroid resistant mosquitoes across Africa and how this influences the effectiveness of insecticide treated bednets used to control malaria. Though this has not led to any specific policy recommendations the work was presented in a WHO document (World Malaria Report 2019, Global report on insecticide resistance in malaria vectors: 2010-2016, accessed https://www.who.int/malaria/publications/atoz/9789241514057/en/ ) and on a live WHO webinar (https://apps.who.int/iris/bitstream/handle/10665/274556/WHO-CDS-GMP-2018.17-eng.pdf?ua=1). This work has supported the development of online threat maps for insecticide resistance status (https://www.who.int/malaria/maps/threats-about/en/). |
| URL | https://www.who.int/malaria/publications/atoz/9789241514057/en/ |
| Description | WHO world malaria report |
| Geographic Reach | Africa |
| Policy Influence Type | Citation in other policy documents |
| Impact | Tracking of ITN numbers and use and inefficiencies |
| Description | World Malaria Report 2019 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Impact | Published estimates of exposure and burden of malaria during pregnancy and associated Low birthweight were incorporated into official WHO estimates underpinning the World Malaria Report estimates of malaria burden and progress. |
| URL | https://www.who.int/publications-detail/world-malaria-report-2019 |
| Description | World Malaria Report 2021 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Impact | LOOK UP WMR - Tom/Sam/Patrick https://endmalaria.org/sites/default/files/Global%20Call%20to%20Action%2C%20final%20EN.pdf Scaling up of drugs to pregnant women - LOOK THIS UP |
| URL | https://www.who.int/publications-detail-redirect/9789240015791 |
| Description | World Malaria Report 2021 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Impact | World Malaria report provides an account of the burden of malaria globally and provides a framework for tackling the burden of disease |
| URL | https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2021 |
| Description | World Malaria Report 2022 - Estimates of malaria in pregnancy risk and burden across Africa |
| Geographic Reach | Africa |
| Policy Influence Type | Citation in other policy documents |
| URL | https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2022 |
| Description | Zimbabwe national AIDs council - workshop on HIV prevention cascade |
| Geographic Reach | Africa |
| Policy Influence Type | Contribution to a national consultation/review |
| Description | (CoroNAb) - Nanobodies and antibodies against 2019-nCoV |
| Amount | € 2,771,658 (EUR) |
| Funding ID | 101003653 |
| Organisation | European Commission |
| Sector | Public |
| Country | European Union (EU) |
| Start | 04/2020 |
| End | 03/2022 |
| Description | 3 PA's for Dr Shevanthi Nayagam BRC |
| Amount | £12,688,094 (GBP) |
| Funding ID | RDF01 |
| Organisation | Imperial College Healthcare NHS Trust |
| Sector | Hospitals |
| Country | United Kingdom |
| Start | 04/2019 |
| End | 11/2023 |
| Description | A genealogical approach to tracking bacterial transmission (Xavier Didelot) |
| Amount | £403,170 (GBP) |
| Funding ID | MR/N010760/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 05/2016 |
| End | 05/2019 |
| Description | A global registry of women affected by COVID-19 in pregnancy, understanding natural history to guide treatment and prevention |
| Amount | £253,257 (GBP) |
| Funding ID | MC_PC 19066 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2020 |
| End | 10/2021 |
| Description | A search-engine inspired platform enabling open sharing and access of both data and results from all genomic studies |
| Amount | £38,832 (GBP) |
| Funding ID | 219699/Z/19/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 01/2020 |
| End | 07/2021 |
| Description | ALPHA network: HIV incidence trends and risk factors to describe patterns and risks for HIV incidence in selected communities in Southern and Eastern Africa |
| Amount | £180,208 (GBP) |
| Funding ID | EPPHZM5513/Imperial |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 10/2018 |
| End | 08/2021 |
| Description | APW WHO Global Malaria Programme |
| Amount | £17,932 (GBP) |
| Funding ID | 202011200 |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Global |
| Start | 06/2018 |
| End | 03/2019 |
| Description | APW for joint modelling of adult mortality in sub-Saharan Africa |
| Amount | £18,000 (GBP) |
| Funding ID | DDI/DNA/SCH |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Global |
| Start | 04/2021 |
| End | 09/2021 |
| Description | Alessandra Lochen - PhD project support June2017 - Dec2020 |
| Amount | £58,818 (GBP) |
| Funding ID | PO 480075829 |
| Organisation | GlaxoSmithKline (GSK) |
| Sector | Private |
| Country | Global |
| Start | 07/2019 |
| End | 06/2021 |
| Description | Analysis and modelling of vaccine-derived poliovirus emergence and spread |
| Amount | £152,220 (GBP) |
| Funding ID | 2022/1217583-0 |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Global |
| Start | 03/2022 |
| End | 12/2023 |
| Description | Analysis of ALPHA Network |
| Amount | £37,490 (GBP) |
| Funding ID | PR2017/724002 EPPHZL91/IMPERIAL |
| Organisation | Joint United Nations Programme on HIV/AIDS (UNAIDS) |
| Sector | Public |
| Country | Global |
| Start | 12/2017 |
| End | 11/2018 |
| Description | Analytic and sequencing tools for poliovirus environmental surveillance |
| Amount | £876,522 (GBP) |
| Funding ID | OPP1171890 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 05/2017 |
| End | 12/2021 |
| Description | Analytics to Support Interruption of Vaccine Derived Poliovirus Transmission |
| Amount | £422,235 (GBP) |
| Funding ID | INV-031605 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 05/2021 |
| End | 11/2023 |
| Description | Anti-tuberculosis drug hepatotoxicity and treatment introduction - Stage 2 |
| Amount | £277,695 (GBP) |
| Funding ID | 19GRM013/HTA/Lim |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 09/2020 |
| End | 12/2028 |
| Description | Antibiotic Resistance: Mathematical modelling simulating the evolutionary response of genococcus within human populations to gepotidacin use |
| Amount | £151,716 (GBP) |
| Funding ID | 3000862100 |
| Organisation | GlaxoSmithKline (GSK) |
| Sector | Private |
| Country | Global |
| Start | 06/2017 |
| End | 12/2020 |
| Description | Application of mathematical models to guide and evaluate malaria control and elimination programs |
| Amount | £1,377,815 (GBP) |
| Funding ID | INV-043624 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 06/2022 |
| End | 05/2025 |
| Description | Artemisinin Resistance in Africa: its emergence and evolution in Rwanda - Rescope |
| Amount | £13,697 (GBP) |
| Funding ID | 00002014 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 08/2021 |
| End | 07/2026 |
| Description | Assessing the impact of waning vaccine efficacy on malarial elimination using a population transmission model |
| Amount | £61,597 (GBP) |
| Funding ID | GAT.0888-30-01320457-COL |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 10/2016 |
| End | 11/2018 |
| Description | Assessing the risk that chytridiomycosis poses to the megadiverse amphibian community of Madagascar |
| Amount | £119,900 (GBP) |
| Funding ID | D16ZO-022 |
| Organisation | Morris Animal Foundation |
| Sector | Private |
| Country | United States |
| Start | 09/2016 |
| End | 04/2020 |
| Description | BMGF Project Grant: Vaccine Modelling Initiative (VMI) 2 |
| Amount | £970,053 (GBP) |
| Funding ID | OPP1092240 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 06/2013 |
| End | 06/2020 |
| Description | Better decisions for Better 1 |
| Amount | £133,109 (GBP) |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 11/2017 |
| End | 12/2021 |
| Description | Beyond 90-90-90: Phylodynamic analysis to guide HIV surveillance, control & elimination |
| Amount | £293,580 (GBP) |
| Organisation | Imperial College London |
| Department | School of Public Health |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 11/2018 |
| End | 09/2022 |
| Description | Building International Collaborations on the Mathematical Modelling of Emerging Infectious Disease Threats (Neil Ferguson) |
| Amount | £49,657 (GBP) |
| Funding ID | P11329/DF118 |
| Organisation | Imperial College London |
| Department | Imperial College Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 04/2008 |
| End | 12/2023 |
| Description | Building TRUST |
| Amount | £143,306 (GBP) |
| Funding ID | Sub Award No. 1800014 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 07/2015 |
| End | 06/2020 |
| Description | COVID 19 - Improving COVID-19 forecasts by accounting for seasonality and environmental responses |
| Amount | £287,120 (GBP) |
| Funding ID | NE/V009710/1 |
| Organisation | Natural Environment Research Council |
| Sector | Public |
| Country | United Kingdom |
| Start | 06/2020 |
| End | 11/2021 |
| Description | COVID-19 Genomics UK (COG-UK) Consortium |
| Amount | £20,790,000 (GBP) |
| Funding ID | G106266 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2020 |
| End | 09/2021 |
| Description | COVID-19 UKRI Website |
| Amount | £64,125 (GBP) |
| Funding ID | 4020019245 |
| Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2020 |
| End | 09/2020 |
| Description | COVID-19 Vaccine Evidence Assessment |
| Amount | £18,681 (GBP) |
| Funding ID | APW PO# 202830303 |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Global |
| Start | 03/2022 |
| End | 08/2022 |
| Description | COVID-19: Modeling sensitivity, time to result in prevalence context |
| Amount | $71,644 (USD) |
| Funding ID | INV-023013 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 10/2020 |
| End | 07/2021 |
| Description | COVID-19: Surveillance using environmental samples in Bangladesh |
| Amount | £39,995 (GBP) |
| Funding ID | GF14319.PO 2287477 |
| Organisation | University of Virginia (UVa) |
| Sector | Academic/University |
| Country | United States |
| Start | 09/2020 |
| End | 12/2022 |
| Description | Capturing the full public health value of RSV vaccines: using mathematical modelling to inform target product profiles |
| Amount | £200,359 (GBP) |
| Organisation | Imperial College London |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 01/2020 |
| End | 12/2023 |
| Description | Characterizing and modelling the relationship between socio-economic status and infectious disease risk in the UK (Kate Mitchell) |
| Amount | £94,692 (GBP) |
| Organisation | Imperial College London |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 04/2022 |
| End | 03/2023 |
| Description | Climate Sensitive Vector Borne Disease Intervention Tools |
| Amount | £519,891 (GBP) |
| Funding ID | 226072/Z/22/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 11/2022 |
| End | 10/2027 |
| Description | Combination prevention and strategies for HIV control: In-depth analysis of data from the HPTN 071 (PopART) trial |
| Amount | £127,927 (GBP) |
| Funding ID | EPIDZS7011 / INPUTT |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 02/2020 |
| End | 01/2023 |
| Description | Contributing quantitative analysis towards accelerating declines in TB burden in India and South Africa |
| Amount | £564,674 (GBP) |
| Funding ID | INV-025664 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 12/2020 |
| End | 01/2024 |
| Description | Control of TB in India: developing analytical tools |
| Amount | £387,267 (GBP) |
| Funding ID | OPP1095710 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2013 |
| End | 03/2020 |
| Description | Controlling emergent Anopheles stephensi in Ethiopia and Sudan (CEASE) |
| Amount | £3,552,923 (GBP) |
| Funding ID | 220870/Z/20/Z |
| Organisation | Liverpool School of Tropical Medicine |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 01/2021 |
| End | 12/2024 |
| Description | Cost-effectiveness of testing and treating latent TB infection (LTBI) and active TB disease in the UK using different strategies of patient targeting and different test technologies: a multidisciplinary transmission-dynamic health-economic |
| Amount | £483,406 (GBP) |
| Funding ID | NIHR HTA 127459 |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 07/2019 |
| End | 03/2023 |
| Description | DeWorm3 DAC Trial Planning Grant |
| Amount | $249,004 (USD) |
| Funding ID | INV-017893 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 07/2020 |
| End | 12/2021 |
| Description | Defining disease importation and target interventions from routine surveillance data |
| Amount | $100,000 (USD) |
| Funding ID | OPP1161898 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2016 |
| End | 04/2018 |
| Description | Dengue in Africa and burden mapping - DNDi project |
| Amount | £92,306 (GBP) |
| Funding ID | n/a |
| Organisation | Drugs for Neglected Diseases initiative (DNDi) |
| Sector | Charity/Non Profit |
| Country | Switzerland |
| Start | 03/2022 |
| End | 06/2023 |
| Description | Develop a novel, cost-effective, surveillance approach for malaria elimination through existing antenatal care platform |
| Amount | £56,255 (GBP) |
| Organisation | PATH |
| Sector | Charity/Non Profit |
| Country | Global |
| Start | 02/2018 |
| End | 08/2018 |
| Description | Developing entomological indicators to assess the public health value of next generation LLINs and IRS chemistries |
| Amount | £176,348 (GBP) |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 09/2019 |
| End | 07/2023 |
| Description | Developing modelling approaches for influenza control in the USA |
| Amount | £210,020 (GBP) |
| Funding ID | BAA 75D301-19-R-67835 |
| Organisation | Centers for Disease Control and Prevention (CDC) |
| Sector | Public |
| Country | United States |
| Start | 08/2019 |
| End | 01/2021 |
| Description | Developing reliable epidemic forecasting using branching processes: Ebola as a case study |
| Amount | £99,998 (GBP) |
| Funding ID | SBF005\1044 |
| Organisation | Academy of Medical Sciences (AMS) |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 10/2020 |
| End | 09/2022 |
| Description | Development and implementation of the Naomi model for second administrative level HIV estimates in Sub-Saharan Africa |
| Amount | £351,155 (GBP) |
| Funding ID | 2019/974072 |
| Organisation | Joint United Nations Programme on HIV/AIDS (UNAIDS) |
| Sector | Public |
| Country | Global |
| Start | 12/2019 |
| End | 12/2021 |
| Description | Development and implementation of the Naomi model for second administrative level HIV estimates in sub-Saharan Africa |
| Amount | £258,879 (GBP) |
| Funding ID | 2022/1203567 |
| Organisation | Joint United Nations Programme on HIV/AIDS (UNAIDS) |
| Sector | Public |
| Country | Global |
| Start | 04/2022 |
| End | 12/2023 |
| Description | Development and pilot implementation of rapid poliovirus detection and sequencing from stool samples using nanopore technology |
| Amount | £200,458 (GBP) |
| Funding ID | OPP1207299 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2018 |
| End | 06/2021 |
| Description | Development evaluation and impact of RT-LAMP diagnostics and sequence surveillance on SARS-CoV-2 transmission in South Africa (RADIATES) |
| Amount | £41,889 (GBP) |
| Funding ID | RIA2020EF-3030 |
| Organisation | European Commission |
| Sector | Public |
| Country | European Union (EU) |
| Start | 10/2020 |
| End | 09/2022 |
| Description | Development of Methods to Measure and Interpret HIV Prevention Cascades in Population-Based Surveys |
| Amount | £897,714 (GBP) |
| Funding ID | OPP1161471 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2016 |
| End | 01/2023 |
| Description | Deworm3 unit for transmission dynamics, trial simulation and data analysis |
| Amount | £1,205,330 (GBP) |
| Funding ID | SON15004 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 04/2016 |
| End | 03/2021 |
| Description | Disentangling serotype diversity and the corresponding patterns of immunity in Streptococcus pyogenes (Liliith Whittles) |
| Amount | £300,000 (GBP) |
| Funding ID | 218669/Z/19/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 10/2021 |
| End | 09/2025 |
| Description | Dynamic Modelling of HSV-2 and HIV Infections to Estimate the Burden of HSV-associated HIV Infections and the Predicted Impact of HSV Vaccines |
| Amount | £118,543 (GBP) |
| Funding ID | 202002015 |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Global |
| Start | 05/2018 |
| End | 12/2019 |
| Description | Early antiretroviral therapy and pre-exposure prophylaxis for HIV prevention among emale sex workers in Benin, West Africa |
| Amount | £121,857 (GBP) |
| Funding ID | OPP1098973 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 08/2014 |
| End | 12/2018 |
| Description | Ed Parker: The effect of maternal and neonatal viral exposure on innate and adaptive immune function |
| Amount | £34,726 (GBP) |
| Funding ID | 204834/Z/16/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2018 |
| End | 08/2019 |
| Description | Effectiveness of Timely Hepatitis B Birth Dose Vaccination in Africa |
| Amount | £1,620,956 (GBP) |
| Funding ID | MEL 11604 6 22 |
| Organisation | Gavi |
| Sector | Charity/Non Profit |
| Country | Switzerland |
| Start | 06/2022 |
| End | 11/2024 |
| Description | Elimination of cervical cancer through vaccination and screening in high HIV prevalence settings: a mathematical modelling and cost effectiveness study |
| Amount | £40,194 (GBP) |
| Funding ID | 251758 |
| Organisation | McGill University |
| Sector | Academic/University |
| Country | Canada |
| Start | 04/2020 |
| End | 03/2025 |
| Description | Emergence and global epidemiology of non-polio enteroviruses |
| Amount | £909,233 (GBP) |
| Funding ID | 216427/Z/19/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 01/2020 |
| End | 01/2025 |
| Description | Epidemiological analysis and mathematical modelling of poliovirus elimination and endgame vaccination strategies |
| Amount | £236,130 (GBP) |
| Funding ID | 2017/769688-0 |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Global |
| Start | 11/2017 |
| End | 08/2019 |
| Description | Epidemiological analysis and mathematical modelling of serotype 2 vaccine-derived poliovirus |
| Amount | £122,044 (GBP) |
| Funding ID | 2020/1014353-0 |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Global |
| Start | 04/2020 |
| End | 12/2021 |
| Description | Epidemiological modelling support to the Net Transition strategic initiative |
| Amount | £241,194 (GBP) |
| Funding ID | 202102265 (IPROJ) |
| Organisation | Global Fund to Fight AIDS, Tuberculosis and Malaria |
| Sector | Charity/Non Profit |
| Country | Switzerland |
| Start | 04/2022 |
| End | 12/2024 |
| Description | Epidemiological modelling to support the global COVID-19 response: How to mitigate impact in low-income and crisis-affected settings |
| Amount | £96,664 (GBP) |
| Funding ID | 221350/Z/20/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 04/2020 |
| End | 10/2020 |
| Description | Evaluation of the potential for rapid diagnostic testing (RDTs) for malaria within antenatal care to provide sustainable, dynamic and scalable malaria surveillance |
| Amount | £802,854 (GBP) |
| Funding ID | INV-005289 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 10/2020 |
| End | 09/2023 |
| Description | Evaluation of the potential for rapid diagnostic testing for malaria within antenatal care to provide sustainable, dynamic and scalable malaria surveillance. |
| Amount | £99,998 (GBP) |
| Funding ID | SBF005\1107 |
| Organisation | Academy of Medical Sciences (AMS) |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2020 |
| End | 02/2022 |
| Description | Evaluation work by LCNTDR for the Geshiaro project in support of EPHI |
| Amount | £1,796,879 (GBP) |
| Funding ID | R-1701-01771 |
| Organisation | Children's Investment Fund Foundation |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 07/2018 |
| End | 06/2023 |
| Description | Evaluations to Inform Decisions using Economics and Epidemiology (EVIDENCE) |
| Amount | £88,510 (GBP) |
| Organisation | United States Agency for International Development |
| Sector | Public |
| Country | United States |
| Start | 07/2019 |
| End | 11/2020 |
| Description | Evidence for and against selection of specific pyrethroids for programmatic purposes |
| Amount | £36,768 (GBP) |
| Funding ID | Collab_TA5_RBPS04426_ICL |
| Organisation | Global Fund to Fight AIDS, Tuberculosis and Malaria |
| Sector | Charity/Non Profit |
| Country | Switzerland |
| Start | 02/2020 |
| End | 12/2020 |
| Description | Evolution, transmission and antimicrobial resistance of pathogenic group B streptococci (EJauneikaite) |
| Amount | £125,000 (GBP) |
| Funding ID | M683 |
| Organisation | Stoneygate Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 11/2017 |
| End | 04/2024 |
| Description | Evolution, transmission and antimicrobial resistance of pathogenic group B streptococci (EJauneikaite) |
| Amount | £125,000 (GBP) |
| Funding ID | M683 |
| Organisation | Rosetrees Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 11/2017 |
| End | 04/2024 |
| Description | Evolutionary dynamics underlying pneumococcal genomic diversity |
| Amount | £640,778 (GBP) |
| Funding ID | 104169/Z/14/A |
| Organisation | Sir Henry Dale Fellowships |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 10/2019 |
| End | 09/2023 |
| Description | Evolutionary dynamics underlying pneumococcal genomic diversity. |
| Amount | £708,513 (GBP) |
| Funding ID | 104169/Z/14/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 01/2014 |
| End | 09/2019 |
| Description | Explore the Pathway of China NICE-like Mechanism by Piloting Three Suggested Projects |
| Amount | £172,623 (GBP) |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 12/2017 |
| End | 05/2019 |
| Description | Feasibility of integrating antenatal testing for HBV into the existing HIV and syphilis dual elimination framework in rural Zimbabwe (Njikizana, Kudzanai): ISSF Global Health Clinical Research Training Fellowship |
| Amount | £76,307 (GBP) |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2021 |
| End | 01/2023 |
| Description | Funding for epidemiological analysis to inform HMGs COVID-19 response |
| Amount | £65,804 (GBP) |
| Funding ID | COV-EPI-01 |
| Organisation | Department of Health (DH) |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2020 |
| End | 03/2021 |
| Description | GPS2: Global Pneumococcal Sequence surveillance 2.0 |
| Amount | £199,851 (GBP) |
| Organisation | The Wellcome Trust Sanger Institute |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 04/2020 |
| End | 11/2023 |
| Description | Geospatial modelling for malaria risk stratification and intervention targeting |
| Amount | £219,507 (GBP) |
| Funding ID | 1606H5002/JH6 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 09/2016 |
| End | 08/2020 |
| Description | Global systematic review of the immunogenicity, safety, efficacy, and durability of HPV vaccines among HIV positive individuals |
| Amount | £70,643 (GBP) |
| Funding ID | 2020/997664-0 |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Global |
| Start | 03/2020 |
| End | 06/2021 |
| Description | HC-HIV modeling activity |
| Amount | £156,940 (GBP) |
| Funding ID | 48345 |
| Organisation | United States Agency for International Development |
| Sector | Public |
| Country | United States |
| Start | 06/2017 |
| End | 08/2018 |
| Description | HIV Modelling Consortium Renewal |
| Amount | £3,527,347 (GBP) |
| Funding ID | OPP1084364 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 06/2013 |
| End | 01/2019 |
| Description | HIV and TB estimation, mathematical modelling, and economic analysis to support national and sub-national HIV policy setting in South Africa |
| Amount | £287,875 (GBP) |
| Organisation | University of Cape Town |
| Sector | Academic/University |
| Country | South Africa |
| Start | 03/2021 |
| End | 12/2023 |
| Description | Health Research Programme Consortia (RPCS): Filling Gaps in Evidence: Building Stronger and More Resilient Health Systems |
| Amount | £114,000 (GBP) |
| Funding ID | 2018/S 196-443482 |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 05/2020 |
| End | 04/2026 |
| Description | Health in a changing climate: the dynamic challenge of snake bite in South Asia |
| Amount | £179,625 (GBP) |
| Funding ID | MR/P024513/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2017 |
| End | 02/2020 |
| Description | Human Infectious Challenge Vaccine (HIC vac) network |
| Amount | £2,041,189 (GBP) |
| Funding ID | MR/R005982/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 05/2018 |
| End | 02/2020 |
| Description | Human challenge with live-attenuated rotavirus to assess next-generation rotavirus vaccines in Africa |
| Amount | £776,687 (GBP) |
| Funding ID | MR/T030321/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2020 |
| End | 08/2023 |
| Description | IDC Genomics Lab refurb |
| Amount | £125,000 (GBP) |
| Organisation | St. Mary's Development Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 06/2018 |
| End | 06/2020 |
| Description | IDDO Repositories: Lymphatic Filariasis in India |
| Amount | £51,936 (GBP) |
| Funding ID | B9R04200 - INV-004713 |
| Organisation | University of Oxford |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 11/2020 |
| End | 12/2022 |
| Description | IImpact of COVID 19 on sexual risk behavior for HIV infection in SSA |
| Amount | £1,117,944 (GBP) |
| Funding ID | INV-023210 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 10/2020 |
| End | 10/2023 |
| Description | IInnovations to improve the speed and sensitivity of global poliovirus surveillance |
| Amount | £2,590,635 (GBP) |
| Funding ID | INV-052182 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2022 |
| End | 12/2024 |
| Description | ISID/ESCMID Fellowship - Using seroprevalence age profiles to identify changes in incidence and interruption of transmission of filarial infections in Mali |
| Amount | £6,125 (GBP) |
| Organisation | International Society for Infectious Diseases (ISID) |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 04/2019 |
| End | 06/2020 |
| Description | Immunological investigation for the implenatation of Live Attenuated Influenza Vaccination |
| Amount | £811,303 (GBP) |
| Funding ID | MR/R021643/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 06/2018 |
| End | 12/2021 |
| Description | Impact of maternally derived antibodies and microbiota on the immunogenicity of rotavirus vaccines in African, Indian and European infants |
| Amount | £255,266 (GBP) |
| Funding ID | JXR11990 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 07/2015 |
| End | 12/2018 |
| Description | Importation and transmission of malaria in Zanzibar: a case study for elimination |
| Amount | £61,161 (GBP) |
| Funding ID | 5121973 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 07/2021 |
| End | 06/2026 |
| Description | Improving HIV phylodynamic research capacity in Botswana |
| Amount | £13,580 (GBP) |
| Organisation | United Kingdom Research and Innovation |
| Department | Global Challenges Research Fund |
| Sector | Public |
| Country | United Kingdom |
| Start | 10/2019 |
| End | 07/2021 |
| Description | Improving the efficacy of malaria prevention in an insecticide resistant Africa |
| Amount | £162,798 (GBP) |
| Funding ID | 200222/B/15/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 05/2016 |
| End | 10/2019 |
| Description | Innovations to improve the speed and sensitivity of poloio surveillance |
| Amount | £1,341,964 (GBP) |
| Funding ID | INV-024477 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2020 |
| End | 12/2023 |
| Description | Innovative epidemiological analysis to support the Blantyre Prevention Study |
| Amount | £104,738 (GBP) |
| Funding ID | GR424146 |
| Organisation | Georgetown University |
| Sector | Academic/University |
| Country | United States |
| Start | 05/2020 |
| End | 04/2025 |
| Description | Integrating Ethics and Equity into Priority Setting for Universal Health Coverage: A Proof-of-Concept Study in South Africa |
| Amount | £128,944 (GBP) |
| Funding ID | 208045/Z/17/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 01/2017 |
| End | 01/2020 |
| Description | Integrating genomic surveillance and ecological modelling to maximise pneumococcal vaccine efficacy |
| Amount | £558,204 (GBP) |
| Funding ID | MR/T016434/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 06/2020 |
| End | 06/2023 |
| Description | Integrating genomic, serological and epidemiological information to undferstand the emergence, spread and establ;ishment of novel SARS-CoV-2 variants |
| Amount | £300,000 (GBP) |
| Funding ID | 224190/Z/21/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2022 |
| End | 03/2026 |
| Description | Investigating the impact of heterogeneity in outcomes on efficacy measured in malaria intervention trials |
| Amount | £89,482 (GBP) |
| Funding ID | 101029EPID |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2021 |
| End | 03/2023 |
| Description | Joint estimation of HIV and adult mortality trends in sub-Saharan Africa |
| Amount | £67,680 (GBP) |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 08/2018 |
| End | 12/2019 |
| Description | Key populations and HIV epidemics in Sub-Saharan Africa: Developing better epidemiologic tools to inform priorities and programs |
| Amount | £179,258 (GBP) |
| Funding ID | PO: 2003388501 |
| Organisation | Family Health International |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 06/2016 |
| End | 03/2019 |
| Description | London Centre for NTD Research |
| Amount | £555,000 (GBP) |
| Organisation | GlaxoSmithKline (GSK) |
| Sector | Private |
| Country | Global |
| Start | 06/2015 |
| End | 05/2019 |
| Description | London Centre for NTD Research (renewal 3) |
| Amount | £785,649 (GBP) |
| Organisation | GlaxoSmithKline (GSK) |
| Sector | Private |
| Country | Global |
| Start | 06/2018 |
| End | 05/2023 |
| Description | MIDAS 2: Models for synthesising molecular, clinical and epidemiological data, and translation to public health response (NIH) |
| Amount | £1,246,328 (GBP) |
| Funding ID | 1U01GM110721-01 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 09/2014 |
| End | 05/2019 |
| Description | MIDAS: Modeling Epidemic Infectious Diseases Using Sequence Analysis |
| Amount | £300,028 (GBP) |
| Funding ID | 258162IMP |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 01/2016 |
| End | 05/2020 |
| Description | Malaria Eradication Metrics |
| Amount | £222,688 (GBP) |
| Funding ID | OPP1197730 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 03/2019 |
| End | 12/2022 |
| Description | Malaria Evaluation and Research Consortium |
| Amount | £5,057 (GBP) |
| Funding ID | AID.574718-01706929-SUB_PAL |
| Organisation | United States Agency for International Development |
| Sector | Public |
| Country | United States |
| Start | 10/2020 |
| End | 12/2020 |
| Description | Management of chronic hepatitis B in Africa: is a one-stop assessment of liver disease enough? The MATCH-B study |
| Amount | £882,167 (GBP) |
| Funding ID | MR/R011117/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2018 |
| End | 12/2020 |
| Description | Mapping the Risk of International Infectious Disease Spread (MRIIDS) |
| Amount | £207,235 (GBP) |
| Funding ID | SBFF-2019-37324 |
| Organisation | International Society for Infectious Diseases (ISID) |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 07/2020 |
| End | 06/2022 |
| Description | Mapping the risk of international infectious disease spread |
| Amount | £120,202 (GBP) |
| Funding ID | AID-OAA-F-16-00115 |
| Organisation | United States Agency for International Development |
| Sector | Public |
| Country | United States |
| Start | 10/2016 |
| End | 04/2019 |
| Description | Mapping the spatial clustering of delayed infant vaccinations in The Gambia: exploring the role of geographic access to immunization service points (Oghenebrume, Wairri): ISSF Global Health Clinical Research Training Fellowship |
| Amount | £61,922 (GBP) |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 11/2020 |
| End | 10/2021 |
| Description | Mathematical Modelling of Microfilaricidal Drugs for River Blindness: from Patients to Populations |
| Amount | £50,870 (GBP) |
| Organisation | Drugs for Neglected Diseases initiative (DNDi) |
| Sector | Charity/Non Profit |
| Country | Switzerland |
| Start | 06/2016 |
| End | 05/2019 |
| Description | Mathematical modeling in the HPTN Renewal |
| Amount | £1,008,218 (GBP) |
| Funding ID | 2UMIAI068617 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 01/2014 |
| End | 11/2020 |
| Description | Mathematical modelling of poliovirus transmission to support the endgame |
| Amount | £487,817 (GBP) |
| Funding ID | OPP1099374 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2013 |
| End | 07/2018 |
| Description | Mathematical modelling of the efficacy at individual and population level of prevention versus treatment of influenza and COVID-19, respectively, by lowering virus load in the upper versus the lower respiratory tract |
| Amount | £427,348 (GBP) |
| Organisation | Leyden Delta BV |
| Sector | Private |
| Country | Netherlands |
| Start | 07/2021 |
| End | 12/2022 |
| Description | Maximising the public health impact of new approaches to control malaria in pregnancy through the translation of evidence-based global policies to country level policies and plans. |
| Amount | £42,075 (GBP) |
| Funding ID | CSA-2014-276 |
| Organisation | European Commission |
| Sector | Public |
| Country | European Union (EU) |
| Start | 01/2016 |
| End | 12/2018 |
| Description | Minimum Models for Optimal Epidemic Monitoring and Control |
| Amount | £288,432 (GBP) |
| Funding ID | MR/S019693/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 11/2018 |
| End | 10/2021 |
| Description | Model development for the draft WHO global report on insecticide resistance in malaria vectors |
| Amount | £258,706 (GBP) |
| Organisation | IVCC |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2018 |
| End | 02/2020 |
| Description | Model development for the draft WHO global report on insecticide resistance in malaria vectors |
| Amount | £13,901 (GBP) |
| Funding ID | 2018/797131-0 |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Global |
| Start | 03/2018 |
| End | 12/2018 |
| Description | Modeling Anorectal HIV Transmission in Women |
| Amount | £288,589 (GBP) |
| Funding ID | 5R01AI057020 Sub#201224310-05 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 11/2014 |
| End | 05/2019 |
| Description | Modelling Alternative Treatment Strategies for Onchocerciasis: Moxidectin for Control and Elimination |
| Amount | £30,000 (GBP) |
| Funding ID | MDL50 6-9010 |
| Organisation | Medicines Development for Global Health |
| Sector | Private |
| Country | Australia |
| Start | 02/2017 |
| End | 12/2021 |
| Description | Modelling To Inform The Planning Of Affordable And Sustainable Programmes To Reduce HIV Incidence In Sub-Saharan Africa. HIV Consortium. |
| Amount | £451,613 (GBP) |
| Funding ID | WT PC 245878 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 10/2019 |
| End | 09/2023 |
| Description | Modelling antimalarial target product profiles for reducing P. falciparum malaria transmission |
| Amount | £316,782 (GBP) |
| Funding ID | PO14/00561 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 10/2013 |
| End | 02/2019 |
| Description | Modelling critical characteristics of a future universal influenza vaccine |
| Amount | £293,230 (GBP) |
| Organisation | National Philanthropic Trust |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 10/2020 |
| End | 12/2022 |
| Description | Modelling in support of India program , development and use of new tools and programmatic prioritization |
| Amount | £257,508 (GBP) |
| Funding ID | OPP1205227 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2018 |
| End | 06/2021 |
| Description | Modelling infectious disease outbreaks using the Hawkes Process |
| Amount | £184,875 (GBP) |
| Organisation | Imperial College London |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 08/2019 |
| End | 07/2023 |
| Description | Modelling support for IVCC ATSB development and delivery activity |
| Amount | £208,044 (GBP) |
| Funding ID | IPROJ |
| Organisation | IVCC |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 11/2021 |
| End | 11/2024 |
| Description | Modelling the Elimination of Onchocerciasis in Cameroon (International Exchanges) |
| Amount | £11,999 (GBP) |
| Funding ID | IES/R2/181017 |
| Organisation | The Royal Society |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 12/2018 |
| End | 12/2022 |
| Description | Modelling the Value of Vaccines in Reducing the Burden of Antimicrobial Resistance |
| Amount | £54,560 (GBP) |
| Funding ID | OPP1190803 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 06/2019 |
| End | 04/2020 |
| Description | Modelling the control of artemisinin-based antimalarial drug resistance |
| Amount | £355,171 (GBP) |
| Funding ID | DH140134 |
| Organisation | The Royal Society |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 01/2016 |
| End | 02/2023 |
| Description | Modelling the dynamics of viral load to reveal mechanisms of protection in COVID-19 |
| Amount | £196,129 (GBP) |
| Funding ID | MR/V027409/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 07/2020 |
| End | 07/2021 |
| Description | Modelling the efficacy and cost effectiveness of community health workers for the control of malaria, pneumonia and diarrhoea. |
| Amount | £197,958 (GBP) |
| Organisation | Imperial College London |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 10/2018 |
| End | 09/2022 |
| Description | Modelling the impact of Seasonal Malaria Chemoprevention in East Africa |
| Amount | £34,150 (GBP) |
| Funding ID | PO18/01036 |
| Organisation | Medicines for Malaria Venture (MMV) |
| Sector | Charity/Non Profit |
| Country | Switzerland |
| Start | 06/2019 |
| End | 10/2019 |
| Description | Modelling the impact of TB31F on population malaria transmission |
| Amount | £22,250 (GBP) |
| Funding ID | A21-0902 |
| Organisation | Radboud University Nijmegen |
| Sector | Academic/University |
| Country | Netherlands |
| Start | 06/2021 |
| End | 10/2021 |
| Description | Modelling the potential impact of intermittent preventive treatment of malaria in pregnancy on antimalarial drug resistance |
| Amount | £99,998 (GBP) |
| Funding ID | ch160084 |
| Organisation | Royal Society of Medicine |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 12/2016 |
| End | 08/2018 |
| Description | Modelling the spatiotemporal dynamics of arbovirus transmission: implications for disease control and elimination |
| Amount | £1,015,575 (GBP) |
| Funding ID | 213494/Z/18/Z |
| Organisation | Sir Henry Dale Fellowships |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2019 |
| End | 03/2025 |
| Description | MoxiMultiDosePedMod |
| Amount | £51,125 (GBP) |
| Funding ID | RIA2017NCT-1843 |
| Organisation | European Commission |
| Sector | Public |
| Country | European Union (EU) |
| Start | 08/2019 |
| End | 07/2024 |
| Description | Multi-Level Behavioral Economics and Community Psychology Approaches to Strengthen HIV Prevention Cascades in Adolescent Girls and Young Women in East Zimbabwe |
| Amount | £2,018,860 (GBP) |
| Funding ID | 1R01MH114562-01 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 09/2017 |
| End | 07/2023 |
| Description | Multidisciplinary Studies of HIV/AIDS and Aging (R21) |
| Amount | £205,531 (GBP) |
| Funding ID | 1R21AG053093 - 01 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 09/2016 |
| End | 07/2019 |
| Description | Multiresolution predictive dynamics of COVID-19 risk and intervention effects |
| Amount | £556,661 (GBP) |
| Funding ID | MR/V038109/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 11/2020 |
| End | 05/2022 |
| Description | NIHR Health Protection Research Unit in Modelling and Health Economics |
| Amount | £3,999,970 (GBP) |
| Funding ID | NIHR200908 |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2020 |
| End | 03/2025 |
| Description | NIHR Senior Investigator Award |
| Amount | £120,000 (GBP) |
| Funding ID | P/O 427921 |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2009 |
| End | 04/2021 |
| Description | NIHR-HPRU Resp - Arinaminpathy |
| Amount | £5,840 (GBP) |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2020 |
| End | 03/2025 |
| Description | NIHR-HPRU Respiratory - Riley |
| Amount | £148,903 (GBP) |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2020 |
| End | 03/2025 |
| Description | NIHR: NIHR HPRU in Modelling Methodology |
| Amount | £4,234,300 (GBP) |
| Funding ID | HPRU-2012-10080 |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2014 |
| End | 03/2020 |
| Description | NTD Consortium - CIFF Project |
| Amount | £184,212 (GBP) |
| Funding ID | MA4501202974 |
| Organisation | Children's Investment Fund Foundation |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 01/2015 |
| End | 04/2018 |
| Description | NTD Consortium Renewal (STH, Schisto, Oncho) |
| Amount | £707,456 (GBP) |
| Funding ID | 1708CR001/VP1 (OPP1184344) |
| Organisation | The Task Force for Global Health |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2017 |
| End | 11/2021 |
| Description | Near-Infrared Spectroscopy: A One-Stop-Shop for Mosquito Epidemiological Monitoring? |
| Amount | £643,683 (GBP) |
| Funding ID | MR/P01111X/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2017 |
| End | 02/2020 |
| Description | Neglected Tropical Diseases Modelling Consortium |
| Amount | £616,460 (GBP) |
| Funding ID | CRR00630 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2021 |
| End | 10/2024 |
| Description | New Data and Models to Track Progress Towards Reducing New HIV Infections |
| Amount | £986,063 (GBP) |
| Funding ID | OPP1190661 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 05/2018 |
| End | 12/2023 |
| Description | Newton Fund Researcher Links Grant |
| Amount | £34,450 (GBP) |
| Funding ID | 2016-RLWK7-10289 |
| Organisation | British Council |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 04/2017 |
| End | 01/2018 |
| Description | Next-generation vector control for malaria: product profiling to implementation |
| Amount | £1,059,509 (GBP) |
| Funding ID | MR/T041986/1 |
| Organisation | United Kingdom Research and Innovation |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2021 |
| End | 01/2025 |
| Description | Optimal spatial scales for deployment of multiple first line therapies for malaria |
| Amount | £112,332 (GBP) |
| Funding ID | RGF\EA180225 |
| Organisation | Royal Society of Medicine |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 12/2017 |
| End | 04/2023 |
| Description | PGx Ethics |
| Amount | £132,943 (GBP) |
| Funding ID | 1R01MH124590-01A1 |
| Organisation | University of California |
| Sector | Academic/University |
| Country | United States |
| Start | 07/2020 |
| End | 04/2022 |
| Description | PMI VectorLink project |
| Amount | £42,855 (GBP) |
| Organisation | Abt Associates |
| Sector | Private |
| Country | United States |
| Start | 11/2020 |
| End | 03/2021 |
| Description | Pete Winskill Fellowship |
| Amount | £197,958 (GBP) |
| Organisation | Imperial College London |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 10/2018 |
| End | 09/2022 |
| Description | Phase variable epigenetic regulation in Firmicutes |
| Amount | £298,700 (GBP) |
| Funding ID | RM33G0360 |
| Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2016 |
| End | 12/2018 |
| Description | Population Effects of Antretroviral Therapy to Reduce HIV Transmission (PopART) - Health Economics |
| Amount | £502,745 (GBP) |
| Funding ID | PO15001410 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 06/2015 |
| End | 01/2020 |
| Description | Population Effects of Antretroviral Therapy to Reduce HIV Transmission (PopART) - Health Economics |
| Amount | £12,709 (GBP) |
| Organisation | UK Department for International Development |
| Sector | Public |
| Country | United Kingdom |
| Start | 11/2015 |
| End | 03/2018 |
| Description | Population genomic analysis of HIV transmission fitness (Wellcome Investigator Award) |
| Amount | £654,391 (GBP) |
| Funding ID | 220885/Z/20/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2020 |
| End | 08/2024 |
| Description | Predicting and reviewing the public health impact of the Volume Guarantee for IG2 bednets in Africa |
| Amount | £81,283 (GBP) |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 01/2020 |
| End | 06/2023 |
| Description | Predicting the impact of insecticide resistance and new paradigms of vector control |
| Amount | £161,331 (GBP) |
| Organisation | IVCC |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 06/2015 |
| End | 05/2018 |
| Description | Predicting the impact of novel vector control interventions |
| Amount | £735,630 (GBP) |
| Organisation | IVCC |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2018 |
| End | 03/2023 |
| Description | Predicting the impact of novel vector control interventions against malaria in selected areas of the Asia Pacific region |
| Amount | £294,243 (GBP) |
| Funding ID | DF1 RBPS 108195 |
| Organisation | IVCC |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 04/2020 |
| End | 06/2023 |
| Description | Predicting the impact of seasonal respiratory infection on temporal dynamics and characteristics of admission rates and time spent in hospital |
| Amount | £115,260 (GBP) |
| Funding ID | RDA02 |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 11/2018 |
| End | 03/2022 |
| Description | Predicting the public health impact of SSM-VIMT Phase III and IV trials |
| Amount | £19,617,788 (GBP) |
| Organisation | Malaria GIA Reference Center - PATH MVI |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 01/2018 |
| End | 12/2019 |
| Description | Preparing for Future Clean Air Challenges |
| Amount | £112,833 (GBP) |
| Funding ID | NE/W002116/1 |
| Organisation | Natural Environment Research Council |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2021 |
| End | 07/2025 |
| Description | Priority Setting for UHC (transfer from NICE) |
| Amount | £222,478 (GBP) |
| Funding ID | 2017 AVH |
| Organisation | Rockefeller Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 10/2016 |
| End | 12/2018 |
| Description | Progestin-based contraceptive modeling in high DMPA-IM use and high HIV incidence settings |
| Amount | £378,999 (GBP) |
| Funding ID | OPP1194416 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 09/2018 |
| End | 07/2020 |
| Description | Projections on eliminating NTDs (integrating mapping with modelling) |
| Amount | £73,998 (GBP) |
| Funding ID | OPP1156227 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2016 |
| End | 10/2018 |
| Description | Projections on eliminating NTDs (integrating mapping with modelling). |
| Amount | £20,392 (GBP) |
| Funding ID | CRR00140 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2017 |
| End | 12/2019 |
| Description | Providing academic leadership through a Secretariat for the UNAIDS reference group on estimates modelling & projections (2018-2019) |
| Amount | £480,563 (GBP) |
| Funding ID | 2017/778519 |
| Organisation | Joint United Nations Programme on HIV/AIDS (UNAIDS) |
| Sector | Public |
| Country | Global |
| Start | 01/2018 |
| End | 12/2019 |
| Description | Providing academic leadership through a Secretariat for the UNAIDS reference group on estimates modelling & projections (2018-2019) |
| Amount | £1,015,050 (GBP) |
| Funding ID | 2017/778519 |
| Organisation | Joint United Nations Programme on HIV/AIDS (UNAIDS) |
| Sector | Public |
| Country | Global |
| Start | 01/2018 |
| End | 03/2022 |
| Description | Quantification of HIV burden and the biomedical, structural, and behavioral factors influencing HIV/AIDS among children and young adolescents |
| Amount | £359,531 (GBP) |
| Funding ID | UWSC12752 |
| Organisation | University of Washington |
| Sector | Academic/University |
| Country | United States |
| Start | 03/2021 |
| End | 11/2025 |
| Description | Quantifying Contact Rates and Mixing Patterns in Workers in Non-healthcare Work Settings in the United States and Modeling the Effect of Workplace Social Distancing Measures in Reducing Influenza Transmission |
| Amount | £26,610 (GBP) |
| Funding ID | GR110431 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 09/2019 |
| End | 08/2021 |
| Description | Quantifying Spatial Representativeness and Uncertainty in Antenatal Care Sentinel Surveillance for HIV in Sub-Saharan Africa. |
| Amount | $53,375 (USD) |
| Funding ID | 1R03AI125001-01A1 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 12/2016 |
| End | 11/2018 |
| Description | Quantifying and preparing for the non-communicable disease burden in the ageing HIV-positive population in Kenya |
| Amount | £134,891 (GBP) |
| Funding ID | OISE-17-62962-1 |
| Organisation | United States President's Emergency Plan for AIDS Relief |
| Sector | Public |
| Country | United States |
| Start | 08/2017 |
| End | 02/2020 |
| Description | R01 Statistical Models for Estimating and Projecting HIV/AIDS Epidemics |
| Amount | £70,711 (GBP) |
| Funding ID | 5776-ICS-DHHS-6664 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 09/2017 |
| End | 08/2023 |
| Description | REACT - Antigen testing and Usability and feasibility study of widespread home self-testing for SARS-CoV-2 antibodies continued support |
| Amount | £278,085 (GBP) |
| Organisation | Department of Health (DH) |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2021 |
| End | 10/2022 |
| Description | REACT - Subproject PSI328 for Institution # P87466 |
| Amount | £471,823 (GBP) |
| Organisation | Department of Health (DH) |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2020 |
| End | 01/2022 |
| Description | Real-time genetic cartography of viral epidemics - Sir Henry Dale Fellowship |
| Amount | £289,799 (GBP) |
| Funding ID | 204311/A/16/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 04/2020 |
| End | 07/2022 |
| Description | Research and Development of Reconstructing HIV Epidemics from HIV Phylogenetics |
| Amount | £72,683 (GBP) |
| Funding ID | Ref: 340798 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 06/2018 |
| End | 02/2019 |
| Description | Research for Health in Conflict (R4HC): multi-sectorial capacity strengthening, partnership building and research across the MENA region |
| Amount | £432,399 (GBP) |
| Funding ID | MOTEAAR |
| Organisation | Kings BRC |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 10/2017 |
| End | 12/2021 |
| Description | Respiratory Infection Health Protection Research Unit |
| Amount | £93,377 (GBP) |
| Funding ID | IS-HPU-1112-10064 |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2014 |
| End | 03/2020 |
| Description | RooPfs (Can improved housing provide additional protection against clinical malaria over current best practice? A household-randomised controlled trial) |
| Amount | £179,101 (GBP) |
| Funding ID | RF020305 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 11/2014 |
| End | 10/2019 |
| Description | Royal Society Laboratory Refurbishment Award |
| Amount | £188,326 (GBP) |
| Organisation | The Royal Society |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2017 |
| End | 08/2017 |
| Description | SDMC: HIV Prevention Trials Network |
| Amount | £1,666,667 (GBP) |
| Funding ID | Subaward 0001058334 |
| Organisation | Fred Hutchinson Cancer Research Center (FHCRC) |
| Sector | Academic/University |
| Country | United States |
| Start | 12/2020 |
| End | 11/2027 |
| Description | SIMPLEGEN: A modeling approach to inform malaria genetic surveillance |
| Amount | £377,183 (GBP) |
| Funding ID | INV-031273 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 07/2021 |
| End | 07/2024 |
| Description | STH Diagnostics Development |
| Amount | £191,445 (GBP) |
| Funding ID | 1902-03568 |
| Organisation | Children's Investment Fund Foundation |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 01/2020 |
| End | 12/2022 |
| Description | Schisto Vaccine project extn via NTD Modelling Consortium, Warwick |
| Amount | £121,248 (GBP) |
| Funding ID | OPP1176780 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 09/2017 |
| End | 03/2019 |
| Description | Smart and scalable epidemic prediction and control (MRC CDA) |
| Amount | £1,298,742 (GBP) |
| Funding ID | MR/W016834/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2022 |
| End | 03/2027 |
| Description | Sources and Impact of Misclassification Errors in HIV Rapid Testing Algorithms in a Hyper-Endemic HIV Setting in sub-Saharan Africa |
| Amount | £886,781 (GBP) |
| Funding ID | OPP1131208 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 07/2015 |
| End | 09/2019 |
| Description | South East Asian Research Collaboration in Hepatitis (SEARCH) |
| Amount | £7,500 (GBP) |
| Funding ID | 206296/Z/17/Z |
| Organisation | Imperial College London |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 03/2000 |
| End | 11/2023 |
| Description | Spatiotemporal regression analysis of Wolbachia releases in Brazil |
| Amount | £32,000 (GBP) |
| Organisation | Monash University |
| Sector | Academic/University |
| Country | Australia |
| Start | 05/2019 |
| End | 11/2022 |
| Description | Spread of antimicrobial resistance in Guyana: A pilot study of private supply and demand side factors |
| Amount | £26,570 (GBP) |
| Organisation | United Kingdom Research and Innovation |
| Department | Global Challenges Research Fund |
| Sector | Public |
| Country | United Kingdom |
| Start | 07/2019 |
| End | 07/2021 |
| Description | TB MAC COVID-19 Webtool |
| Amount | £35,022 (GBP) |
| Funding ID | EPIDZJ62 |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 07/2020 |
| End | 10/2020 |
| Description | TB Modelling and Analysis Consortium |
| Amount | £37,133 (GBP) |
| Funding ID | EPIDZJ6210/Imperial |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 01/2018 |
| End | 06/2019 |
| Description | TaqMan Array Card method for polio environmental surveillance |
| Amount | £37,729 (GBP) |
| Funding ID | GF13847.159399 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 07/2018 |
| End | 06/2023 |
| Description | Target Malaria Phase II grant - Epimodelling sub |
| Amount | £410,788 (GBP) |
| Funding ID | OPP1210755 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 03/2020 |
| End | 12/2025 |
| Description | Thanzi La Mawa: Integrated Analysis of Health System Capabilities and Effects on Population Health in Malawi and Eastern, Central and Southern Africa |
| Amount | £3,984,636 (GBP) |
| Funding ID | 223120/Z/21/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 10/2021 |
| End | 09/2025 |
| Description | Thanzi La Onse -Frameworks and analysis to ensure value-for-money health care: developing theory, changing practices in low- and middle-income settings. |
| Amount | £772,329 (GBP) |
| Funding ID | R18664 |
| Organisation | Research Councils UK (RCUK) |
| Sector | Public |
| Country | United Kingdom |
| Start | 10/2017 |
| End | 03/2022 |
| Description | The Leverhulme Trust Research Centre for The Holobiont |
| Amount | £571,585 (GBP) |
| Funding ID | n/a |
| Organisation | The Leverhulme Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 10/2022 |
| End | 09/2032 |
| Description | The delay-care cascade and its implications for TB transmission: a study in three country settings |
| Amount | £125,031 (GBP) |
| Organisation | Stop TB Partnership |
| Sector | Charity/Non Profit |
| Country | Switzerland |
| Start | 08/2017 |
| End | 12/2018 |
| Description | The development of an Alzheimer's disease clinical trial simulator, parameter estimation from international patient cohorts and standardizing epidemiological measurement platforms for cohort studies |
| Amount | £775,501 (GBP) |
| Funding ID | HQR00720 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2019 |
| End | 12/2020 |
| Description | The direct and indirect consequences of large health system shocks to population health in Malawi (Tara Mangal): ISSF Springboard Fellowship |
| Amount | £94,554 (GBP) |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 10/2021 |
| End | 03/2023 |
| Description | The evolution of influenza virus: studies of within host and between host evolution to improve pandemic risk assessment and vaccine |
| Amount | £1,269,464 (GBP) |
| Funding ID | 200187/Z/15/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2016 |
| End | 12/2022 |
| Description | The evolutionary dynamics of multiazole resistance in pathogenic Aspergillus fungi |
| Amount | £427,006 (GBP) |
| Funding ID | NE/P001165/1 |
| Organisation | Natural Environment Research Council |
| Sector | Public |
| Country | United Kingdom |
| Start | 11/2016 |
| End | 04/2020 |
| Description | The farm environment: an overlooked reservoir of Mycobacterium bovis? |
| Amount | £21,364 (GBP) |
| Funding ID | RLFEW3022 |
| Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2016 |
| End | 12/2020 |
| Description | The life course of human immune responses to influenza infection and vaccination |
| Amount | £1,928,979 (GBP) |
| Funding ID | 200861/Z/16/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 05/2016 |
| End | 10/2022 |
| Description | Tools for direct detection of AMR pathogens from sewage |
| Amount | £951,870 (GBP) |
| Funding ID | INV-047158 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2022 |
| End | 10/2024 |
| Description | Tracking the flow of malaria parasites and drug resistance within the DRC and across its borders |
| Amount | £264,838 (GBP) |
| Funding ID | 00001346 |
| Organisation | National Institute of Allergy and Infectious Diseases (NIAID) |
| Sector | Public |
| Country | United States |
| Start | 11/2018 |
| End | 05/2023 |
| Description | Trial Modelling Collaboration - renewal |
| Amount | £1,701,830 (GBP) |
| Funding ID | P22539540R |
| Organisation | Johnson & Johnson |
| Department | Janssen Vaccines & Prevention bv |
| Sector | Private |
| Country | Netherlands |
| Start | 05/2017 |
| End | 05/2020 |
| Description | Typhoid ES in Nigeria |
| Amount | £358,736 (GBP) |
| Funding ID | INV-048663 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2022 |
| End | 05/2024 |
| Description | Typhoid ES site selection characteristics |
| Amount | £1,141,323 (GBP) |
| Funding ID | INV_002381 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2019 |
| End | 09/2023 |
| Description | Understanding The Eco-evolutionary Drivers Of Emerging Antifungal Resistance |
| Amount | £1,074,166 (GBP) |
| Funding ID | NE/X00547X/1 |
| Organisation | Natural Environment Research Council |
| Sector | Public |
| Country | United Kingdom |
| Start | 10/2022 |
| End | 11/2026 |
| Description | Understanding acquisition and evolution of antifungal resistance in Cystic Fibrosis (FREAL) |
| Amount | £38,000 (GBP) |
| Funding ID | VIA 081 |
| Organisation | Cystic Fibrosis Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 06/2020 |
| End | 12/2022 |
| Description | Understanding acquisition and evolution of antifungal resistance in chronic respiratory disease |
| Amount | £201,103 (GBP) |
| Funding ID | MR/T005572/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2020 |
| End | 12/2022 |
| Description | Understanding acquisition and evolution of antifungal resistance in chronic respiratory disease (Anand Shah): MRC CARP (Clinical Academic Research Fellowship) |
| Amount | £205,103 (GBP) |
| Funding ID | MR/T005572/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 10/2020 |
| End | 12/2022 |
| Description | Understanding and mitigating the impact of emerging antifungal resistance |
| Amount | £2,200,879 (GBP) |
| Funding ID | 219551/Z/19/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2020 |
| End | 03/2024 |
| Description | Understanding host heterogeneity to vector-borne disease exposure: Implications for modelling disease transmission and improving the design of control intervention |
| Amount | £8,778 (GBP) |
| Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 06/2019 |
| End | 09/2020 |
| Description | Understanding links between microbial communities and emerging fungal pathogens in complex ecosystems |
| Amount | £394,290 (GBP) |
| Funding ID | NE/S000844/1 |
| Organisation | Natural Environment Research Council |
| Sector | Public |
| Country | United Kingdom |
| Start | 11/2018 |
| End | 10/2022 |
| Description | Understanding the potential impact of new vector control tools |
| Amount | £165,000 (GBP) |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 06/2020 |
| End | 01/2021 |
| Description | Unifying COVID-19 Serology, Genomics and Epidemiology in Brazil |
| Amount | £102,879 (GBP) |
| Funding ID | INV-034540 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 09/2021 |
| End | 05/2023 |
| Description | Unravelling and predicting the spatiotemporal structure of infectious disease outbreaks |
| Amount | £99,995 (GBP) |
| Funding ID | SBF004/1080 |
| Organisation | Academy of Medical Sciences (AMS) |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 04/2019 |
| End | 06/2021 |
| Description | Vaccine Efficacy Evaluation for Priority Emerging Diseases |
| Amount | £679,937 (GBP) |
| Funding ID | EPIDZO34 |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2018 |
| End | 03/2022 |
| Description | Vaccine Impact Modelling Consortium (VIMC) - Secretariat |
| Amount | £4,364,371 (GBP) |
| Funding ID | OPP1157270 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 12/2016 |
| End | 10/2022 |
| Description | Vaccine Impact Modelling Consortium (VIMC) - Sub-contracts |
| Amount | £4,788,528 (GBP) |
| Funding ID | PO008511 |
| Organisation | Bill and Melinda Gates Foundation |
| Department | Global Alliance for Vaccination and Immunisation (GAVI) |
| Sector | Charity/Non Profit |
| Country | Switzerland |
| Start | 01/2017 |
| End | 08/2022 |
| Description | Vaccine Impact Modelling Consortium (VIMC) 2.0 |
| Amount | £4,701,481 (GBP) |
| Funding ID | MEL-Imperial-VIMC2-01/09/2022 |
| Organisation | Gavi |
| Sector | Charity/Non Profit |
| Country | Switzerland |
| Start | 09/2022 |
| End | 08/2027 |
| Description | Vaccine Impact Modelling Consortium (VIMC) 2.0 |
| Amount | £4,405,053 (GBP) |
| Funding ID | INV-034281 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 09/2022 |
| End | 08/2027 |
| Description | Vaccine Impact Modelling Consortium research programme on climate change and vaccine-preventable diseases |
| Amount | £3,120,676 (GBP) |
| Funding ID | 226727/Z/22/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2021 |
| End | 08/2027 |
| Description | Validation of New Technologies for Diagnostic Evaluation of Tuberculosis (VANTDET) |
| Amount | £1,212,037 (GBP) |
| Funding ID | 12/65/27 |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2014 |
| End | 12/2017 |
| Description | Wellcome Trust Joint Senior Investiogator Award - Informing strategies for malaria eradication: a combined epidemiological and economics approach |
| Amount | £1,409,484 (GBP) |
| Funding ID | 220900/Z/20/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 01/2021 |
| End | 12/2025 |
| Description | What's the cost of poor quality medicine? Estimating the prevalence, health impact and economic cost of substandard and falsified medicines in Indonesia in the age of UHC |
| Amount | £1,982,131 (GBP) |
| Funding ID | NIHR131145 |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 11/2020 |
| End | 10/2023 |
| Description | Widening real-time genomic infectious disease epidemiology in response to a global pandemic |
| Amount | £19,338 (GBP) |
| Funding ID | C16F2E7C-5912-4ADE-A7C8-67BE6C |
| Organisation | Mozilla |
| Sector | Charity/Non Profit |
| Country | Global |
| Start | 08/2020 |
| End | 12/2020 |
| Description | Work productivity effects of HIV prevention and treatment interventions on populations from endemic settings |
| Amount | £286,454 (GBP) |
| Funding ID | MR/T025409/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 09/2019 |
| End | 09/2022 |
| Description | Zika: A fast new intervention and an innovative method of evaluation |
| Amount | £34,518 (GBP) |
| Funding ID | AID-OAA-F-16-00094 |
| Organisation | United States Agency for International Development |
| Sector | Public |
| Country | United States |
| Start | 10/2016 |
| End | 09/2019 |
| Description | iDSI 2 |
| Amount | £6,063,871 (GBP) |
| Funding ID | OPP1134345 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 05/2018 |
| End | 09/2021 |
| Description | iDSI 2 (DFID Supplement) |
| Amount | £1,506,767 (GBP) |
| Funding ID | OPP1134345 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 04/2017 |
| End | 03/2021 |
| Description | iDSI 2 (DFID Supplement) |
| Amount | £1,982,131 (GBP) |
| Funding ID | NIHR131145 |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 11/2020 |
| End | 10/2023 |
| Title | Development of an individual based model for stochastic simulations of onchocerciasis |
| Description | Individual host model incorporating complex life cycle in humans and vectors to investigate interventions against human onchocerciasis that may require targeting of individuals and/or age sex groups |
| Type Of Material | Model of mechanisms or symptoms - human |
| Year Produced | 2019 |
| Provided To Others? | Yes |
| Impact | This research tool is now being used for; business case for macrofilaricides, development of clinical trial simulators, epidemiological impact of moxidectin, assessment of anti-Wolbachia drugs for the treatment of filariases. |
| URL | https://www.ncbi.nlm.nih.gov/pubmed/?term=hamley%2C+basanez |
| Title | Development of clinical trial simulators to guide clinical development of macrofilaricides |
| Description | Collaboration with Drugs for Neglected Diseases Initiative (Geneva) Adaptation of a stochastic simulation model of transmission to mimic characteristics of clinical trials to help assess; optimal sample sizes, optimal interim and end points, demonstrate superiority or non-inferiority of novel drugs in comparison with current therapies |
| Type Of Material | Model of mechanisms or symptoms - human |
| Year Produced | 2019 |
| Provided To Others? | No |
| Impact | Not known yet Paper under review in Nature Communications |
| Title | HPCs-integrated formulations |
| Description | Generic core and expanded formulations of HIV prevention cascades for use in tracking progress with implementation of efficacious methods of HIV prevention including combination HIV prevention. The core cascade is applied to a population at a given risk of HIV infection and comprises three steps - motivation to use the method(s), accessibility of the method(s), and effective use of the method(s). The core cascade can be used for high-level monitoring and advocacy. The expanded formulation adds factors that can contribute to drop-offs between the main steps in the core cascade which can aid identification of time- and place-specifically appropriate interventions to increase the level of effective use. These cascades can be used in mathematical models to measure the impact of current levels of use of HIV prevention methods on on HIV incidence and evaluate the potential impact of alternative interventions targeted at the different steps in the cascade (i.e. to improve motivation, accessibility and/or effective use). |
| Type Of Material | Model of mechanisms or symptoms - human |
| Year Produced | 2019 |
| Provided To Others? | Yes |
| Impact | This work contributed to a decision by UNAIDS to adopt HIV prevention cascades as an international framework for tracking progress with implementing primary methods of HIV prevention and to produce international guidelines for countries on formulations to use and methods of measurement. |
| Title | HPCs-questionnaire |
| Description | Questionnaire comprising questions to measure and interpret HIV prevention cascades for male and female condoms, pre-exposure prophylaxis, voluntary medical male circumcision, sexual partner reduction and combination HIV prevention in general population surveys. |
| Type Of Material | Model of mechanisms or symptoms - human |
| Year Produced | 2018 |
| Provided To Others? | No |
| Impact | None as yet - the tool is currently being piloted in a large population survey in east Zimbabwe Updated in 2023: Pilot now completed and results being disseminated. |
| Title | Machine Learning methods for Force-of-Infection modelling of Chagas Disease |
| Description | Chagas disease is a long-lasting disease with a prolonged asymptomatic period. Cumulative indices of infection such as prevalence do not shed light on the current epidemiological situation, as they integrate infection over long periods. Instead, metrics such as the Force-of-Infection (FoI) provide information about the rate at which susceptible people become infected and permit sharper inference about temporal changes in infection rates. FoI is estimated by fitting (catalytic) models to available age-stratified serological (ground-truth) data. Predictive FoI modelling frameworks are then used to understand spatial and temporal trends indicative of heterogeneity in transmission and changes effected by control interventions. Ideally, these frameworks should be able to propagate uncertainty and handle spatiotemporal issues. We compared three methods in their ability to propagate uncertainty and provide reliable estimates of FoI for Chagas disease in Colombia as a case study: two Machine Learning (ML) methods (Boosted Regression Trees (BRT) and Random Forest (RF)), and a Linear Model (LM) framework that we had developed previously. Our analyses show consistent results between the three modelling methods under scrutiny. The predictors (explanatory variables) selected, as well as the location of the most uncertain FoI values, were coherent across frameworks. RF was faster than BRT and LM, and provided estimates with fewer extreme values when extrapolating to areas where no ground-truth data were available. However, BRT and RF were less efficient at propagating uncertainty. The choice of FoI predictive models will depend on the objectives of the analysis. ML methods will help characterise the mean behaviour of the estimates, while LM will provide insight into the uncertainty surrounding such estimates. Our approach can be extended to the modelling of FoI patterns in other Chagas disease-endemic countries and to other infectious diseases for which serosurveys are regularly conducted for surveillance. |
| Type Of Material | Model of mechanisms or symptoms - human |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| Impact | This model will be used to populate a pipeline for Chagas disease burden modelling as exemplified for Colombia in the paper submitted at the ned of 2022 to the Philos Trans R Soc B: In 2012, the World Health Organization set the elimination of Chagas disease intradomicilary vectorial transmission as a goal by 2020. After a decade, some progress has been made, but the new 2021-2030 WHO roadmap has set even more ambitious targets. Innovative and robust modelling methods are required to monitor progress towards these goals. We present a modelling pipeline using local seroprevalence data to obtain national disease burden estimates by disease stage. Firstly, local seroprevalence information is used to estimate spatiotemporal trends in the Force-of-Infection (FoI). FoI estimates are then used to predict such trends across larger and finescale geographical areas (using the model methodology described above). Finally, predicted FoI values are used to estimate disease burden based on a disease progression model. Using Colombia as a case study, we estimated that the number of infected people would reach 506,000 (95%CrI= 395,000?648,000) in 2020 with a 1.0% (95%CrI = 0.8%?1.3%) prevalence in the general population and 2,400 (95%CrI = 1,900?3,400) deaths (~0.5% of those infected). The interplay between a decrease in infection exposure (FoI and relative proportion of acute cases) was overcompensated by a large increase in population size and gradual population ageing, leading to an increase in the absolute number of Chagas disease cases over time. It is anticipated that we will be able to use this modelling pipeline in other Chagas disease endemic countries in the region. |
| URL | https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0010594 |
| Title | New method to detect and sequence poliovirus |
| Description | Direct molecular detection and nanopore sequencing of poliovirus |
| Type Of Material | Technology assay or reagent |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | Awarded new grant to evaluate wider use and implementation of new method globally UPDATE 2022: National and Regional poliovirus laboratories are now implementing this method for poliovirus detection. These labs are abel to detect poliovirus outbreaks quicker than using the standard method |
| Title | RDTs-smartphone camera app |
| Description | Smartphone camera application developed by our collaborators on the study on HIV misclassification errors (Global Solutions for Infectious Diseases) to collect and transmit images of the outputs from HIV rapid tests used in routine health services - thereby enabling evaluation by external experts of the quality of outputs from these tests and the accuracy of interpretation of these outputs by local clinic staff. |
| Type Of Material | Physiological assessment or outcome measure |
| Year Produced | 2016 |
| Provided To Others? | No |
| Impact | The tool has enabled us to establish that approximately 50% of false-negative HIV test results occurring in routine health services in Zimbabwe could be due to errors by local clinic staff in reading or recording the outputs from HIV rapid tests. |
| Title | Typhoid Environmental surveillance tools |
| Description | Methods to design and implement typhoid environmental surveillance, including site selection, sample collection and laboratory processinf |
| Type Of Material | Technology assay or reagent |
| Year Produced | 2019 |
| Provided To Others? | Yes |
| Impact | Expansion of environmental surveillance for typhoid |
| URL | https://www.protocols.io/workspaces/typhoides |
| Title | YZ-UHP! survey management portal |
| Description | Portal showing progress with conducting general population surveys on use of HIV prevention methods. |
| Type Of Material | Improvements to research infrastructure |
| Year Produced | 2018 |
| Provided To Others? | No |
| Impact | Improvements in tracking progress against targets and errors/inconsistencies in the data requiring investigation and correction resulting in improved data completeness and quality. |
| Title | A dynamic power-law sexual network model of gonorrhoea outbreaks |
| Description | Generates a dynamic power-law sexual network |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2019 |
| Provided To Others? | Yes |
| Impact | Impacts not yet recognised |
| URL | https://github.com/lwhittles/simdynet |
| Title | AIDS data repository |
| Description | Data repository for national HIV programmes to store AIDS data. Supported by UNAIDs |
| Type Of Material | Database/Collection of data |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | Used by multiple countries to support collation and analysis of HIV data |
| URL | https://adr.unaids.org/ |
| Title | All-India TB Model |
| Description | Model developed in collaboration with India National TB Programme, combining the best available epidemiological and surveillance data to capture India's TB epidemic on a national level. The model now forms the basis for different modelling analyses, conducted by the group, relating to TB in India. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2018 |
| Provided To Others? | Yes |
| Impact | Model is currently being used to help inform India Government on strategic priorities for TB control in the country Updated 2020: model is applied by Indian government for their updated national strategic plan |
| Title | COVID-19 Austria |
| Description | This site gives estimates of the reproduction number of COVID-19 and projections of cases for districts in Austria based on testing data and mortality data. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | No impacts yet |
| URL | https://www.covid19model.at/ |
| Title | COVID-19 Hotspot map Austria (estimates of R and cases). Published January 4, 2021. |
| Description | Valka F, Mishra S, Scott J, Flaxman S, Bhatt S, Gandy A. COVID-19 Hotspot map Austria (estimates of R and cases). Published January 4, 2021. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | https://www.covid19model.at/ |
| URL | https://www.covid19model.at/ |
| Title | COVID-19 LMIC Reports (Future scenarios of the healthcare burden of COVID-19 in Low- or Middle-Income Countries). Published May 8, 2020. |
| Description | The LMIC reports are generated using an age-structured SEIR model. The developed model is an extension of the model used in our previous report (see Report 12) and the source code for the model can be found at https://github.com/mrc-ide/squire. In this model, the infectious class is divided into different stages reflecting progression through different disease severity pathways. Ghani A, Watson O. COVID-19 LMIC Reports (Future scenarios of the healthcare burden of COVID-19 in Low- or Middle-Income Countries). Published May 8, 2020. https://mrc-ide.github.io/global-lmic-reports/ |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | The global fits from this model were used to directly inform WHO estimates of global financial need. The team also directly supported control efforts in 10 countries (Columbia, India, Indonesia, Italy, Malawi, Nigeria, Senegal, Sudan, the United States and Zimbabwe) providing local model reports through academic and public health partners to support government responses. Ongoing. Example: Announcement by New York Governor's Office of Research Partnership with Imperial College London https://www.governor.ny.gov/news/amid-ongoing-covid-19-pandemic-governor-cuomo-announces-state-bringing-international-experts |
| URL | http://mrc-ide.github.io/global-lmic-reports/ |
| Title | COVID-19 NAT-RDT (identify optimal diagnostic testing strategy). |
| Description | Ricks S, Kendall EA, Dowdy DW, Sacks JA, Schumacher SG, Arinaminpathy N. COVID-19 NAT-RDT (identify optimal diagnostic testing strategy). Published January 15, 2021. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | https://covid-ag-rdt.shinyapps.io/model/ |
| URL | https://covid-ag-rdt.shinyapps.io/model/ |
| Title | COVID-19 Orphanhood Trends (webtool to estimate numbers of children affected by COVID-19 and excess deaths during the pandemic). Published July 20, 2021. |
| Description | Hillis S, Unwin J, Cluver L, et al. COVID-19 Orphanhood Trends (webtool to estimate numbers of children affected by COVID-19 and excess deaths during the pandemic). Published July 20, 2021. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | https://imperialcollegelondon.github.io/orphanhood_trends/ |
| URL | https://imperialcollegelondon.github.io/orphanhood_trends/ |
| Title | COVID-19 Orphanhood calculator (realtime minimum estimates for the number of children affected by COVID-19 and excess deaths). Published July 20, 2021. |
| Description | Hillis S, Unwin J, Cluver L, et al. COVID-19 Orphanhood calculator (realtime minimum estimates for the number of children affected by COVID-19 and excess deaths). Published July 20, 2021. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | https://imperialcollegelondon.github.io/orphanhood_calculator |
| URL | https://imperialcollegelondon.github.io/orphanhood_calculator |
| Title | COVID/TB disruption model |
| Description | Model developed to simulate the adverse impact of COVID related disruptions on TB control in different countries |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | Model was used by WHO South East Asia region to inform regional TB strategies at country level Publication in E Clinical Medicine |
| URL | https://beta.avstaging.org/tbcovidapp/ |
| Title | Case Surveillance and Vital Registration (CSAVR) tool |
| Description | Model for the estimation of HIV incidence from case surveillance and AIDS deaths |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2016 |
| Provided To Others? | Yes |
| Impact | Used by 40-60 countries to produce official HIV national statistics |
| Title | Code and the data necessary to run the model and associated Bayesian analysis to estimate SARS-CoV-2 HFR |
| Description | his repository contains the code and the data necessary to run the model and associated Bayesian analysis via Stan in A Brizzi, C Whittaker, LMS Servo et al. "Factors driving extensive spatial and temporal fluctuations in COVID-19 fatality rates in Brazilian hospitals". Imperial College London (06-10-2021), doi https://doi.org/10.25561/91875. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| Impact | This research dataset contains curated hospital admission data, Brazilian registry death data, hospital resource data obtained from the National Register of Health Facilities (processed and redistributed under CC BY-4.0), vaccination data, genomic data, population projections and data on daily burials from Manaus. . |
| URL | https://github.com/CADDE-CENTRE/covid19_brazil_hfr |
| Title | Covid 19 elective care scheduling: |
| Description | Covid 19 elective care scheduling: this tool models optimal weekly scheduling of patient admissions to all hosptials across england Moret S. COVID-19 elective care optimal scheduling tool. Published online July 5, 2021. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | No impacts recognised yet |
| URL | http://github.com/ImperialCollegeLondon/OptimalScheduling4COVID |
| Title | Creation and analysis of clinical trial databases |
| Description | DW3, Gates funded clinical trail for control of soil transmitted helminths. Tumikia - Gates funder clinical trial for control of soil transmitted helminths Geshiyaro - CIFF funded clinical trial for control of schistosomiasis and soil transmitted helminths |
| Type Of Material | Database/Collection of data |
| Year Produced | 2018 |
| Provided To Others? | Yes |
| Impact | Sophisticated analysis of data and scientific publications |
| Title | Data from: Adaptive estimation for epidemic renewal and phylogenetic skyline models |
| Description | Estimating temporal changes in a target population from phylogenetic or count data is an important problem in ecology and epidemiology. Reliable estimates can provide key insights into the climatic and biological drivers influencing the diversity or structure of that population and evidence hypotheses concerning its future growth or decline. In infectious disease applications, the individuals infected across an epidemic form the target population. The renewal model estimates the effective reproduction number, R, of the epidemic from counts of observed incident cases. The skyline model infers the effective population size, N, underlying a phylogeny of sequences sampled from that epidemic. Practically, R measures ongoing epidemic growth while N informs on historical caseload. While both models solve distinct problems, the reliability of their estimates depends on p-dimensional piecewise-constant functions. If p is misspecified, the model might underfit significant changes or overfit noise and promote a spurious understanding of the epidemic, which might misguide intervention policies or misinform forecasts. Surprisingly, no transparent yet principled approach for optimising p exists. Usually, p is heuristically set, or obscurely controlled via complex algorithms. We present a computable and interpretable p-selection method based on the minimum description length (MDL) formalism of information theory. Unlike many standard model selection techniques, MDL accounts for the additional statistical complexity induced by how parameters interact. As a result, our method optimises p so that R and N estimates properly and meaningfully adapt to available data. It also outperforms comparable Akaike and Bayesian information criteria on several classification problems, given minimal knowledge of the parameter space, and exposes statistical similarities among renewal, skyline and other models in biology. Rigorous and interpretable model selection is necessary if trustworthy and justifiable conclusions are to be drawn from piecewise models. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2019 |
| Provided To Others? | Yes |
| URL | http://datadryad.org/stash/dataset/doi:10.5061/dryad.mpg4f4qv6 |
| Title | Data from: Are skyline plot-based demographic estimates overly dependent on smoothing prior assumptions? |
| Description | In Bayesian phylogenetics, the coalescent process provides an informative framework for inferring changes in the effective size of a population from a phylogeny (or tree) of sequences sampled from that population. Popular coalescent inference approaches such as the Bayesian Skyline Plot, Skyride and Skygrid all model these population size changes with a discontinuous, piecewise-constant function but then apply a smoothing prior to ensure that their posterior population size estimates transition gradually with time. These prior distributions implicitly encode extra population size information that is not available from the observed coalescent data i.e. the tree. Here we present a novel statistic, O, to quantify and disaggregate the relative contributions of the coalescent data and prior assumptions to the resulting posterior estimate precision. Our statistic also measures the additional mutual information introduced by such priors. Using O we show that, because it is surprisingly easy to over-parametrise piecewise-constant population models, common smoothing priors can lead to overconfident and potentially misleading inference, even under robust experimental designs. We propose O as a useful tool for detecting when posterior estimate precision is overly reliant on prior choices. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| URL | http://datadryad.org/stash/dataset/doi:10.5061/dryad.1jwstqjs2 |
| Title | Data from: Barrier bednets target malaria vectors and expand the range of usable insecticides |
| Description | Transmission of Plasmodium falciparum malaria parasites occurs when nocturnal Anopheles mosquito vectors feed on human blood. In Africa, where malaria burden is greatest, bednets treated with pyrethroid insecticide were highly effective in preventing mosquito bites and reducing transmission, and essential to achieving unprecedented reductions in malaria until 2015. Since then, progress has stalled and with insecticidal bednets losing efficacy against pyrethroid-resistant Anopheles vectors, methods that restore performance are urgently needed to eliminate any risk of malaria returning to the levels seen prior to their widespread use throughout sub-Saharan Africa. Here we show that the primary malaria vector Anopheles gambiae is targeted and killed by small insecticidal net barriers positioned above a standard bednet, in a spatial region of high mosquito activity but zero contact with sleepers, opening the way for deploying many more insecticides on bednets than currently possible. Tested against wild pyrethroid-resistant Anopheles gambiae in Burkina Faso, pyrethroid bednets with organophosphate barriers achieved significantly higher killing rates than bednets alone. Treated barriers on untreated bednets were equally effective, without significant loss of personal protection. Mathematical modelling of transmission dynamics predicted reductions in clinical malaria incidence with barrier bednets that exceeded those of 'next-generation' nets recommended by WHO against resistant vectors. Mathematical models of mosquito-barrier interactions identified alternative barrier designs to increase performance. Barrier bednets that overcome insecticide resistance are feasible using existing insecticides and production technology, and early implementation of affordable vector control tools is a realistic prospect. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| URL | http://datadryad.org/stash/dataset/doi:10.5061/dryad.hqbzkh1b7 |
| Title | Data from: Effect of culling on individual badger Meles meles behaviour: potential implications for bovine tuberculosis transmission |
| Description | 1. Culling wildlife as a form of disease management can have unexpected and sometimes counterproductive outcomes. In the UK, badgers (Meles meles) are culled in efforts to reduce badger-to-cattle transmission of Mycobacterium bovis, the causative agent of bovine tuberculosis (TB). However, culling has previously been associated with both increased and decreased incidence of M. bovis infection in cattle. 2. The adverse effects of culling have been linked to cull-induced changes in badger ranging, but such changes are not well documented at the individual level. Using GPS-collars, we characterised individual badger behaviour within an area subjected to widespread industry-led culling, comparing it with the same area before culling and with three unculled areas. 3. Culling was associated with a 61% increase (95% CI 27-103%) in monthly home range size, a 39% increase (95% CI 28-51%) in nightly maximum distance from the sett, and a 17% increase (95% CI 11-24%) in displacement between successive GPS-collar locations recorded at 20-minute intervals. Despite travelling further, we found a 91.2 minute (95% CI 67.1-115.3 minute) reduction in the nightly activity time of individual badgers associated with culling. These changes became apparent while culls were ongoing and persisted after culling ended. 4. Expanded ranging in culled areas was associated with individual badgers visiting 45% (95% CI 15-80%) more fields each month, suggesting that surviving individuals had the opportunity to contact more cattle. Moreover, surviving badgers showed a 19.9-fold increase (95% CI 10.8-36.4 increase) in the odds of trespassing into neighbouring group territories, increasing opportunities for intergroup contact. 5. Synthesis and Applications: Badger culling was associated with behavioural changes among surviving badgers which potentially increased opportunities for both badger-to-badger and badger-to-cattle transmission of M. bovis. Furthermore, by reducing the time badgers spent active, culling may have reduced badgers' accessibility to shooters, potentially undermining subsequent population control efforts. Our results specifically illustrate the challenges posed by badger behaviour to cull-based TB control strategies and furthermore, they highlight the negative impacts culling can have on integrated disease control strategies. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2019 |
| Provided To Others? | Yes |
| Title | Database of global coastal conditions |
| Description | Database of coastal conditions - used of infectious disease-climate modelling |
| Type Of Material | Database/Collection of data |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | Forms part of underlying analysis for Lancet Countdown Report |
| Title | Dataset to estimate SARS-CoV-2 seroprevalence in 8 cities in Brazil |
| Description | We provide 4 datasets needed to reproduce the analyses: https://datadryad.org/stash/dataset/doi:10.5061/dryad.dz08kps08. We also provide a dataset containing convalescent plasma donors used to estimate sensitivity; a dataset containing tested samples collected before the beginning of the SARS-CoV-2 pandemic in Brazil; a dataset containing repeat blood donors used to estimate the seroreversion probability curve. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| Impact | This dataset shed light on the attack rates and infection fatality ratio across age-groups in 8 cities in Brazil. |
| URL | https://github.com/CADDE-CENTRE/seroprevalence_eight_cities |
| Title | Develop statistical methods for determining whether a cases of malaria was acquired in the country of detection or imported from abroad. |
| Description | Develop a Bayesian method of taking a persons travel history, details of malaria endemicity and seasonality of transmission and determining the percentage likelihood that the case of malaria was: (1) acquired at home, (2) imported from abroad, (3) imported from another region of the country (4) was of unknown origin. |
| Type Of Material | Data analysis technique |
| Year Produced | 2018 |
| Provided To Others? | No |
| Impact | None as yet |
| Title | EPP-ASM model for estimation HIV epidemic trends |
| Description | The EPP-ASM model is a new demographic-structured model for estimating HIV epidemic trends in sub-Saharan Africa. Compared to previously existing tools, the new model better captures the demographic impacts of the HIV epidemic and improves estimates of recent HIV incidence trends in generalised epidemic settings. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2019 |
| Provided To Others? | Yes |
| Impact | - Model implemented in 2019 version of Spectrum software (v5.73) supported by UNAIDS for global HIV estimates and projections in developed in 2019 (to be published June 2019). - Model and software code utilised for HIV estimation by the Global Burden of Disease study by the Institute for Health Metrics and Evaluation |
| URL | https://github.com/mrc-ide/eppasm |
| Title | Estimating duration of protection provided by antimalarials |
| Description | This analysis code in R software is freely available and can be used to estimate the duration of protection provided after treatment with an antimalarial. The analysis uses Bayesian techniques and adjusts for common confounders. |
| Type Of Material | Data analysis technique |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | Unknown |
| URL | https://github.com/lucyokell/duration_protection_AL_ASAQ |
| Title | Experiments for detection of Plasmodium berghei infected Anopheles stephensi mosquitoes using near-infrared spectroscopy |
| Description | Spectra from uninfected, indected and infectious mosquitoes |
| Type Of Material | Database/Collection of data |
| Year Produced | 2018 |
| Provided To Others? | Yes |
| Impact | None currently |
| URL | https://doi.org/10.5281/zenodo.1001720 |
| Title | Fluscape project dataset |
| Description | Serological data from a study in China |
| Type Of Material | Database/Collection of data |
| Year Produced | 2015 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | http://www.fluscape.org |
| Title | Framework for assessing spatial and temporal fluctuations in hospital fatality rates |
| Description | A novel statistical framework able to characterise and interpret (COVID-19) fatality rates occurring at hospitals. |
| Type Of Material | Data analysis technique |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| Impact | Unknown |
| URL | https://www.nature.com/articles/s41591-022-01807-1 |
| Title | Framework for assessment and characterisation of epidemiological/entomological time-series data |
| Description | A novel method for characterising and analysing epidemiological and entomological time-series data, with a specific focus on characterising dynamical archetypes and elucidating their ecological drivers. |
| Type Of Material | Data analysis technique |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| Impact | Used to analyse the seasonal dynamics of An. stephensi - results are to be presented by invitation at a WHO meeting in March 2023. Formed the basis for an ongoing collaboration with the Malaria Atlas Project who are based at Curtin University, Perth, Australia. |
| URL | https://royalsocietypublishing.org/doi/full/10.1098/rspb.2022.0089 |
| Title | Global COVID-19 LMIC reports |
| Description | COVID-19 has caused large-scale outbreaks in many countries, particularly in Europe and Asia where many countries have experienced a level of healthcare demand that have placed health systems under strain. Many countries, particularly Low- or Middle Income countries (LMICs) (shown below), are at an earlier stage of the epidemic. 26 countries have reported fewer than 100 COVID-19 deaths. However, following the implementation of widespread suppression measures around the world, COVID-19 burden is increasingly becoming concentrated in LMICs. Here we aim to provide each country with an indication of where they are in their epidemic and scenarios of how healthcare demand is likely to vary over the next 28 days. Changes in transmission from today will also shape the next 28 days so these estimates should not be viewed as predictions but scenarios to help countries understand how strategies today are likely to shape the next phase of the epidemic. Specifically, these reports will aim to help countries understand: 1. The total number of COVID-19 infections 2. The expected number of deaths within the next 28 days 3. The number of individuals requiring oxygen or mechanical ventilation in the next 28 days 4. The impact of changing their current intervention policy |
| Type Of Material | Database/Collection of data |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | Database has been used widely by individual country programmes to inform their COVID response and the database has led to the development of WHO software. The outputs were directly included in the WHO Essential Supplies Forecasting Tool. They were also used to support work we undertook for Gavi in estimating the public health impact of COVID-19 vaccines and COVAX. |
| URL | https://mrc-ide.github.io/global-lmic-reports/ |
| Title | Gubbins phylogenetic software |
| Description | Gubbins (Genealogies Unbiased By recomBinations In Nucleotide Sequences) is an algorithm that iteratively identifies loci containing elevated densities of base substitutions while concurrently constructing a phylogeny based on the putative point mutations outside of these regions. Simulations demonstrate the algorithm generates highly accurate reconstructions under realistic models of short-term bacterial evolution, and can be run in only a few hours on alignments of hundreds of bacterial genome sequences. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | [14:52] Croucher, Nicholas J Impact: new version updates the algorithm to use the latest phylogenetic software, to allow for the continuing use of this software, which has already been cited >800 times. |
| URL | https://github.com/sanger-pathogens/gubbins |
| Title | HBV incidence and prevalence |
| Description | Model based estimates of age specific incidence and prevalence forward projections under range of scenarios for implementation of WHO guidelines |
| Type Of Material | Database/Collection of data |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | Not yet recognised |
| Title | HIV model for MSM in the USA |
| Description | Model to look at the impact of HIV treatment and PrEP for MSM in the USA |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2007 |
| Provided To Others? | No |
| Impact | Numerous publications: https://app.dimensions.ai/details/publication/pub.1143331831 Helped in the design of interventions for future clinical trials - hptn 078 , hptn 096 Assistance in monitoring of ending HIV epidemic within USA Assess the impact of CAB : https://www.thelancet.com/pdfs/journals/lanam/PIIS2667-193X(22)00233-2.pdf |
| URL | https://app.dimensions.ai/details/publication/pub.1135470055 |
| Title | HIV model in MSM in SSA |
| Description | Model of HIV among MSM in Benin to assess the impact of PreP |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2022 |
| Provided To Others? | No |
| Impact | The results will inform PreP policy in Benin |
| Title | HIV models for Senegal, Ivory Coast and Mali |
| Description | Models created for UNITAID Atlas project to investigate the impact of HIV self-testing |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | No |
| Impact | Not yet recognised |
| Title | HPV and HIV vaccination model |
| Description | Mathematical model of HIV and HPV transmission to assess HPV vaccination and screening programme for cervical cancer elimination in South Africa. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2019 |
| Provided To Others? | No |
| Impact | Development is still ongoing. As a result of development, funding was received from WHO to carry out further modelling analysis to provide guidance for the vaccination and screening programmes to reach cervical cancer elimination in countries with high HIV prevalence. |
| Title | HSV2 - HIV Model |
| Description | Mathematical model designed to estimate the contribution of HSV2 to HIV transmission and impact of HSV2 vaccination globally |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2019 |
| Provided To Others? | No |
| Impact | Resulted in publications that will inform WHO business investment case for development of HSV2 vaccine |
| Title | Harvard Consortium for the creation of an international Alzheimer's database |
| Description | Drawing together of multiple longitudinal cohort databases |
| Type Of Material | Database/Collection of data |
| Year Produced | 2018 |
| Provided To Others? | No |
| Impact | Publications in 'Brain', 'Neuroscience' and 'Lancet' |
| Title | Household survey in Eastern Zimbawe |
| Description | Conducting a household survey in Eastern Zimbawe to determine HIV risks as part of a 20 year old study. See Manicaland HIV project (.org) |
| Type Of Material | Database/Collection of data |
| Year Produced | 2007 |
| Provided To Others? | No |
| Impact | This has been going on since 2007 and it is on-going |
| Title | Improved reproduction number estimation techniques |
| Description | Developed a real-time method that improves on standard reproduction number estimates, especially at low incidence. It involves a novel application of smoothing theory from engineering. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | Several dashboards and analyses have now adopted this approach. It is available as an open access and easy to use R package. Collaborations have also been resulted from this technique as well as invited talks. Publications: https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1009347 and https://royalsocietypublishing.org/doi/10.1098/rsif.2021.0569 |
| URL | https://github.com/kpzoo/EpiFilter/tree/master |
| Title | International risk of disease spread due to air travel |
| Description | Model to establish the number of exported cases due to air travel during an outbreak. This has been applied to Zika, Yellow Fever and COVID-19. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2018 |
| Provided To Others? | Yes |
| Impact | Model has been used to inform US CDC on the risk of importation of Yellow Fever from Brazil Model is used to advise on the need of travel restrictions and role of travellers vaccinations. Paper published in 2019 in Scientific Reports. |
| URL | https://www.nature.com/articles/s41598-019-56521-9 |
| Title | MARDY - Antifiungal Resistance Database |
| Description | Online database of anti fungal resistance alleles for multiple fungal pathogens |
| Type Of Material | Database/Collection of data |
| Year Produced | 2018 |
| Provided To Others? | Yes |
| Impact | Published in 2018 |
| URL | http://mardy.dide.ic.ac.uk |
| Title | MRIIDS (Mapping the Risk of International Infectious Disease Spread - forecasts case numbers and estimates risk). Published May 12, 2022. |
| Description | Bhatia S, Cori A, Wardle J, et al. MRIIDS (Mapping the Risk of International Infectious Disease Spread - forecasts case numbers and estimates risk). Published May 12, 2022. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| Impact | https://mriids.org/ |
| URL | https://mriids.org/ |
| Title | Malaria socio-economic data |
| Description | qualitative and quantitative data from several West African countries on perceptions of quality, risk, costs and cost effectiveness |
| Type Of Material | Database/Collection of data |
| Year Produced | 2018 |
| Provided To Others? | No |
| Impact | Too early to identify impacts |
| Title | Manicaland - HPCs |
| Description | SQL database comprising data from the baseline general population survey for a study to measure and interpret HIV prevention cascades and to evaluate the impact of novel behavioural economics and community psychology interventions to strengthen these cascades in adolescent girls and young women and their male partners. The database includes HIV infection data obtained from provider-initiated HIV testing and counselling (PITC) and, for those who decline PITC, from laboratory tests conducted using dried blood spots collected in the survey. UPDATE 2021 - data from 2 follow up surveys completed in 2020 and now being added to the database. These data will be used to measure the impact of the interventions. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2018 |
| Provided To Others? | No |
| Impact | None as yet - data collection still in progress |
| Title | Manicaland - cohort |
| Description | SQL database comprising data from 6 rounds of a general population cohort survey in Manicaland, east Zimbabwe, with linked HIV test results |
| Type Of Material | Database/Collection of data |
| Year Produced | 2017 |
| Provided To Others? | Yes |
| Impact | Data describing and interpreting declines in HIV prevalence, HIV incidence and AIDS mortality within the general population over the period 1998 to 2013. Results have been published in more than 200 scientific papers including Science and The Lancet. The findings from the study led to our being requested by UNAIDS to conduct in-depth investigations into the existence and causes of national HIV decline in Zimbabwe. |
| Title | Manicaland - test & treat |
| Description | Database containing data extracted from routine programme records at health centres in three districts of Manicaland province for the periods 6 months prior to and 6 months following the introduction of the 'treat all' policy for people living with HIV infection. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2018 |
| Provided To Others? | No |
| Impact | None as yet. This database was compiled by a PhD student. Papers are currently being drafted for publication. UPDATE 2021 - papers submitted for publication. |
| Title | Mathematical model of HIV prevention cascades |
| Description | Mathematical model of HIV prevention cascades - adaptation of previous model developed at Imperial for the POPART study to incorporate an HIV prevention cascade structure into the model |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | No |
| Impact | Not yet recognised |
| Title | Meningitis bacterial GWAS metadata |
| Description | ENA accessions and sample metadata for pneumococcal samples used in 'Joint sequencing of human and pathogen genomes reveals the genetics underlying susceptibility to and severity of pneumococcal meningitis'.Update: Version 2 removes ERR909292/ERS638983, which has been removed from the ENA due to being identified as being contaminated. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| URL | https://figshare.com/articles/dataset/Meningitis_bacterial_GWAS_metadata/5915314/2 |
| Title | Methodology for spatial mapping |
| Description | Developed two new statistical approaches. One now underpins the local burden of disease project at IHME |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2017 |
| Provided To Others? | Yes |
| Impact | Model results used widely for policy. |
| Title | Metrics for defining the end of an epidemic |
| Description | Developed a mathematical model for assessing the probability that an epidemic is over in real time. This approach provides unique insight into when an infectious disease outbreak may be considered eliminated and can help diagnose biases in end-of-epidemic declarations. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | Open access code available for public use. Couple researchers have contacted me to use this approach. It may also form part of the real-time analyses that Imperial provides to the WHO for outbreak situational awareness. Papers with methods: https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1008478 and https://www.medrxiv.org/content/10.1101/2020.11.23.20236968v2 |
| URL | https://github.com/kpzoo/EpiFilter/tree/new-zealand |
| Title | Mishra S, Scott J, Zhu H, et al. COVID-19 Hotspot map UK (estimates of R and cases). |
| Description | Mishra S, Scott J, Zhu H, et al. COVID-19 Hotspot map UK (estimates of R and cases). doi:10.5281/zenodo.4330647 |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | doi:10.5281/zenodo.4330647 |
| Title | Model of COVID transmission in Zimbabwe |
| Description | Mathematical model projecting likely trends in COVID infections and mortality and impact of alternative interventions in Zimbabwe |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | Results from mathematical modelling used by the Chief coordinator of the national COVID response in the Presidents office in Zimbabwe |
| Title | Model of HIV prevention cascade in East Zimbabwe |
| Description | Individual based model of the transmission dynamics of HIV infection in East Zimbabwe incorporating an HIV prevention cascade framework |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2021 |
| Provided To Others? | No |
| Impact | Not yet recognised |
| URL | http://www.manicalandhivproject.org/resources.html |
| Title | Model to estimate the impact of test and trace programme in UK |
| Description | Mathematical model developed and available on github to estimate the impact of different COVID testing strategies |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | Model used in guidance to UK govt COVID-SAGE group to inform response to COVID-19 pandemic response |
| Title | Molecular Markers of Anti-malaria Partner Drug Resistence |
| Description | Systematic review of mutations in Pfmdr1 |
| Type Of Material | Database/Collection of data |
| Year Produced | 2018 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | https://gh.bmj.com/content/3/5/e000999 |
| Title | Monkeypox genome data |
| Description | Raw sequence genome data from earliest case in Brazil. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| Impact | The publication of raw sequence data from the first mpox case in Brazil aimed to encourage researchers to make data available to the community. |
| URL | https://github.com/CADDE-CENTRE/Monkeypox |
| Title | Multi-locus negative frequency dependent selection model |
| Description | This model describes the multi-locus negative frequency dependent selection model of bacterial population evolution. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2017 |
| Provided To Others? | Yes |
| Impact | This model was described in the original publication (Corander et al 2017 Nat. Ecol. Evol. 1:1950-1960), and has subsequently been used to optimise vaccine designs as a part of current work-in-progress. |
| URL | https://github.com/nickjcroucher/multilocusNFDS/ |
| Title | Nimue: compartmental COVID vaccination model. |
| Description | Nimue is an extension to the squire modelling package that allows vaccination to be included in the COVID 19 compartmental modelling framework. Nimue adds an additional dimension to the squire model, allowing us to track the vaccination status across the modelled population. This allows us to caetgorise people into 4 groups: Unvaccinated - those who have not yet received a vaccinate course; Vaccinated but not protected - those who have received a vaccine course, but are not yet protected buy the vaccine; Vaccinated and protected - those who have received a vaccine course and are protected; Previously vaccinated - those who were previously protected by the vaccinate but are no longer so. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | The nimue modelling has been used to support COVID19 policy decision making at the country and global level. The model underpins work in a number of associated open-access peer-reviewed publications exploring vaccine allocation strategies and the impact of vaccine hesitancy. |
| URL | https://mrc-ide.github.io/nimue/ |
| Title | ONS Excessive Deaths from non COVID-19 |
| Description | ONS excess deaths: This tool provides weekly updates of deaths in England and Wales using publicly available data on the provisional number of deaths registered in the past week from the ONS |
| Type Of Material | Database/Collection of data |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | Tool has been used by advisors to UK cabinet office to understand and report on excess deaths |
| URL | http://j-idea.github.io/ONSdeaths/ |
| Title | Outbreaker2 |
| Description | Tool for reconstructing transmission chains using genomic and epidemiological data |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2018 |
| Provided To Others? | Yes |
| Impact | Tool has been used frequently to support response to epidemics Tool has served as a basis for further refinement from others |
| URL | http://www.repidemicsconsortium.org/outbreaker2/ |
| Title | Pandemic Hospital planning tool |
| Description | Hospital planning tool: this tool calculates how much capacity in terms of beds, staff and ventilators is obtained by implementing healthcare provision interventions affecting the management of patient care in hospitals Christen P, D'Aeth J, Lochen A, et al. Hospital Pandemic Planner. Published online April 23, 2020. http://www.imperial.ac.uk/media/imperial-college/medicine/mrc-gida/2020-04-17-COVID19-Report-15-hospital-planner.xlsm |
| Type Of Material | Database/Collection of data |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | This tool has been developed to assist hospitals in dealing with surges in demands due to the COVID pandemic and to understand which interventions can increase capacity most effectively. This tool has been used by hospitals globally to support treatment of patients during the pandemic. |
| URL | https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.imperial.ac.uk%2Fmedia%2Fimperia... |
| Title | Phylodynamic Subsampling |
| Description | This code and data were used for the analysis presented in "Using multiple sampling strategies to estimate SARS-CoV-2 epidemiological parameters from genomic sequencing data" - https://www.medrxiv.org/content/10.1101/2022.02.04.22270165v1 |
| Type Of Material | Data analysis technique |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| Impact | We found that analysis using unsampled datasets result in the most biased estimates of epidemiological parameters. Sampling strategy choices may be an influential yet neglected component of sequencing analysis pipelines. |
| URL | https://github.com/rhysinward/Phylodynamic-Subsampling |
| Title | PopPUNK |
| Description | PopPUNK is software for bacterial genomic epidemiology. It can rapidly calculate core and accessory distances between genomes, use these distances to cluster genomes, assign clusters to new genomes using an existing database, and produce visualisations of these outputs. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | Impact: release of a new version that extends the application of this algorithm to larger bacterial datasets, and to datasets of non-bacterial pathogens. |
| URL | https://github.com/johnlees/PopPUNK |
| Title | Quantifying noise in epidemic data |
| Description | Fisher information based metric for deciding how much information is contained within an epidemic time series (e.g. of cases or deaths) for estimating epidemic transmissibility. |
| Type Of Material | Data analysis technique |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| Impact | The paper containing the method https://www.nature.com/articles/s43588-022-00313-1 was well received and an accompanying news and views in Nature computational science was published at https://www.nature.com/articles/s43588-022-00319-9 |
| URL | https://github.com/kpzoo/information-in-epidemic-curves |
| Title | Re-parameterisedindividual-based simulation model developed for influenza pandemic planning |
| Description | To support the UK response to the pandemic, an individual-based simulation model developed for influenza pandemic planning was re-parameterised to enable specific policy scenarios to be explored, including home isolation of suspect cases, home quarantine of household members, social distancing and school closures. Working closely with the NHS executive, the model parameter assumptions were aligned with emerging UK data to explicitly output demand on hospital beds and intensive care facilities in the UK. The outputs from this work - summarised in "Report 9" - demonstrated that under even the most stringent mitigation scenarios (whereby transmission is reduced but not interrupted), the UK health service would quickly become overwhelmed. In contrast, suppression strategies, whilst enabling the epidemic to be brought quickly under control, would need to be intermittently sustained until other therapeutic options became available. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | Ongoing. Ferguson NM, Cummings DAT, Fraser C, Cajka JC, Cooley PC, Burke DS (2006) Strategies for mitigating an influenza pandemic. Nature 442(7101):448-452. doi:10.1038/nature04795 Ferguson NM et al. (2020) Report 9 - Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. https://doi.org/10.25561/77482 |
| Title | Renewal-equation based model of pathogen transmission |
| Description | Novel extension to renewal-equation based modelling frameworks enabling inference of prevalence in addition to disease incidence. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| Impact | Unknown |
| URL | https://arxiv.org/abs/2107.05579 |
| Title | Research database for Chagas disease |
| Description | This database is for the DICTUM Platform (Decreasing the Impact of Chagas disease Through Modelling), in collaboration with the Pan American Health Organization. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2022 |
| Provided To Others? | No |
| Impact | The component of the database based in Colombia has already been used to model the Incidence (Force-of-Infection) and Burden of Disease (cardiac morbidity and mortality) for Colombia. The components of the database for Chile and Paraguay are well advanced and we are preparing two sister papers to describe the data. Both serosurvey and entomological data for Chagas disease have been collated with the support of PAHO. Workshops have taken place in these countries for training in data collation and use. |
| URL | https://www.londonntd.org/research/projects-search/estimating-the-burden-of-chagas-disease-and-impac... |
| Title | Research database for lymphatic filariasis |
| Description | Clinical and parasitological outcomes of chemotherapeutic and non-therapeutic interventions. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2021 |
| Provided To Others? | No |
| Impact | Not yet recognised |
| Title | Research database on schistosomiasis and soil-transmitted helminthiases |
| Description | The schistosomiasis and soil-transmitted helminthiases (STHs) research theme aims to pool and make available Individual Patient Data (IPD) from all available studies to address knowledge gaps and improve treatment outcomes for people affected by these diseases. By amalgamating and standardising available individual patient data, the utility of existing resources can be maximised to address priority questions on the treatment of schistosomiasis and STHs, to create a framework to prospectively assemble future studies, to guide the design of future studies, and to make research progress more efficient. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2018 |
| Provided To Others? | No |
| Impact | Update 2022 - Paper published in Wellcome Open Research. Research agenda based upon the availability of data outlined and published |
| URL | https://www.iddo.org/research-themes/schistosomiasis-sths |
| Title | Review of the effectiveness of indoor spraying of insecticide for control of malaria |
| Description | Systematic review of experimental hut trial data |
| Type Of Material | Database/Collection of data |
| Year Produced | 2018 |
| Provided To Others? | Yes |
| Impact | Not known yet |
| Title | Risk averse reproduction numbers |
| Description | Computational framework for processing local reproduction numbers into global metrics of infectious disease transmissibility. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| Impact | None so far but case study on COVID-19 data from the Delta wave of Israel looks promising (and is an example application in the preprint https://www.medrxiv.org/content/10.1101/2022.08.31.22279450v2). |
| URL | https://github.com/kpzoo/risk-averse-R-numbers |
| Title | SARS Coronavirus 2 Phylodynamics |
| Description | Our mission is to advance epidemiological surveillance of COVID19 by studying the evolution of SARS Coronavirus 2. By using publicly available virus genomic data, phylogenetic analysis and advanced population genetic modeling, we aim to shed light on Growth and decline of COVID19 in various populations Epidemic origins The impact of public health interventions Future epidemic trends |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | Not yet recognised |
| URL | http://sarscov2phylodynamics.org/ |
| Title | SARS-CoV-2 non-pharmaceutical interventions in Brazilian municipalities |
| Description | Brazil has one of the fastest-growing COVID-19 epidemics worldwide. Non-pharmaceutical interventions (NPIs) have been adopted on a municipal level, with asynchronous actions taken across 5,568 municipalities and the Federal District. This paper addresses this complexity reporting on a novel dataset with survey responses from 4,027 mayors, 72.3% of the total municipalities in the country. This dataset responds to the urgency to track and share findings on fragmented policies to tackle health crises like the COVID-19 pandemic. Quantifying NPIs can allow for understanding the effectiveness of interventions in reducing transmission. We offer temporal details for a range of measures aimed at generating social distancing as well as when local governments started to relax those measures. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| URL | http://datadryad.org/stash/dataset/doi:10.5061/dryad.vdncjsxs2 |
| Title | SEIR stochastic compartmental model |
| Description | Developed to enable real-time estimates of the state of the epidemic to be evaluated and to provide short-term projections of hospital care demand. This has been fitted to sub-national data from the UK epidemic with updates provided at least weekly to the SPI-M modelling subgroup, SAGE and other government departments. These include estimate of the reproduction number and epidemic growth rate, and medium-term projections number of infections, cases, hospitalisations and deaths in different sub-populations, including care homes. Model-based analyses have also been performed in support of the test- and trace strategy, quantifying the impact of PCR-testing of symptomatic cases (and self-isolation of positive cases), weekly screening of health-care workers and contact tracing on the rate of transmission. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | No |
| Impact | Ongoing. |
| Title | Serosolver R package |
| Description | This R package allows other scientists to investigate the life course of infection of an individual with influenza strains by using serological data from different historical strains gathered at different time points. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | It is being used by other members of the scientific community to support research |
| URL | https://github.com/seroanalytics/serosolver |
| Title | Survey on the effects of COVID on HIV risk behaviours and use of HIV prevention methods in Zimbabwe |
| Description | Data on the effects of COVID on HIV risk behaviours and use of HIV prevention methods in Zimbabwe. 2022 - Additional data on HIV risk behaviour as the covid situation eased. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2021 |
| Provided To Others? | No |
| Impact | Data was used by Zimbabwean government in the application for funds from the Global Fund for their national COVID control programme |
| URL | http://www.manicalandhivproject.org/resources.html |
| Title | Systematic collation of coronavirus cases Internationally and in mainland China |
| Description | Collation fo publically available data from government sources ad media to reconstruct linelist of cases for cases detected outside of China Daily updated case numbers across 33 provinces in China |
| Type Of Material | Database/Collection of data |
| Year Produced | 2020 |
| Provided To Others? | No |
| Impact | Used in COVID-19 response and publciation in MRC reports. |
| Title | Systematic review of key parameters for the WHO R&D priority pathogens |
| Description | Systematic review of key parameters required for mathematical modelling and outbreak analytics for the 9 pathogens identified by WHO as high potential to cause epidemics. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2019 |
| Provided To Others? | No |
| Impact | Not yet recognised, though used to support COVID-19 analysis. |
| Title | TB burden estimation model |
| Description | Model to estimate TB burden in different countries, based on their case reporting data. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | Model now used by WHO to estimate global TB burden in the wake of COVID disruptions. |
| Title | TB service disruption simulator. Published January 14, 2021. |
| Description | WHO SEARO, Arinaminpathy N. TB service disruption simulator. Published January 14, 2021. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | https://beta.avstaging.org/tbcovidapp/ |
| URL | https://beta.avstaging.org/tbcovidapp/ |
| Title | The Imperial HBV Model |
| Description | The open-source code for the model that has undermined our analyses in HBV is now available publicly. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2023 |
| Provided To Others? | Yes |
| Impact | Release of this code has facilitated researchers in other institutions to use the model independently. Enquires received suggest this has been done by at least two groups. |
| URL | https://github.com/mrc-ide/icl-hbv |
| Title | The angular reproduction number |
| Description | A new method for computing a measure of transmissibility that shares common properties with the effective reproduction number but also modulates with changes in the generation time distribution to an extent. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| Impact | None so far but may be applicable as a tool for tracking epidemic spread when the generation time changes considerably. |
| URL | https://github.com/kpzoo/Omega |
| Title | The impact of NTD prevalence and intensity as measured by large scale field studies in Ethiopia, India, Malawi and Benin |
| Description | Assessing the impact of mass drug administration on infection prevalence and intensity |
| Type Of Material | Database/Collection of data |
| Year Produced | 2018 |
| Provided To Others? | No |
| Impact | Refinement of treatment protocols for community wide for NTDs |
| Title | Timing of treatment in severe malaria versus uncomplicated malaria patients: individual patient meta-analysis dataset |
| Description | We did a systematic review and requested data from original studies in order to do a individual patient analysis examining the relationship between different types of severe malaria and delayed treatment. This included 3,989 severe malaria cases and 5780 uncomplicated malaria cases. The data were all shared publicly with permission of our co-authors and collaborators. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | Discussion with Malaria Consortium about interventions to increase the speed of treatment in their Community Health Worker programmes in countries in Africa. |
| URL | https://doi.org/10.1371/journal.pmed.1003359.s032 |
| Title | VGSC Allele Frequencies in African malaria vector species: field data and predictive map grids |
| Description | Geo-located frequencies of genetic markers of insecticide resistance in field sampled mosquitoes. Predictive maps of genetic marker frequencies for nine African countries |
| Type Of Material | Database/Collection of data |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| Impact | Not yet recognised |
| Title | VIMES - Visualisation and monitoring of epidemics |
| Description | A graph-based evidence synthesis approach to detecting outbreak clusters |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2018 |
| Provided To Others? | Yes |
| Impact | Used by PHE to detect outbreak clusters |
| URL | https://github.com/reconhub/vimes |
| Title | Website for snakebite research (VenBank) |
| Description | Interactive web portal for global snakebite epidemiological study |
| Type Of Material | Database/Collection of data |
| Year Produced | 2019 |
| Provided To Others? | Yes |
| Impact | none yet (beta testing) |
| URL | https://venbank.info/ |
| Title | Weekly short term forecasts of COVID-19 deaths in multiple countries. Published April 15, 2020. |
| Description | This weekly report presents forecasts of the reported number of deaths in the week ahead and analysis of case reporting trends (case ascertainment) for countries with active transmission. Bhatia S, Wardle J, Nash R, et al. Weekly short term forecasts of COVID-19 deaths in multiple countries. Published April 15, 2020. https://mrc-ide.github.io/covid19-short-term-forecasts |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | No impacts yet |
| URL | http://mrc-ide.github.io/covid19-short-term-forecasts/index.html#content |
| Title | Window selection methods for renewal processes |
| Description | Developed two approaches (see publications) for choosing the window size for reproduction number inference (and hence model complexity) under renewal or branching process models in epidemiology. Window size determines the smoothness of the estimates of reproduction numbers obtained from incidence curves and these approaches reflect a natural bias-variance trade-off. These methods could also be applied to other problems in population dynamics and ecology, since the renewal process approach generalises the Euler-Lotka equation, which was derived for ecological applications. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | None so far, beyond a clear development of the theory surrounding window sizing. |
| Title | Within host and within community impact of prophylactic and therapeutic monoclonal antibodies for the treatment of COVID-19 |
| Description | Development of monoclonal antibodies. Database in experimental studies - clinical trials expected Dec-22 |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2021 |
| Provided To Others? | No |
| Impact | Not yet recognised |
| Title | Within-host evolution model |
| Description | Compartmental model of within-host recombination between bacteria. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2016 |
| Provided To Others? | Yes |
| Impact | This model was the basis of the publication Croucher et al. (2016) PLoS Biol. 14(3):e1002394. |
| URL | https://github.com/nickjcroucher/mgeTransformation |
| Title | apothecary - SEIR SARS-CoV-2 Transmission Model |
| Description | SEIR transmission model of COVID-19 with an extended clinical component and explicit modelling of pharmaceutical/therapeutic interventions. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| Impact | Used to guide disbursement of COVID-19-related funds for lower and middle-income countries by The Global Fund. |
| URL | https://github.com/mrc-ide/apothecary |
| Title | covid19 forecasts orderly |
| Description | Bhatia S, Wardle J, Nash R, et al. covid19 forecasts orderly. Published online May 10, 2021. https://github.com/mrc-ide/covid19-forecasts-orderly |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | https://github.com/mrc-ide/covid19-forecasts-orderly |
| URL | https://github.com/mrc-ide/covid19-forecasts-orderly |
| Title | covid19model Europe |
| Description | covid19model Europe |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | No impacts yet |
| Title | covid19model USA |
| Description | covid19model USA |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | No impacts yet |
| Title | epihawkes package |
| Description | This package implements Hawkes Process methods for infectious disease modelling. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | Used in paper in Plos Computational biology. |
| URL | https://github.com/mrc-ide/epihawkes |
| Title | https://github.com/j-idea/DAEDALUS-an-integrated-epidemiological-economic-model |
| Description | Doohan P, Hauck K. DAEDALUS (an integrated-epidemiological economic model). Published online November 16, 2020. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | An integrated economic-epidemiological model to project closure strategies differentiated by economic sector for maximizing economic production in the presence of SARS-CoV-2 |
| URL | https://github.com/j-idea/DAEDALUS-an-integrated-epidemiological-economic-model |
| Title | progressionEstimation Rstan package |
| Description | This package uses Bayesian models implemented in stan to estimate the rates at which microbes progress from carriage to disease using case and carrier data. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| Impact | Application of estimates from this package are being used to evaluate alternative vaccination policies. |
| URL | https://github.com/nickjcroucher/progressionEstimation |
| Title | react - Real-time Assessment of Community Transmission (REACT) Study |
| Description | react gives the number of positive COVID-19 samples and total number of samples by region and age group for each of 13 rounds of the survey |
| Type Of Material | Database/Collection of data |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | Data has been used by other research groups, including analyses that has been provided to SAGE to inform government response to COVID-19 pandemic |
| URL | https://github.com/mrc-ide/reactidd/tree/master/inst/extdata/region_age_week_aggregated |
| Title | safir: individual-based model of COVID |
| Description | safir is a model and associated software package that can run individual based stochastic versions of the squire and nimue COVID compartmental models. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | The model has been used to explore complex vaccine allocation, booster-dose and timing strategies. |
| Title | threeMC model |
| Description | Spatiotemporal statistical model for district/sex/age stratified estimates of male circumcision rates and male circumcision coverage from household survey data in sub-Saharan Africa. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| Impact | Implemented in the DMPPT2 modelling used by national HIV programmes in sub-Saharan Africa to do HIV programme targeting and budget allocations. |
| URL | http://github.com/mrc-ide/threemc/ |
| Description | ALPHA Network |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Provision of data from Manicaland, Zimbabwe for use in pooled and comparative analyses of trends and determinants of HIV incidence in sub-Saharan African countries with generalised epidemics in the post-antiretroviral treatment era. Contributions to analyses of the pooled and site-specific data. |
| Collaborator Contribution | The ALPHA Network coordinated by researchers at the LSHTM sourced funding from BMGF for the project, are designing the data analyses to be conducted in the project, and will be organising data analysis workshops and results dissemination activities for the project. |
| Impact | No outputs as yet UPDATE 2021 - publications currently under review. Application submitted to Wellcome Trust for funding support |
| Start Year | 2019 |
| Description | Abdul Latif Jameel Institute for Disease and Emergency Analytics |
| Organisation | Imperial College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | The Jameel Institute brings together researchers from multiple disciplines across the School of Public Health and the College to utilise the expertise in data analytics to help combat disease threats worldwide. The Jameel Institute improves our understanding of diseases across different populations around the world and links governments, research institutions and communities to develop practical and effective long term solutions, shape health policy and deliver better quality of life for all. |
| Collaborator Contribution | Community Jameel is an international organisation tackling some of the world's most urgent issues and challenges, using a pioneering approach grounded in evidence, science, data and technology. Founded by Mohammed Jameel KBE - a graduate of MIT and engineer by training - Community Jameel employs a new approach to achieving impact, by driving scientific and technological breakthroughs and innovations in the fields of education, health and climate. Community Jameel supports programmes, projects and ideas that unlock the power of data, research and AI to understand and address pressing human challenges, with a commitment to evidence-based policymaking in global development. Taking a collaborative approach, Community Jameel partners with major institutions such as MIT and Imperial College London, building platforms for researchers to push the boundaries of their fields and develop new solutions to advance human development. Community Jameel also supports on-the-ground implementation of initiatives with organisations such as Save the Children and the International Rescue Committee. The work enabled and supported by Community Jameel has led to significant new breakthroughs and achievements; including the discovery of the new antibiotic Halicin, critical modelling of the spread of COVID-19, and a Nobel Prize winning approach to global poverty alleviation. |
| Impact | https://www.imperial.ac.uk/jameel-institute/ |
| Start Year | 2019 |
| Description | Academic Collaboration with Dr William Marciel de Souza |
| Organisation | University of Texas at Galveston |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Contributed to analysis and interpretation of chikungunya surveillance data from Brazil. |
| Collaborator Contribution | Provision of and analysis o chikungunya surveillance data from Brazil. |
| Impact | Scientific publication published in The Lancet Microbe |
| Start Year | 2023 |
| Description | Academic Collaboration with Malaria Atlas Project (MAP) |
| Organisation | Telethon Kids Institute |
| Country | Australia |
| Sector | Charity/Non Profit |
| PI Contribution | Working closely with colleagues at MAP to analyse and process a database of malaria seasonality data they have compiled. |
| Collaborator Contribution | Both data collation and analysis. |
| Impact | None yet |
| Start Year | 2023 |
| Description | Academic Research & Capacity Building Partnership with Dr Zulma Cucunuba |
| Organisation | Pontifical Xavierian University |
| Country | Colombia |
| Sector | Academic/University |
| PI Contribution | I have been working closely with Dr Zulma Cucunuba from Javeriana University, Bogota, Colombia and the rest of her team analysing SARS-CoV-2 data (cases, deaths, genomes) generated across the 4 COVID-19 waves the city of Bogota has experienced. Together, we are co-authoring several manuscripts summarising and presenting these results - I've contributed analytical and technical guidance to her and her team, as well as limited supervision of several of her students. Additionally, I helped deliver several lectures and workshops during a visit to Bogota in late 2022, where I supported Dr Cucunuba in delivering materials around mathematical modelling and public health decision making to public health practitioners from the Bogota Secretary of Health. |
| Collaborator Contribution | Our collaboration has involved analysis of the data collated by Dr Cucunuba's team by both myself and members of her team. Dr Cucunuba hosted me for two weeks in late 2022 during which we co-convened and delivered a series of workshops on mathematical modelling and public health decision making. |
| Impact | Outputs: Week-long course of mathematical modelling and public health delivered to the Bogota Secretary of Health; manuscript(s) under preparation for submission to peer-reviewed journal. Interdisciplinary: Epidemiology & Public Health; Mathematical Modelling |
| Start Year | 2022 |
| Description | Academic Research Collaboration with Professor Ester Sabino |
| Organisation | Universidade de São Paulo |
| Country | Brazil |
| Sector | Academic/University |
| PI Contribution | Contributed technical and analytical expertise around mathematical modelling to support and collaborate with Prof Sabino regarding the analysis and exploration of SARS-CoV-2 serological and genomic data her team had generated during the ongoing COVID-19 pandemic. |
| Collaborator Contribution | Genomic and serological data from routine and blood-bank based monitoring of SARS-CoV-2 spread, as well as analysis and insight. |
| Impact | Multiple scientific publications published in Science, eLife and Vaccine amongst other journals. |
| Start Year | 2020 |
| Description | Academic Research Partnership with Dr Jean Paul Carrera |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Working closely with Dr Jean Paul Carerra - a DPhil student at University of Oxford and lead investigator at the Gorgas Institute in Panama. Collaboration has involved joint-analysis of epidemiological and genomic SARS-CoV-2 data collected by Dr Carrera and his team during surveys carried out in Panama; and preparation of scientific manuscript based on the results of the analyses. |
| Collaborator Contribution | As above - Dr Carerra has contributed both data and analyses to the collaboration we have developed together. |
| Impact | Scientific manuscript under preparation, for eventual submission to peer-reviewed journal |
| Start Year | 2022 |
| Description | Academic Research Partnership with Marianne Sinka |
| Organisation | University of Oxford |
| Department | Oxford Hub |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | I have worked closely with Dr Marianne Sinka on a project relating to the seasonal dynamics on Anopheles stephensi, an emergent malaria vector in the Horn of Africa. Our work has focussed on characterising the seasonality of the vector, and the implications of this seasonality for control efforts. We have developed analytical frameworks for characterising seasonal patterns, and then integrating these patterns into mathematical models of malaria transmission. Simulating these models allows assessment of control intervention impact. |
| Collaborator Contribution | Dr Sinka kindly provided several of the data sources required for our project on An. stephensi to be carried out, as well as extensive input, advice and guidance on both the analyses conducted, and the writing up process to convert them into a scientific publication. |
| Impact | Scientific Publication: Whittaker, Charles, et al. "A novel statistical framework for exploring the population dynamics and seasonality of mosquito populations." Proceedings of the Royal Society B 289.1972 (2022): 20220089. Scientific Publication: Whittaker, Charles, et al. "Seasonal Dynamics of Anopheles stephensi and its Implications for Mosquito Detection and Emergent Malaria Control in the Horn of Africa." medRxiv (2022): 2022-09. |
| Start Year | 2021 |
| Description | Access to COVID-19 tools accelerator |
| Organisation | Foundation for Innovative New Diagnostics (FIND) |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Informing the investment case for diagnostics for COVID-19 in LMICs Mathematical modelling |
| Collaborator Contribution | Result dissemination |
| Impact | Not yet recognised |
| Start Year | 2020 |
| Description | Access to COVID-19 tools accelerator |
| Organisation | Global Fund to Fight AIDS, Tuberculosis and Malaria |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Informing the investment case for diagnostics for COVID-19 in LMICs Mathematical modelling |
| Collaborator Contribution | Result dissemination |
| Impact | Not yet recognised |
| Start Year | 2020 |
| Description | African Consortium in Modeling for Effective Vector Control |
| Organisation | African Institute for Mathematical Sciences |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | One of the founders of an African wide consortium to increase the use of mathematical models in controlling malaria. Imperial will provide support for 15 PhD students. |
| Collaborator Contribution | Running a grant provided by the Bill & Melinda Gates Foundation which supports the PhD Programme. |
| Impact | Better planning of malaria control through interactions with multiple national malaria control programmes |
| Start Year | 2022 |
| Description | African Consortium in Modeling for Effective Vector Control |
| Organisation | Centre for Research in Infectious Diseases (CRID) |
| Country | Cameroon |
| Sector | Academic/University |
| PI Contribution | One of the founders of an African wide consortium to increase the use of mathematical models in controlling malaria. Imperial will provide support for 15 PhD students. |
| Collaborator Contribution | Running a grant provided by the Bill & Melinda Gates Foundation which supports the PhD Programme. |
| Impact | Better planning of malaria control through interactions with multiple national malaria control programmes |
| Start Year | 2022 |
| Description | African Consortium in Modeling for Effective Vector Control |
| Organisation | Ifakara Health Institute |
| Country | Tanzania, United Republic of |
| Sector | Charity/Non Profit |
| PI Contribution | One of the founders of an African wide consortium to increase the use of mathematical models in controlling malaria. Imperial will provide support for 15 PhD students. |
| Collaborator Contribution | Running a grant provided by the Bill & Melinda Gates Foundation which supports the PhD Programme. |
| Impact | Better planning of malaria control through interactions with multiple national malaria control programmes |
| Start Year | 2022 |
| Description | African Consortium in Modeling for Effective Vector Control |
| Organisation | Makerere University |
| Country | Uganda |
| Sector | Academic/University |
| PI Contribution | One of the founders of an African wide consortium to increase the use of mathematical models in controlling malaria. Imperial will provide support for 15 PhD students. |
| Collaborator Contribution | Running a grant provided by the Bill & Melinda Gates Foundation which supports the PhD Programme. |
| Impact | Better planning of malaria control through interactions with multiple national malaria control programmes |
| Start Year | 2022 |
| Description | African Consortium in Modeling for Effective Vector Control |
| Organisation | University of Malawi |
| Department | College of Medicine |
| Country | Malawi |
| Sector | Academic/University |
| PI Contribution | One of the founders of an African wide consortium to increase the use of mathematical models in controlling malaria. Imperial will provide support for 15 PhD students. |
| Collaborator Contribution | Running a grant provided by the Bill & Melinda Gates Foundation which supports the PhD Programme. |
| Impact | Better planning of malaria control through interactions with multiple national malaria control programmes |
| Start Year | 2022 |
| Description | African Consortium in Modeling for Effective Vector Control |
| Organisation | University of Yaoundé |
| Country | Cameroon |
| Sector | Academic/University |
| PI Contribution | One of the founders of an African wide consortium to increase the use of mathematical models in controlling malaria. Imperial will provide support for 15 PhD students. |
| Collaborator Contribution | Running a grant provided by the Bill & Melinda Gates Foundation which supports the PhD Programme. |
| Impact | Better planning of malaria control through interactions with multiple national malaria control programmes |
| Start Year | 2022 |
| Description | Alzheimers Disease Epidemiology Research Group (ADERG) |
| Organisation | Erasmus University Rotterdam |
| Country | Netherlands |
| Sector | Academic/University |
| PI Contribution | expertise, intellectual input and the training of staff |
| Collaborator Contribution | expertise, intellectual input and the training of staff, access to data, equipment and facilities. |
| Impact | Scientific publucations |
| Start Year | 2017 |
| Description | Alzheimers Disease Epidemiology Research Group (ADERG) |
| Organisation | MRC Dementias Platform UK |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | expertise, intellectual input and the training of staff |
| Collaborator Contribution | expertise, intellectual input and the training of staff, access to data, equipment and facilities. |
| Impact | Scientific publucations |
| Start Year | 2017 |
| Description | Alzheimers Disease Epidemiology Research Group (ADERG) |
| Organisation | University of Gothenburg |
| Country | Sweden |
| Sector | Academic/University |
| PI Contribution | expertise, intellectual input and the training of staff |
| Collaborator Contribution | expertise, intellectual input and the training of staff, access to data, equipment and facilities. |
| Impact | Scientific publucations |
| Start Year | 2017 |
| Description | Analysing Longitudinal Population cohort data on HIV/AIDS in Africa (ALPHA) Network |
| Organisation | Africa Health Research Institute |
| Country | South Africa |
| Sector | Charity/Non Profit |
| PI Contribution | - Mathematical modelling, demographic analysis, and epidemiological analysis of general population HIV cohort studies in southern and eastern Africa. |
| Collaborator Contribution | - Collection, curation, and analysis of general population HIV cohort studies in southern and eastern Africa - Organization of workshops and support for research dissemination from population cohort study research partners - Methodological training and skills development for scientists based at partner research sites |
| Impact | - Multiple publications in peer reviewed journals: http://alpha.lshtm.ac.uk/publications/ - Inputs to global HIV epidemic estimates and HIV policy at UNAIDS and WHO |
| Start Year | 2013 |
| Description | Analysing Longitudinal Population cohort data on HIV/AIDS in Africa (ALPHA) Network |
| Organisation | Biomedical Research and Training Institute (BRTI) |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | - Mathematical modelling, demographic analysis, and epidemiological analysis of general population HIV cohort studies in southern and eastern Africa. |
| Collaborator Contribution | - Collection, curation, and analysis of general population HIV cohort studies in southern and eastern Africa - Organization of workshops and support for research dissemination from population cohort study research partners - Methodological training and skills development for scientists based at partner research sites |
| Impact | - Multiple publications in peer reviewed journals: http://alpha.lshtm.ac.uk/publications/ - Inputs to global HIV epidemic estimates and HIV policy at UNAIDS and WHO |
| Start Year | 2013 |
| Description | Analysing Longitudinal Population cohort data on HIV/AIDS in Africa (ALPHA) Network |
| Organisation | Kenyan Institute for Medical Research (KEMRI) |
| Country | Kenya |
| Sector | Public |
| PI Contribution | - Mathematical modelling, demographic analysis, and epidemiological analysis of general population HIV cohort studies in southern and eastern Africa. |
| Collaborator Contribution | - Collection, curation, and analysis of general population HIV cohort studies in southern and eastern Africa - Organization of workshops and support for research dissemination from population cohort study research partners - Methodological training and skills development for scientists based at partner research sites |
| Impact | - Multiple publications in peer reviewed journals: http://alpha.lshtm.ac.uk/publications/ - Inputs to global HIV epidemic estimates and HIV policy at UNAIDS and WHO |
| Start Year | 2013 |
| Description | Analysing Longitudinal Population cohort data on HIV/AIDS in Africa (ALPHA) Network |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Department | Alpha Network |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | - Mathematical modelling, demographic analysis, and epidemiological analysis of general population HIV cohort studies in southern and eastern Africa. |
| Collaborator Contribution | - Collection, curation, and analysis of general population HIV cohort studies in southern and eastern Africa - Organization of workshops and support for research dissemination from population cohort study research partners - Methodological training and skills development for scientists based at partner research sites |
| Impact | - Multiple publications in peer reviewed journals: http://alpha.lshtm.ac.uk/publications/ - Inputs to global HIV epidemic estimates and HIV policy at UNAIDS and WHO |
| Start Year | 2013 |
| Description | Analysing Longitudinal Population cohort data on HIV/AIDS in Africa (ALPHA) Network |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Department | Department of Population Health |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | - Mathematical modelling, demographic analysis, and epidemiological analysis of general population HIV cohort studies in southern and eastern Africa. |
| Collaborator Contribution | - Collection, curation, and analysis of general population HIV cohort studies in southern and eastern Africa - Organization of workshops and support for research dissemination from population cohort study research partners - Methodological training and skills development for scientists based at partner research sites |
| Impact | - Multiple publications in peer reviewed journals: http://alpha.lshtm.ac.uk/publications/ - Inputs to global HIV epidemic estimates and HIV policy at UNAIDS and WHO |
| Start Year | 2013 |
| Description | Analysing Longitudinal Population cohort data on HIV/AIDS in Africa (ALPHA) Network |
| Organisation | MRC/UVRI Uganda Research Unit on AIDS |
| Country | Uganda |
| Sector | Public |
| PI Contribution | - Mathematical modelling, demographic analysis, and epidemiological analysis of general population HIV cohort studies in southern and eastern Africa. |
| Collaborator Contribution | - Collection, curation, and analysis of general population HIV cohort studies in southern and eastern Africa - Organization of workshops and support for research dissemination from population cohort study research partners - Methodological training and skills development for scientists based at partner research sites |
| Impact | - Multiple publications in peer reviewed journals: http://alpha.lshtm.ac.uk/publications/ - Inputs to global HIV epidemic estimates and HIV policy at UNAIDS and WHO |
| Start Year | 2013 |
| Description | Analysing Longitudinal Population cohort data on HIV/AIDS in Africa (ALPHA) Network |
| Organisation | Rakai Health Sciences Program |
| Country | Uganda |
| Sector | Public |
| PI Contribution | - Mathematical modelling, demographic analysis, and epidemiological analysis of general population HIV cohort studies in southern and eastern Africa. |
| Collaborator Contribution | - Collection, curation, and analysis of general population HIV cohort studies in southern and eastern Africa - Organization of workshops and support for research dissemination from population cohort study research partners - Methodological training and skills development for scientists based at partner research sites |
| Impact | - Multiple publications in peer reviewed journals: http://alpha.lshtm.ac.uk/publications/ - Inputs to global HIV epidemic estimates and HIV policy at UNAIDS and WHO |
| Start Year | 2013 |
| Description | Analysing nosocomial COVID-19 outbreaks in Switzerland |
| Organisation | University of Geneva |
| Country | Switzerland |
| Sector | Academic/University |
| PI Contribution | Design of methodology Statistical support |
| Collaborator Contribution | Providing data Contextual knowledge |
| Impact | Papers published - Explosive nosocomial outbreak of SARS-CoV-2 in a rehabilitation clinic: the limits of genomics for outbreak reconstruction Journal of Hospital Infection Occupational versus community risk of SARS-CoV-2 infection among employees of a long-term care facility: an observational study Antimicrobial resistance and infection control Reconstruction of transmission chains of SARS-CoV-2 amidst multiple outbreaks in a geriatric acute-care hospital: a combined retrospective epidemiological and genomic study life + Papers in preparation |
| Start Year | 2020 |
| Description | Analysis of SARS-COV2 data |
| Organisation | New York University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Phylogenetic analysis |
| Collaborator Contribution | Data provision Writing of manuscript Dissemination of results |
| Impact | Publication in Genome Research Publication under review |
| Start Year | 2020 |
| Description | Analysis of poliovirus sequence data from Pakistan and Afghanistan |
| Organisation | Institute for Disease Modeling |
| Country | United States |
| Sector | Public |
| PI Contribution | Novel methods for analysing and visualising poliovirus outbreaks based on genetic data |
| Collaborator Contribution | Shared methodology |
| Impact | Visualisation of poliovirus sequence data shared with NIH Pakistan and the Global Polio Eradication Initiative |
| Start Year | 2022 |
| Description | Analysis of the ChadOx1 COVID vaccine clinical trial data |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Novel analysis methods to correct for statistical bias |
| Collaborator Contribution | Provision of clinical trial data |
| Impact | Paper published in Clinical Infectious Diseases |
| Start Year | 2021 |
| Description | Anticipating impact of COVID disruptions on TB burden |
| Organisation | Stop TB Partnership |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Modelling of potential impact of COVID disruptions on TB burden in 3 high burden countries (India, Kenya and Ukraine) and subsequently worked with individual countries to help them estimate likely impact on their TB epidemics. Those countries were Phillippines, Tajekistan and Indonesia. |
| Collaborator Contribution | Provision of data for modelling and validation Coordination of country engagement |
| Impact | Publication in 2020 - E-Clinical medicine and contributed to paper published in Lancet Global Health Country reports produced for the National TB Programmes - these reports were used in their applications for Global Funds, funding Report on disruption to TB programmes was widely circulated and brought attention to the impacts of COVID-19 on other infectious disease control programmes |
| Start Year | 2020 |
| Description | Assessing the potential impact of disruptions due to COVID-19 on HIV among key and lower-risk populations in the largest cities of Cameroon and Benin |
| Organisation | Fred Hutchinson Cancer Research Center (FHCRC) |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Conception Data analysis Mathematical modelling expertise Writing of paper |
| Collaborator Contribution | Writing of paper Interpretation of results and implication |
| Impact | Paper has been accepted for publication in Journal of AIDS |
| Start Year | 2020 |
| Description | Assessing the potential impact of disruptions due to COVID-19 on HIV among key and lower-risk populations in the largest cities of Cameroon and Benin |
| Organisation | National Institutes of Health (NIH) |
| Department | HIV Prevention Trials Network HPTN |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Conception Data analysis Mathematical modelling expertise Writing of paper |
| Collaborator Contribution | Writing of paper Interpretation of results and implication |
| Impact | Paper has been accepted for publication in Journal of AIDS |
| Start Year | 2020 |
| Description | Avian influenza in wild african penguins |
| Organisation | University of Pretoria |
| Department | Faculty of Veterinary Science |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | Statistical and epidemiological design, analysis and interpretation |
| Collaborator Contribution | Provide veterinary expertise Data collection Diagnostic analysis Provide ecological expertise |
| Impact | None reported yet |
| Start Year | 2019 |
| Description | Baylor School of Medicine (Sasirekha Ramani) |
| Organisation | Baylor School |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Lead coordinator on a study and design of clinical study design |
| Collaborator Contribution | Rotavirus virology |
| Impact | Not yet |
| Start Year | 2016 |
| Description | Behaviour and bovine TB |
| Organisation | Cardiff University |
| Department | School of Geography and Planning |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Statistical analysis |
| Collaborator Contribution | Behavioural science expertise |
| Impact | Publication in Vaccine |
| Start Year | 2019 |
| Description | Biomedical Research and Training Institute, Zimbawe |
| Organisation | Biomedical Research and Training Institute (BRTI) |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | Provide Analysis |
| Collaborator Contribution | They provide fieldwork |
| Impact | Awarded a grant with Simon Gregson: Multi-Level Behavioral Economics and Community Psychology Approaches to Strengthen HIV Prevention Cascades in Adolescent Girls and Young Women in East Zimbabwe. |
| Start Year | 2017 |
| Description | Blantyre HIV prevention strategy |
| Organisation | Cooper Smith |
| Country | United States |
| Sector | Private |
| PI Contribution | Modelling expertise Data analysis |
| Collaborator Contribution | Project coordination Secretariat support Data infrastructure and tools Development of strategy documents |
| Impact | Not yet recognised |
| Start Year | 2020 |
| Description | Blantyre HIV prevention strategy |
| Organisation | Georgetown University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Modelling expertise Data analysis |
| Collaborator Contribution | Project coordination Secretariat support Data infrastructure and tools Development of strategy documents |
| Impact | Not yet recognised |
| Start Year | 2020 |
| Description | Blantyre HIV prevention strategy |
| Organisation | Government of Malawi |
| Country | Malawi |
| Sector | Public |
| PI Contribution | Modelling expertise Data analysis |
| Collaborator Contribution | Project coordination Secretariat support Data infrastructure and tools Development of strategy documents |
| Impact | Not yet recognised |
| Start Year | 2020 |
| Description | Blantyre HIV prevention strategy |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Modelling expertise Data analysis |
| Collaborator Contribution | Project coordination Secretariat support Data infrastructure and tools Development of strategy documents |
| Impact | Not yet recognised |
| Start Year | 2020 |
| Description | Blantyre HIV prevention strategy |
| Organisation | Population Services International |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Modelling expertise Data analysis |
| Collaborator Contribution | Project coordination Secretariat support Data infrastructure and tools Development of strategy documents |
| Impact | Not yet recognised |
| Start Year | 2020 |
| Description | Bounds on epidemic control |
| Organisation | Lund University |
| Country | Sweden |
| Sector | Academic/University |
| PI Contribution | Designed models and defined the project and its outputs. |
| Collaborator Contribution | Developed control theoretic techniques for models. |
| Impact | No outputs yet but also gained collaborator buy-in for future projects. |
| Start Year | 2020 |
| Description | Bristol University |
| Organisation | University of Bristol |
| Department | Proteomics Facility |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Modelling, data analysis |
| Collaborator Contribution | Economic analysis and modelling. Supervision of researchers. |
| Impact | Publications on the impact of the Avahan intervention in India. On-going HIV projects funded by linkages. A collaboration HSV 2 vaccination. |
| Description | Building phylodynamic capacity in Botswana |
| Organisation | Botswana Harvard AIDS Institute Partnership |
| Country | Botswana |
| Sector | Academic/University |
| PI Contribution | - Manon Ragonnet spent 3 months at BHP in early 2020, teaching courses in R, phylogenetics and statistics; and organising a multi-day course on Next Generation Sequencing - Manon is supervising two students based in Botswana and has been able to purchase laptops for them through a Research England GCRF grant - One additional student from Botswana has applied for funding from PANGEA (pangea-hiv.org) to spend 12 months at Imperial working with Manon - We have submitted two papers with 3/4 more in preparation |
| Collaborator Contribution | - BHP hosted Manon for 3 months at the lab in Botswana |
| Impact | - NGS course organised (https://www.santheafrica.org/sites/default/files/course-files/course_flyer_ngs_v5.pdf) - One paper submitted to The Journal of Infectious Diseases in January 2021 (published) - One paper summitted to ARHR in Nov 2021 (in review) - 2 asbtracts submitted (to HIV Dynamics + AIDS) - funding received for MSc student to do project supervised by Manon Ragonnet + Erik Volz for one year (through Oxford/PANGEA) |
| Start Year | 2019 |
| Description | Building phylodynamic capacity in Botswana |
| Organisation | University of Oxford |
| Department | Big Data Institute |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | - Manon Ragonnet spent 3 months at BHP in early 2020, teaching courses in R, phylogenetics and statistics; and organising a multi-day course on Next Generation Sequencing - Manon is supervising two students based in Botswana and has been able to purchase laptops for them through a Research England GCRF grant - One additional student from Botswana has applied for funding from PANGEA (pangea-hiv.org) to spend 12 months at Imperial working with Manon - We have submitted two papers with 3/4 more in preparation |
| Collaborator Contribution | - BHP hosted Manon for 3 months at the lab in Botswana |
| Impact | - NGS course organised (https://www.santheafrica.org/sites/default/files/course-files/course_flyer_ngs_v5.pdf) - One paper submitted to The Journal of Infectious Diseases in January 2021 (published) - One paper summitted to ARHR in Nov 2021 (in review) - 2 asbtracts submitted (to HIV Dynamics + AIDS) - funding received for MSc student to do project supervised by Manon Ragonnet + Erik Volz for one year (through Oxford/PANGEA) |
| Start Year | 2019 |
| Description | CADDE Collaboration with INIS Angola |
| Organisation | Ministry of Health |
| Country | Angola |
| Sector | Public |
| PI Contribution | We have trained several members of the Angola Ministry of Health laboratory in the detection and sequencing of mosquito-borne viruses such as dengue and yellow fever, viruses also circulating in Brazil. |
| Collaborator Contribution | Transfer of knowledge and information about ongoing circulation of mosquito-borne viruses. |
| Impact | Genomic sequencing and epidemiological analysis. Outcome was a publication: https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0010255 |
| Start Year | 2020 |
| Description | CDC Outbreak |
| Organisation | Centers for Disease Control and Prevention (CDC) |
| Country | United States |
| Sector | Public |
| PI Contribution | Developing rapid methodologies for analysis of fungal disease outbreaks |
| Collaborator Contribution | Methodological and technological advances |
| Impact | Ongoing manuscript preparation |
| Start Year | 2014 |
| Description | CIFAR Fungal Kingdoms |
| Organisation | Canadian Institute for Advanced Research (CIFAR) |
| Country | Canada |
| Sector | Public |
| PI Contribution | Developed funding application and participated |
| Collaborator Contribution | Developed funding application and participated |
| Impact | One Health: Fungal Pathogens of Humans, Animals, and Plants https://asm.org/a/ASMScience |
| Start Year | 2019 |
| Description | COVID 19 and HIV risk behaviour |
| Organisation | Biomedical Research and Training Institute (BRTI) |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | Secured the funding. Developed the study design protocol and tools/questionnaire. Conducted preliminary data analysis. |
| Collaborator Contribution | BRTI - conducted the data collection. University of Copenhagen - designed qualitative studies. MoH Zimbabwe - advised on the study design. Assisted with interpretation and dissemination of results. |
| Impact | Results being presentation at national and international conferences - Canada, Zimbabwe, South Africa. |
| Start Year | 2020 |
| Description | COVID 19 and HIV risk behaviour |
| Organisation | Ministry of Health and Child Welfare of the Republic of Zimbabwe |
| Country | Zimbabwe |
| Sector | Public |
| PI Contribution | Secured the funding. Developed the study design protocol and tools/questionnaire. Conducted preliminary data analysis. |
| Collaborator Contribution | BRTI - conducted the data collection. University of Copenhagen - designed qualitative studies. MoH Zimbabwe - advised on the study design. Assisted with interpretation and dissemination of results. |
| Impact | Results being presentation at national and international conferences - Canada, Zimbabwe, South Africa. |
| Start Year | 2020 |
| Description | COVID 19 and HIV risk behaviour |
| Organisation | University of Copenhagen |
| Country | Denmark |
| Sector | Academic/University |
| PI Contribution | Secured the funding. Developed the study design protocol and tools/questionnaire. Conducted preliminary data analysis. |
| Collaborator Contribution | BRTI - conducted the data collection. University of Copenhagen - designed qualitative studies. MoH Zimbabwe - advised on the study design. Assisted with interpretation and dissemination of results. |
| Impact | Results being presentation at national and international conferences - Canada, Zimbabwe, South Africa. |
| Start Year | 2020 |
| Description | COVID-19 genomics consortium |
| Organisation | Government of the UK |
| Department | Department of Health and Social Care |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Analysis of data collected from the consortium Mathematical modelling expertise |
| Collaborator Contribution | Data provision Dissemination of results Public engagement |
| Impact | Report to SAGE Publication in Cell Report 42 and paper under review Reports to NERVTAG in December 2020 regarding Kent variant - input to policy decisions |
| Start Year | 2020 |
| Description | COVID-19 genomics consortium |
| Organisation | Public Health England |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Analysis of data collected from the consortium Mathematical modelling expertise |
| Collaborator Contribution | Data provision Dissemination of results Public engagement |
| Impact | Report to SAGE Publication in Cell Report 42 and paper under review Reports to NERVTAG in December 2020 regarding Kent variant - input to policy decisions |
| Start Year | 2020 |
| Description | COVID-19 genomics consortium |
| Organisation | The Wellcome Trust Sanger Institute |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | Analysis of data collected from the consortium Mathematical modelling expertise |
| Collaborator Contribution | Data provision Dissemination of results Public engagement |
| Impact | Report to SAGE Publication in Cell Report 42 and paper under review Reports to NERVTAG in December 2020 regarding Kent variant - input to policy decisions |
| Start Year | 2020 |
| Description | COVID-19 genomics consortium |
| Organisation | University of Cambridge |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Analysis of data collected from the consortium Mathematical modelling expertise |
| Collaborator Contribution | Data provision Dissemination of results Public engagement |
| Impact | Report to SAGE Publication in Cell Report 42 and paper under review Reports to NERVTAG in December 2020 regarding Kent variant - input to policy decisions |
| Start Year | 2020 |
| Description | Capacity building for research in conflict |
| Organisation | King's College London |
| Department | Fondation Peters, King's College London |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | Co-Principle Investigators on the project on capacity building for research in conflict. |
| Collaborator Contribution | Co-Principle Investigators on the project on capacity building for research in conflict. |
| Impact | Papers currently in draft. |
| Start Year | 2018 |
| Description | Capacity building for research in conflict |
| Organisation | University of Cambridge |
| Department | Cambridge Neuroscience |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Co-Principle Investigators on the project on capacity building for research in conflict. |
| Collaborator Contribution | Co-Principle Investigators on the project on capacity building for research in conflict. |
| Impact | Papers currently in draft. |
| Start Year | 2018 |
| Description | Central TB Division, Ministry of Health, Government of India |
| Organisation | Indian Ministry of Health |
| Country | India |
| Sector | Public |
| PI Contribution | Ongoing work with Central TB Division to develop a modelling framework that can help them prioritise their TB control efforts across the country |
| Collaborator Contribution | Developing the analytical framework in collaboration with national TB programme; coordinating with the programme to ensure that the model is maximally applicable; subcontracting additional analytical support from relevant experts in India |
| Impact | Publications in IJTLD and Lancet Global Health |
| Start Year | 2018 |
| Description | Centre for Infectious Disease Research Zambia |
| Organisation | Centre for Infectious Disease Research in Zambia |
| Country | Zambia |
| Sector | Charity/Non Profit |
| PI Contribution | Study design and lab support for a rotavirus study Liaising with funders Grant writing |
| Collaborator Contribution | Running a clinical trial of rotavirus vaccine in Zambia Performance of lab assays Project Management |
| Impact | Successful application for "Human infection challenge vaccine (HIC-vac) network" with Roma Chilengi |
| Start Year | 2018 |
| Description | Cervical Cancer Elimination |
| Organisation | Harvard University |
| Department | Harvard Medical School |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Mathematical modelling expertise and systematic reviews of epidemiological studies |
| Collaborator Contribution | WHO - co-ordinating meetings and leading the initiative. Defining guidelines and co-ordinating media response Harvard University - Modelling analysis Laval - Modelling analysis and providing guidance McGill - Modelling analysis and providing guidance |
| Impact | Numerous publications Informing WHO guidelines for cervical cancer elimination globally Media coverage UPDATE 2021: further publications |
| Start Year | 2018 |
| Description | Cervical Cancer Elimination |
| Organisation | McGill University |
| Department | Department of Epidemiology, Biostatistics and Occupational Health |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Mathematical modelling expertise and systematic reviews of epidemiological studies |
| Collaborator Contribution | WHO - co-ordinating meetings and leading the initiative. Defining guidelines and co-ordinating media response Harvard University - Modelling analysis Laval - Modelling analysis and providing guidance McGill - Modelling analysis and providing guidance |
| Impact | Numerous publications Informing WHO guidelines for cervical cancer elimination globally Media coverage UPDATE 2021: further publications |
| Start Year | 2018 |
| Description | Cervical Cancer Elimination |
| Organisation | University Hospital of Laval University |
| Country | Canada |
| Sector | Hospitals |
| PI Contribution | Mathematical modelling expertise and systematic reviews of epidemiological studies |
| Collaborator Contribution | WHO - co-ordinating meetings and leading the initiative. Defining guidelines and co-ordinating media response Harvard University - Modelling analysis Laval - Modelling analysis and providing guidance McGill - Modelling analysis and providing guidance |
| Impact | Numerous publications Informing WHO guidelines for cervical cancer elimination globally Media coverage UPDATE 2021: further publications |
| Start Year | 2018 |
| Description | Cervical Cancer Elimination |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Mathematical modelling expertise and systematic reviews of epidemiological studies |
| Collaborator Contribution | WHO - co-ordinating meetings and leading the initiative. Defining guidelines and co-ordinating media response Harvard University - Modelling analysis Laval - Modelling analysis and providing guidance McGill - Modelling analysis and providing guidance |
| Impact | Numerous publications Informing WHO guidelines for cervical cancer elimination globally Media coverage UPDATE 2021: further publications |
| Start Year | 2018 |
| Description | Collaboration agreement with National Institute of Health, Italy |
| Organisation | National Institute of Health |
| Country | Italy |
| Sector | Public |
| PI Contribution | Writings of confidential reports Epidemiological modelling expertise |
| Collaborator Contribution | Expert advice on local situation in Italy Advice on policy options under consideration |
| Impact | Confidential reports to support COVID-19 response in Italy |
| Start Year | 2020 |
| Description | Collaboration of understanding the burden of Non-Communicable Diseases on Healthcare Systems |
| Organisation | Malawi Epidemiology & Intervention Research Unit |
| Country | United Kingdom |
| Sector | Learned Society |
| PI Contribution | We have worked with MEIRU to use the data they have published on the prevalence of certain conditions in Malawi to parameterise a model that is being used to assess the impact of these conditions on resource use and health impact in the healthcare system. |
| Collaborator Contribution | Collection and publication of data, and advice in its interpretation and application. |
| Impact | Publications forthcoming |
| Start Year | 2022 |
| Description | Collaboration on integrated economic-epidemiological modelling (Mexico) |
| Organisation | The National Institute of Public Health of Mexico (INSP) |
| Country | Mexico |
| Sector | Academic/University |
| PI Contribution | Modelling of the hypothetical impact of policies to reduce body mass index on COVID-19 infection fatality rates in Mexico |
| Collaborator Contribution | The INSP contributed modelling of the impact of policies on body mass index in Mexico, further the partners contributed data |
| Impact | the project is multidisciplinary, involving disciplines of economics and epidemiology; draft report under preparation; early findings have been presented at an internal seminar at WHO HQ in February 2023 |
| Start Year | 2022 |
| Description | Collaboration with HIV model consortium |
| Organisation | University College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Lead on model comparison exercises |
| Collaborator Contribution | Contribution of results |
| Impact | Presented at CROY conference |
| Start Year | 2020 |
| Description | Collaboration with Natashia Morris, Health GIS Centre, MRC South Africa |
| Organisation | Medical Research Council of South Africa (MRC) |
| Country | South Africa |
| Sector | Public |
| PI Contribution | We have been in discussions with Dr Natashia Morris the Manager Health GIS Centre about how to determine whether a case of malaria identified by routine surveillance was contracted in country or imported from abroad. We have presented our methods and Dr Morris is looking to put into place systems which would allow the probability that a case of malaria was imported to be calculated instead of dichotomous decisions based on personal opinion. |
| Collaborator Contribution | Provided information on data collected by the South African national malaria control programme and other countries in the E8 Partnership. |
| Impact | None as yet. |
| Start Year | 2018 |
| Description | Collaboration with Statistics Denmark |
| Organisation | Statistics Denmark |
| Country | Denmark |
| Sector | Public |
| PI Contribution | In a collaboration with Statistics Denmark (the data science lab) we have gained access to their servers to utilise GPU computation for image processing. The use of images in understanding longitudinal patterns is a key deliverable of my grant and this collaboration will facilitate its completion. |
| Collaborator Contribution | Statistics Denmark has provided computational resources. Under the budget of the grant we had previously listed a large budget for compute, but this will be pushed to later years when needed. |
| Impact | This partnership has resulting in us getting access to novel data |
| Start Year | 2022 |
| Description | Collaboration with the Statens Serum Institut |
| Organisation | The Statens Serum Institute (SSI) |
| Country | Denmark |
| Sector | Public |
| PI Contribution | In collaboration with the SSI my group worked on evaluating Omicron severity in Denmark. Since this initial collaboration with the SSI this partnership has matured into a more formal collaboration. The key individuals at the SSI running this partnership are Henrik Ullam and Tyra Grove Krause. Currently, we are studying the longitudinal speak of SARS-COV2 in Denmark, and the heterogenities in this spread. The SSI has given us access to all genetic records, and these are currently being moved to Statistics Denmark (under Laust Mortensens Data Science Lab) for analysis. The large scale publication from this collaboration will deliver on key aspects including, models for longitudinal spread as well as genetic linkages to risk factors |
| Collaborator Contribution | The SSI has allowed us access to their genetic data pipe lines, and provided staff time in terms of a project manager Christian Anders Wathne Bruhn. The SSI will also provide scientific input throughout the collaboration |
| Impact | This work has resulted in a publication in Lancet Infectious diseases and a commentary in the lancet. |
| Start Year | 2022 |
| Description | Collaborations with WHO Global Hepatitis Unit on viral hepatitis elimination strategies |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | We have been collaborating with the WHO, both at headquarter level and at regional WPRO level on viral hepatitis strategies. Our primary work has focus on the use of applied modelling in guiding public health policy, modelling global targets for elimination, country level work in China and elimination of mother-to-child transmission of HBV. |
| Collaborator Contribution | The WHO provided the contacts and the context of the priority policy questions to be addressed. |
| Impact | Our work has been referenced in the Global Health Sector Strategy on Viral Hepatitis and other policy documents (see other sections of form for further details). We have been invited to national consultations in China and Malaysia on the elimination of mother to child transmission of HBV. Participants of this consultative process included academics, representatives of the health ministries and other key policy makers. |
| Start Year | 2014 |
| Description | Collection of data post-interruption of mass drug administration to assess the impact of COVID-19 on control programmes and validate modelling projections |
| Organisation | University of Energy and Natural Resources |
| Country | Ghana |
| Sector | Academic/University |
| PI Contribution | Assistance with grant submission Project management Mentorship Modelling expertise |
| Collaborator Contribution | Fieldwork Collection of data Liaison with Ghana health services |
| Impact | Paper published in the Transaction of the Royal Society of Tropical Medicine and Hygiene |
| Start Year | 2021 |
| Description | Comparison of mathematical modelling of the world for HBV |
| Organisation | Center for Disease Analysis |
| Country | United States |
| Sector | Public |
| PI Contribution | Provision of modelling expertise |
| Collaborator Contribution | Mathematical modelling expertise |
| Impact | One publication under review Joint contribution to GAVI decision regarding the funding of HBV birth dose Updated 2021: Contribution to guidelines on prevention of mother to child transmission Publications of the investment case in China, including HBV drugs in the national insurance programme |
| Start Year | 2018 |
| Description | Comprehensively profiling social mixing patterns in workplace settings to model pandemic influenza transmissions |
| Organisation | Yale University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Infectious disease dynamics expertise Developing code Data interpretation Writing of papers |
| Collaborator Contribution | Obtained funding Data collection Project management |
| Impact | Not yet |
| Start Year | 2020 |
| Description | Consolidated guidelines on HIV testing services for a changing epidemic |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | - Mathematical modelling of new algorithms and strategies for HIV diagnosis. |
| Collaborator Contribution | - Technical leadership and oversight, production of normative guidance. |
| Impact | - Revised 2019 WHO Consolidated Guidelines on HIV Testing Services - Policy brief: Consolidated guidelines on HIV testing services for a changing epidemic - Policy brief: WHO encourages countries to adapt HIV testing strategies in response to changing epidemic |
| Start Year | 2018 |
| Description | Consultancy to develop guidelines for National Malaria Programmes for stratification, prioritisation and optimised resource allocation within strategic planning |
| Organisation | World Health Organization (WHO) |
| Department | Global Malaria Programme |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | I am developing a document for National Malaria Programmes for stratification, prioritisation and optimised resource allocation within strategic planning as part of a wider drive to use routine malaria surveillance data for operational action. |
| Collaborator Contribution | WHO is providing consultancy pay as well as general guidance and feedback |
| Impact | No outputs to date. |
| Start Year | 2019 |
| Description | Coronab |
| Organisation | Karolinska Institute |
| Country | Sweden |
| Sector | Academic/University |
| PI Contribution | Mathematical modelling Modelling NPIs and anti-virals |
| Collaborator Contribution | Grant applications Networking and collaborations |
| Impact | Publication in Cell Software outputs: https://github.com/robj411/sequencing_coverage https://github.com/robj411/lineageApp |
| Start Year | 2020 |
| Description | Covid 19 mathematical modelling Zimbabwe |
| Organisation | Medical Research Council of Zimbabwe |
| Country | Zimbabwe |
| Sector | Public |
| PI Contribution | Made the Imperial College London SEIR model available for use in Zimbabwe. Provided a research associate, Mike Pickles, to apply the model to Zimbabwe. |
| Collaborator Contribution | Made data available for application of model. Presented model results to key national policy makers on Covid response. |
| Impact | This collaboration has led to establish an infectious disease consortium in Zimbabwe. This collaboration contributed to policy development in the Covid response in Zimbabwe. |
| Start Year | 2020 |
| Description | Covid 19 mathematical modelling Zimbabwe |
| Organisation | National Blood Service Zimbabwe |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | Made the Imperial College London SEIR model available for use in Zimbabwe. Provided a research associate, Mike Pickles, to apply the model to Zimbabwe. |
| Collaborator Contribution | Made data available for application of model. Presented model results to key national policy makers on Covid response. |
| Impact | This collaboration has led to establish an infectious disease consortium in Zimbabwe. This collaboration contributed to policy development in the Covid response in Zimbabwe. |
| Start Year | 2020 |
| Description | Covid 19 mathematical modelling Zimbabwe |
| Organisation | National Institute of Health Research |
| Country | Zimbabwe |
| Sector | Public |
| PI Contribution | Made the Imperial College London SEIR model available for use in Zimbabwe. Provided a research associate, Mike Pickles, to apply the model to Zimbabwe. |
| Collaborator Contribution | Made data available for application of model. Presented model results to key national policy makers on Covid response. |
| Impact | This collaboration has led to establish an infectious disease consortium in Zimbabwe. This collaboration contributed to policy development in the Covid response in Zimbabwe. |
| Start Year | 2020 |
| Description | DAEDALUS project: : integrated economic-epidemiological model for COVID-19 |
| Organisation | Imperial College London |
| Department | Imperial College Business School |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Project lead and management Integration of epidemiological and economic modelling |
| Collaborator Contribution | Economic modelling |
| Impact | MRC-GIDA report 35 |
| Start Year | 2020 |
| Description | DAEDALUS project: : integrated economic-epidemiological model for COVID-19 |
| Organisation | Umea University |
| Department | Umea School of Business, Economics and Statistics (USBE) |
| Country | Sweden |
| Sector | Academic/University |
| PI Contribution | Project lead and management Integration of epidemiological and economic modelling |
| Collaborator Contribution | Economic modelling |
| Impact | MRC-GIDA report 35 |
| Start Year | 2020 |
| Description | DENV seroprevalence surveys and estimating the force of infection in African countries |
| Organisation | Drugs for Neglected Diseases initiative (DNDi) |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Project Management Dat Analysis Mathematical modelling expertise |
| Collaborator Contribution | Organisation of seroprevalence surveys Data collection Management of collaborators Fieldwork |
| Impact | Not et recognised |
| Start Year | 2021 |
| Description | DFID Ebola Situational Reports |
| Organisation | Government of the UK |
| Department | Department for International Development (DfID) |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | We have continued to share reports of the analysis of the ongoing Ebola outbreak in the Democratic Republic of the Congo. This has included projections of future incidence, bed demand, and vaccine demand estimates. |
| Collaborator Contribution | Context for analysis needs e.g. requirements for vaccine demand. |
| Impact | Reports for internal use at DFID and White Hall. |
| Start Year | 2018 |
| Description | Data platforms for Lymphatic Filariasis |
| Organisation | Indian Council of Medical Research (ICMR) |
| Country | India |
| Sector | Public |
| PI Contribution | Systematic reviews to scope papers containing individual patient data on treatments and outcomes for LF globally in general and in India in particular. Training in epidemiological modelling of Indian students during the Short Course on Epidemiology of Infectious Diseases, September 2022, Imperial College. Drafting of papers. |
| Collaborator Contribution | Post-doctoral support at ICMR, drafting of papers. |
| Impact | Paper in preparation, on a Scoping Review of LF data. |
| Start Year | 2021 |
| Description | Data platforms for Lymphatic Filariasis |
| Organisation | Infectious Diseases Data Observatory |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Systematic reviews to scope papers containing individual patient data on treatments and outcomes for LF globally in general and in India in particular. Training in epidemiological modelling of Indian students during the Short Course on Epidemiology of Infectious Diseases, September 2022, Imperial College. Drafting of papers. |
| Collaborator Contribution | Post-doctoral support at ICMR, drafting of papers. |
| Impact | Paper in preparation, on a Scoping Review of LF data. |
| Start Year | 2021 |
| Description | Data platforms for Schistosomiasis and Soil-transmitted Helminthiases |
| Organisation | Infectious Diseases Data Observatory |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Systematic reviews to identify individual patient data in publications on SCH and STH |
| Collaborator Contribution | Data curation, CDISK, Data platform hosted at IDDO, University of Oxford |
| Impact | A research agenda on SCH & STH ha been published in Wellcome Open Res in 2022. |
| Start Year | 2017 |
| Description | Data platforms for Schistosomiasis and Soil-transmitted Helminthiases |
| Organisation | Royal Veterinary College (RVC) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Systematic reviews to identify individual patient data in publications on SCH and STH |
| Collaborator Contribution | Data curation, CDISK, Data platform hosted at IDDO, University of Oxford |
| Impact | A research agenda on SCH & STH ha been published in Wellcome Open Res in 2022. |
| Start Year | 2017 |
| Description | DeWorm3 |
| Organisation | Natural History Museum |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Intellectual input, expertise and the training of staff. |
| Collaborator Contribution | Intellectual input, expertise and the training of staff. |
| Impact | Scientific journal publications in PLoS NTDs, Epidemics, Journal of Theoretical Biology, Lancet and Parasites and Vectors |
| Start Year | 2016 |
| Description | DeWorm3 |
| Organisation | University of Washington |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Intellectual input, expertise and the training of staff. |
| Collaborator Contribution | Intellectual input, expertise and the training of staff. |
| Impact | Scientific journal publications in PLoS NTDs, Epidemics, Journal of Theoretical Biology, Lancet and Parasites and Vectors |
| Start Year | 2016 |
| Description | Detection and Management of Ivermectin Resistance |
| Organisation | McGill University |
| Department | Institute of Parasitology |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Mahematical modelling; preparation of papers; successful preparation of grant proposals |
| Collaborator Contribution | Data on genetic analysis of filarial parasites (lymphatic filariasis, onchocerciasis) for mathematical modelling of the evolution and spread of anthelmintic resistance |
| Impact | Outputs in the form of publications: PubMed ID numbers: 19805362; 19154624; 18382607; 17320006; 16834821. Outcomes in the form of invitations to speak at scientific meetings (Am Soc Trop Med Hyg, December 2008; Royal Society UK-Ghana collaboration, April 2008), and Expert Groups (WHO/World Bank, January 2008). Impacts in the form of invitation to belong to the Disease Reference Group on Helminths, World Health Organization. |
| Description | Detection of SARS-COV2 in sewage (Dhaka, Bangladesh) |
| Organisation | International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) |
| Country | Bangladesh |
| Sector | Public |
| PI Contribution | Statistical analysis and Mathematical analysis of epidemiological and sewage data |
| Collaborator Contribution | Data provision |
| Impact | Not yet |
| Start Year | 2020 |
| Description | Detection of SARS-COV2 in sewage (Dhaka, Bangladesh) |
| Organisation | University of Virginia (UVa) |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Statistical analysis and Mathematical analysis of epidemiological and sewage data |
| Collaborator Contribution | Data provision |
| Impact | Not yet |
| Start Year | 2020 |
| Description | Developing immuno-assays to detect vector salivary antigens for measuring human exposure to vector bites |
| Organisation | Charles University |
| Country | Czech Republic |
| Sector | Academic/University |
| PI Contribution | Preparation of grant submission Data analysis Drafting and reviewing of manuscripts Modelling expertise |
| Collaborator Contribution | Fieldwork Development of assays Drafting and reviewing of papers |
| Impact | Two papers published in PLoS NTDs Paper in preparation |
| Start Year | 2019 |
| Description | Developing immuno-assays to detect vector salivary antigens for measuring human exposure to vector bites |
| Organisation | University of Warwick |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Preparation of grant submission Data analysis Drafting and reviewing of manuscripts Modelling expertise |
| Collaborator Contribution | Fieldwork Development of assays Drafting and reviewing of papers |
| Impact | Two papers published in PLoS NTDs Paper in preparation |
| Start Year | 2019 |
| Description | Developing models to determine the impact of specific non-pharmaceutical interventions |
| Organisation | Imperial College London |
| Department | Department of Mathematics |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Developing models to determine the impact of specific non-pharmaceutical interventions, A collaboration between the School of Public Health and the Department of Mathematicsm Imperial College London. |
| Collaborator Contribution | Developing models to determine the impact of specific non-pharmaceutical interventions, A collaboration between the School of Public Health and the Department of Mathematicsm Imperial College London. |
| Impact | This was used to evaluate the effectiveness of NPIs in Europe [Flaxman S, Mishra S, Gandy A et al. (2020) Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe: Flaxman S, Mishra S, Gandy A et al. (2020) Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature 584 257-261 doi: 10.1038/s41586-020-2405-7 And the US: Unwin HJT, Mishra S, Bradley VC et al. (2020) State-level tracking of COVID-19 in the United States. Nature Comms 11:6189 doi:10.1038/s41467-020-19652-6] With outputs provided on open-access dashboards. |
| Start Year | 2020 |
| Description | Developing monoclonal antibodies for SARS-COV2 |
| Organisation | Leiden University Medical Center |
| Country | Netherlands |
| Sector | Academic/University |
| PI Contribution | Developing models to predict the impact of products in development |
| Collaborator Contribution | Development of monoclonal antibodies - prophylactic and therapeutic |
| Impact | Not yet recognised Paper in draft form |
| Start Year | 2021 |
| Description | Development of Clinical Trial Simulators for Macrofilaricidal Drugs for the Control of Filariases |
| Organisation | Drugs for Neglected Diseases initiative (DNDi) |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Development of clinical trial modelling simulators (paper in preparation) |
| Collaborator Contribution | Meetings to discuss coordination of project |
| Impact | Presentations to the Bill & Melinda Gates Foundation, American Society of Tropical Medicine and Hygiene, paper in preparation |
| Start Year | 2016 |
| Description | Development of a viral kinetic model for Dengue infection |
| Organisation | Johnson & Johnson |
| Department | Janssen Pharmaceuticals |
| Country | United States |
| Sector | Private |
| PI Contribution | The aim of the Project is to develop a viral kinetics model for dengue infection in different species that enables evaluating the impact of a prophylactic intervention and/or therapeutic treatment on dengue infection. The goal is to build a viral kinetics model that has the potential to be translatable between species (mice - non-human primates (NHP) - human). The viral kinetics model will be used to gain more insight in the mechanism of action of the direct anti-viral drug candidates and to inform various stages of the drug development process, e.g. in determining different dosing regimens for upcoming studies. The hands-on modeling will be performed by an employee (post-doctoral research fellow) of the UNIVERSITY and a Global Clinical Pharmacology scientist of JANSSEN internally, under the supervision and scientific guidance from the Dengue development team, employees of Quantitative Sciences within JANSSEN, and appropriate representatives of the UNIVERSITY. |
| Collaborator Contribution | The hands-on modeling will be performed by an employee (post-doctoral research fellow) of the UNIVERSITY and a Global Clinical Pharmacology scientist of JANSSEN internally, under the supervision and scientific guidance from the Dengue development team, employees of Quantitative Sciences within JANSSEN, and appropriate representatives of the UNIVERSITY. |
| Impact | N/A at this stage. |
| Start Year | 2019 |
| Description | Disaggregating the impact of the prior and data on posterior estimate precision in phylodynamic models |
| Organisation | University of Oxford |
| Department | Department of Statistics |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Developing metrics and analytics for assessing whether prior distributions or data contribute more to the observed posterior estimates for coalescent models. This is particularly important since for complex phylodynamics models it can be difficult to assess how much of the posterior conclusions result from prior assumptions. The outputs of this work provide ways of diagnosing when analyses are too reliant on prior distributions. |
| Collaborator Contribution | Practical implementation of the developed theory on existing coalescent models. |
| Impact | Paper on findings published in Systematic Biology at https://academic.oup.com/sysbio/article/71/1/121/6275766 |
| Start Year | 2019 |
| Description | District-level HIV estimation and HIV resource allocation in South Africa |
| Organisation | Government of South Africa |
| Department | Department of Health |
| Country | South Africa |
| Sector | Public |
| PI Contribution | - Statistical modelling of HIV surveillance and program data |
| Collaborator Contribution | - Curation of survey and programme data. - Interpretation and implementation of estimates. |
| Impact | - Official HIV estimates and targets for South Africa HIV programme Further funding from Gates to continue work https://www.hivdata.org.za |
| Start Year | 2019 |
| Description | District-level HIV estimation and HIV resource allocation in South Africa |
| Organisation | Human Sciences Research Council (HSRC) |
| Country | South Africa |
| Sector | Charity/Non Profit |
| PI Contribution | - Statistical modelling of HIV surveillance and program data |
| Collaborator Contribution | - Curation of survey and programme data. - Interpretation and implementation of estimates. |
| Impact | - Official HIV estimates and targets for South Africa HIV programme Further funding from Gates to continue work https://www.hivdata.org.za |
| Start Year | 2019 |
| Description | District-level HIV estimation and HIV resource allocation in South Africa |
| Organisation | University of Cape Town |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | - Statistical modelling of HIV surveillance and program data |
| Collaborator Contribution | - Curation of survey and programme data. - Interpretation and implementation of estimates. |
| Impact | - Official HIV estimates and targets for South Africa HIV programme Further funding from Gates to continue work https://www.hivdata.org.za |
| Start Year | 2019 |
| Description | District-level HIV estimation and HIV resource allocation in South Africa |
| Organisation | Wits Health Consortium |
| Country | South Africa |
| Sector | Private |
| PI Contribution | - Statistical modelling of HIV surveillance and program data |
| Collaborator Contribution | - Curation of survey and programme data. - Interpretation and implementation of estimates. |
| Impact | - Official HIV estimates and targets for South Africa HIV programme Further funding from Gates to continue work https://www.hivdata.org.za |
| Start Year | 2019 |
| Description | Dr. Kounbobr Roch Dabiré of IRSS (Burkina Faso) |
| Organisation | National Center for Scientific and Technological Research (CNRST) |
| Department | Institute of Research in Health Sciences |
| Country | Burkina Faso |
| Sector | Public |
| PI Contribution | We have provided training in the use of spectroscopy and the alalytical methods needed to interpret the results. |
| Collaborator Contribution | Dr Dabiré leads a research team which is extending the methods we have developed to mosquito vectors of malaria in Africa. |
| Impact | Project meeting in London (UK) and Bobo Dioulasso (Burkina Faso). |
| Start Year | 2017 |
| Description | EDCTP South Africa Grant |
| Organisation | University of the Western Cape |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | Contributed phylogenetic analysis and mathematical modelling expertise |
| Collaborator Contribution | Contributed phylogenetic analysis and mathematical modelling expertise Data provision |
| Impact | Not yet recognised |
| Start Year | 2020 |
| Description | EIT Cross KIC Education 2018 - Challenge Based Learning |
| Organisation | Sorbonne University |
| Country | France |
| Sector | Academic/University |
| PI Contribution | co-PI |
| Collaborator Contribution | co-PIs |
| Impact | Climate change and Health MOOC: https://www.futurelearn.com/courses/climate-change-public-health |
| Start Year | 2018 |
| Description | EIT Cross KIC Education 2018 - Challenge Based Learning |
| Organisation | University of Grenoble |
| Country | France |
| Sector | Academic/University |
| PI Contribution | co-PI |
| Collaborator Contribution | co-PIs |
| Impact | Climate change and Health MOOC: https://www.futurelearn.com/courses/climate-change-public-health |
| Start Year | 2018 |
| Description | EIT Cross KIC Education 2018 - Challenge Based Learning |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | co-PI |
| Collaborator Contribution | co-PIs |
| Impact | Climate change and Health MOOC: https://www.futurelearn.com/courses/climate-change-public-health |
| Start Year | 2018 |
| Description | Early warning indicators for resurgence or elimination |
| Organisation | University of Hong Kong |
| Country | Hong Kong |
| Sector | Academic/University |
| PI Contribution | Developed methodology for providing advanced warnings of resurgence or elimination of an epidemic. Part of EpiFilter package (see software tools section). |
| Collaborator Contribution | Provided data for analysis and verified simulation results. |
| Impact | Paper with analyses of multiple waves of COVID-19 in different countries and regions: https://royalsocietypublishing.org/doi/10.1098/rsif.2021.0569 Paper on the limits of resurgence detection: https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1010004 Contribution to projects in Hong Kong university on the influence of super-spreading. Method already being used by different researchers to aid COVID-19 situational awareness. Potential buy-in from collaborators for future studies. |
| Start Year | 2020 |
| Description | Elimination of HBV in China |
| Organisation | Chinese Center for Disease Control and Prevention (China CDC) |
| Country | China |
| Sector | Public |
| PI Contribution | Provision of technical expertise and software for undertaking an analysis on the likelihood of elimination of HBV in China. |
| Collaborator Contribution | Data and a dedicated researcher (PhD student) undertaking this work. |
| Impact | Publication forthcoming |
| Start Year | 2022 |
| Description | Elimination of cervical cancer through vaccination and screening in high HIV prevalence settings: a mathematical modeling and cost effectiveness study |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Modelling expertise Design of the study Data synthesis Provision of staff Data analysis |
| Collaborator Contribution | Modelling expertise Design of the study WHO - Interpretation of results Laval - Technical expertise and model development LSHTM - Interpretation of data and published literature |
| Impact | Not yet recognised |
| Start Year | 2018 |
| Description | Elimination of cervical cancer through vaccination and screening in high HIV prevalence settings: a mathematical modeling and cost effectiveness study |
| Organisation | McGill University |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Modelling expertise Design of the study Data synthesis Provision of staff Data analysis |
| Collaborator Contribution | Modelling expertise Design of the study WHO - Interpretation of results Laval - Technical expertise and model development LSHTM - Interpretation of data and published literature |
| Impact | Not yet recognised |
| Start Year | 2018 |
| Description | Elimination of cervical cancer through vaccination and screening in high HIV prevalence settings: a mathematical modeling and cost effectiveness study |
| Organisation | University of the Witwatersrand |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | Modelling expertise Design of the study Data synthesis Provision of staff Data analysis |
| Collaborator Contribution | Modelling expertise Design of the study WHO - Interpretation of results Laval - Technical expertise and model development LSHTM - Interpretation of data and published literature |
| Impact | Not yet recognised |
| Start Year | 2018 |
| Description | Elimination of cervical cancer through vaccination and screening in high HIV prevalence settings: a mathematical modeling and cost effectiveness study |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Modelling expertise Design of the study Data synthesis Provision of staff Data analysis |
| Collaborator Contribution | Modelling expertise Design of the study WHO - Interpretation of results Laval - Technical expertise and model development LSHTM - Interpretation of data and published literature |
| Impact | Not yet recognised |
| Start Year | 2018 |
| Description | Entomological Adaptive Sampling Advisory Group (EASAG) |
| Organisation | University of California, San Francisco |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | EASAG is a newly formed group led by the University of California, San Francisco's (UCSF) Malaria Elimination Initiative (MEI), working in collaboration with the University of Notre Dame, Lancaster University, and the National Malaria Programs and Partners from Mozambique and Nigeria aiming to develop, pilot, and evaluate a spatiotemporal model-based entomological adaptive sampling framework (EASF). The project is funded by the Bill & Melinda Gates Foundation, and will run for the period of July 2021-March 2024. I have been invited as an advisory member to help provide technical expertise on the statistical modelling and protocol, brainstorm adaptive sampling and link findings to other platforms which could include the MINT webtool designed as part of the deliverables of the UKRI FLF award. I look forward to the first virtual meeting to be held in April. |
| Collaborator Contribution | The group has identified that using adaptive surveillance sampling methods could produce better data for decision making. The key question asks whether the EASF's sampling strategies can improve the accuracy and efficiently of surveillance efforts to capture spatial and temporal changes in vector species compositions, behavior and insecticide resistance relative to current approaches over two transmission seasons in Mozambique and Nigeria. This has potential to better protect communities within countries suffering high burdens of malaria parasite infections, illness and deaths by optimising surveillance data methods for decision makers. |
| Impact | The project has just begun. |
| Start Year | 2021 |
| Description | Epidemiology and Control of Cystic Echinococcosis in Argentina and Peru |
| Organisation | National University of Río Negro |
| Country | Argentina |
| Sector | Academic/University |
| PI Contribution | Participation in and presentations at Newton Fund Workshop in Lima, September 2018 Updated February 2020: Joint supervision of MSc Epidemiology student at Imperial College London and external supervision of a PhD student at the University of Surrey |
| Collaborator Contribution | Convening and organisation of Newton Fund Workshop Updated February 2020: Joint supervision of MSc Epidemiology student at Imperial College London and external supervision of a PhD student at the University of Surrey |
| Impact | Multidisciplinary collaboration: epidemiologists, veterinarians, parasitologists, mathematical modellers Update 2022/2023 - this collaboration has led to expansion of the work to include Argentina. Paper was published in One Health on data collected from Argentina. Another paper was published in Data in Brief regarding diagnostic tools for this disease in livestock (2022), and publication of a scoping review for economic evaluations of cystic echinococcosis control strategies in zoonotic hosts (2022). |
| Start Year | 2018 |
| Description | Epidemiology and Control of Cystic Echinococcosis in Argentina and Peru |
| Organisation | National University of San Marcos |
| Country | Peru |
| Sector | Academic/University |
| PI Contribution | Participation in and presentations at Newton Fund Workshop in Lima, September 2018 Updated February 2020: Joint supervision of MSc Epidemiology student at Imperial College London and external supervision of a PhD student at the University of Surrey |
| Collaborator Contribution | Convening and organisation of Newton Fund Workshop Updated February 2020: Joint supervision of MSc Epidemiology student at Imperial College London and external supervision of a PhD student at the University of Surrey |
| Impact | Multidisciplinary collaboration: epidemiologists, veterinarians, parasitologists, mathematical modellers Update 2022/2023 - this collaboration has led to expansion of the work to include Argentina. Paper was published in One Health on data collected from Argentina. Another paper was published in Data in Brief regarding diagnostic tools for this disease in livestock (2022), and publication of a scoping review for economic evaluations of cystic echinococcosis control strategies in zoonotic hosts (2022). |
| Start Year | 2018 |
| Description | Epidemiology and Control of Cystic Echinococcosis in Argentina and Peru |
| Organisation | University of Surrey |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Participation in and presentations at Newton Fund Workshop in Lima, September 2018 Updated February 2020: Joint supervision of MSc Epidemiology student at Imperial College London and external supervision of a PhD student at the University of Surrey |
| Collaborator Contribution | Convening and organisation of Newton Fund Workshop Updated February 2020: Joint supervision of MSc Epidemiology student at Imperial College London and external supervision of a PhD student at the University of Surrey |
| Impact | Multidisciplinary collaboration: epidemiologists, veterinarians, parasitologists, mathematical modellers Update 2022/2023 - this collaboration has led to expansion of the work to include Argentina. Paper was published in One Health on data collected from Argentina. Another paper was published in Data in Brief regarding diagnostic tools for this disease in livestock (2022), and publication of a scoping review for economic evaluations of cystic echinococcosis control strategies in zoonotic hosts (2022). |
| Start Year | 2018 |
| Description | Epidemiology and Control of Schistosomiasis and Soil-Transmitted Helminthiasis |
| Organisation | University of Cambridge |
| Department | University of Cambridge, BBSRC IGF Drosophila Genomics Facility |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Supervision of PhD students, in UK (together with the Schistosomiasis Control Initiative and the Royal Veterinary College) and Australia, for the analysis of data and preparation of joint publications |
| Collaborator Contribution | Sharing of parasitological and epidemiological data pre- and post-implementation of control interventions based on anthelmintic chemotherapy in Africa for joint analysis through shared students |
| Impact | Publications in peer-review journals |
| Description | Epidemiology and Control of Schistosomiasis and Soil-Transmitted Helminthiasis |
| Organisation | University of Queensland |
| Department | University of Queensland Diamantina Institute |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Supervision of PhD students, in UK (together with the Schistosomiasis Control Initiative and the Royal Veterinary College) and Australia, for the analysis of data and preparation of joint publications |
| Collaborator Contribution | Sharing of parasitological and epidemiological data pre- and post-implementation of control interventions based on anthelmintic chemotherapy in Africa for joint analysis through shared students |
| Impact | Publications in peer-review journals |
| Description | Epidemiology and Control of Taeniasis/Cysticercosis |
| Organisation | Government of Madagascar |
| Country | Madagascar |
| Sector | Public |
| PI Contribution | Preparation of joint manuscripts; presentations of talks and posters (e.g. ASTMH); organisation of a workshop on modelling comparison and data needs (EPICYST and CYSTISIM) to take place at Imperial College in March 2019 Updated January 2020 - Workshop occured 26-27 April 2019 at Imperial College London. Paper published in Bulletin of the WHO as a result of workshop. Preparation of joint manuscripts |
| Collaborator Contribution | Preparation of joint manuscripts Updated January 2020 Contribution to preparation of joint presentation to the WHO meeting in April 2019 as part of the consultation for setting the new road map for NTDs for 2021-2030. |
| Impact | Publications under review (e.g. in PLoS Neglected Tropical Diseases) and in preparation. Updated February 2020: Publications in Bulletin of WHO, Open Gates Research (2019) Paper under review in Scientific Reports Update for 2022/23: Papers published in Scientific Reports (2020); Advances in Parasitology (2021); Trop Med Int Health (2021); Parasites & Vectors (2021); Gates Open Research (2022); eLife (2022). Paper in preparation (age-structured EPICYST mathematical model) to be submitted to NTD Modelling Consortium Collection in Journal of Infectious Diseases (anticipated submission date end of March 2023). |
| Start Year | 2017 |
| Description | Epidemiology and Control of Taeniasis/Cysticercosis |
| Organisation | Imperial College London |
| Department | Schistosomiasis Control Initiative (SCI) |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | Preparation of joint manuscripts; presentations of talks and posters (e.g. ASTMH); organisation of a workshop on modelling comparison and data needs (EPICYST and CYSTISIM) to take place at Imperial College in March 2019 Updated January 2020 - Workshop occured 26-27 April 2019 at Imperial College London. Paper published in Bulletin of the WHO as a result of workshop. Preparation of joint manuscripts |
| Collaborator Contribution | Preparation of joint manuscripts Updated January 2020 Contribution to preparation of joint presentation to the WHO meeting in April 2019 as part of the consultation for setting the new road map for NTDs for 2021-2030. |
| Impact | Publications under review (e.g. in PLoS Neglected Tropical Diseases) and in preparation. Updated February 2020: Publications in Bulletin of WHO, Open Gates Research (2019) Paper under review in Scientific Reports Update for 2022/23: Papers published in Scientific Reports (2020); Advances in Parasitology (2021); Trop Med Int Health (2021); Parasites & Vectors (2021); Gates Open Research (2022); eLife (2022). Paper in preparation (age-structured EPICYST mathematical model) to be submitted to NTD Modelling Consortium Collection in Journal of Infectious Diseases (anticipated submission date end of March 2023). |
| Start Year | 2017 |
| Description | Epidemiology and Control of Taeniasis/Cysticercosis |
| Organisation | Institute of Tropical Medicine Antwerp |
| Country | Belgium |
| Sector | Academic/University |
| PI Contribution | Preparation of joint manuscripts; presentations of talks and posters (e.g. ASTMH); organisation of a workshop on modelling comparison and data needs (EPICYST and CYSTISIM) to take place at Imperial College in March 2019 Updated January 2020 - Workshop occured 26-27 April 2019 at Imperial College London. Paper published in Bulletin of the WHO as a result of workshop. Preparation of joint manuscripts |
| Collaborator Contribution | Preparation of joint manuscripts Updated January 2020 Contribution to preparation of joint presentation to the WHO meeting in April 2019 as part of the consultation for setting the new road map for NTDs for 2021-2030. |
| Impact | Publications under review (e.g. in PLoS Neglected Tropical Diseases) and in preparation. Updated February 2020: Publications in Bulletin of WHO, Open Gates Research (2019) Paper under review in Scientific Reports Update for 2022/23: Papers published in Scientific Reports (2020); Advances in Parasitology (2021); Trop Med Int Health (2021); Parasites & Vectors (2021); Gates Open Research (2022); eLife (2022). Paper in preparation (age-structured EPICYST mathematical model) to be submitted to NTD Modelling Consortium Collection in Journal of Infectious Diseases (anticipated submission date end of March 2023). |
| Start Year | 2017 |
| Description | Epidemiology and Control of Taeniasis/Cysticercosis |
| Organisation | Royal Veterinary College (RVC) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Preparation of joint manuscripts; presentations of talks and posters (e.g. ASTMH); organisation of a workshop on modelling comparison and data needs (EPICYST and CYSTISIM) to take place at Imperial College in March 2019 Updated January 2020 - Workshop occured 26-27 April 2019 at Imperial College London. Paper published in Bulletin of the WHO as a result of workshop. Preparation of joint manuscripts |
| Collaborator Contribution | Preparation of joint manuscripts Updated January 2020 Contribution to preparation of joint presentation to the WHO meeting in April 2019 as part of the consultation for setting the new road map for NTDs for 2021-2030. |
| Impact | Publications under review (e.g. in PLoS Neglected Tropical Diseases) and in preparation. Updated February 2020: Publications in Bulletin of WHO, Open Gates Research (2019) Paper under review in Scientific Reports Update for 2022/23: Papers published in Scientific Reports (2020); Advances in Parasitology (2021); Trop Med Int Health (2021); Parasites & Vectors (2021); Gates Open Research (2022); eLife (2022). Paper in preparation (age-structured EPICYST mathematical model) to be submitted to NTD Modelling Consortium Collection in Journal of Infectious Diseases (anticipated submission date end of March 2023). |
| Start Year | 2017 |
| Description | Epidemiology and Control of Taeniasis/Cysticercosis |
| Organisation | Technical University of Munich |
| Country | Germany |
| Sector | Academic/University |
| PI Contribution | Preparation of joint manuscripts; presentations of talks and posters (e.g. ASTMH); organisation of a workshop on modelling comparison and data needs (EPICYST and CYSTISIM) to take place at Imperial College in March 2019 Updated January 2020 - Workshop occured 26-27 April 2019 at Imperial College London. Paper published in Bulletin of the WHO as a result of workshop. Preparation of joint manuscripts |
| Collaborator Contribution | Preparation of joint manuscripts Updated January 2020 Contribution to preparation of joint presentation to the WHO meeting in April 2019 as part of the consultation for setting the new road map for NTDs for 2021-2030. |
| Impact | Publications under review (e.g. in PLoS Neglected Tropical Diseases) and in preparation. Updated February 2020: Publications in Bulletin of WHO, Open Gates Research (2019) Paper under review in Scientific Reports Update for 2022/23: Papers published in Scientific Reports (2020); Advances in Parasitology (2021); Trop Med Int Health (2021); Parasites & Vectors (2021); Gates Open Research (2022); eLife (2022). Paper in preparation (age-structured EPICYST mathematical model) to be submitted to NTD Modelling Consortium Collection in Journal of Infectious Diseases (anticipated submission date end of March 2023). |
| Start Year | 2017 |
| Description | Epidemiology and Control of Taeniasis/Cysticercosis |
| Organisation | The Statens Serum Institute (SSI) |
| Country | Denmark |
| Sector | Public |
| PI Contribution | Preparation of joint manuscripts; presentations of talks and posters (e.g. ASTMH); organisation of a workshop on modelling comparison and data needs (EPICYST and CYSTISIM) to take place at Imperial College in March 2019 Updated January 2020 - Workshop occured 26-27 April 2019 at Imperial College London. Paper published in Bulletin of the WHO as a result of workshop. Preparation of joint manuscripts |
| Collaborator Contribution | Preparation of joint manuscripts Updated January 2020 Contribution to preparation of joint presentation to the WHO meeting in April 2019 as part of the consultation for setting the new road map for NTDs for 2021-2030. |
| Impact | Publications under review (e.g. in PLoS Neglected Tropical Diseases) and in preparation. Updated February 2020: Publications in Bulletin of WHO, Open Gates Research (2019) Paper under review in Scientific Reports Update for 2022/23: Papers published in Scientific Reports (2020); Advances in Parasitology (2021); Trop Med Int Health (2021); Parasites & Vectors (2021); Gates Open Research (2022); eLife (2022). Paper in preparation (age-structured EPICYST mathematical model) to be submitted to NTD Modelling Consortium Collection in Journal of Infectious Diseases (anticipated submission date end of March 2023). |
| Start Year | 2017 |
| Description | Epidemiology and Control of Taeniasis/Cysticercosis |
| Organisation | University of Ghent |
| Country | Belgium |
| Sector | Academic/University |
| PI Contribution | Preparation of joint manuscripts; presentations of talks and posters (e.g. ASTMH); organisation of a workshop on modelling comparison and data needs (EPICYST and CYSTISIM) to take place at Imperial College in March 2019 Updated January 2020 - Workshop occured 26-27 April 2019 at Imperial College London. Paper published in Bulletin of the WHO as a result of workshop. Preparation of joint manuscripts |
| Collaborator Contribution | Preparation of joint manuscripts Updated January 2020 Contribution to preparation of joint presentation to the WHO meeting in April 2019 as part of the consultation for setting the new road map for NTDs for 2021-2030. |
| Impact | Publications under review (e.g. in PLoS Neglected Tropical Diseases) and in preparation. Updated February 2020: Publications in Bulletin of WHO, Open Gates Research (2019) Paper under review in Scientific Reports Update for 2022/23: Papers published in Scientific Reports (2020); Advances in Parasitology (2021); Trop Med Int Health (2021); Parasites & Vectors (2021); Gates Open Research (2022); eLife (2022). Paper in preparation (age-structured EPICYST mathematical model) to be submitted to NTD Modelling Consortium Collection in Journal of Infectious Diseases (anticipated submission date end of March 2023). |
| Start Year | 2017 |
| Description | Epidemiology of Onchocerciasis and Loiasis in Central Africa |
| Organisation | University of Montpellier |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Preparation of joint publications and research proposals that have been successfully funded (e.g. Royal Society) |
| Collaborator Contribution | Sharing of data for joint analysis of parasitological and epidemiological features of infections caused by Onchocerca volvulus and Loa loa |
| Impact | Publications in peer-review journals; reports for World Health Organization (on Alternative Treatment Strategies for onchocerciasis). See also presence in London Centre for Neglected Tropical Disease Research: https://www.londonntd.org/research/projects-search/developing-models-of-loiasis-transmission-to-inform-control-of-the-disease |
| Description | Epidemiology of Onchocerciasis and Loiasis in Central Africa |
| Organisation | University of Yaoundé |
| Country | Cameroon |
| Sector | Academic/University |
| PI Contribution | Preparation of joint publications and research proposals that have been successfully funded (e.g. Royal Society) |
| Collaborator Contribution | Sharing of data for joint analysis of parasitological and epidemiological features of infections caused by Onchocerca volvulus and Loa loa |
| Impact | Publications in peer-review journals; reports for World Health Organization (on Alternative Treatment Strategies for onchocerciasis). See also presence in London Centre for Neglected Tropical Disease Research: https://www.londonntd.org/research/projects-search/developing-models-of-loiasis-transmission-to-inform-control-of-the-disease |
| Description | Estimating reproduction numbers at small scales |
| Organisation | University of Warwick |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Developing methodology and mathematical frameworks for thinking about epidemic spread at small scales (e.g. at events). |
| Collaborator Contribution | Contributing expertise in mathematical modelling towards developing our inference framework. |
| Impact | Currently preparing a preprint with preliminary results. |
| Start Year | 2022 |
| Description | Estimating the potential impact of COVID-19-related disruptions on HIV incidence and mortality among men who have sex with men in the United States: a modelling study |
| Organisation | Fred Hutchinson Cancer Research Center (FHCRC) |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Writing of paper for publication Conception Data analysis Mathematical modelling expertise |
| Collaborator Contribution | Writing of paper for publication Interpretation of results |
| Impact | Paper submitted for publication in Lancet:HIV |
| Start Year | 2020 |
| Description | Ethics in universal health coverage |
| Organisation | University of Stellenbosch |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | Principle investigator for the research project on ethics in universal health coverage. |
| Collaborator Contribution | Co-principle investigator for the research project on ethics in universal health coverage. |
| Impact | Conference presentations, publications in process. |
| Start Year | 2018 |
| Description | Ethics in universal health coverage |
| Organisation | University of the Witwatersrand |
| Department | Wits Reproductive Health and HIV Institute |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | Principle investigator for the research project on ethics in universal health coverage. |
| Collaborator Contribution | Co-principle investigator for the research project on ethics in universal health coverage. |
| Impact | Conference presentations, publications in process. |
| Start Year | 2018 |
| Description | Event triggered end-of-epidemic declarations |
| Organisation | University of Oxford |
| Department | Mathematical Institute Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Developed a method for declaring infectious disease epidemics over that is event triggered (depends on an informative trigger signal) as opposed to the WHO time-triggered approach (depends on waiting a deterministic amount of time). |
| Collaborator Contribution | Provided guidance on designing some of the simulations |
| Impact | Paper published now in PLOS Computational Biology, provides clear guidelines on biases that may affect the declaration of the end of an epidemic. Method under consideration for use as part of the weekly reports/analyses provided by Imperial College London to the WHO for Ebola virus disease. |
| Start Year | 2019 |
| Description | Evolutionary epidemiology of respiratory bacterial pathogens |
| Organisation | The Wellcome Trust Sanger Institute |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | Imperial team are processing microbiological samples and providing modelling expertise of data |
| Collaborator Contribution | Sequencing of data Provision of samples |
| Impact | Not yet recognised |
| Start Year | 2020 |
| Description | Evolutionary epidemiology of respiratory bacterial pathogens |
| Organisation | University of Oxford |
| Department | Cambodia Oxford Medical Research Unit |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Imperial team are processing microbiological samples and providing modelling expertise of data |
| Collaborator Contribution | Sequencing of data Provision of samples |
| Impact | Not yet recognised |
| Start Year | 2020 |
| Description | Floyd Dowell of United States Department of Agriculture |
| Organisation | U.S. Department of Agriculture USDA |
| Department | Agricultural Research Service |
| Country | United States |
| Sector | Public |
| PI Contribution | We have developed new analytical methods to understand how mosquito age, species and infection status (with the malaria parasite) changes the light being measured by a spectrometer |
| Collaborator Contribution | Dr Dowell is a Research Agricultural Engineer who has pioneered work using Near Infrared Spectroscopy to investigate the age of mosquitoes. Dr Dowell provided training and technical advice to scientists from Imperial College London and our partners |
| Impact | Training of UK, Burkinabe and Australian Scientists in the use of spectrometer |
| Start Year | 2017 |
| Description | FluScape |
| Organisation | Johns Hopkins University |
| Department | Johns Hopkins Bloomberg School of Public Health |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | We run an epidemiological study in Southern China. At imperial we manage the field site and conduct mathematical and statistical analysis. |
| Collaborator Contribution | Johns Hopkins manage the information systems and also conduct mathematical and statistical analysis. |
| Impact | Any paper with Cummings as a co-author. |
| Start Year | 2008 |
| Description | Forming of exceptional think tank to inform COVID-19 response in Malawi |
| Organisation | Government of Malawi |
| Country | Malawi |
| Sector | Public |
| PI Contribution | Analytics investigation to help inform policy choices in response to COVID-19 for the government of Malawi Mathematical modelling Data analysis Data processing |
| Collaborator Contribution | Collaborative work Data provision |
| Impact | Papers published: https://www.medrxiv.org/content/10.1101/2020.10.06.20207878v1 Informed the policy choices for the government of Malawi in response to COVID-19 pandemic |
| Start Year | 2020 |
| Description | Forming of exceptional think tank to inform COVID-19 response in Malawi |
| Organisation | Ministry of Health Malawi |
| Country | Malawi |
| Sector | Public |
| PI Contribution | Analytics investigation to help inform policy choices in response to COVID-19 for the government of Malawi Mathematical modelling Data analysis Data processing |
| Collaborator Contribution | Collaborative work Data provision |
| Impact | Papers published: https://www.medrxiv.org/content/10.1101/2020.10.06.20207878v1 Informed the policy choices for the government of Malawi in response to COVID-19 pandemic |
| Start Year | 2020 |
| Description | Forming of exceptional think tank to inform COVID-19 response in Malawi |
| Organisation | University of Malawi |
| Country | Malawi |
| Sector | Academic/University |
| PI Contribution | Analytics investigation to help inform policy choices in response to COVID-19 for the government of Malawi Mathematical modelling Data analysis Data processing |
| Collaborator Contribution | Collaborative work Data provision |
| Impact | Papers published: https://www.medrxiv.org/content/10.1101/2020.10.06.20207878v1 Informed the policy choices for the government of Malawi in response to COVID-19 pandemic |
| Start Year | 2020 |
| Description | Forming of exceptional think tank to inform COVID-19 response in Malawi |
| Organisation | University of York |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Analytics investigation to help inform policy choices in response to COVID-19 for the government of Malawi Mathematical modelling Data analysis Data processing |
| Collaborator Contribution | Collaborative work Data provision |
| Impact | Papers published: https://www.medrxiv.org/content/10.1101/2020.10.06.20207878v1 Informed the policy choices for the government of Malawi in response to COVID-19 pandemic |
| Start Year | 2020 |
| Description | Foundation for Innovative New Diagnostics |
| Organisation | Foundation for Innovative New Diagnostics (FIND) |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Contributing modelling analysis in support of WHO recommendations for new diagnostic tools for tuberculosis |
| Collaborator Contribution | Developing a modelling framework to project the potential impact of new diagnostic tools being supported by FIND, on the TB epidemic in settings such as South Africa. The work will be used to inform new WHO guidelines. |
| Impact | Update 2021: Work has been published in PLoS Medicine and contributed towards the guideline development group in WHO. |
| Start Year | 2018 |
| Description | Future preventive therapy regimens for TB |
| Organisation | Aurum Institute |
| Country | South Africa |
| Sector | Charity/Non Profit |
| PI Contribution | Modelling analysis in support of new WHO guidelines for target profiles of future regimens |
| Collaborator Contribution | Providing data and inputs for the modelling Update 2022 - papers under review |
| Impact | New target product profiles from WHO currently in preparation - will incorporate modelling Manuscript pending Updated 2021: Target product profiles from WHO have been released including core of modelling Joint manuscript currently under preparation with WHO |
| Start Year | 2019 |
| Description | Future preventive therapy regimens for TB |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Modelling analysis in support of new WHO guidelines for target profiles of future regimens |
| Collaborator Contribution | Providing data and inputs for the modelling Update 2022 - papers under review |
| Impact | New target product profiles from WHO currently in preparation - will incorporate modelling Manuscript pending Updated 2021: Target product profiles from WHO have been released including core of modelling Joint manuscript currently under preparation with WHO |
| Start Year | 2019 |
| Description | GEAR for health |
| Organisation | Health Intervention and Technology Assessment Program |
| Country | Thailand |
| Sector | Charity/Non Profit |
| PI Contribution | Provision of health economic expertise to individuals in LMICs |
| Collaborator Contribution | Management of web interface |
| Impact | Individual support to researchers in LMICs |
| Start Year | 2020 |
| Description | Gagandeep Kang-Christian Medical College |
| Organisation | Christian Medical College, Vellore |
| Country | India |
| Sector | Academic/University |
| PI Contribution | Gastrointestinal Sciences. Statistical, epidemiological and mathematical analysis |
| Collaborator Contribution | Clinical studies, immunological analysis |
| Impact | multiple publications, grant renewal in 2020 |
| Start Year | 2010 |
| Description | Gavi - COVID-19 |
| Organisation | Gavi |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Estimates of the public health impact of COVID-19 vaccination - both retrospective and future scenarios to inform Gavi PPC and Board decisions. |
| Collaborator Contribution | Provided estimates of vaccine demand and discussion and interpretation of results. |
| Impact | PMID: 35753318 |
| Start Year | 2021 |
| Description | Gavi - malaria |
| Organisation | Gavi |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Provided public health and cost-effectiveness estimates of introduction of the RTS,S malaria vaccine to support Gavi PPC and Board decisions in 2021. |
| Collaborator Contribution | Provided estimates of vaccine demand and discussed outputs to support communication. |
| Impact | PMID: 36400084 |
| Start Year | 2021 |
| Description | Genetics of insecticide resistance in Malaria transmitting mosquitoes (Penny Hancock) |
| Organisation | Liverpool School of Tropical Medicine |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Geo-spatial modelling of genetic markers in field sample mosquitoes. Transmission dynamic modelling of impacts of insecticide resistance on malaria intervention performance. |
| Collaborator Contribution | Collection and analysis of genetic data from mosquito samples. Assays to assess function of genetic markers of insecticide resistance. |
| Impact | No outcomes yet |
| Start Year | 2021 |
| Description | Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings |
| Organisation | Fundação Pró-Sangue Hemocentro de São Paulo |
| Country | Brazil |
| Sector | Public |
| PI Contribution | Project management Coordination of teams Genomic analysis Viral genomic expertise Data analysis Data processing Data interpretation Writing of paper Coordination of media response |
| Collaborator Contribution | Viral genomic expertise Data analysis Provision of data Data processing Data interpretation Writing of paper |
| Impact | Report published in Virological 85k views on Virological Widely cited on social media - 393k impressions on Twitter |
| Start Year | 2020 |
| Description | Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings |
| Organisation | Harvard University |
| Department | Harvard T.H. Chan School of Public Health |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Project management Coordination of teams Genomic analysis Viral genomic expertise Data analysis Data processing Data interpretation Writing of paper Coordination of media response |
| Collaborator Contribution | Viral genomic expertise Data analysis Provision of data Data processing Data interpretation Writing of paper |
| Impact | Report published in Virological 85k views on Virological Widely cited on social media - 393k impressions on Twitter |
| Start Year | 2020 |
| Description | Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings |
| Organisation | Oswaldo Cruz Foundation (Fiocruz) |
| Country | Brazil |
| Sector | Public |
| PI Contribution | Project management Coordination of teams Genomic analysis Viral genomic expertise Data analysis Data processing Data interpretation Writing of paper Coordination of media response |
| Collaborator Contribution | Viral genomic expertise Data analysis Provision of data Data processing Data interpretation Writing of paper |
| Impact | Report published in Virological 85k views on Virological Widely cited on social media - 393k impressions on Twitter |
| Start Year | 2020 |
| Description | Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings |
| Organisation | Universidade de São Paulo |
| Country | Brazil |
| Sector | Academic/University |
| PI Contribution | Project management Coordination of teams Genomic analysis Viral genomic expertise Data analysis Data processing Data interpretation Writing of paper Coordination of media response |
| Collaborator Contribution | Viral genomic expertise Data analysis Provision of data Data processing Data interpretation Writing of paper |
| Impact | Report published in Virological 85k views on Virological Widely cited on social media - 393k impressions on Twitter |
| Start Year | 2020 |
| Description | Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings |
| Organisation | University of California, San Francisco |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Project management Coordination of teams Genomic analysis Viral genomic expertise Data analysis Data processing Data interpretation Writing of paper Coordination of media response |
| Collaborator Contribution | Viral genomic expertise Data analysis Provision of data Data processing Data interpretation Writing of paper |
| Impact | Report published in Virological 85k views on Virological Widely cited on social media - 393k impressions on Twitter |
| Start Year | 2020 |
| Description | Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings |
| Organisation | University of Edinburgh |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Project management Coordination of teams Genomic analysis Viral genomic expertise Data analysis Data processing Data interpretation Writing of paper Coordination of media response |
| Collaborator Contribution | Viral genomic expertise Data analysis Provision of data Data processing Data interpretation Writing of paper |
| Impact | Report published in Virological 85k views on Virological Widely cited on social media - 393k impressions on Twitter |
| Start Year | 2020 |
| Description | Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Project management Coordination of teams Genomic analysis Viral genomic expertise Data analysis Data processing Data interpretation Writing of paper Coordination of media response |
| Collaborator Contribution | Viral genomic expertise Data analysis Provision of data Data processing Data interpretation Writing of paper |
| Impact | Report published in Virological 85k views on Virological Widely cited on social media - 393k impressions on Twitter |
| Start Year | 2020 |
| Description | Genomic epidemiology methods development |
| Organisation | EMBL European Bioinformatics Institute (EMBL - EBI) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Co-development of software (https://github.com/bacpop/PopPUNK) and web resources (https://beebop.dide.ic.ac.uk). |
| Collaborator Contribution | Advising and contributing to software development and data analysis. |
| Impact | Online tool for genomic epidemiology (https://beebop.dide.ic.ac.uk) and associated software. |
| Start Year | 2022 |
| Description | Geshiaro |
| Organisation | Ethiopian Public Health Institute |
| Country | Ethiopia |
| Sector | Public |
| PI Contribution | expertise, intellectual input and the training of staff |
| Collaborator Contribution | expertise, intellectual input and the training of staff, access to data, equipment and facilities |
| Impact | No outputs yet. |
| Start Year | 2018 |
| Description | Geshiaro |
| Organisation | Ministry of Health, Ethiopia |
| Country | Ethiopia |
| Sector | Public |
| PI Contribution | expertise, intellectual input and the training of staff |
| Collaborator Contribution | expertise, intellectual input and the training of staff, access to data, equipment and facilities |
| Impact | No outputs yet. |
| Start Year | 2018 |
| Description | Geshiaro |
| Organisation | Simprints |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | expertise, intellectual input and the training of staff |
| Collaborator Contribution | expertise, intellectual input and the training of staff, access to data, equipment and facilities |
| Impact | No outputs yet. |
| Start Year | 2018 |
| Description | Geshiaro |
| Organisation | World Vision Ethiopia |
| Country | Ethiopia |
| Sector | Public |
| PI Contribution | expertise, intellectual input and the training of staff |
| Collaborator Contribution | expertise, intellectual input and the training of staff, access to data, equipment and facilities |
| Impact | No outputs yet. |
| Start Year | 2018 |
| Description | Geshiyaro project (clinical trial) |
| Organisation | Ethiopian Public Health Institute |
| Country | Ethiopia |
| Sector | Public |
| PI Contribution | Design of trial Monitoring and evaluation of progress |
| Collaborator Contribution | Implementers of NTD treatments Partners in Monitoring and Evaluation |
| Impact | Publication on protocol of trial in 'Parasites and Vectors' in October 2019 |
| Start Year | 2019 |
| Description | Global Burden of Disease study |
| Organisation | Institute for Health Metrics and Evaluation (IHME) |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Modelling expertise Development of tools |
| Collaborator Contribution | Production of GBD study |
| Impact | Publication of GBD 2019 study Local burden of disease HIV estimates in SSA |
| Start Year | 2018 |
| Description | Global Burden of disease |
| Organisation | Institute for Health Metrics and Evaluation (IHME) |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Provided algorithms for the local burden of disease project |
| Collaborator Contribution | Publications (3 in nature 1 in the New England Journal of Medicine, 1 in Lancet) |
| Impact | Publications (3 in nature 1 in the New England Journal of Medicine, 1 in Lancet) |
| Start Year | 2015 |
| Description | Global HITAP |
| Organisation | Government of Thailand |
| Country | Thailand |
| Sector | Public |
| PI Contribution | Working with Health Intervention and Technology Assessment Program within the Ministry of Health in Thailand. Producing methodological papers that provide a comprehensive explanation of fundamental topics relating to how to conduct or interpret economic evaluations |
| Collaborator Contribution | Co-author on papers |
| Impact | Publication of paper in Frontiers in Public Health and another paper under review. |
| Start Year | 2021 |
| Description | Global pneumococcal sequencing project/Juno project |
| Organisation | The Wellcome Trust Sanger Institute |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | We design tools and methods to analyse the data produced by these cohorts. We provide supervision to some members of the partnership. We also undertake secondary data analysis to test methods, and evolutionary/ecological hypotheses. |
| Collaborator Contribution | Our partners have established a global network of collaborations, from which they are receiving bacterial samples which are sequenced and analysed in a centralised manner. They design and arrange bioinformatic training for members of this network, sometimes guided by our methods. Programming support is provided mutually between institutions. We more directly collaborate on some analysis and method development. Our partners have funded a programmer to work with us for further method development. |
| Impact | Three key papers include: Lo, S. W. et al. Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study. Lancet Infect. Dis. 19, 759-769 (2019) Gladstone, R. A. et al. International genomic definition of pneumococcal lineages, to contextualise disease, antibiotic resistance and vaccine impact. EBioMedicine 43, 338-346 (2019) Lo, S. W. et al. Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study. Lancet Infect. Dis. 19, 759-769 (2019) Gladstone, R. A. et al. Visualizing variation within Global Pneumococcal Sequence Clusters (GPSCs) and country population snapshots to contextualize pneumococcal isolates. Microb Genom 6, (2020) And a key joint method paper/software tool: Lees, J. A. et al. Fast and flexible bacterial genomic epidemiology with PopPUNK. Genome Res. 29, 304-316 (2019) |
| Start Year | 2012 |
| Description | Google - Covid-19 mobility data research program - Data Access Agreement |
| Organisation | |
| Department | Research at Google |
| Country | United States |
| Sector | Private |
| PI Contribution | COVID-19 Data analysis |
| Collaborator Contribution | COVID-19 Data provision via Data Access Agreement |
| Impact | Ongoing |
| Start Year | 2020 |
| Description | Greg Devine at QIMR Berghofer (Brisbane, Australia) |
| Organisation | QIMR Berghofer Medical Research Institute |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Provide funding to run experiments in Australia on local Aedes mosquito populations |
| Collaborator Contribution | Partner running experiments in Australia on local Aedes mosquito populations |
| Impact | None yet |
| Start Year | 2017 |
| Description | Group testing for COVID-19 |
| Organisation | Simon Fraser University |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Conceptualisation of the project Analysis of group testing strategies Laboratory based implementation of strategies Preparation of manuscripts |
| Collaborator Contribution | Implementation of the project Analysis of group testing strategies Preparation of manuscripts |
| Impact | Manuscript under preparation |
| Start Year | 2020 |
| Description | HIV DREAMS evaluation |
| Organisation | United States Department of State |
| Department | Office of the Global AIDS Coordinator |
| Country | United States |
| Sector | Public |
| PI Contribution | Samir Bhatt's group worked with OGAC to estimate the rate of change of new diagnoses among pregnant women. |
| Collaborator Contribution | Technical expertise in data preparation |
| Impact | Samir Bhatt produced the modelled estimates that were used by OGAC in their world AIDS day report. The announcement was made by Amb Birx in December 2019. Updated 2021: Paper accepted AIDs supplement, in collaboration with OGAC |
| Start Year | 2016 |
| Description | HIV Preventation Trial Network |
| Organisation | Fred Hutchinson Cancer Research Center (FHCRC) |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | A collaborative centre that develops and uses mathematical models to support HPTN research activities and inform research directions. We collaborate with: Statistical Centre for HIV/AIDS Research and Prevention. |
| Collaborator Contribution | See above |
| Impact | See publications, presentations and workshops on https://hptnmodelling.org/resources/ |
| Start Year | 2014 |
| Description | HIV Prevention Trial Network Modelling Centre |
| Organisation | Fred Hutchinson Cancer Research Center (FHCRC) |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Lead on Mathematical modelling to inform and complement research activities of the HPTN. Conduct mathematical modelling and computer simulation studies anchored to the best available data to support and inform HPTN research activities and directions with the overarching aim to combat the HIV/AIDS epidemic more efficiently |
| Collaborator Contribution | Lead of statistical centre who is funding the HPTN modelling centre. Provide data and statistical expertise, conduct trials that provide data for mathematical modelling. |
| Impact | A number of publications: https://hptnmodelling.org/resources/?resourcetype=publications Multidisciplinary - epidemiology, mathematical modelling, statistics, clinical research |
| Start Year | 2013 |
| Description | HIV modelling consortium |
| Organisation | University College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Modelling Data analysis |
| Collaborator Contribution | Modelling Data analysis Dissemination of results |
| Impact | Multiple publications, including in Lancet HIV |
| Start Year | 2019 |
| Description | HIV prevention cascades |
| Organisation | Bill and Melinda Gates Foundation |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Project leadership, project design, development of integrated HIV prevention cascade formulations, data collection, data analysis, and scientific publications. |
| Collaborator Contribution | The Bill and Melinda Gates Foundation, LSHTM, Zimbabwe Ministry of Health and Child Care, and UNAIDS provided intellectual inputs into the development of the HIV prevention cascade formulations to be measured and interpreted in the study. BMGF also funded the study. Zimbabwe Ministry of Health and Child Care and Population Services International assisted with the establishment and provision of pre-exposure prophylaxis (PrEP) and voluntary medical male circumcision (VMMC) services in the study areas. |
| Impact | UNAIDS draft guidelines on HIV prevention cascades Scientific publications: doi.org/10.1016/S2352-3018(16)30039-X doi.org/10.1007/s10461-018-2374-0 doi.org/10.1016/S2352-3018(18)30327-8 Collaboration is multi-disciplinary - epidemiology, demography, social science, public health UPDATE 2023: Publication in PLoS ONE - Status of the HIV epidemic in Manicaland, east Zimbabwe prior to the outbreak of the COVID-19 pandemic. https://doi.org/10.1371/journal.pone.0273776 |
| Start Year | 2015 |
| Description | HIV prevention cascades |
| Organisation | Biomedical Research and Training Institute (BRTI) |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | Project leadership, project design, development of integrated HIV prevention cascade formulations, data collection, data analysis, and scientific publications. |
| Collaborator Contribution | The Bill and Melinda Gates Foundation, LSHTM, Zimbabwe Ministry of Health and Child Care, and UNAIDS provided intellectual inputs into the development of the HIV prevention cascade formulations to be measured and interpreted in the study. BMGF also funded the study. Zimbabwe Ministry of Health and Child Care and Population Services International assisted with the establishment and provision of pre-exposure prophylaxis (PrEP) and voluntary medical male circumcision (VMMC) services in the study areas. |
| Impact | UNAIDS draft guidelines on HIV prevention cascades Scientific publications: doi.org/10.1016/S2352-3018(16)30039-X doi.org/10.1007/s10461-018-2374-0 doi.org/10.1016/S2352-3018(18)30327-8 Collaboration is multi-disciplinary - epidemiology, demography, social science, public health UPDATE 2023: Publication in PLoS ONE - Status of the HIV epidemic in Manicaland, east Zimbabwe prior to the outbreak of the COVID-19 pandemic. https://doi.org/10.1371/journal.pone.0273776 |
| Start Year | 2015 |
| Description | HIV prevention cascades |
| Organisation | Joint United Nations Programme on HIV/AIDS (UNAIDS) |
| Country | Global |
| Sector | Public |
| PI Contribution | Project leadership, project design, development of integrated HIV prevention cascade formulations, data collection, data analysis, and scientific publications. |
| Collaborator Contribution | The Bill and Melinda Gates Foundation, LSHTM, Zimbabwe Ministry of Health and Child Care, and UNAIDS provided intellectual inputs into the development of the HIV prevention cascade formulations to be measured and interpreted in the study. BMGF also funded the study. Zimbabwe Ministry of Health and Child Care and Population Services International assisted with the establishment and provision of pre-exposure prophylaxis (PrEP) and voluntary medical male circumcision (VMMC) services in the study areas. |
| Impact | UNAIDS draft guidelines on HIV prevention cascades Scientific publications: doi.org/10.1016/S2352-3018(16)30039-X doi.org/10.1007/s10461-018-2374-0 doi.org/10.1016/S2352-3018(18)30327-8 Collaboration is multi-disciplinary - epidemiology, demography, social science, public health UPDATE 2023: Publication in PLoS ONE - Status of the HIV epidemic in Manicaland, east Zimbabwe prior to the outbreak of the COVID-19 pandemic. https://doi.org/10.1371/journal.pone.0273776 |
| Start Year | 2015 |
| Description | HIV prevention cascades |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Project leadership, project design, development of integrated HIV prevention cascade formulations, data collection, data analysis, and scientific publications. |
| Collaborator Contribution | The Bill and Melinda Gates Foundation, LSHTM, Zimbabwe Ministry of Health and Child Care, and UNAIDS provided intellectual inputs into the development of the HIV prevention cascade formulations to be measured and interpreted in the study. BMGF also funded the study. Zimbabwe Ministry of Health and Child Care and Population Services International assisted with the establishment and provision of pre-exposure prophylaxis (PrEP) and voluntary medical male circumcision (VMMC) services in the study areas. |
| Impact | UNAIDS draft guidelines on HIV prevention cascades Scientific publications: doi.org/10.1016/S2352-3018(16)30039-X doi.org/10.1007/s10461-018-2374-0 doi.org/10.1016/S2352-3018(18)30327-8 Collaboration is multi-disciplinary - epidemiology, demography, social science, public health UPDATE 2023: Publication in PLoS ONE - Status of the HIV epidemic in Manicaland, east Zimbabwe prior to the outbreak of the COVID-19 pandemic. https://doi.org/10.1371/journal.pone.0273776 |
| Start Year | 2015 |
| Description | HIV prevention cascades |
| Organisation | Ministry of Health and Child Welfare of the Republic of Zimbabwe |
| Country | Zimbabwe |
| Sector | Public |
| PI Contribution | Project leadership, project design, development of integrated HIV prevention cascade formulations, data collection, data analysis, and scientific publications. |
| Collaborator Contribution | The Bill and Melinda Gates Foundation, LSHTM, Zimbabwe Ministry of Health and Child Care, and UNAIDS provided intellectual inputs into the development of the HIV prevention cascade formulations to be measured and interpreted in the study. BMGF also funded the study. Zimbabwe Ministry of Health and Child Care and Population Services International assisted with the establishment and provision of pre-exposure prophylaxis (PrEP) and voluntary medical male circumcision (VMMC) services in the study areas. |
| Impact | UNAIDS draft guidelines on HIV prevention cascades Scientific publications: doi.org/10.1016/S2352-3018(16)30039-X doi.org/10.1007/s10461-018-2374-0 doi.org/10.1016/S2352-3018(18)30327-8 Collaboration is multi-disciplinary - epidemiology, demography, social science, public health UPDATE 2023: Publication in PLoS ONE - Status of the HIV epidemic in Manicaland, east Zimbabwe prior to the outbreak of the COVID-19 pandemic. https://doi.org/10.1371/journal.pone.0273776 |
| Start Year | 2015 |
| Description | HIV prevention cascades |
| Organisation | Population Services International |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Project leadership, project design, development of integrated HIV prevention cascade formulations, data collection, data analysis, and scientific publications. |
| Collaborator Contribution | The Bill and Melinda Gates Foundation, LSHTM, Zimbabwe Ministry of Health and Child Care, and UNAIDS provided intellectual inputs into the development of the HIV prevention cascade formulations to be measured and interpreted in the study. BMGF also funded the study. Zimbabwe Ministry of Health and Child Care and Population Services International assisted with the establishment and provision of pre-exposure prophylaxis (PrEP) and voluntary medical male circumcision (VMMC) services in the study areas. |
| Impact | UNAIDS draft guidelines on HIV prevention cascades Scientific publications: doi.org/10.1016/S2352-3018(16)30039-X doi.org/10.1007/s10461-018-2374-0 doi.org/10.1016/S2352-3018(18)30327-8 Collaboration is multi-disciplinary - epidemiology, demography, social science, public health UPDATE 2023: Publication in PLoS ONE - Status of the HIV epidemic in Manicaland, east Zimbabwe prior to the outbreak of the COVID-19 pandemic. https://doi.org/10.1371/journal.pone.0273776 |
| Start Year | 2015 |
| Description | HIV rapid test misclassification errors |
| Organisation | Biomedical Research and Training Institute (BRTI) |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | Research design, project management and coordination, staff recruitment, training and management, data processing and cleaning, data analysis, mathematical modelling, and report writing. |
| Collaborator Contribution | The Zimbabwe Ministry of Health and Child Care gave permission for the study to be done as an extension to a round of national HIV surveillance and contributed to the study design, data collection and dissemination of results. US-CDC contributed to the study design and implementation and co-funded the underlying round of national HIV surveillance with the United Nations Global Fund for HIV, Malaria and TB control. Global Solutions for Infectious Disease developed and assisted in the implementation and interpretation of results obtained from a smartphone camera application used to identify poor quality outputs from HIV rapid tests and errors made by nursing staff in reading the output from these tests Researchers from the Universities of Copenhagen and Roehampton designed and led the implementation of the qualitative research components of the study BRTI provided a local institutional base in Zimbabwe from which to conduct the study |
| Impact | Mathematical model data on the cost-effectiveness of repeat HIV testing prior to initiation on antiretroviral treatment for HIV Data on levels of false-positive and false-negative HIV test results occurring in routine HIV testing services in Zimbabwe Publication: doi.org/10.1093/cid/cix341 - The Cost of Not Retesting: Human Immunodeficiency Virus Misdiagnosis in the Antiretroviral Therapy "Test-and-Offer" Era The outputs of the study to date contributed to increased adoption of a WHO recommendation to countries to carry out repeat HIV testing prior to initiating people living with HIV on antiretroviral therapy (including in Zimbabwe) Multi-disciplinary collaboration - epidemiology, demography, public health, mathematical modelling, social science, anthropology UPDATE 2022: Publications in The Journal of International AIDs society UPDATE 2023: Publication in Medical Anthropology: 2022 - The (in)visibility of misdiagnosis in point-of-care HIV testing in Zimbabwe. Publication in Global Public Health 2022 - Rituals of Care: Careful work by HIV testers to avoid misdiagnosis in rapid HIV testing in Zimbabwe. |
| Start Year | 2015 |
| Description | HIV rapid test misclassification errors |
| Organisation | Centers for Disease Control and Prevention (CDC) |
| Country | United States |
| Sector | Public |
| PI Contribution | Research design, project management and coordination, staff recruitment, training and management, data processing and cleaning, data analysis, mathematical modelling, and report writing. |
| Collaborator Contribution | The Zimbabwe Ministry of Health and Child Care gave permission for the study to be done as an extension to a round of national HIV surveillance and contributed to the study design, data collection and dissemination of results. US-CDC contributed to the study design and implementation and co-funded the underlying round of national HIV surveillance with the United Nations Global Fund for HIV, Malaria and TB control. Global Solutions for Infectious Disease developed and assisted in the implementation and interpretation of results obtained from a smartphone camera application used to identify poor quality outputs from HIV rapid tests and errors made by nursing staff in reading the output from these tests Researchers from the Universities of Copenhagen and Roehampton designed and led the implementation of the qualitative research components of the study BRTI provided a local institutional base in Zimbabwe from which to conduct the study |
| Impact | Mathematical model data on the cost-effectiveness of repeat HIV testing prior to initiation on antiretroviral treatment for HIV Data on levels of false-positive and false-negative HIV test results occurring in routine HIV testing services in Zimbabwe Publication: doi.org/10.1093/cid/cix341 - The Cost of Not Retesting: Human Immunodeficiency Virus Misdiagnosis in the Antiretroviral Therapy "Test-and-Offer" Era The outputs of the study to date contributed to increased adoption of a WHO recommendation to countries to carry out repeat HIV testing prior to initiating people living with HIV on antiretroviral therapy (including in Zimbabwe) Multi-disciplinary collaboration - epidemiology, demography, public health, mathematical modelling, social science, anthropology UPDATE 2022: Publications in The Journal of International AIDs society UPDATE 2023: Publication in Medical Anthropology: 2022 - The (in)visibility of misdiagnosis in point-of-care HIV testing in Zimbabwe. Publication in Global Public Health 2022 - Rituals of Care: Careful work by HIV testers to avoid misdiagnosis in rapid HIV testing in Zimbabwe. |
| Start Year | 2015 |
| Description | HIV rapid test misclassification errors |
| Organisation | Global Solutions for Infectious Disease |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Research design, project management and coordination, staff recruitment, training and management, data processing and cleaning, data analysis, mathematical modelling, and report writing. |
| Collaborator Contribution | The Zimbabwe Ministry of Health and Child Care gave permission for the study to be done as an extension to a round of national HIV surveillance and contributed to the study design, data collection and dissemination of results. US-CDC contributed to the study design and implementation and co-funded the underlying round of national HIV surveillance with the United Nations Global Fund for HIV, Malaria and TB control. Global Solutions for Infectious Disease developed and assisted in the implementation and interpretation of results obtained from a smartphone camera application used to identify poor quality outputs from HIV rapid tests and errors made by nursing staff in reading the output from these tests Researchers from the Universities of Copenhagen and Roehampton designed and led the implementation of the qualitative research components of the study BRTI provided a local institutional base in Zimbabwe from which to conduct the study |
| Impact | Mathematical model data on the cost-effectiveness of repeat HIV testing prior to initiation on antiretroviral treatment for HIV Data on levels of false-positive and false-negative HIV test results occurring in routine HIV testing services in Zimbabwe Publication: doi.org/10.1093/cid/cix341 - The Cost of Not Retesting: Human Immunodeficiency Virus Misdiagnosis in the Antiretroviral Therapy "Test-and-Offer" Era The outputs of the study to date contributed to increased adoption of a WHO recommendation to countries to carry out repeat HIV testing prior to initiating people living with HIV on antiretroviral therapy (including in Zimbabwe) Multi-disciplinary collaboration - epidemiology, demography, public health, mathematical modelling, social science, anthropology UPDATE 2022: Publications in The Journal of International AIDs society UPDATE 2023: Publication in Medical Anthropology: 2022 - The (in)visibility of misdiagnosis in point-of-care HIV testing in Zimbabwe. Publication in Global Public Health 2022 - Rituals of Care: Careful work by HIV testers to avoid misdiagnosis in rapid HIV testing in Zimbabwe. |
| Start Year | 2015 |
| Description | HIV rapid test misclassification errors |
| Organisation | Ministry of Health and Child Welfare of the Republic of Zimbabwe |
| Country | Zimbabwe |
| Sector | Public |
| PI Contribution | Research design, project management and coordination, staff recruitment, training and management, data processing and cleaning, data analysis, mathematical modelling, and report writing. |
| Collaborator Contribution | The Zimbabwe Ministry of Health and Child Care gave permission for the study to be done as an extension to a round of national HIV surveillance and contributed to the study design, data collection and dissemination of results. US-CDC contributed to the study design and implementation and co-funded the underlying round of national HIV surveillance with the United Nations Global Fund for HIV, Malaria and TB control. Global Solutions for Infectious Disease developed and assisted in the implementation and interpretation of results obtained from a smartphone camera application used to identify poor quality outputs from HIV rapid tests and errors made by nursing staff in reading the output from these tests Researchers from the Universities of Copenhagen and Roehampton designed and led the implementation of the qualitative research components of the study BRTI provided a local institutional base in Zimbabwe from which to conduct the study |
| Impact | Mathematical model data on the cost-effectiveness of repeat HIV testing prior to initiation on antiretroviral treatment for HIV Data on levels of false-positive and false-negative HIV test results occurring in routine HIV testing services in Zimbabwe Publication: doi.org/10.1093/cid/cix341 - The Cost of Not Retesting: Human Immunodeficiency Virus Misdiagnosis in the Antiretroviral Therapy "Test-and-Offer" Era The outputs of the study to date contributed to increased adoption of a WHO recommendation to countries to carry out repeat HIV testing prior to initiating people living with HIV on antiretroviral therapy (including in Zimbabwe) Multi-disciplinary collaboration - epidemiology, demography, public health, mathematical modelling, social science, anthropology UPDATE 2022: Publications in The Journal of International AIDs society UPDATE 2023: Publication in Medical Anthropology: 2022 - The (in)visibility of misdiagnosis in point-of-care HIV testing in Zimbabwe. Publication in Global Public Health 2022 - Rituals of Care: Careful work by HIV testers to avoid misdiagnosis in rapid HIV testing in Zimbabwe. |
| Start Year | 2015 |
| Description | HIV rapid test misclassification errors |
| Organisation | Roehampton University |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Research design, project management and coordination, staff recruitment, training and management, data processing and cleaning, data analysis, mathematical modelling, and report writing. |
| Collaborator Contribution | The Zimbabwe Ministry of Health and Child Care gave permission for the study to be done as an extension to a round of national HIV surveillance and contributed to the study design, data collection and dissemination of results. US-CDC contributed to the study design and implementation and co-funded the underlying round of national HIV surveillance with the United Nations Global Fund for HIV, Malaria and TB control. Global Solutions for Infectious Disease developed and assisted in the implementation and interpretation of results obtained from a smartphone camera application used to identify poor quality outputs from HIV rapid tests and errors made by nursing staff in reading the output from these tests Researchers from the Universities of Copenhagen and Roehampton designed and led the implementation of the qualitative research components of the study BRTI provided a local institutional base in Zimbabwe from which to conduct the study |
| Impact | Mathematical model data on the cost-effectiveness of repeat HIV testing prior to initiation on antiretroviral treatment for HIV Data on levels of false-positive and false-negative HIV test results occurring in routine HIV testing services in Zimbabwe Publication: doi.org/10.1093/cid/cix341 - The Cost of Not Retesting: Human Immunodeficiency Virus Misdiagnosis in the Antiretroviral Therapy "Test-and-Offer" Era The outputs of the study to date contributed to increased adoption of a WHO recommendation to countries to carry out repeat HIV testing prior to initiating people living with HIV on antiretroviral therapy (including in Zimbabwe) Multi-disciplinary collaboration - epidemiology, demography, public health, mathematical modelling, social science, anthropology UPDATE 2022: Publications in The Journal of International AIDs society UPDATE 2023: Publication in Medical Anthropology: 2022 - The (in)visibility of misdiagnosis in point-of-care HIV testing in Zimbabwe. Publication in Global Public Health 2022 - Rituals of Care: Careful work by HIV testers to avoid misdiagnosis in rapid HIV testing in Zimbabwe. |
| Start Year | 2015 |
| Description | HIV rapid test misclassification errors |
| Organisation | University of Copenhagen |
| Department | Department of Public Health |
| Country | Denmark |
| Sector | Academic/University |
| PI Contribution | Research design, project management and coordination, staff recruitment, training and management, data processing and cleaning, data analysis, mathematical modelling, and report writing. |
| Collaborator Contribution | The Zimbabwe Ministry of Health and Child Care gave permission for the study to be done as an extension to a round of national HIV surveillance and contributed to the study design, data collection and dissemination of results. US-CDC contributed to the study design and implementation and co-funded the underlying round of national HIV surveillance with the United Nations Global Fund for HIV, Malaria and TB control. Global Solutions for Infectious Disease developed and assisted in the implementation and interpretation of results obtained from a smartphone camera application used to identify poor quality outputs from HIV rapid tests and errors made by nursing staff in reading the output from these tests Researchers from the Universities of Copenhagen and Roehampton designed and led the implementation of the qualitative research components of the study BRTI provided a local institutional base in Zimbabwe from which to conduct the study |
| Impact | Mathematical model data on the cost-effectiveness of repeat HIV testing prior to initiation on antiretroviral treatment for HIV Data on levels of false-positive and false-negative HIV test results occurring in routine HIV testing services in Zimbabwe Publication: doi.org/10.1093/cid/cix341 - The Cost of Not Retesting: Human Immunodeficiency Virus Misdiagnosis in the Antiretroviral Therapy "Test-and-Offer" Era The outputs of the study to date contributed to increased adoption of a WHO recommendation to countries to carry out repeat HIV testing prior to initiating people living with HIV on antiretroviral therapy (including in Zimbabwe) Multi-disciplinary collaboration - epidemiology, demography, public health, mathematical modelling, social science, anthropology UPDATE 2022: Publications in The Journal of International AIDs society UPDATE 2023: Publication in Medical Anthropology: 2022 - The (in)visibility of misdiagnosis in point-of-care HIV testing in Zimbabwe. Publication in Global Public Health 2022 - Rituals of Care: Careful work by HIV testers to avoid misdiagnosis in rapid HIV testing in Zimbabwe. |
| Start Year | 2015 |
| Description | HIV self-testing amongst key populations in 3 West African countries |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Mathematical modelling and cost-effectiveness analysis |
| Collaborator Contribution | Data collection Input into cost-effective analysis Conceptualisation Project management |
| Impact | Multiple publications |
| Start Year | 2019 |
| Description | HIV self-testing amongst key populations in 3 West African countries |
| Organisation | National Conservatory of Arts and Crafts |
| Country | France |
| Sector | Hospitals |
| PI Contribution | Mathematical modelling and cost-effectiveness analysis |
| Collaborator Contribution | Data collection Input into cost-effective analysis Conceptualisation Project management |
| Impact | Multiple publications |
| Start Year | 2019 |
| Description | HIV self-testing amongst key populations in 3 West African countries |
| Organisation | Programme PAC-CI |
| Country | Cote d'Ivoire |
| Sector | Charity/Non Profit |
| PI Contribution | Mathematical modelling and cost-effectiveness analysis |
| Collaborator Contribution | Data collection Input into cost-effective analysis Conceptualisation Project management |
| Impact | Multiple publications |
| Start Year | 2019 |
| Description | HIV self-testing amongst key populations in 3 West African countries |
| Organisation | World Health Organization (WHO) |
| Department | UNITAID |
| Country | Switzerland |
| Sector | Public |
| PI Contribution | Mathematical modelling and cost-effectiveness analysis |
| Collaborator Contribution | Data collection Input into cost-effective analysis Conceptualisation Project management |
| Impact | Multiple publications |
| Start Year | 2019 |
| Description | HIV self-testing amongst key populations in 3 West African countries |
| Organisation | Yale University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Mathematical modelling and cost-effectiveness analysis |
| Collaborator Contribution | Data collection Input into cost-effective analysis Conceptualisation Project management |
| Impact | Multiple publications |
| Start Year | 2019 |
| Description | HPRU Modelling |
| Organisation | Public Health England |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | I am a theme lead for the HPRU in Modelling Methodology held by Neil Ferguson. |
| Collaborator Contribution | Marc Baguelin (co-I for this MRC grant) is also a theme lead. |
| Impact | None yet. |
| Start Year | 2014 |
| Description | HPRU Respiratory Infections |
| Organisation | Public Health England |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | I am a theme lead for Respiratory infections and will help to supervise staff at Imperial and PHE. |
| Collaborator Contribution | They will also co supervise staff and helped to write the grant. |
| Impact | None yet. |
| Start Year | 2014 |
| Description | HSV2 vaccine |
| Organisation | Joint United Nations Programme on HIV/AIDS (UNAIDS) |
| Country | Global |
| Sector | Public |
| PI Contribution | Mathematical Modelling expertise and modelling analysis |
| Collaborator Contribution | Bristol - mathematical modelling and epidemiological review Fiocruz - assisting with access to data UNAIDs - provided data for analysis WHO - leading the coordination of project. Building a business case for development of HSV2 vaccine. Provide scientific input and guidance LSHTM - provide guidance and assist with systematic reviews |
| Impact | Publications to come UPDATE 2021 - papers published in 'Lancet Infectious Disease' and submitted in 'Journal of AIDS' |
| Start Year | 2019 |
| Description | HSV2 vaccine |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Mathematical Modelling expertise and modelling analysis |
| Collaborator Contribution | Bristol - mathematical modelling and epidemiological review Fiocruz - assisting with access to data UNAIDs - provided data for analysis WHO - leading the coordination of project. Building a business case for development of HSV2 vaccine. Provide scientific input and guidance LSHTM - provide guidance and assist with systematic reviews |
| Impact | Publications to come UPDATE 2021 - papers published in 'Lancet Infectious Disease' and submitted in 'Journal of AIDS' |
| Start Year | 2019 |
| Description | HSV2 vaccine |
| Organisation | Oswaldo Cruz Foundation (Fiocruz) |
| Country | Brazil |
| Sector | Public |
| PI Contribution | Mathematical Modelling expertise and modelling analysis |
| Collaborator Contribution | Bristol - mathematical modelling and epidemiological review Fiocruz - assisting with access to data UNAIDs - provided data for analysis WHO - leading the coordination of project. Building a business case for development of HSV2 vaccine. Provide scientific input and guidance LSHTM - provide guidance and assist with systematic reviews |
| Impact | Publications to come UPDATE 2021 - papers published in 'Lancet Infectious Disease' and submitted in 'Journal of AIDS' |
| Start Year | 2019 |
| Description | HSV2 vaccine |
| Organisation | University of Bristol |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Mathematical Modelling expertise and modelling analysis |
| Collaborator Contribution | Bristol - mathematical modelling and epidemiological review Fiocruz - assisting with access to data UNAIDs - provided data for analysis WHO - leading the coordination of project. Building a business case for development of HSV2 vaccine. Provide scientific input and guidance LSHTM - provide guidance and assist with systematic reviews |
| Impact | Publications to come UPDATE 2021 - papers published in 'Lancet Infectious Disease' and submitted in 'Journal of AIDS' |
| Start Year | 2019 |
| Description | HSV2 vaccine |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Mathematical Modelling expertise and modelling analysis |
| Collaborator Contribution | Bristol - mathematical modelling and epidemiological review Fiocruz - assisting with access to data UNAIDs - provided data for analysis WHO - leading the coordination of project. Building a business case for development of HSV2 vaccine. Provide scientific input and guidance LSHTM - provide guidance and assist with systematic reviews |
| Impact | Publications to come UPDATE 2021 - papers published in 'Lancet Infectious Disease' and submitted in 'Journal of AIDS' |
| Start Year | 2019 |
| Description | Health economic support to Oxford University Clinical Research Unit |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Health economic expertise Supervision of two PhD students and one research assistant |
| Collaborator Contribution | Management of clinical trials Provision of data |
| Impact | Nine peer reviewed papers and other papers currently being drafted/under submission |
| Start Year | 2020 |
| Description | Health system strengthening collaboration |
| Organisation | East Central and Southern Africa Health Community |
| Country | Tanzania, United Republic of |
| Sector | Public |
| PI Contribution | Co-applicants to a grant that was funded Modelling expertise Software expertise |
| Collaborator Contribution | Designing policy relevant analyses Connecting to datasets |
| Impact | Not yet recognised |
| Start Year | 2021 |
| Description | Herbert Smith Freehills LLP - Consultancy Agreement (COVID-19) |
| Organisation | Herbert Smith Freehills |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | Provision of Expert Witness Consultancy Services (COVID-19) |
| Collaborator Contribution | Request to team (COVID-19) |
| Impact | No outputs yet. |
| Start Year | 2020 |
| Description | Heterogeneity in phylodynamics |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Developed models for assessing heterogeneity of transmission from genetic data. Contributed some insights from this project into the publication at https://www.sciencedirect.com/science/article/pii/S1755436522000676 |
| Collaborator Contribution | Designed study and generated data. |
| Impact | Paper informed by this work but main results not published yet https://science.sciencemag.org/content/371/6530/708.abstract |
| Start Year | 2020 |
| Description | How can modelling contribute to achieving the goals for Chagas disease in the horizon 2020 and beyond? |
| Organisation | Pan American Health Organization |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Development of a data platform for collation and curation of Chagas disease epidemiological data Development of force of infection models for Chagas disease Contribution to papers on Chagas disease modelling |
| Collaborator Contribution | Princeton: Contribution of expertise in mathematical modelling Sussex: Contribution of machine learning methods PAHO: Funding of in country workshops and person based in Washington dedicated to systematic reviews, data entry and liaising with endemic countries |
| Impact | Publication of papers in Clinical Infectious Diseases, BMJ Global Health Attendance to WHO meeting in Geneva in April 2019 to help assess through modelling, the feasibility of the WHO proposed goals for Chagas disease, 2021- 2030 Publication of a Gates Open Research open letter in 2019 and in 2022 Publication of papers in BMC Med Res Methodol and PLoS Negl Trop Dis in 2022 Submission of a paper for the NTD Collection of Philos Trans R Soc B at the end of 2022 (under review) |
| Start Year | 2018 |
| Description | How can modelling contribute to achieving the goals for Chagas disease in the horizon 2020 and beyond? |
| Organisation | Pontifical Xavierian University |
| Country | Colombia |
| Sector | Academic/University |
| PI Contribution | Development of a data platform for collation and curation of Chagas disease epidemiological data Development of force of infection models for Chagas disease Contribution to papers on Chagas disease modelling |
| Collaborator Contribution | Princeton: Contribution of expertise in mathematical modelling Sussex: Contribution of machine learning methods PAHO: Funding of in country workshops and person based in Washington dedicated to systematic reviews, data entry and liaising with endemic countries |
| Impact | Publication of papers in Clinical Infectious Diseases, BMJ Global Health Attendance to WHO meeting in Geneva in April 2019 to help assess through modelling, the feasibility of the WHO proposed goals for Chagas disease, 2021- 2030 Publication of a Gates Open Research open letter in 2019 and in 2022 Publication of papers in BMC Med Res Methodol and PLoS Negl Trop Dis in 2022 Submission of a paper for the NTD Collection of Philos Trans R Soc B at the end of 2022 (under review) |
| Start Year | 2018 |
| Description | How can modelling contribute to achieving the goals for Chagas disease in the horizon 2020 and beyond? |
| Organisation | Princeton University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Development of a data platform for collation and curation of Chagas disease epidemiological data Development of force of infection models for Chagas disease Contribution to papers on Chagas disease modelling |
| Collaborator Contribution | Princeton: Contribution of expertise in mathematical modelling Sussex: Contribution of machine learning methods PAHO: Funding of in country workshops and person based in Washington dedicated to systematic reviews, data entry and liaising with endemic countries |
| Impact | Publication of papers in Clinical Infectious Diseases, BMJ Global Health Attendance to WHO meeting in Geneva in April 2019 to help assess through modelling, the feasibility of the WHO proposed goals for Chagas disease, 2021- 2030 Publication of a Gates Open Research open letter in 2019 and in 2022 Publication of papers in BMC Med Res Methodol and PLoS Negl Trop Dis in 2022 Submission of a paper for the NTD Collection of Philos Trans R Soc B at the end of 2022 (under review) |
| Start Year | 2018 |
| Description | How can modelling contribute to achieving the goals for Chagas disease in the horizon 2020 and beyond? |
| Organisation | University of Sussex |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Development of a data platform for collation and curation of Chagas disease epidemiological data Development of force of infection models for Chagas disease Contribution to papers on Chagas disease modelling |
| Collaborator Contribution | Princeton: Contribution of expertise in mathematical modelling Sussex: Contribution of machine learning methods PAHO: Funding of in country workshops and person based in Washington dedicated to systematic reviews, data entry and liaising with endemic countries |
| Impact | Publication of papers in Clinical Infectious Diseases, BMJ Global Health Attendance to WHO meeting in Geneva in April 2019 to help assess through modelling, the feasibility of the WHO proposed goals for Chagas disease, 2021- 2030 Publication of a Gates Open Research open letter in 2019 and in 2022 Publication of papers in BMC Med Res Methodol and PLoS Negl Trop Dis in 2022 Submission of a paper for the NTD Collection of Philos Trans R Soc B at the end of 2022 (under review) |
| Start Year | 2018 |
| Description | Human challenge with live-attenuated rotavirus to assess next-generation rotavirus vaccines in Africa |
| Organisation | Centre for Infectious Disease Research in Zambia |
| Country | Zambia |
| Sector | Charity/Non Profit |
| PI Contribution | Project Management Study design Reporting to funders |
| Collaborator Contribution | Conducting the clinical trial in Zambia Local knowledge Immunological training Virology expertise Community Engagement Conducting all lab assays |
| Impact | Knowledge share - successful training of CIDRZ lab in ELISPOT assays Additional funds awarded from BMGF to partners at CIDRZ to extend study and carry out additional lab assays Supplementary funds awarded from MRC to support trial activities due to impact of COVID-19 |
| Start Year | 2020 |
| Description | Human challenge with live-attenuated rotavirus to assess next-generation rotavirus vaccines in Africa |
| Organisation | National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS) |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Project Management Study design Reporting to funders |
| Collaborator Contribution | Conducting the clinical trial in Zambia Local knowledge Immunological training Virology expertise Community Engagement Conducting all lab assays |
| Impact | Knowledge share - successful training of CIDRZ lab in ELISPOT assays Additional funds awarded from BMGF to partners at CIDRZ to extend study and carry out additional lab assays Supplementary funds awarded from MRC to support trial activities due to impact of COVID-19 |
| Start Year | 2020 |
| Description | Human challenge with live-attenuated rotavirus to assess next-generation rotavirus vaccines in Africa |
| Organisation | University of Liverpool |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Project Management Study design Reporting to funders |
| Collaborator Contribution | Conducting the clinical trial in Zambia Local knowledge Immunological training Virology expertise Community Engagement Conducting all lab assays |
| Impact | Knowledge share - successful training of CIDRZ lab in ELISPOT assays Additional funds awarded from BMGF to partners at CIDRZ to extend study and carry out additional lab assays Supplementary funds awarded from MRC to support trial activities due to impact of COVID-19 |
| Start Year | 2020 |
| Description | IMPPACT: Maximising the public health impact of interventions to control malaria in pregnancy |
| Organisation | Liverpool School of Tropical Medicine |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | To generate modelling and mapping of optimal preventative strategies for the prevention of malaria in pregnancy. These results were presented at Regional meetings of national policymakers in West and East Africa in Togo and Kenya respectively. |
| Collaborator Contribution | Other partners were responsible for organising meetings, developing stakeholder interviews and translating results from recent trials into other policy-relevant recommendations and outputs. |
| Impact | Multi-disciplinary: Modelling, Qualitative and Quantitive research, health economics and policy-making Regional meetings in Togo and Kenya Publication in PLoS Medicine and further publication pending. |
| Start Year | 2015 |
| Description | IMPPACT: Maximising the public health impact of interventions to control malaria in pregnancy |
| Organisation | Sixth Framework Programme (FP6) |
| Department | European and Developing Countries Clinical Trials Partnership |
| Country | Netherlands |
| Sector | Public |
| PI Contribution | To generate modelling and mapping of optimal preventative strategies for the prevention of malaria in pregnancy. These results were presented at Regional meetings of national policymakers in West and East Africa in Togo and Kenya respectively. |
| Collaborator Contribution | Other partners were responsible for organising meetings, developing stakeholder interviews and translating results from recent trials into other policy-relevant recommendations and outputs. |
| Impact | Multi-disciplinary: Modelling, Qualitative and Quantitive research, health economics and policy-making Regional meetings in Togo and Kenya Publication in PLoS Medicine and further publication pending. |
| Start Year | 2015 |
| Description | Immunisation Agenda 2030 |
| Organisation | UNICEF |
| Country | United States |
| Sector | Public |
| PI Contribution | VIMC estimates are used in the development of a framework to estimate the impact of all vaccination globally as part of the IA2030 VIMC research lead Katy Gaythorpe is a project team member and stakeholder committee member Data analysis Mathematical modelling |
| Collaborator Contribution | Dissemination of research Policy recommendations - shaping strategic priorities for Immunisation Agenda 2030 Project Management |
| Impact | Not yet recognised |
| Start Year | 2020 |
| Description | Immunisation Agenda 2030 |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | VIMC estimates are used in the development of a framework to estimate the impact of all vaccination globally as part of the IA2030 VIMC research lead Katy Gaythorpe is a project team member and stakeholder committee member Data analysis Mathematical modelling |
| Collaborator Contribution | Dissemination of research Policy recommendations - shaping strategic priorities for Immunisation Agenda 2030 Project Management |
| Impact | Not yet recognised |
| Start Year | 2020 |
| Description | Impact of COVID-19 on malaria control programmes (National malaria elimination programme Nigeria) |
| Organisation | National Malaria Control Programme |
| Country | Swaziland |
| Sector | Public |
| PI Contribution | Justification of continuing to support malaria during COVID Mathematical modelling expertise Writing up of scientific paper |
| Collaborator Contribution | Writing up of scientific paper Data provision - district level estimates |
| Impact | Modelling highlighted the need to continue national elimination programmes. Supported the justification of continued distribution of 22 million bed nets that otherwise would not have been distributed due to COVID-19 |
| Start Year | 2020 |
| Description | Impact of the GPELF |
| Organisation | GlaxoSmithKline (GSK) |
| Country | Global |
| Sector | Private |
| PI Contribution | Development of the impact model for the Global Programme to Eliminate Lymphatic Filariasis |
| Collaborator Contribution | Supporting the development |
| Impact | Paper under review |
| Start Year | 2021 |
| Description | Impact of therapeutics and vaccines on COVID-19 |
| Organisation | Medical Research Council (MRC) |
| Department | MRC Clinical Trials Unit |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Modelling expertise Data Analysis |
| Collaborator Contribution | Design of clinical trial Management of clinical trials Clinical expertise |
| Impact | Multiple grant applications generated to support clinical trials Paper under preparation |
| Start Year | 2020 |
| Description | Imperial College Healthcare NHS Trust Collaboration - patient- level data analysis |
| Organisation | Imperial College Healthcare NHS Trust |
| Country | United Kingdom |
| Sector | Hospitals |
| PI Contribution | Analysis of patient-level data on the COVID-19 hospitalisations workstream led by Katharina Hauck |
| Collaborator Contribution | Provision of patient-level data |
| Impact | Clinical papers. Ongoing. Update 2022 - papers published: http://dx.doi.org/10.1186/s12913-021-07008-9 http://dx.doi.org/10.1038/s43588-021-00111-1 http://dx.doi.org/10.1097/MLR.0000000000001502 http://dx.doi.org/10.1038/s41598-021-81930-0 http://dx.doi.org/10.1002/jmv.26594 http://dx.doi.org/10.1016/j.jinf.2020.06.049 |
| Start Year | 2020 |
| Description | Improving phylodynamic models by integrating epidemiological and genetic data |
| Organisation | University of Oxford |
| Department | Oxford Martin School |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Guided model development and provided input into design choices. Aided verification of its outputs. Supervised project outputs. |
| Collaborator Contribution | Collaborators led the project, developed the central model and accompanying software and benchmarking tests. |
| Impact | Paper in PLOS Computational Biology (which I jointly supervised) on the benefits of integrative approaches. New work ongoing int how this can remove reproduction number estimates from genomic data. |
| Start Year | 2020 |
| Description | Information on a novel malaria transmission blocking vaccine candidate |
| Organisation | National Institutes of Health (NIH) |
| Department | Vaccine Research Center (VRC) |
| Country | United States |
| Sector | Public |
| PI Contribution | We are using mathematical models to predict the effectiveness of a novel vaccine candidate when used in a small scale field trial and in a wider mass distribution campaign. |
| Collaborator Contribution | Provide details on the vaccine candidate including its efficacy and duration of protection. |
| Impact | Predictive models that can support sample size calculations to adequately power studies. |
| Start Year | 2019 |
| Description | Innovations to improve the speed and sensitivity of polio surveillance |
| Organisation | Congo National Institute of Biomedical Research |
| Country | Congo, the Democratic Republic of the |
| Sector | Academic/University |
| PI Contribution | Project Management Coordination of lab equipment and reagents Development of lab methods Analysis of samples and laboratory performance Updating of protocols Website management |
| Collaborator Contribution | Bioinformatic expertise Software development Sample provision Testing of Environmental and stool samples Methods development |
| Impact | Publication in Journal of Clinical Microbiology Training of 3 labs - NICD in South Africa, INRB in DRC and NIH in Pakistan Detection of new poliovirus outbreaks that are programmatically significant to the polio eradication programmes Update 2023: Additional funding awarded (2023 - 2024) for methods development and training of Global polio labs in direct detection methods Publication in Lancet |
| Start Year | 2020 |
| Description | Innovations to improve the speed and sensitivity of polio surveillance |
| Organisation | National Institute for Biological Standards and Control (NIBSC) |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Project Management Coordination of lab equipment and reagents Development of lab methods Analysis of samples and laboratory performance Updating of protocols Website management |
| Collaborator Contribution | Bioinformatic expertise Software development Sample provision Testing of Environmental and stool samples Methods development |
| Impact | Publication in Journal of Clinical Microbiology Training of 3 labs - NICD in South Africa, INRB in DRC and NIH in Pakistan Detection of new poliovirus outbreaks that are programmatically significant to the polio eradication programmes Update 2023: Additional funding awarded (2023 - 2024) for methods development and training of Global polio labs in direct detection methods Publication in Lancet |
| Start Year | 2020 |
| Description | Innovations to improve the speed and sensitivity of polio surveillance |
| Organisation | National Institute of Health, Pakistan |
| Country | Pakistan |
| Sector | Public |
| PI Contribution | Project Management Coordination of lab equipment and reagents Development of lab methods Analysis of samples and laboratory performance Updating of protocols Website management |
| Collaborator Contribution | Bioinformatic expertise Software development Sample provision Testing of Environmental and stool samples Methods development |
| Impact | Publication in Journal of Clinical Microbiology Training of 3 labs - NICD in South Africa, INRB in DRC and NIH in Pakistan Detection of new poliovirus outbreaks that are programmatically significant to the polio eradication programmes Update 2023: Additional funding awarded (2023 - 2024) for methods development and training of Global polio labs in direct detection methods Publication in Lancet |
| Start Year | 2020 |
| Description | Innovations to improve the speed and sensitivity of polio surveillance |
| Organisation | University of Edinburgh |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Project Management Coordination of lab equipment and reagents Development of lab methods Analysis of samples and laboratory performance Updating of protocols Website management |
| Collaborator Contribution | Bioinformatic expertise Software development Sample provision Testing of Environmental and stool samples Methods development |
| Impact | Publication in Journal of Clinical Microbiology Training of 3 labs - NICD in South Africa, INRB in DRC and NIH in Pakistan Detection of new poliovirus outbreaks that are programmatically significant to the polio eradication programmes Update 2023: Additional funding awarded (2023 - 2024) for methods development and training of Global polio labs in direct detection methods Publication in Lancet |
| Start Year | 2020 |
| Description | Integrated economic epidemiological modelling (Katharina) |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Data analytics and modelling projections |
| Collaborator Contribution | Project management and liaison with policy makers |
| Impact | Modelling projections on the economic and health impact of alternative pandemic mitigation strategies (confidential) |
| Start Year | 2021 |
| Description | Integrating genomic surveillance and ecological modelling to maximise pneumococcal vaccine efficacy |
| Organisation | Public Health England |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Providing expertise in mathematical modelling and genomic epidemiology. |
| Collaborator Contribution | Genome sequencing, sharing of data and expertise in epidemiology and vaccinology. Updated 2021 - provision of data |
| Impact | No outputs yet. |
| Start Year | 2019 |
| Description | International Severe Acute Respiratory and emerging Infection Consortium |
| Organisation | The Global Health Network |
| Department | International Severe Acute Respiratory Infection Consortium (ISARIC) |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | Method and analysis of clinical data collected internationally on hospitalised COVID-19 patients |
| Collaborator Contribution | Collection of and curation of data Medical interpretation of results |
| Impact | Publications in ERJ Open Research and E-Life |
| Start Year | 2020 |
| Description | Investigating the potential impact of a cure for HIV as part of PEPFAR/NIH planning |
| Organisation | National Institutes of Health (NIH) |
| Country | United States |
| Sector | Public |
| PI Contribution | I provided technical guidance and leadership in the investigation of the potential impact and cost of a cure for HIV, which is used for planning and industry engagement. |
| Collaborator Contribution | Partners provided expert knowledge and undertook analyses. |
| Impact | Publication forthcoming. |
| Start Year | 2022 |
| Description | Investigating the potential impact of a cure for HIV as part of PEPFAR/NIH planning |
| Organisation | United States President's Emergency Plan for AIDS Relief |
| Country | United States |
| Sector | Public |
| PI Contribution | I provided technical guidance and leadership in the investigation of the potential impact and cost of a cure for HIV, which is used for planning and industry engagement. |
| Collaborator Contribution | Partners provided expert knowledge and undertook analyses. |
| Impact | Publication forthcoming. |
| Start Year | 2022 |
| Description | Javier Martin (Dr) -NIBSC |
| Organisation | National Institute for Biological Standards and Control (NIBSC) |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Sequencing and analysis of polio virus in stool and environmental samples |
| Collaborator Contribution | Virus isolation and sequencing |
| Impact | A supplement to the existing grant and a new grant |
| Start Year | 2017 |
| Description | Jinan University |
| Organisation | Jinan University |
| Country | China |
| Sector | Academic/University |
| PI Contribution | We will provide samples and analysis and Jinan will conduct immunological assays |
| Collaborator Contribution | We will provide samples and analysis and Jinan will conduct immunological assays |
| Impact | None yet |
| Start Year | 2016 |
| Description | Kenya National Aid Control Council - Dr Nduku Kilonzo - Preparing for the double burden HIV |
| Organisation | Kenya National Malaria Control Programme |
| Country | Kenya |
| Sector | Public |
| PI Contribution | Tim Hallett leads the research to inform policy |
| Collaborator Contribution | Partners run the programme in Kenya |
| Impact | A grant was obtained in 2017 and it is still active. Publication of 2 manuscripts in BMJ Global Health and CID |
| Start Year | 2014 |
| Description | LSHTM collaboration on forecasting |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | We have provided feedback and guidance on the design of an R package developed by LSHTM colleagues to evaluate and compare epidemic forecasts. I am a co-supervisor of a PhD student and we have multiple papers submitted or accepted together. |
| Collaborator Contribution | They led the development and implementation of models and packages. |
| Impact | One paper published, two papers submitted, one R package developed |
| Start Year | 2020 |
| Description | Laval University |
| Organisation | University Hospital of Laval University |
| Country | Canada |
| Sector | Hospitals |
| PI Contribution | Collaborating with two teams lead by Michel Alary (HIV) and Marc Brisson (HPV Vaccination). I provide expetise in Modelling Statistical Analysis and Epidemiological expertise at the intersection between HIV and HPV. |
| Collaborator Contribution | Michel Alary provides the epidemiological expertise and Marc Brisson provides modelling in health economic expertise. |
| Impact | Multiple Publications and successful grant applications. |
| Description | Linking selection and function in bacterial genomes |
| Organisation | DeepBlue Technology (Shanghai) Co., Ltd. |
| Country | China |
| Sector | Private |
| PI Contribution | Design and supervision of the research project |
| Collaborator Contribution | 50% FTE of a researcher working on the project. Technical advice on GPUs. |
| Impact | Prototype software: https://github.com/jingjing-z/dN-dS-project |
| Start Year | 2021 |
| Description | London Centre for NTD Research |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | expertise, intellectual input and the training of staff, equipment and facilities, data sharing, facilitation of collaboration |
| Collaborator Contribution | expertise, intellectual input and the training of staff, equipment and facilities, data sharing, facilitation of collaboration |
| Impact | Scientific publicatons, public engagement events, network events, policy advocacy, facilitating research collaborations. |
| Start Year | 2013 |
| Description | London Centre for NTD Research |
| Organisation | Natural History Museum |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | expertise, intellectual input and the training of staff, equipment and facilities, data sharing, facilitation of collaboration |
| Collaborator Contribution | expertise, intellectual input and the training of staff, equipment and facilities, data sharing, facilitation of collaboration |
| Impact | Scientific publicatons, public engagement events, network events, policy advocacy, facilitating research collaborations. |
| Start Year | 2013 |
| Description | London Centre for NTD Research |
| Organisation | Royal Veterinary College (RVC) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | expertise, intellectual input and the training of staff, equipment and facilities, data sharing, facilitation of collaboration |
| Collaborator Contribution | expertise, intellectual input and the training of staff, equipment and facilities, data sharing, facilitation of collaboration |
| Impact | Scientific publicatons, public engagement events, network events, policy advocacy, facilitating research collaborations. |
| Start Year | 2013 |
| Description | London Centre for NTD Research |
| Organisation | The Wellcome Trust Sanger Institute |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | expertise, intellectual input and the training of staff, equipment and facilities, data sharing, facilitation of collaboration |
| Collaborator Contribution | expertise, intellectual input and the training of staff, equipment and facilities, data sharing, facilitation of collaboration |
| Impact | Scientific publicatons, public engagement events, network events, policy advocacy, facilitating research collaborations. |
| Start Year | 2013 |
| Description | MIT Broad Institute |
| Organisation | Broad Institute |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Contribution of whole genome sequences of Cryptococcus neoformans, analysis and experimental data |
| Collaborator Contribution | Contribution of whole genome sequences of Cryptococcus neoformans and analysis. |
| Impact | Paper in submission |
| Start Year | 2012 |
| Description | MRC Centre for Global Health Analysis - "Breaking silos and building collaborations for integrated and sustainable management of cholangiocarcinoma and its causal pathogen Opisthorchis viverrini in LMICs in the Lower Mekong Region |
| Organisation | Global Health Asia Institute |
| Country | Thailand |
| Sector | Charity/Non Profit |
| PI Contribution | PI |
| Collaborator Contribution | co-I |
| Impact | none yet |
| Start Year | 2018 |
| Description | MRC Centre for Global Health Analysis - "Breaking silos and building collaborations for integrated and sustainable management of cholangiocarcinoma and its causal pathogen Opisthorchis viverrini in LMICs in the Lower Mekong Region |
| Organisation | International Agency for Research on Cancer (IARC) |
| Country | France |
| Sector | Academic/University |
| PI Contribution | PI |
| Collaborator Contribution | co-I |
| Impact | none yet |
| Start Year | 2018 |
| Description | MRC Centre for Global Health Analysis - "Breaking silos and building collaborations for integrated and sustainable management of cholangiocarcinoma and its causal pathogen Opisthorchis viverrini in LMICs in the Lower Mekong Region |
| Organisation | Phramongkutklao College of Medicine |
| Country | Thailand |
| Sector | Academic/University |
| PI Contribution | PI |
| Collaborator Contribution | co-I |
| Impact | none yet |
| Start Year | 2018 |
| Description | MRC Dementias Collaboration |
| Organisation | MRC Dementias Platform UK |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Creation of clinical trial simulator for possible therapies for Alzheimer's New methods for analysis of epidemiological data for Alzheimer's disease progression |
| Collaborator Contribution | Clincial, Statistical and Epidemiological input |
| Impact | Publications in scientific journals |
| Start Year | 2019 |
| Description | MRC GCRF Foundation Award - Snake Bite |
| Organisation | Liverpool School of Tropical Medicine |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Liverpool School of Tropical Medicine, Lancaster University, Tel Aviv Uni, Kelaniya Uni. Co PI Ecological modelling expertise Data collection Epidemiological Model development |
| Collaborator Contribution | LSTM - Clinical expertise Analysis of burden of snake bites |
| Impact | Multiple Publications in prep Web portal being developed Update 2021: Publications in PLoS One, The Lancet, PLoS Neglected Tropical Disease Publications in development Web Portal on hiatus |
| Start Year | 2017 |
| Description | Malaria in Pregnancy |
| Organisation | Liverpool School of Tropical Medicine |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | This collaboration involves estimating the burden of malaria in pregnancy, its relationship with transmission and the impact of interventions. I provide mathematical modelling expertise, data analysis to questions relevant to these issues. |
| Collaborator Contribution | Members of the Malaria in Pregnancy Consortium Secretariat provide support for these analyses in terms of providing access to data and academic support and input. As well as providing funding for travel to meetings. |
| Impact | I developed the first model of malaria in pregnancy (Walker et al, Nature Communications 2012) and its link to transmission and using this was able to develop the first map of potential low birth weight burden attributable to malaria (Walker et al, Lancet Global Health 2014). I am also part of a working group looking at the incremental impact of switching to a policy of testing pregnant women for malaria and treating them if infected (Incremental Screening and Treatment) relative to treating them presumptively which will provide scientific support to an Evidence Review Group which will report to the Malaria Policy Advisory Committee of the World Health Organisation about the potential area of application of this strategy. I provided a preliminary version of this analysis during a Malaria in Pregnancy symposium at ASTMH 2014 in New Orleans. Research from this collaboration was also presented at the Evidence Review Group meeting into Intermittent screening and treatment in pregnancy and the safety of ACTs in the first trimester at WHO in Geneva in July 2015 and had direct influence on WHO malaria in pregnancy policy. |
| Start Year | 2014 |
| Description | Malaria mapping and burden |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | I provided supervision and worked collaboratively to produce malaria estimates for the global burden of disease project, the WHO and the global fund. |
| Collaborator Contribution | Two subcontract grants, computational facilities, data preparation and synthesis, facility space at the Big data institute |
| Impact | 2 papers accepted in Lancet, 1 paper accepted in Nature and 1 paper in Nature Medicine |
| Start Year | 2016 |
| Description | Malawi Public Health Institute |
| Organisation | Public Health Institute of Malawi |
| Country | Malawi |
| Sector | Public |
| PI Contribution | Analysis of data |
| Collaborator Contribution | Collation of data |
| Impact | Updated 2021: 3 papers published in BMJ Global Health, Tropical Medicine and International Health and The Malawian Public Health Journal |
| Start Year | 2018 |
| Description | Malawi/Kenya |
| Organisation | Wellcome Trust |
| Department | Malawi-Liverpool Wellcome Trust Clinical Research Programme |
| Country | Malawi |
| Sector | Academic/University |
| PI Contribution | I recruited a Research Assistant from Malawi, on a UK Royal Society Global Challenges grant, in June 2017 to undertake modelling of the impact of intermittent treatment in pregnancy for malaria on drug resistance development. He worked for a year and a half working with me training in mathematical modelling. |
| Collaborator Contribution | The partner hosted our postdoc for a number of months in Malawi, provided supervision and regular phone calls to discuss the progress of the project. They are also currently undertaking large trials of intermittent preventive treatment in pregnant women, and these trials helped to inform our modelling analysis. |
| Impact | The RA recruited has now gone on to a PhD to LSHTM in the same field, which we hope will contribute to capacity building. |
| Start Year | 2016 |
| Description | Mapping housing quality |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | A collaborative project mapping housing quality in Africa |
| Collaborator Contribution | Research support, data assistance |
| Impact | 1 paper accepted in Nature (article) 1 paper accepted in PLoS Medicine (2021) 1 paper accepted in Lancet Planetary Health |
| Start Year | 2018 |
| Description | Mapping the risk of international infectious disease spread |
| Organisation | HealthMap |
| Sector | Charity/Non Profit |
| PI Contribution | Developing a mathematical model of spatial spread of infectious diseases |
| Collaborator Contribution | Providing data on Ebola UPDATE 2022 - Design and maintenance of website and input on methods |
| Impact | Talks at several conferences - Epidemics 8th edition - https://www.elsevier.com/events/conferences/international-conference-on-infectious-disease-dynamics Papers in preparation - https://www.medrxiv.org/content/10.1101/2021.11.26.21266899v1 UPDATE 2022 - papers published: Data Journalism and the COVID-19 Pandemic - Challenges and Opportunities The Lancet Digital Health Using digital surveillance tools for near real-time mapping of the risk of international infectious disease spread: Ebola as a case study, NPJ Digital Medicine 4, 73 |
| Start Year | 2016 |
| Description | Mapping the risk of international infectious disease spread |
| Organisation | Healthsites.io |
| Country | France |
| Sector | Private |
| PI Contribution | Developing a mathematical model of spatial spread of infectious diseases |
| Collaborator Contribution | Providing data on Ebola UPDATE 2022 - Design and maintenance of website and input on methods |
| Impact | Talks at several conferences - Epidemics 8th edition - https://www.elsevier.com/events/conferences/international-conference-on-infectious-disease-dynamics Papers in preparation - https://www.medrxiv.org/content/10.1101/2021.11.26.21266899v1 UPDATE 2022 - papers published: Data Journalism and the COVID-19 Pandemic - Challenges and Opportunities The Lancet Digital Health Using digital surveillance tools for near real-time mapping of the risk of international infectious disease spread: Ebola as a case study, NPJ Digital Medicine 4, 73 |
| Start Year | 2016 |
| Description | Mapping the risk of international infectious disease spread |
| Organisation | International Society for Infectious Diseases (ISID) |
| Department | Program for Monitoring Emerging Diseases |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Developing a mathematical model of spatial spread of infectious diseases |
| Collaborator Contribution | Providing data on Ebola UPDATE 2022 - Design and maintenance of website and input on methods |
| Impact | Talks at several conferences - Epidemics 8th edition - https://www.elsevier.com/events/conferences/international-conference-on-infectious-disease-dynamics Papers in preparation - https://www.medrxiv.org/content/10.1101/2021.11.26.21266899v1 UPDATE 2022 - papers published: Data Journalism and the COVID-19 Pandemic - Challenges and Opportunities The Lancet Digital Health Using digital surveillance tools for near real-time mapping of the risk of international infectious disease spread: Ebola as a case study, NPJ Digital Medicine 4, 73 |
| Start Year | 2016 |
| Description | Mapping the risk of international infectious disease spread |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Developing a mathematical model of spatial spread of infectious diseases |
| Collaborator Contribution | Providing data on Ebola UPDATE 2022 - Design and maintenance of website and input on methods |
| Impact | Talks at several conferences - Epidemics 8th edition - https://www.elsevier.com/events/conferences/international-conference-on-infectious-disease-dynamics Papers in preparation - https://www.medrxiv.org/content/10.1101/2021.11.26.21266899v1 UPDATE 2022 - papers published: Data Journalism and the COVID-19 Pandemic - Challenges and Opportunities The Lancet Digital Health Using digital surveillance tools for near real-time mapping of the risk of international infectious disease spread: Ebola as a case study, NPJ Digital Medicine 4, 73 |
| Start Year | 2016 |
| Description | Mapping the risk of international infectious disease spread |
| Organisation | University of Sussex |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Developing a mathematical model of spatial spread of infectious diseases |
| Collaborator Contribution | Providing data on Ebola UPDATE 2022 - Design and maintenance of website and input on methods |
| Impact | Talks at several conferences - Epidemics 8th edition - https://www.elsevier.com/events/conferences/international-conference-on-infectious-disease-dynamics Papers in preparation - https://www.medrxiv.org/content/10.1101/2021.11.26.21266899v1 UPDATE 2022 - papers published: Data Journalism and the COVID-19 Pandemic - Challenges and Opportunities The Lancet Digital Health Using digital surveillance tools for near real-time mapping of the risk of international infectious disease spread: Ebola as a case study, NPJ Digital Medicine 4, 73 |
| Start Year | 2016 |
| Description | Measuring the impact of birth dose for GAVI |
| Organisation | Gavi |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Measuring the impact of birth dose vaccine to inform GAVI strategy |
| Collaborator Contribution | Funding and formulation of policy questions |
| Impact | Not yet recognised |
| Start Year | 2021 |
| Description | Medicines for Malaria Venture |
| Organisation | Medicines for Malaria Venture (MMV) |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | We are using mathematical modelling to estimate the impact of both existing antimalarial drugs and also products in development on malaria transmission, and their cost-effectiveness. |
| Collaborator Contribution | Funding (research costs and 1 postdoc for 3 years), requests for research and advice on ongoing work. |
| Impact | A data collaboration with the Worldwide Antimalarial Resistance Network and Sanofi Ltd to access clinical trial data. We published three papers: Nature Communications (2017), Malaria Journal (2017) and Trends in Parasitology (2017). |
| Start Year | 2013 |
| Description | Member of Malaria Modelling Consortium |
| Organisation | Bill and Melinda Gates Foundation |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | I participated in consortium meetings, and contributed substantially to a Malaria Modelling Consortium report to the World Health Organization Malaria Policy Advisory Group on results from modelling mass drug administration for malaria control. |
| Collaborator Contribution | Other modelling partners contribute modelling results, the Gates Foundation coordinate activities, arrange meetings and fund travel for the meetings. |
| Impact | Malaria Modelling Consortium report to the World Health Organization Malaria Policy Advisory Group on results from modelling mass drug administration for malaria control. This is now published as a paper in Lancet Global Health. A preprint is out on medrxiv on modelling drug resistance. |
| Start Year | 2015 |
| Description | Memorandum of Understanding with National Institute of Health - Colombia |
| Organisation | Government of Colombia |
| Department | National Institute of Health, Colombia |
| Country | Colombia |
| Sector | Public |
| PI Contribution | Cooperative working and exchange of research in public health and education activities in science and technology. Overseeing study design, data analysis and write-up. |
| Collaborator Contribution | Cooperative working and exchange of research in public health and education activities in science and technology. Data sharing. |
| Impact | Kelly Charniga (PhD) funded by Imperial President Scholarship |
| Start Year | 2017 |
| Description | MeninGene study |
| Organisation | Academic Medical Center |
| Department | Section of Pediatric Oncology |
| Country | Netherlands |
| Sector | Hospitals |
| PI Contribution | We have produced sequence data, analysed most of the data produced (in terms of both statistical genetics and microbiology) and written papers on these results. Additionally, I have analysed biomarker data produced by another study from the group, to determine its sensitivity/specificity at meningitis diagnosis. I am now providing supervision for a PhD student continuing statistical genetic analysis of the resulting data. |
| Collaborator Contribution | Our partners collected all the samples and associated metadata, and continue to run the study. They have also contributed to analysis and critical editing of papers. A PhD and a postdoc from this group have performed some analysis jointly with me, and some under my supervision. |
| Impact | Papers: Kremer, P. H. C. et al. Diversification in immunogenicity genes caused by selective pressures in invasive meningococci. Microb Genom 6, (2020) Kremer, P. H. C. et al. Genetic Variation in Neisseria meningitidis Does Not Influence Disease Severity in Meningococcal Meningitis. Front. Med. 7, 594769 (2020) Lees, J. A. et al. Joint sequencing of human and pathogen genomes reveals the genetics of pneumococcal meningitis. Nat. Commun. 10, 2176 (2019) Koelman, D. et al. Bacterial hypervirulence in haemophilus influenzae meningitis identified by whole genome sequencing. J. Neurol. Sci. 381, 181-182 (2017) Lees, J. A., Brouwer, M., van der Ende, A., Parkhill, J., van de Beek, D., & Bentley, S. D. (2017). Within-Host Sampling of a Natural Population Shows Signs of Selection on Pde1 during Bacterial Meningitis. Infection and Immunity, 85(3). https://doi.org/10.1128/IAI.01061-16 Kremer, P. H. C., Lees, J. A., Koopmans, M. M., Ferwerda, B., Arends, A. W. M., Feller, M. M., Bentley, S. D. (2016). Benzalkonium tolerance genes and outcome in Listeria monocytogenes meningitis. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. https://doi.org/10.1016/j.cmi.2016.12.008 Lees, J. A., Kremer, P. H. C., Manso, A. S., Croucher, N. J., Ferwerda, B., Serón, M. V., Bentley, S. D. (2016). Large scale genomic analysis shows no evidence for pathogen adaptation between the blood and cerebrospinal fluid niches during bacterial meningitis. Microbial Genomics. https://doi.org/10.1099/mgen.0.000103 Khatib, U., van de Beek, D., Lees, J. A., & Brouwer, M. C. (2016). Adults with suspected central nervous system infection: A prospective study of diagnostic accuracy. The Journal of Infection. https://doi.org/10.1016/j.jinf.2016.09.007 |
| Start Year | 2014 |
| Description | MeninGene study |
| Organisation | The Wellcome Trust Sanger Institute |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | We have produced sequence data, analysed most of the data produced (in terms of both statistical genetics and microbiology) and written papers on these results. Additionally, I have analysed biomarker data produced by another study from the group, to determine its sensitivity/specificity at meningitis diagnosis. I am now providing supervision for a PhD student continuing statistical genetic analysis of the resulting data. |
| Collaborator Contribution | Our partners collected all the samples and associated metadata, and continue to run the study. They have also contributed to analysis and critical editing of papers. A PhD and a postdoc from this group have performed some analysis jointly with me, and some under my supervision. |
| Impact | Papers: Kremer, P. H. C. et al. Diversification in immunogenicity genes caused by selective pressures in invasive meningococci. Microb Genom 6, (2020) Kremer, P. H. C. et al. Genetic Variation in Neisseria meningitidis Does Not Influence Disease Severity in Meningococcal Meningitis. Front. Med. 7, 594769 (2020) Lees, J. A. et al. Joint sequencing of human and pathogen genomes reveals the genetics of pneumococcal meningitis. Nat. Commun. 10, 2176 (2019) Koelman, D. et al. Bacterial hypervirulence in haemophilus influenzae meningitis identified by whole genome sequencing. J. Neurol. Sci. 381, 181-182 (2017) Lees, J. A., Brouwer, M., van der Ende, A., Parkhill, J., van de Beek, D., & Bentley, S. D. (2017). Within-Host Sampling of a Natural Population Shows Signs of Selection on Pde1 during Bacterial Meningitis. Infection and Immunity, 85(3). https://doi.org/10.1128/IAI.01061-16 Kremer, P. H. C., Lees, J. A., Koopmans, M. M., Ferwerda, B., Arends, A. W. M., Feller, M. M., Bentley, S. D. (2016). Benzalkonium tolerance genes and outcome in Listeria monocytogenes meningitis. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. https://doi.org/10.1016/j.cmi.2016.12.008 Lees, J. A., Kremer, P. H. C., Manso, A. S., Croucher, N. J., Ferwerda, B., Serón, M. V., Bentley, S. D. (2016). Large scale genomic analysis shows no evidence for pathogen adaptation between the blood and cerebrospinal fluid niches during bacterial meningitis. Microbial Genomics. https://doi.org/10.1099/mgen.0.000103 Khatib, U., van de Beek, D., Lees, J. A., & Brouwer, M. C. (2016). Adults with suspected central nervous system infection: A prospective study of diagnostic accuracy. The Journal of Infection. https://doi.org/10.1016/j.jinf.2016.09.007 |
| Start Year | 2014 |
| Description | Meta-population models and ecology |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Aided the design and development of meta-population models with ecological and infectious disease applications in mind. |
| Collaborator Contribution | Collaborators led project and developed code and modelling framework. |
| Impact | Metapopulation model still in development. Consulted on some related ecology work now published at https://onlinelibrary.wiley.com/doi/full/10.1111/mec.16778 |
| Start Year | 2020 |
| Description | Microcosm - HIV and employment |
| Organisation | University of Cape Town |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | Input to model HIV and employment relationship; coding relationship in an exiting micro-simulation model. We plan a research paper to identify the long-term employment effects of HIV interventions, and vice-versa, in South Africa. |
| Collaborator Contribution | Provided the micro-simulation model and guidance and inputs for the research; will provide facilities to work at for the planned research visit from November this year, for six months. |
| Impact | No outputs yet. We are at the coding phase and plan to generate outputs in autumn this year - at the time of my planned research visit at the University of Cape Town. The collaboration is multi-disciplinary with Leigh Johnson being an epidemiologist and myself a health economist. |
| Start Year | 2020 |
| Description | Miren Iturizza-Gomara (Prof-Mrs) University of Liverpool |
| Organisation | University of Liverpool |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Microbiome analysis |
| Collaborator Contribution | Provide rotavirus |
| Impact | 1 publication BMJ Open |
| Start Year | 2018 |
| Description | Modelling RSV transmission dynamics in Lombardy region throughout the COVID-19 pandemic |
| Organisation | Fondazione Bruno Kessler |
| Country | Italy |
| Sector | Private |
| PI Contribution | Analysis of syndromic, virological and hospitalisation data Modelling RSV transmission throughout the pandemic Paper in development |
| Collaborator Contribution | Data provision Interpretation of results |
| Impact | Paper in development |
| Start Year | 2022 |
| Description | Modelling RSV transmission dynamics in Lombardy region throughout the COVID-19 pandemic |
| Organisation | University of Milan |
| Country | Italy |
| Sector | Academic/University |
| PI Contribution | Analysis of syndromic, virological and hospitalisation data Modelling RSV transmission throughout the pandemic Paper in development |
| Collaborator Contribution | Data provision Interpretation of results |
| Impact | Paper in development |
| Start Year | 2022 |
| Description | Modelling West Nile Virus transmisison from entomological surveillance in Emilia Romagna, Italy |
| Organisation | Edmund Mach Foundation |
| Country | Italy |
| Sector | Charity/Non Profit |
| PI Contribution | Mathematical modelling expertise |
| Collaborator Contribution | Provision of data Mathematical modelling expertise |
| Impact | 1 paper published in PLoS NTDs and one manuscript under review Conference presentations |
| Start Year | 2018 |
| Description | Modelling West Nile Virus transmisison from entomological surveillance in Emilia Romagna, Italy |
| Organisation | Lombardy and Emilia Romagna Experimental Zootechnic Institute (IZSLER) |
| Country | Italy |
| Sector | Public |
| PI Contribution | Mathematical modelling expertise |
| Collaborator Contribution | Provision of data Mathematical modelling expertise |
| Impact | 1 paper published in PLoS NTDs and one manuscript under review Conference presentations |
| Start Year | 2018 |
| Description | Modelling West Nile Virus transmisison from entomological surveillance in Emilia Romagna, Italy |
| Organisation | Pasteur Institute, Paris |
| Country | France |
| Sector | Charity/Non Profit |
| PI Contribution | Mathematical modelling expertise |
| Collaborator Contribution | Provision of data Mathematical modelling expertise |
| Impact | 1 paper published in PLoS NTDs and one manuscript under review Conference presentations |
| Start Year | 2018 |
| Description | Modelling West Nile Virus transmisison from entomological surveillance in Emilia Romagna, Italy |
| Organisation | University of Trento |
| Country | Italy |
| Sector | Academic/University |
| PI Contribution | Mathematical modelling expertise |
| Collaborator Contribution | Provision of data Mathematical modelling expertise |
| Impact | 1 paper published in PLoS NTDs and one manuscript under review Conference presentations |
| Start Year | 2018 |
| Description | Modelling and dengue vaccines |
| Organisation | Takeda Pharmaceutical Company |
| Department | Takeda Global Research & Development Centre (Europe) |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | Modelling related to Dengue disease and vaccination. |
| Collaborator Contribution | Know how with regard to its therapeutic area vaccines and in particular, but limited to its Dengue, Norovirus and Polio candidate vaccines. |
| Impact | N?A at this stage. |
| Start Year | 2018 |
| Description | Modelling critical characteristics of a future universal influenza vaccine |
| Organisation | Flu Lab |
| Sector | Charity/Non Profit |
| PI Contribution | Leading modelling efforts, epidemiology and economic threads |
| Collaborator Contribution | Helping to develop epidemiological model |
| Impact | Not yet recognised - work ongoing |
| Start Year | 2020 |
| Description | Modelling critical characteristics of a future universal influenza vaccine |
| Organisation | Princeton University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Leading modelling efforts, epidemiology and economic threads |
| Collaborator Contribution | Helping to develop epidemiological model |
| Impact | Not yet recognised - work ongoing |
| Start Year | 2020 |
| Description | Modelling dengue vaccination |
| Organisation | Sanofi |
| Department | Sanofi Research Division |
| Country | France |
| Sector | Private |
| PI Contribution | Mathematical modelling of immunogenicity and efficacy data |
| Collaborator Contribution | Provision of data Contribution to mathematical modelling |
| Impact | Publication of several papers Talks at numerous conferences |
| Start Year | 2013 |
| Description | Modelling evolutionary adaptation and selection acting on bacterial genomes |
| Organisation | DeepBlue Technology (Shanghai) Co., Ltd. |
| Country | China |
| Sector | Private |
| PI Contribution | Design and supervision of project. Development of code into software, writing results as scientific documents. |
| Collaborator Contribution | Visiting research assistant working directly under our supervision for the project period. Some additional supervision provided. Hardware and knowhow related to deep learning. |
| Impact | Development of a model for genetic evolution. Spans computer science, AI and evolutionary biology. |
| Start Year | 2020 |
| Description | Modelling of COVID-19 pandemic in India |
| Organisation | Christian Medical College, Vellore |
| Country | India |
| Sector | Academic/University |
| PI Contribution | Development of model of SARS-COV2 transmission to forecast hospital bed needs and to estimate the proportion of population infected |
| Collaborator Contribution | Coordination of results and analysis with Indian government and sharing of data |
| Impact | Confidential Paper written (pre-print) UPDATE 2022: Paper accepted in EID Impact - work was used by the chief scientific advisor to the Indian govt |
| Start Year | 2020 |
| Description | Modelling optimal COVID-19 response in India |
| Organisation | Indian Council of Medical Research (ICMR) |
| Country | India |
| Sector | Public |
| PI Contribution | Developed mathematical model of impact of COVID-19 vaccination in India Examined impact of different strategies for prioritisation of clinical risk groups |
| Collaborator Contribution | Provided guidance on potential policy options Validated mathematical model |
| Impact | Series of manuscripts now published as a result of this collaboration: https://bmjopen.bmj.com/content/11/7/e048874 https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00284-9/fulltext https://pubmed.ncbi.nlm.nih.gov/34519335/ https://gh.bmj.com/content/bmjgh/7/5/e008710.full.pdf Co-authors include Director General and Deputy Director General of ICMR - informed Indian Government planning for vaccine rollout |
| Start Year | 2020 |
| Description | Modelling pandemic influenza in the USA |
| Organisation | Centers for Disease Control and Prevention (CDC) |
| Country | United States |
| Sector | Public |
| PI Contribution | Building model of pandemic influenza in USA to support CDC planning |
| Collaborator Contribution | Providing data and convening network of modelling |
| Impact | Consortium Publication under preparation Imperial/CDC Manuscript under preparation Update 2022 - paper under review |
| Start Year | 2019 |
| Description | Modelling public/private mix strategies in TB, following COVID disruptions |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | WHO has developed an active workstream in how COVID disruptions have affected the private sector in TB control. The IC research team developed modelling analyses in support of this workstream, to address the implications of private sector disruption in high burden countries. The work was presented to the WHO global PPM working group and is now being prepared for publication. |
| Collaborator Contribution | Provision of data for analysis and validation |
| Impact | The work was presented to the WHO global PPM working group and is now being prepared for publication. |
| Start Year | 2021 |
| Description | Modelling structural determinants of HIV among MSM in SSA |
| Organisation | McGill University |
| Department | Department of Epidemiology, Biostatistics and Occupational Health |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Co-supervise a PhD student at McGill university - I contribute to ideas, research direction and supervision |
| Collaborator Contribution | Main supervisor of the PhD students- day to day supervisions and methodology and directions |
| Impact | Submitted publication and conference abstract to AIDS conference 2022(https://programme.aids2022.org/PAGMaterial/PPT/2038_7183/A-AIDS-2022-06564-JamesStannah.pdf) Trends in HIV testing, the treatment cascade, and HIV incidence among men who have sex with men in Africa: A systematic review and meta-regression analysis View ORCID ProfileJames Stannah, Nirali Soni, Jin Keng Stephen Lam, Katia Giguère, Kate M Mitchell, Nadine Kronfli, View ORCID ProfileJoseph Larmarange, Raoul Moh, Marcelin N'zebo Nouaman, Gérard Menan Kouamé, View ORCID ProfileMathieu Maheu-Giroux, Marie-Claude Boily doi: https://doi.org/10.1101/2022.11.14.22282329 1 publications in preparation 1 grant application |
| Start Year | 2020 |
| Description | Modelling structural determinants of HIV among MSM in SSA |
| Organisation | McGill University |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Co-supervise a PhD student at McGill university - I contribute to ideas, research direction and supervision |
| Collaborator Contribution | Main supervisor of the PhD students- day to day supervisions and methodology and directions |
| Impact | Submitted publication and conference abstract to AIDS conference 2022(https://programme.aids2022.org/PAGMaterial/PPT/2038_7183/A-AIDS-2022-06564-JamesStannah.pdf) Trends in HIV testing, the treatment cascade, and HIV incidence among men who have sex with men in Africa: A systematic review and meta-regression analysis View ORCID ProfileJames Stannah, Nirali Soni, Jin Keng Stephen Lam, Katia Giguère, Kate M Mitchell, Nadine Kronfli, View ORCID ProfileJoseph Larmarange, Raoul Moh, Marcelin N'zebo Nouaman, Gérard Menan Kouamé, View ORCID ProfileMathieu Maheu-Giroux, Marie-Claude Boily doi: https://doi.org/10.1101/2022.11.14.22282329 1 publications in preparation 1 grant application |
| Start Year | 2020 |
| Description | Modelling the dynamics of hand, foot and mouth disease in Malaysia |
| Organisation | University of Malaya |
| Country | Malaysia |
| Sector | Academic/University |
| PI Contribution | Data analysis and modelling |
| Collaborator Contribution | Provision of data |
| Impact | Not yet |
| Start Year | 2019 |
| Description | Modelling the elimination of onchocerciasis in Cameroon |
| Organisation | Royal Veterinary College (RVC) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Joint publication in Systematic Reviews Mentoring of a PhD student from Cameroon through AIMS Cameroon for mathematical modelling Provide the mathematical and geostatistical modelling expertise |
| Collaborator Contribution | Responsible for collating and curating the data Drafting of manuscript for publication |
| Impact | Mentoring of a PhD student and modelling outcomes that will help the MoH in Cameroon to identify optimal interventions for onchocerciasis elimination |
| Start Year | 2018 |
| Description | Modelling the elimination of onchocerciasis in Cameroon |
| Organisation | University of Yaoundé |
| Country | Cameroon |
| Sector | Academic/University |
| PI Contribution | Joint publication in Systematic Reviews Mentoring of a PhD student from Cameroon through AIMS Cameroon for mathematical modelling Provide the mathematical and geostatistical modelling expertise |
| Collaborator Contribution | Responsible for collating and curating the data Drafting of manuscript for publication |
| Impact | Mentoring of a PhD student and modelling outcomes that will help the MoH in Cameroon to identify optimal interventions for onchocerciasis elimination |
| Start Year | 2018 |
| Description | Modelling the epidemiological impact of moxidectin for the control and elimination of onchocerciasis |
| Organisation | Medicines Development for Global Health |
| Country | Australia |
| Sector | Private |
| PI Contribution | Providing modelling simulations to assess the probabilities of elimination in policy relevant settings. Preparation of joint publications and posters |
| Collaborator Contribution | Provision of phase III clinical trial data for model parameterisation Provision of input throughout the collaboration |
| Impact | Preparation of FDA dossier for approval of moxidectin for human use |
| Start Year | 2017 |
| Description | Modelling to inform strategy for the Global Fund |
| Organisation | Global Fund to Fight AIDS, Tuberculosis and Malaria |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Contribution of modelling and epidemiological expertise |
| Collaborator Contribution | Dissemination and use of modelling |
| Impact | Two successful replenishments of the Global Fund Update 2022- keynote to be given to the delegates at the Pre-Replenishment conference |
| Start Year | 2012 |
| Description | Modelling to support Kenya's National Strategic Plan for TB control |
| Organisation | Ministry of Health, Kenya |
| Country | Kenya |
| Sector | Public |
| PI Contribution | Providing analysis and modelling in support of Kenya's upcoming National Strategic Plan for TB control |
| Collaborator Contribution | Kenya's new national strategic plan will be used as a model by funding agencies such as the Global Fund, for applications by other countries. The modelling component of the strategic plan plays a key role in prioritisation amongst different interventions, and the Global Fund and other donors will require that other future applications are structured in the same way. |
| Impact | Modelling input into National Strategic Plan, to be launched on World TB Day (24 Mar 2019) Work ongoing Updated 2021: National Strategic Plan has been published, including modelling input Donors including Global Fund and Gates Foundation have been developing new 'patient centred approach' to NSPs, including central role of modelling. Kenya was one of the first countries to adopt this approach. We (Imperial and Kenya team) are currently being called upon to share learning for this approach for other countries. |
| Start Year | 2017 |
| Description | Modelling within host dynamics of SARS-CoV-2 Omicron and Delta variants |
| Organisation | Imperial College London |
| Department | Department of Infectious Diseases and Immunity |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Data analysis |
| Collaborator Contribution | Modelling laboratory data Testing mechanisms for Omicron's increased viral fitness through modelling Paper in development |
| Impact | Paper in development |
| Start Year | 2022 |
| Description | Modelling within host dynamics of dengue virus with/without anti-viral treatments |
| Organisation | Janssen Pharmaceutica NV |
| Country | Belgium |
| Sector | Private |
| PI Contribution | Infectious disease modelling expertise Development of model Development of code and software |
| Collaborator Contribution | Data provision Expert advice |
| Impact | Grant awarded Papers in production |
| Start Year | 2019 |
| Description | MozCOVID |
| Organisation | Centro de Investigação em Saúde de Manhiça |
| Country | Mozambique |
| Sector | Charity/Non Profit |
| PI Contribution | Analytical and modelling support |
| Collaborator Contribution | Conducting PCR and sero-prevalence data Community based mortality data |
| Impact | Not yet recognised |
| Start Year | 2020 |
| Description | Multi Province modelling on COVID-19: impact of heterogeneity and intervention |
| Organisation | McGill University |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Modelling analysis for vaccination |
| Collaborator Contribution | Data analysis Modelling on non-pharmaceutical interventions Group discussions |
| Impact | Not yet recgonised |
| Start Year | 2020 |
| Description | Multi Province modelling on COVID-19: impact of heterogeneity and intervention |
| Organisation | Simon Fraser University |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Modelling analysis for vaccination |
| Collaborator Contribution | Data analysis Modelling on non-pharmaceutical interventions Group discussions |
| Impact | Not yet recgonised |
| Start Year | 2020 |
| Description | Multi Province modelling on COVID-19: impact of heterogeneity and intervention |
| Organisation | University of Toronto |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Modelling analysis for vaccination |
| Collaborator Contribution | Data analysis Modelling on non-pharmaceutical interventions Group discussions |
| Impact | Not yet recgonised |
| Start Year | 2020 |
| Description | NHIR emergency room demand |
| Organisation | Imperial College London |
| Department | NIHR/Wellcome Trust Imperial Clinical Research Facility |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Assisting St Mary hospital and Charing-cross to predict A&E patient demand. |
| Collaborator Contribution | Funding and data assistance (preparation and collection) Updated in 2021: Paper published in BMC Emergency Medicine |
| Impact | None yet |
| Start Year | 2018 |
| Description | NIRS Queensland |
| Organisation | QIMR Berghofer Medical Research Institute |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Providing technical support and specialist knowledge |
| Collaborator Contribution | Data and field expertise |
| Impact | not known |
| Start Year | 2017 |
| Description | NOVONORDISK Young Investigator Award |
| Organisation | University of Copenhagen |
| Country | Denmark |
| Sector | Academic/University |
| PI Contribution | Established collaboration with the section of Epidemiology reevnvisioning life course theory. |
| Collaborator Contribution | 5% funded Helen Coupland PhD student |
| Impact | Not yet recognised |
| Start Year | 2020 |
| Description | NPI effectiveness |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Senior author on project Supervision of modelling efforts and data analysis Contribution to writing and editing manuscript |
| Collaborator Contribution | Mathematical modelling expertise Data collection, provision and analysis Contribution to writing and editing of manuscript |
| Impact | Paper published in Science ' |
| Start Year | 2020 |
| Description | NTD Modelling Consortium |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | expertise, intellectual input and the training of staff |
| Collaborator Contribution | expertise, intellectual input and the training of staff, access to data. |
| Impact | Scientific publications |
| Start Year | 2015 |
| Description | NTD Modelling Consortium |
| Organisation | University of Warwick |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | expertise, intellectual input and the training of staff |
| Collaborator Contribution | expertise, intellectual input and the training of staff, access to data. |
| Impact | Scientific publications |
| Start Year | 2015 |
| Description | Naomi model for district-level HIV estimates in sub-Saharan Africa |
| Organisation | Centers for Disease Control and Prevention (CDC) |
| Country | United States |
| Sector | Public |
| PI Contribution | - Developed new model for district-level estimates of HIV prevalence, antiretroviral treatment coverage, and new HIV infections in sub-Saharan Africa. - Developed web-based software interface for district HIV estimates used by national governments in 25 sub-Saharan African countries. |
| Collaborator Contribution | - Provided technical expertise on surveillance data and statistical modelling. - Provided data inputs to modelling. - Supported implementation of software tool with national governments. |
| Impact | - District HIV estimates used for US Government PEPFAR 2020 budget allocations. - Manuscript in preparation. - District level HIV estimates to be publicly released by UNAIDS in June 2020. Update 2021: Used again in 2021 by Global Fund to support work |
| Start Year | 2019 |
| Description | Naomi model for district-level HIV estimates in sub-Saharan Africa |
| Organisation | Joint United Nations Programme on HIV/AIDS (UNAIDS) |
| Country | Global |
| Sector | Public |
| PI Contribution | - Developed new model for district-level estimates of HIV prevalence, antiretroviral treatment coverage, and new HIV infections in sub-Saharan Africa. - Developed web-based software interface for district HIV estimates used by national governments in 25 sub-Saharan African countries. |
| Collaborator Contribution | - Provided technical expertise on surveillance data and statistical modelling. - Provided data inputs to modelling. - Supported implementation of software tool with national governments. |
| Impact | - District HIV estimates used for US Government PEPFAR 2020 budget allocations. - Manuscript in preparation. - District level HIV estimates to be publicly released by UNAIDS in June 2020. Update 2021: Used again in 2021 by Global Fund to support work |
| Start Year | 2019 |
| Description | Naomi model for district-level HIV estimates in sub-Saharan Africa |
| Organisation | United States President's Emergency Plan for AIDS Relief |
| Country | United States |
| Sector | Public |
| PI Contribution | - Developed new model for district-level estimates of HIV prevalence, antiretroviral treatment coverage, and new HIV infections in sub-Saharan Africa. - Developed web-based software interface for district HIV estimates used by national governments in 25 sub-Saharan African countries. |
| Collaborator Contribution | - Provided technical expertise on surveillance data and statistical modelling. - Provided data inputs to modelling. - Supported implementation of software tool with national governments. |
| Impact | - District HIV estimates used for US Government PEPFAR 2020 budget allocations. - Manuscript in preparation. - District level HIV estimates to be publicly released by UNAIDS in June 2020. Update 2021: Used again in 2021 by Global Fund to support work |
| Start Year | 2019 |
| Description | Naomi model for district-level HIV estimates in sub-Saharan Africa |
| Organisation | University of Washington |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | - Developed new model for district-level estimates of HIV prevalence, antiretroviral treatment coverage, and new HIV infections in sub-Saharan Africa. - Developed web-based software interface for district HIV estimates used by national governments in 25 sub-Saharan African countries. |
| Collaborator Contribution | - Provided technical expertise on surveillance data and statistical modelling. - Provided data inputs to modelling. - Supported implementation of software tool with national governments. |
| Impact | - District HIV estimates used for US Government PEPFAR 2020 budget allocations. - Manuscript in preparation. - District level HIV estimates to be publicly released by UNAIDS in June 2020. Update 2021: Used again in 2021 by Global Fund to support work |
| Start Year | 2019 |
| Description | New York State - Non Disclosure Agreement (COVID-19) |
| Organisation | State of New York |
| Department | New York State Department of Health |
| Country | United States |
| Sector | Public |
| PI Contribution | Data analysis and reporting. To help the Chamber better understand the possible impavts of the COVID_19 emergency disaster on New York State ("State") ("the Permitted Purpose"). |
| Collaborator Contribution | Request to team (COVID-19) |
| Impact | Confidential |
| Start Year | 2020 |
| Description | Noise in epidemic models |
| Organisation | French National Institute of Agricultural Research |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Designed study and modelling framework. Looking into applying for a small grant to further this work. |
| Collaborator Contribution | Provided mathematical input and guided theory development. |
| Impact | None yet. |
| Start Year | 2021 |
| Description | Novel candidate vaccine for Schistoma mansoni |
| Organisation | Bill and Melinda Gates Foundation |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Design on end points and potential impact of vaccine in resource poor settings |
| Collaborator Contribution | Implementation of the pilot experiments in animal models and phase I trials in humans |
| Impact | Successful trials in baboons. Imperial team helped analyse trial data |
| Start Year | 2019 |
| Description | Novel candidate vaccine for Schistoma mansoni |
| Organisation | National Institutes of Health (NIH) |
| Country | United States |
| Sector | Public |
| PI Contribution | Design on end points and potential impact of vaccine in resource poor settings |
| Collaborator Contribution | Implementation of the pilot experiments in animal models and phase I trials in humans |
| Impact | Successful trials in baboons. Imperial team helped analyse trial data |
| Start Year | 2019 |
| Description | Official WHO COVID-19 modelling collaborating centre: Global estimates of the potential scale of the epidemic across all countries - Report 12 (International response) |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | During the early phase of the pandemic, the Imperial College team worked closely with WHO as an official modelling collaborating centre, providing estimates of the transmissibility and severity of SARS-CoV-2 during January and February. |
| Collaborator Contribution | Official WHO COVID-19 modelling collaborating centre |
| Impact | In March, in response to a direct request, we developed global estimates of the potential scale of the epidemic across all countries ("Report 12" {https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-12-global-impact-covid-19/} subsequently published in Walker PGT, Whittaker C, Watson OJ et al. (2020) The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries. Science. 369(6502):413-422. doi: 10.1126/science.abc0035]; shared across several UN organisations, the World Bank, the International Monetary Fund to inform early resource planning. |
| Start Year | 2020 |
| Description | Official WHO COVID-19 modelling collaborating centre: WHO Global Costing (International response) |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | WHO Global Costing: Building on early research estimating the transmissibility and severity of SARS-CoV-2, we fitted models to the state of the epidemic across all Low- and Middle-income countries. |
| Collaborator Contribution | Official WHO COVID-19 modelling collaborating centre |
| Impact | Regular updates on the epidemic state have been provided via an open-access dashboard (https://mrc-ide.github.io/global-lmic-reports/ ) that has been accessed over xxx times as of 1st January 2021 and a user interface to the model software (www.covidsim.org). The global fits from this model were used to directly inform WHO estimates of global financial need (co-authored as a paper). |
| Start Year | 2020 |
| Description | Optimal national prioritization policies for hospital care during the SARS-CoV-2 pandemic (Katharina) |
| Organisation | The Health Foundation |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | Data analysis |
| Collaborator Contribution | Data analysis Contribution of hospital episode statistics |
| Impact | Publication in Nature Computational Science |
| Start Year | 2020 |
| Description | P4P Mozambique |
| Organisation | Government of Mozambique |
| Department | Ministry of Health Mozambique |
| Country | Mozambique |
| Sector | Public |
| PI Contribution | Design, setup and conduct of analysis (shared with collaborators); significant contribution to draft writing and interpretation of output |
| Collaborator Contribution | Conduct of analysis, forming research question, draft commenting on/ writing, interpretation of output,contextual inputs. |
| Impact | Research paper written and under review at Health Economics an academic journal; work disseminated to UN conference in late 2019 in Mozambique and to internal seminar series at Imperial College London |
| Start Year | 2019 |
| Description | P4P Mozambique |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Design, setup and conduct of analysis (shared with collaborators); significant contribution to draft writing and interpretation of output |
| Collaborator Contribution | Conduct of analysis, forming research question, draft commenting on/ writing, interpretation of output,contextual inputs. |
| Impact | Research paper written and under review at Health Economics an academic journal; work disseminated to UN conference in late 2019 in Mozambique and to internal seminar series at Imperial College London |
| Start Year | 2019 |
| Description | P4P Mozambique |
| Organisation | University of Bath |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Design, setup and conduct of analysis (shared with collaborators); significant contribution to draft writing and interpretation of output |
| Collaborator Contribution | Conduct of analysis, forming research question, draft commenting on/ writing, interpretation of output,contextual inputs. |
| Impact | Research paper written and under review at Health Economics an academic journal; work disseminated to UN conference in late 2019 in Mozambique and to internal seminar series at Imperial College London |
| Start Year | 2019 |
| Description | P4P Mozambique |
| Organisation | University of Manchester |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Design, setup and conduct of analysis (shared with collaborators); significant contribution to draft writing and interpretation of output |
| Collaborator Contribution | Conduct of analysis, forming research question, draft commenting on/ writing, interpretation of output,contextual inputs. |
| Impact | Research paper written and under review at Health Economics an academic journal; work disseminated to UN conference in late 2019 in Mozambique and to internal seminar series at Imperial College London |
| Start Year | 2019 |
| Description | PANGEA-HIV |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Estimates of HIV infections |
| Collaborator Contribution | Secretariat support Collection of sequence and meta sata Data processing |
| Impact | 2 papers in pre-print |
| Start Year | 2019 |
| Description | PATH Innovation Collaboration - ANC-based surveillance tool |
| Organisation | Kenyan Institute for Medical Research (KEMRI) |
| Department | KEMRI/CDC Research and Public Health Collaboration |
| Country | Kenya |
| Sector | Charity/Non Profit |
| PI Contribution | I am developing a statistical model using routine testing data from antenatal clinics in Western Kenya to estimate malaria transmission within the general population |
| Collaborator Contribution | In-country collaborators PATH, Kenya Medical Research Institute and the US CDC are responsible for collecting, collating and providing the data, as well as organising dissemination workshops. |
| Impact | A dissemination meeting took place in Kisumu in August 2018. |
| Start Year | 2016 |
| Description | PATH Innovation Collaboration - ANC-based surveillance tool |
| Organisation | Program for Appropriate Technology in Health (PATH) |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | I am developing a statistical model using routine testing data from antenatal clinics in Western Kenya to estimate malaria transmission within the general population |
| Collaborator Contribution | In-country collaborators PATH, Kenya Medical Research Institute and the US CDC are responsible for collecting, collating and providing the data, as well as organising dissemination workshops. |
| Impact | A dissemination meeting took place in Kisumu in August 2018. |
| Start Year | 2016 |
| Description | PATH to pilot novel bednet in pilot intervention trials |
| Organisation | PATH |
| Country | Global |
| Sector | Charity/Non Profit |
| PI Contribution | Provide technical support to help design a programme to monitor the efficacy and effectiveness of the introduction of a new type of bednet in Burkina Faso, Rwanda and Mozambique. |
| Collaborator Contribution | Liaison with National Malaria Control Programmes and local partners to set up data collection and regulatory approval. |
| Impact | Entomological and epidemiological data on the effectiveness of the Interceptor G2 bednet. Data on the ability of near infra-red spectroscopy for monitoring the age of mosquito populations. Update 2020 - Work conducted as part of this project has facilitated funding which will distribute 38 million improved bednets in Africa. Mathematical models predict that this will avert an additional 49.1 million clinical cases of malaria (95% confidence intervals 39.1-55.7 million cases) over the three-year life-expectancy of the net. This will save approximately 73,500 lives during this time. |
| Start Year | 2018 |
| Description | PB-PG-0317-20039 - Uptake, effectiveness and acceptability of routine screening of pregnant migrants for latent tuberculosis infection in antenatal care: a feasibility study |
| Organisation | University College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Economic analysis |
| Collaborator Contribution | Collecting data |
| Impact | None yet |
| Start Year | 2019 |
| Description | PGX Ethics |
| Organisation | University of California, San Diego (UCSD) |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Development of simulations to estimate risk of voluntary disclosure of HIV diagnoses |
| Collaborator Contribution | Contribution of data Behavioural Science expertise Coordination of project (secretariat support) |
| Impact | Not yet recognised |
| Start Year | 2020 |
| Description | PROMPT study |
| Organisation | University of North Carolina at Chapel Hill |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Data analysis Software development |
| Collaborator Contribution | Data provision |
| Impact | Pre-print - https://www.biorxiv.org/content/10.1101/2021.01.18.427056v2.abstract |
| Start Year | 2021 |
| Description | Pneumococcal protein vaccine feasibility |
| Organisation | University of Liverpool |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Identification of candidate antigens to use in a protein vaccine against pneumococci. |
| Collaborator Contribution | They are identifying the diversity of these proteins in circulating pneumococcal populations and ascertaining the immunogenicity of these antigens in an animal model of disease. |
| Impact | Award of a grant from Bactivac that funds the experimental work. |
| Start Year | 2022 |
| Description | Pneumococcal vaccine modelling collaboration |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | We are now working jointly with LSHTM, alongside PHE, to model the serotype replacement processes expected to occur when new pneumococcal conjugate vaccines are introduced. |
| Collaborator Contribution | Prof. Elizabeth Miller and Dr. Stefan Flasche provide expert knowledge of pneumococcal epidemiology and transmission dynamic modelling. |
| Impact | The generation of a pneumococcal genomic dataset, processed in collaboration between Imperial, PHE and LSHTM: https://www.mdpi.com/2073-4425/10/9/687/htm. |
| Start Year | 2020 |
| Description | Policy response to ECHO trial |
| Organisation | University of California, Berkeley |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Mathematical modelling |
| Collaborator Contribution | Expertise in reproductive health and modelling |
| Impact | Publication in The Lancet |
| Start Year | 2019 |
| Description | Polio Environmental Surveillance in Dhaka |
| Organisation | International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) |
| Country | Bangladesh |
| Sector | Public |
| PI Contribution | Statistical and mathematical analysis; genetic sequencing of detected enteroviruses |
| Collaborator Contribution | Collection of demographic data, sewage physicochemical properties and pathogen data from sewage |
| Impact | 2021: Written report on analysis of data to funders 2021: publication accepted in Lancet Microbe |
| Start Year | 2018 |
| Description | Polio Environmental Surveillance in Dhaka |
| Organisation | University of Virginia (UVa) |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Statistical and mathematical analysis; genetic sequencing of detected enteroviruses |
| Collaborator Contribution | Collection of demographic data, sewage physicochemical properties and pathogen data from sewage |
| Impact | 2021: Written report on analysis of data to funders 2021: publication accepted in Lancet Microbe |
| Start Year | 2018 |
| Description | PopART wider HIV analyses |
| Organisation | Imperial College London |
| Department | Imperial College Business School |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | I have provided a cleaned and setup data used in a range of research projects to understand the effect of Universal Test and Treat on: HIV-stigma, secondary care utilisation, inequalities in health and health care. I am also advising on the various methodological approaches to analyses, comment and edit the various research works/papers produced. |
| Collaborator Contribution | My partners lead on the various analyses, i.e. they conduct the analyses and the first draft write-up. |
| Impact | No outputs yet. The collaboration is multi-disciplinary, combining economists, public health experts and epidemiologists. |
| Start Year | 2020 |
| Description | PopART wider HIV analyses |
| Organisation | London School of Economics and Political Science (University of London) |
| Department | LSE Health and Social Care |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | I have provided a cleaned and setup data used in a range of research projects to understand the effect of Universal Test and Treat on: HIV-stigma, secondary care utilisation, inequalities in health and health care. I am also advising on the various methodological approaches to analyses, comment and edit the various research works/papers produced. |
| Collaborator Contribution | My partners lead on the various analyses, i.e. they conduct the analyses and the first draft write-up. |
| Impact | No outputs yet. The collaboration is multi-disciplinary, combining economists, public health experts and epidemiologists. |
| Start Year | 2020 |
| Description | PopART wider HIV analyses |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | I have provided a cleaned and setup data used in a range of research projects to understand the effect of Universal Test and Treat on: HIV-stigma, secondary care utilisation, inequalities in health and health care. I am also advising on the various methodological approaches to analyses, comment and edit the various research works/papers produced. |
| Collaborator Contribution | My partners lead on the various analyses, i.e. they conduct the analyses and the first draft write-up. |
| Impact | No outputs yet. The collaboration is multi-disciplinary, combining economists, public health experts and epidemiologists. |
| Start Year | 2020 |
| Description | PopART wider HIV analyses |
| Organisation | University of Stellenbosch |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | I have provided a cleaned and setup data used in a range of research projects to understand the effect of Universal Test and Treat on: HIV-stigma, secondary care utilisation, inequalities in health and health care. I am also advising on the various methodological approaches to analyses, comment and edit the various research works/papers produced. |
| Collaborator Contribution | My partners lead on the various analyses, i.e. they conduct the analyses and the first draft write-up. |
| Impact | No outputs yet. The collaboration is multi-disciplinary, combining economists, public health experts and epidemiologists. |
| Start Year | 2020 |
| Description | PopART wider HIV analyses |
| Organisation | Zambart |
| Country | Zambia |
| Sector | Public |
| PI Contribution | I have provided a cleaned and setup data used in a range of research projects to understand the effect of Universal Test and Treat on: HIV-stigma, secondary care utilisation, inequalities in health and health care. I am also advising on the various methodological approaches to analyses, comment and edit the various research works/papers produced. |
| Collaborator Contribution | My partners lead on the various analyses, i.e. they conduct the analyses and the first draft write-up. |
| Impact | No outputs yet. The collaboration is multi-disciplinary, combining economists, public health experts and epidemiologists. |
| Start Year | 2020 |
| Description | Population Dynamics of Human Ascariasis |
| Organisation | University of Westminster |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Data analysis, statistical and mathematical modelling through MRc-funded PhD student |
| Collaborator Contribution | Sharing of data on chemo-expulsion studies of Ascaris lumbricoides in Bangladesh for the analysis and modelling of the population dynamics of ascariasis in human populations |
| Impact | Publications, PubMed ID Number: 19208229; 20385140; 20620142 |
| Start Year | 2006 |
| Description | Population genomic statistical methods |
| Organisation | University of Oslo |
| Department | Department of Oceanography |
| Country | Norway |
| Sector | Academic/University |
| PI Contribution | Provided data analysis |
| Collaborator Contribution | They provided software and statistical methods |
| Impact | Software and publications |
| Start Year | 2015 |
| Description | Postdischarge malaria chemoprevention modelling |
| Organisation | Kenyan Institute for Medical Research (KEMRI) |
| Country | Kenya |
| Sector | Public |
| PI Contribution | Conducting modelling of a novel malaria control intervention: post-discharge malaria chemoprevention. Calibrating models to trial results working with the team. |
| Collaborator Contribution | Providing trial results, contributing to designing the analysis and conducting modelling. |
| Impact | None yet. |
| Start Year | 2020 |
| Description | Postdischarge malaria chemoprevention modelling |
| Organisation | Liverpool School of Tropical Medicine |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Conducting modelling of a novel malaria control intervention: post-discharge malaria chemoprevention. Calibrating models to trial results working with the team. |
| Collaborator Contribution | Providing trial results, contributing to designing the analysis and conducting modelling. |
| Impact | None yet. |
| Start Year | 2020 |
| Description | Postdischarge malaria chemoprevention modelling |
| Organisation | University of Bergen |
| Country | Norway |
| Sector | Academic/University |
| PI Contribution | Conducting modelling of a novel malaria control intervention: post-discharge malaria chemoprevention. Calibrating models to trial results working with the team. |
| Collaborator Contribution | Providing trial results, contributing to designing the analysis and conducting modelling. |
| Impact | None yet. |
| Start Year | 2020 |
| Description | Predicting impact of invasion of urban mosquito into Africa |
| Organisation | Centers for Disease Control and Prevention (CDC) |
| Country | United States |
| Sector | Public |
| PI Contribution | Mathematical modelling Predicting increase in malaria due to invasion of mosquitoes |
| Collaborator Contribution | Data provision Local knowledge |
| Impact | 2022 - predicted the public health impact of the arrival of Anophelise stephensi into Ethiopia. Models predict the number of malaria cases could double in 3 years |
| Start Year | 2020 |
| Description | Predicting impact of invasion of urban mosquito into Africa |
| Organisation | Liverpool School of Tropical Medicine |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Mathematical modelling Predicting increase in malaria due to invasion of mosquitoes |
| Collaborator Contribution | Data provision Local knowledge |
| Impact | 2022 - predicted the public health impact of the arrival of Anophelise stephensi into Ethiopia. Models predict the number of malaria cases could double in 3 years |
| Start Year | 2020 |
| Description | Predicting impact of invasion of urban mosquito into Africa |
| Organisation | Ministry of Health, Ethiopia |
| Country | Ethiopia |
| Sector | Public |
| PI Contribution | Mathematical modelling Predicting increase in malaria due to invasion of mosquitoes |
| Collaborator Contribution | Data provision Local knowledge |
| Impact | 2022 - predicted the public health impact of the arrival of Anophelise stephensi into Ethiopia. Models predict the number of malaria cases could double in 3 years |
| Start Year | 2020 |
| Description | Predicting impact of invasion of urban mosquito into Africa |
| Organisation | U.S. President's Malaria Initiative |
| Country | United States |
| Sector | Public |
| PI Contribution | Mathematical modelling Predicting increase in malaria due to invasion of mosquitoes |
| Collaborator Contribution | Data provision Local knowledge |
| Impact | 2022 - predicted the public health impact of the arrival of Anophelise stephensi into Ethiopia. Models predict the number of malaria cases could double in 3 years |
| Start Year | 2020 |
| Description | Predicting the impact of transmission blocking vaccines for malaria |
| Organisation | GlaxoSmithKline (GSK) |
| Country | Global |
| Sector | Private |
| PI Contribution | Provided expertise in data analysis and mathematical modelling |
| Collaborator Contribution | Provided data from randomised control trial of new vaccine in Burkina Faso Partnership with GSK begins 2020 - in discussions regarding data provision |
| Impact | No outputs yet |
| Start Year | 2019 |
| Description | Predicting the impact of transmission blocking vaccines for malaria |
| Organisation | National Institutes of Health (NIH) |
| Country | United States |
| Sector | Public |
| PI Contribution | Provided expertise in data analysis and mathematical modelling |
| Collaborator Contribution | Provided data from randomised control trial of new vaccine in Burkina Faso Partnership with GSK begins 2020 - in discussions regarding data provision |
| Impact | No outputs yet |
| Start Year | 2019 |
| Description | Preparation of a business case for investment in the development of macrofilaricides for onchocerciasis |
| Organisation | MM Global Health Consulting |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Modelling the epidemiological impact of hypothetical macrofilaricides in comparison with moxidectin and ivermectin across APOC projects in Africa. |
| Collaborator Contribution | Provision of framework to support business case Regular input Act as liaison with WHO and Bill and Melinda Gates Foundation. |
| Impact | No outputs known yet. Simulations will be linked to economic evaluations at Imperial College London. |
| Start Year | 2019 |
| Description | Preparation of a business case for the deployment of moxidectin mass drug administration (MDA) to accelerate elimination of onchocerciasis in sub-Saharan Africa |
| Organisation | Bill and Melinda Gates Foundation |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | We have performed the simulations of the epidemiological impact of moxidectin MDA strategies (in comparison with ivermectin MDA) in various endemicity and coverage scenarios, and have commenced investigation of economic analyses (the latter with Dr Hugo Turner, at DIDE). |
| Collaborator Contribution | Preparation of a concept note to be discussed among all partners. |
| Impact | A paper has been submitted to the Neglected Tropical Disease Collection of the Philosophical Transactions of the Royal Society, Series B. This paper is under review. |
| Start Year | 2023 |
| Description | Preparation of a business case for the deployment of moxidectin mass drug administration (MDA) to accelerate elimination of onchocerciasis in sub-Saharan Africa |
| Organisation | Medicines Development for Global Health |
| Country | Australia |
| Sector | Private |
| PI Contribution | We have performed the simulations of the epidemiological impact of moxidectin MDA strategies (in comparison with ivermectin MDA) in various endemicity and coverage scenarios, and have commenced investigation of economic analyses (the latter with Dr Hugo Turner, at DIDE). |
| Collaborator Contribution | Preparation of a concept note to be discussed among all partners. |
| Impact | A paper has been submitted to the Neglected Tropical Disease Collection of the Philosophical Transactions of the Royal Society, Series B. This paper is under review. |
| Start Year | 2023 |
| Description | Preparation of a business case for the deployment of moxidectin mass drug administration (MDA) to accelerate elimination of onchocerciasis in sub-Saharan Africa |
| Organisation | Neglected Tropical Diseases Modelling Consortium |
| Sector | Charity/Non Profit |
| PI Contribution | We have performed the simulations of the epidemiological impact of moxidectin MDA strategies (in comparison with ivermectin MDA) in various endemicity and coverage scenarios, and have commenced investigation of economic analyses (the latter with Dr Hugo Turner, at DIDE). |
| Collaborator Contribution | Preparation of a concept note to be discussed among all partners. |
| Impact | A paper has been submitted to the Neglected Tropical Disease Collection of the Philosophical Transactions of the Royal Society, Series B. This paper is under review. |
| Start Year | 2023 |
| Description | Preparation of a business case for the deployment of moxidectin mass drug administration (MDA) to accelerate elimination of onchocerciasis in sub-Saharan Africa |
| Organisation | Oriole Global Health |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | We have performed the simulations of the epidemiological impact of moxidectin MDA strategies (in comparison with ivermectin MDA) in various endemicity and coverage scenarios, and have commenced investigation of economic analyses (the latter with Dr Hugo Turner, at DIDE). |
| Collaborator Contribution | Preparation of a concept note to be discussed among all partners. |
| Impact | A paper has been submitted to the Neglected Tropical Disease Collection of the Philosophical Transactions of the Royal Society, Series B. This paper is under review. |
| Start Year | 2023 |
| Description | Prevention and Restriction on Anti Microbial Resistance AMR) in Pneumococci by Multi Level Modelling |
| Organisation | The Wellcome Trust Sanger Institute |
| Department | MRC Centre for Genomics and Global Health, WTCHG and WTSI |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Data analysis and lab work |
| Collaborator Contribution | Data provision |
| Impact | Multiple publications; sequenced data has emerged.Work ongoing on publication. |
| Start Year | 2012 |
| Description | Principal scientific advisor to the Vector Atlas project |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Supervising a PhD student at the Centre for Insect Physiology and Ecology in Nairobi and developing training materials for PhD students and Research Assistants |
| Collaborator Contribution | Partners include researchers involved in the development of geospatial models for analyses of African malaria vector populations. |
| Impact | No publications as yet. |
| Start Year | 2022 |
| Description | Priority setting for healthcare services in India |
| Organisation | Center for Global Development |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Provision of technical expertise Analysis of data Policy translation (evidence into action) |
| Collaborator Contribution | CHAI - analysis of data NHAI - Policy makers - provision of data and identification of areas of development |
| Impact | No recognised ouputs yet |
| Start Year | 2020 |
| Description | Priority setting for healthcare services in India |
| Organisation | Clinton Health Access Initiative |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Provision of technical expertise Analysis of data Policy translation (evidence into action) |
| Collaborator Contribution | CHAI - analysis of data NHAI - Policy makers - provision of data and identification of areas of development |
| Impact | No recognised ouputs yet |
| Start Year | 2020 |
| Description | Priority setting for healthcare services in India |
| Organisation | Government of India |
| Department | National Health Authority, India |
| Country | India |
| Sector | Public |
| PI Contribution | Provision of technical expertise Analysis of data Policy translation (evidence into action) |
| Collaborator Contribution | CHAI - analysis of data NHAI - Policy makers - provision of data and identification of areas of development |
| Impact | No recognised ouputs yet |
| Start Year | 2020 |
| Description | Production of Short Films: Burnt Orange Theatre Company |
| Organisation | Burnt Orange Theatre Company |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Imperial College London partnered with the Burnt OrangeTheatre Company to engage 20 young creatives between the ages of 14-20 in COVID-19 research. ICL provided the reports on which the films were centered. |
| Collaborator Contribution | Each group of young people created a short film which incorporated some of their personal experiences during the pandemic, and elements of the COVID-19 research report their group was assigned. The project was initiated and managed by Fola Afolabi; the creative aspects were facilitated by the Burnt Orange Theatre Company. The NIHR Applied Research Collaboration Northwest London funded the project. https://www.facebook.com/burntorangetheatre/ |
| Impact | Production of short films for Report 1, 6, 10, 22 and 24. Episode 1, Report 1 https://youtu.be/H6Zifam_wng Episode 2, Report 10 https://youtu.be/vfzBgYnZg2o Episode 3, Report 13 https://youtu.be/xjKQt6Qc6d0 Episode 4, Report 22 https://youtu.be/5A22gWcL98Y Episode 5, Report 24 https://youtu.be/UB3zpV5T67I |
| Start Year | 2020 |
| Description | Productivity Analysis PopART |
| Organisation | Imperial College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | The goal of the project is to analyse averted productive days lost due a Universal Test and Treat intervention in South Africa and Zambia. We have contribute by phrasing the research question, cleaning and setting up the data, the analysis of the data and writing draft document. |
| Collaborator Contribution | Inputs to design of analysis and interpretation of findings, contributions to writing draft document |
| Impact | Research paper produced which is in the process of being prepared to be submitted to an academic journal ; work was presented at a seminar at HERO, a health economic analysis group affiliated to the University of Witwatersrand, based in Johannesburg, South Africa. The work was also presented presented several times at internal seminars of the PopART trial study. |
| Start Year | 2020 |
| Description | Productivity Analysis PopART |
| Organisation | London School of Economics and Political Science (University of London) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | The goal of the project is to analyse averted productive days lost due a Universal Test and Treat intervention in South Africa and Zambia. We have contribute by phrasing the research question, cleaning and setting up the data, the analysis of the data and writing draft document. |
| Collaborator Contribution | Inputs to design of analysis and interpretation of findings, contributions to writing draft document |
| Impact | Research paper produced which is in the process of being prepared to be submitted to an academic journal ; work was presented at a seminar at HERO, a health economic analysis group affiliated to the University of Witwatersrand, based in Johannesburg, South Africa. The work was also presented presented several times at internal seminars of the PopART trial study. |
| Start Year | 2020 |
| Description | Productivity Analysis PopART |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | The goal of the project is to analyse averted productive days lost due a Universal Test and Treat intervention in South Africa and Zambia. We have contribute by phrasing the research question, cleaning and setting up the data, the analysis of the data and writing draft document. |
| Collaborator Contribution | Inputs to design of analysis and interpretation of findings, contributions to writing draft document |
| Impact | Research paper produced which is in the process of being prepared to be submitted to an academic journal ; work was presented at a seminar at HERO, a health economic analysis group affiliated to the University of Witwatersrand, based in Johannesburg, South Africa. The work was also presented presented several times at internal seminars of the PopART trial study. |
| Start Year | 2020 |
| Description | Quantifying the potential value of antigen-detection rapid diagnostic tests for COVID-19: a modelling analysis |
| Organisation | Foundation for Innovative New Diagnostics (FIND) |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Development and implementation of modelling Contributed to development of user friendly web tool |
| Collaborator Contribution | JHU colleagues helped develop the model and led on the development of the web tool FIND colleagues provided data and validated the study |
| Impact | Published in BMC Medicine: https://pubmed.ncbi.nlm.nih.gov/33685466/ |
| Start Year | 2020 |
| Description | Quantifying the potential value of antigen-detection rapid diagnostic tests for COVID-19: a modelling analysis |
| Organisation | Johns Hopkins University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Development and implementation of modelling Contributed to development of user friendly web tool |
| Collaborator Contribution | JHU colleagues helped develop the model and led on the development of the web tool FIND colleagues provided data and validated the study |
| Impact | Published in BMC Medicine: https://pubmed.ncbi.nlm.nih.gov/33685466/ |
| Start Year | 2020 |
| Description | REACT Programme |
| Organisation | Department of Health (DH) |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | I co-led REACT-1 with Paul Ellitt |
| Collaborator Contribution | DHSC provided funding. IPSOS provided logistical support. |
| Impact | Many publications and media engagements. |
| Start Year | 2020 |
| Description | Rapid Assessment Framework for the impact of Seasonal Malaria Chemoprevention in East Africa |
| Organisation | Malaria Consortium |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | We work with malaria consortium to provide modelling support as part of rapid assessment toolkit aimed towards assessing the likely impact of expanding Seasonal Malaria Chemoprevention to East African geographies where it has yet to be deployed. This will involve providing estimates of the suitability of target areas and simulations of difference chemoprevention scenarios. |
| Collaborator Contribution | Malaria consortium provide us with funding for this work as well as helping us to access relevant datasets. Their wealth of experience working with national malaria control programmes also ensures that our work can have maximum policy-relevance and impact. |
| Impact | As the collaboration has just begun no impact has yet to be effected. |
| Start Year | 2023 |
| Description | Real Time estimation of transmission intensity of SARS-COV2 |
| Organisation | University of the Philippines |
| Country | Philippines |
| Sector | Academic/University |
| PI Contribution | Production of estimates of R numbers by region |
| Collaborator Contribution | Data provision |
| Impact | Poster presentation at EPIDEMICS conference |
| Start Year | 2020 |
| Description | Real time outbreak modelling and analysis |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Continuous provision on modelling expertise and analysis for ongoing Ebola virus disease outbreak in DRC and current Corona virus outbreak. |
| Collaborator Contribution | Provision of data for analysis and coordination of interactions with additional modelling groups. |
| Impact | 40 reports sent to WHO which have been used to inform situational awareness and fed into policy decisions, particularly estimates of admissibility and future projections of case numbers for Ebola outbreak. |
| Start Year | 2010 |
| Description | Recent HIV infection surveillance to monitor HIV incidence and evaluate intervention impact |
| Organisation | Centers for Disease Control and Prevention (CDC) |
| Country | United States |
| Sector | Public |
| PI Contribution | - Development of mathematical and statistical models for analysing novel recent HIV infection surveillance data. - Design of evaluation study about impact of secondary schools on HIV risk and pregnancy amongst adolescent girls and young women. |
| Collaborator Contribution | - Collection and interpretation of novel surveillance data. |
| Impact | Not yet recognised |
| Start Year | 2018 |
| Description | Recent HIV infection surveillance to monitor HIV incidence and evaluate intervention impact |
| Organisation | Ministry of Health Malawi |
| Country | Malawi |
| Sector | Public |
| PI Contribution | - Development of mathematical and statistical models for analysing novel recent HIV infection surveillance data. - Design of evaluation study about impact of secondary schools on HIV risk and pregnancy amongst adolescent girls and young women. |
| Collaborator Contribution | - Collection and interpretation of novel surveillance data. |
| Impact | Not yet recognised |
| Start Year | 2018 |
| Description | Recent HIV infection surveillance to monitor HIV incidence and evaluate intervention impact |
| Organisation | University of California, San Francisco |
| Department | School of Medicine (UCSF) |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | - Development of mathematical and statistical models for analysing novel recent HIV infection surveillance data. - Design of evaluation study about impact of secondary schools on HIV risk and pregnancy amongst adolescent girls and young women. |
| Collaborator Contribution | - Collection and interpretation of novel surveillance data. |
| Impact | Not yet recognised |
| Start Year | 2018 |
| Description | Reciprocal capacity building workshop - focus on yellow fever outbreak and response |
| Organisation | Government of Brazil |
| Department | Ministry of Health Brazil |
| Country | Brazil |
| Sector | Public |
| PI Contribution | Provision of expertise in capacity building for modelling and data analytics - particularly for regional partners in LMICs. |
| Collaborator Contribution | MoH - provision of data for analysis Fiocruz - provision of field training for workshop for Imperial staff and coordination of networking |
| Impact | Workshop planned for July 2020. |
| Start Year | 2017 |
| Description | Reciprocal capacity building workshop - focus on yellow fever outbreak and response |
| Organisation | Oswaldo Cruz Foundation (Fiocruz) |
| Country | Brazil |
| Sector | Public |
| PI Contribution | Provision of expertise in capacity building for modelling and data analytics - particularly for regional partners in LMICs. |
| Collaborator Contribution | MoH - provision of data for analysis Fiocruz - provision of field training for workshop for Imperial staff and coordination of networking |
| Impact | Workshop planned for July 2020. |
| Start Year | 2017 |
| Description | Reconstructing dengue transmission intensity in Indonesia from multiple data sources |
| Organisation | Sanofi |
| Country | Global |
| Sector | Private |
| PI Contribution | Provision of Mathematical modelling expertise |
| Collaborator Contribution | Provision of data Expertise in data interpretation |
| Impact | Publication in PLoS NTDs available at https://doi.org/10.1371/journal.pntd.0008102 Poster and talk at ASTMH (American Society of Tropical Medicine and Hygiene) Update 2022 - another publication in PLoS NTDs available at https://doi.org/10.1371/journal.pntd.0010592 |
| Start Year | 2018 |
| Description | Reconstructing dengue transmission intensity in Indonesia from multiple data sources |
| Organisation | Universitas Indonesia |
| Country | Indonesia |
| Sector | Academic/University |
| PI Contribution | Provision of Mathematical modelling expertise |
| Collaborator Contribution | Provision of data Expertise in data interpretation |
| Impact | Publication in PLoS NTDs available at https://doi.org/10.1371/journal.pntd.0008102 Poster and talk at ASTMH (American Society of Tropical Medicine and Hygiene) Update 2022 - another publication in PLoS NTDs available at https://doi.org/10.1371/journal.pntd.0010592 |
| Start Year | 2018 |
| Description | Research collaboration on the development of an R package for the analysis of data from micro-neutralisation assays |
| Organisation | University of Exeter |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Designing research study, co-supervision of student. |
| Collaborator Contribution | Methods development and code implementation. |
| Impact | No outputs yet |
| Start Year | 2021 |
| Description | Research collaboration on the development of analytical frameworks for enterovirus seroepidemiologic data |
| Organisation | Pasteur Institute, Paris |
| Country | France |
| Sector | Charity/Non Profit |
| PI Contribution | Design research study. |
| Collaborator Contribution | Contribution to model design. |
| Impact | No outputs yet. |
| Start Year | 2023 |
| Description | Research collaboration with Oxford University |
| Organisation | University of Oxford |
| Department | Oxford Hub |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | We performed the data analysis. |
| Collaborator Contribution | Shared data. |
| Impact | No outcomes yet. |
| Start Year | 2018 |
| Description | Research collaboration with Princeton University |
| Organisation | Princeton University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | We performed statistical analysis. |
| Collaborator Contribution | Contributed to the design of the anlaysis and interpretation of the results. |
| Impact | Pons-Salort M, Oberste MS, Pallansch MA, Abedi GR, Takahashi S, Grenfell BT, Grassly NC. The seasonality of nonpolio enteroviruses in the United States: Patterns and drivers. Proc Natl Acad Sci USA 2018; 115(12):3078- 3083. |
| Start Year | 2015 |
| Description | Research collaboration with US CDC |
| Organisation | Centers for Disease Control and Prevention (CDC) |
| Country | United States |
| Sector | Public |
| PI Contribution | We analysed the data provided by the US CDC. |
| Collaborator Contribution | Shared historical national enterovirus surveillance data. |
| Impact | Pons-Salort M, Oberste MS, Pallansch MA, Abedi GR, Takahashi S, Grenfell BT, Grassly NC. The seasonality of nonpolio enteroviruses in the United States: Patterns and drivers. Proc Natl Acad Sci USA 2018; 115(12):3078- 3083. |
| Start Year | 2015 |
| Description | Research to Improve the Detection and Treatment of Latent Tuberculosis Infection (RID-TB) |
| Organisation | University College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Economic analysis |
| Collaborator Contribution | Collecting data |
| Impact | None yet |
| Start Year | 2018 |
| Description | Respiratory infections sample collection |
| Organisation | Mahidol University |
| Country | Thailand |
| Sector | Academic/University |
| PI Contribution | Data analysis |
| Collaborator Contribution | Provide knowledge, data, samples and DNA |
| Impact | Publications; sequenced data |
| Start Year | 2012 |
| Description | Restriction modification analysis |
| Organisation | University of Leicester |
| Department | University of Leicester, Proteomics facility |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Provided strains, DNA and data analysis |
| Collaborator Contribution | Provided techniques and new strains |
| Impact | Publication and sequenced data Publications in Nucleic Acid Research Publications in Genes Publications in Environmental Microbiology Publications in Journal of Bacteriology |
| Start Year | 2015 |
| Description | Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence |
| Organisation | Fundação Pró-Sangue Hemocentro de São Paulo |
| Country | Brazil |
| Sector | Public |
| PI Contribution | Project management Project co-ordination Writing of manuscript Conceptualisation |
| Collaborator Contribution | Project management Project co-ordination Writing of manuscript |
| Impact | Paper published in The Lancet - widely discussed across different media CITATIONS12 Citation Indexes12 CrossRef12 Scopus1 CAPTURES125 Readers125 Mendeley125 MENTIONS215 News Mentions204 News204 Blog Mentions11 Blog11 SOCIAL MEDIA14,735 Shares, Likes & Comments8,384 Facebook8,384 Tweets6,351 Twitter6,351 |
| Start Year | 2021 |
| Description | Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence |
| Organisation | Harvard University |
| Department | Harvard T.H. Chan School of Public Health |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Project management Project co-ordination Writing of manuscript Conceptualisation |
| Collaborator Contribution | Project management Project co-ordination Writing of manuscript |
| Impact | Paper published in The Lancet - widely discussed across different media CITATIONS12 Citation Indexes12 CrossRef12 Scopus1 CAPTURES125 Readers125 Mendeley125 MENTIONS215 News Mentions204 News204 Blog Mentions11 Blog11 SOCIAL MEDIA14,735 Shares, Likes & Comments8,384 Facebook8,384 Tweets6,351 Twitter6,351 |
| Start Year | 2021 |
| Description | Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Project management Project co-ordination Writing of manuscript Conceptualisation |
| Collaborator Contribution | Project management Project co-ordination Writing of manuscript |
| Impact | Paper published in The Lancet - widely discussed across different media CITATIONS12 Citation Indexes12 CrossRef12 Scopus1 CAPTURES125 Readers125 Mendeley125 MENTIONS215 News Mentions204 News204 Blog Mentions11 Blog11 SOCIAL MEDIA14,735 Shares, Likes & Comments8,384 Facebook8,384 Tweets6,351 Twitter6,351 |
| Start Year | 2021 |
| Description | Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence |
| Organisation | Oswaldo Cruz Foundation (Fiocruz) |
| Country | Brazil |
| Sector | Public |
| PI Contribution | Project management Project co-ordination Writing of manuscript Conceptualisation |
| Collaborator Contribution | Project management Project co-ordination Writing of manuscript |
| Impact | Paper published in The Lancet - widely discussed across different media CITATIONS12 Citation Indexes12 CrossRef12 Scopus1 CAPTURES125 Readers125 Mendeley125 MENTIONS215 News Mentions204 News204 Blog Mentions11 Blog11 SOCIAL MEDIA14,735 Shares, Likes & Comments8,384 Facebook8,384 Tweets6,351 Twitter6,351 |
| Start Year | 2021 |
| Description | Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence |
| Organisation | Universidade de São Paulo |
| Country | Brazil |
| Sector | Academic/University |
| PI Contribution | Project management Project co-ordination Writing of manuscript Conceptualisation |
| Collaborator Contribution | Project management Project co-ordination Writing of manuscript |
| Impact | Paper published in The Lancet - widely discussed across different media CITATIONS12 Citation Indexes12 CrossRef12 Scopus1 CAPTURES125 Readers125 Mendeley125 MENTIONS215 News Mentions204 News204 Blog Mentions11 Blog11 SOCIAL MEDIA14,735 Shares, Likes & Comments8,384 Facebook8,384 Tweets6,351 Twitter6,351 |
| Start Year | 2021 |
| Description | Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence |
| Organisation | University of California, San Francisco |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Project management Project co-ordination Writing of manuscript Conceptualisation |
| Collaborator Contribution | Project management Project co-ordination Writing of manuscript |
| Impact | Paper published in The Lancet - widely discussed across different media CITATIONS12 Citation Indexes12 CrossRef12 Scopus1 CAPTURES125 Readers125 Mendeley125 MENTIONS215 News Mentions204 News204 Blog Mentions11 Blog11 SOCIAL MEDIA14,735 Shares, Likes & Comments8,384 Facebook8,384 Tweets6,351 Twitter6,351 |
| Start Year | 2021 |
| Description | Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Project management Project co-ordination Writing of manuscript Conceptualisation |
| Collaborator Contribution | Project management Project co-ordination Writing of manuscript |
| Impact | Paper published in The Lancet - widely discussed across different media CITATIONS12 Citation Indexes12 CrossRef12 Scopus1 CAPTURES125 Readers125 Mendeley125 MENTIONS215 News Mentions204 News204 Blog Mentions11 Blog11 SOCIAL MEDIA14,735 Shares, Likes & Comments8,384 Facebook8,384 Tweets6,351 Twitter6,351 |
| Start Year | 2021 |
| Description | SARS-CoV-2 tranmission heterogeneity in the UK Alpha wave estimated through phylodynamic modeling |
| Organisation | Utrecht University |
| Country | Netherlands |
| Sector | Academic/University |
| PI Contribution | Supervisio of project by Erik Volz + Manon Ragonnet |
| Collaborator Contribution | Project is being carried by medical student based at Utrecht |
| Impact | not yet, abstract to be submitted shortly |
| Start Year | 2021 |
| Description | START-IPT study collaborator |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | We have produced models of Intermittent Preventive Treatment for malaria in school children, to assist the design of a trial and give an estimate of likely effect. |
| Collaborator Contribution | Design and carrying out a cluster-randomized trial of Intermittent Preventive Treatment for malaria in school children in Uganda. |
| Impact | Informed trial design. The collaboration is multi disciplinary, including mathematical modellers, clinicians, epidemiologists. |
| Start Year | 2014 |
| Description | STARmeds project (Katharina) |
| Organisation | Pancasila University |
| Country | Indonesia |
| Sector | Academic/University |
| PI Contribution | Data analysis Project management |
| Collaborator Contribution | Data analysis Data collection Project management Policy engagement |
| Impact | Not yet recognised |
| Start Year | 2020 |
| Description | Sanofi data collaboration |
| Organisation | Sanofi |
| Country | Global |
| Sector | Private |
| PI Contribution | We have carried out secondary analysis of trial data, to estimate the post-treatment prophylactic effect of artesunate amodiaquine. |
| Collaborator Contribution | They contributed data. |
| Impact | Published in BMC Medicine 2020. |
| Start Year | 2014 |
| Description | Sarah Cleveland - Glasgow |
| Organisation | University of Glasgow |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Centre Investigator, Christl Donnelly directly involved in the design and analysis of epidemological and ecological data relating to rabies control in Tanzania |
| Collaborator Contribution | Provide data and ecological expertise |
| Impact | A PhD student, Sarah Hayes -SPH EPSRC scholarship |
| Start Year | 2016 |
| Description | Sarah Cleveland and Katie Hampson- Glasgow |
| Organisation | University of Glasgow |
| Department | MRC - University of Glasgow Centre for Virus Research |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Centre Investigator, Christl Donnelly directly involved in the design and analysis of epidemological and ecological data relating to rabies control in Tanzania |
| Collaborator Contribution | Provide data and ecological expertise |
| Impact | A PhD student, Sarah Hayes -SPH EPSRC scholarship |
| Start Year | 2016 |
| Description | Scientific Advisory Group for Emergencies (SAGE) |
| Organisation | Government of the UK |
| Department | Scientific Advisory Group for Emergencies (SAGE) |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | As part of SAGE, this grant was instrumental in the UK unlocking roadmap https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/963440/S1129__Unlocking__Roadmap_Scenarios_for_England_.pdf As part of SAGE, documents were published on the UK strategy for vaccinations and the removal of NPIs https://www.gov.uk/government/publications/imperial-college-london-strategies-for-gradually-lifting-npis-in-parallel-to-covid-19-vaccine-roll-out-in-the-uk-4-february-2021 https://www.gov.uk/government/publications/imperial-college-london-potential-profile-of-the-covid-19-epidemic-in-the-uk-under-different-vaccination-roll-out-strategies-13-january-2021 |
| Collaborator Contribution | Data and advisory expertise |
| Impact | https://www.gov.uk/government/publications/imperial-college-london-potential-profile-of-the-covid-19-epidemic-in-the-uk-under-different-vaccination-roll-out-strategies-13-january-2021 https://www.gov.uk/government/publications/imperial-college-london-strategies-for-gradually-lifting-npis-in-parallel-to-covid-19-vaccine-roll-out-in-the-uk-4-february-2021 https://www.gov.uk/government/publications/imperial-college-london-unlocking-roadmap-scenarios-for-england-18-february-2021 |
| Start Year | 2021 |
| Description | Scientific Pandemic Influenza - Modelling - Operational Committee |
| Organisation | Government of the UK |
| Department | Department of Health and Social Care |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | We provided analysis and advice. |
| Collaborator Contribution | SPI-M-O provided data and questions. |
| Impact | Many peer-reviewed papers and government advice notes. |
| Start Year | 2020 |
| Description | Secretary of State for Defence (Defence Science and Technology Laboratory) (DTSL) - Non-Disclosure and Data Protection Agreement (COVID-19) |
| Organisation | Defence Science & Technology Laboratory (DSTL) |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Imperial College London possesses valuable technical and commercial information relating to epidemiological modelling. ICL desires to evaluate the data with a view to model the COVID pandemic, including generating now casts and forecasts and provide advice to government, and especially advice to the Scientific Advisory Group for Emergencies ("SAGE") ("the Purpose"). |
| Collaborator Contribution | Dstl has access to NHS sensitive information relating to data collected by the NHS (the "Data Owner") relating to the COVID-19 pandemic ("COVID Data"). This may include anonymised patient data or supply chain hospital data. Dstl has permission from the NHS to disclose the COVID Data to members of the Scientific Pandemic Influenza Group on Modelling (SPI-M). In order for ICL to carry out said evaluation it is necessary for Dstl to provide the COVID Data for evaluation and analysis. |
| Impact | No outputs yet. |
| Start Year | 2020 |
| Description | Seq&Treat Consortium |
| Organisation | Foundation for Innovative New Diagnostics (FIND) |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Overseeing methodology for identifying mutations associated with drug resistance in TB Method development Contribution to writing the WHO report |
| Collaborator Contribution | Overseeing methodology for identifying mutations associated with drug resistance in TB Method development Contribution to writing the WHO report |
| Impact | Contributed to WHO report - expected March 2021 Collation of largest existing dataset of whole genome sequence data and drug resistance profiles for TB Update 2022 - WHO report was published in July 2021 - multiple countries adopting the catalogue as a basis for their surveillance and diagnosis programmes in TB https://www.who.int/publications/i/item/9789240028173 |
| Start Year | 2020 |
| Description | Serological surveillance of SARS-COV-2 in Manaus and Sao Paulo |
| Organisation | Fundação Pró-Sangue Hemocentro de São Paulo |
| Country | Brazil |
| Sector | Public |
| PI Contribution | Project lead Coordination of research teams Provided methodological input Writing of paper Epidemiological expertise Conception Data Analysis |
| Collaborator Contribution | Provision of data Analysis of data Interpretation of data Contribution to writing of paper |
| Impact | Paper submitted and accepted in Science. Picked up by 295 news outlets Blogged by 18 Tweeted by 5480 On 8 Facebook pages Referenced in 2 Wikipedia pages Reddited by 6 On 1 videos 160 readers on Mendeley |
| Start Year | 2020 |
| Description | Serological surveillance of SARS-COV-2 in Manaus and Sao Paulo |
| Organisation | Harvard University |
| Department | Harvard T.H. Chan School of Public Health |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Project lead Coordination of research teams Provided methodological input Writing of paper Epidemiological expertise Conception Data Analysis |
| Collaborator Contribution | Provision of data Analysis of data Interpretation of data Contribution to writing of paper |
| Impact | Paper submitted and accepted in Science. Picked up by 295 news outlets Blogged by 18 Tweeted by 5480 On 8 Facebook pages Referenced in 2 Wikipedia pages Reddited by 6 On 1 videos 160 readers on Mendeley |
| Start Year | 2020 |
| Description | Serological surveillance of SARS-COV-2 in Manaus and Sao Paulo |
| Organisation | Oswaldo Cruz Foundation (Fiocruz) |
| Country | Brazil |
| Sector | Public |
| PI Contribution | Project lead Coordination of research teams Provided methodological input Writing of paper Epidemiological expertise Conception Data Analysis |
| Collaborator Contribution | Provision of data Analysis of data Interpretation of data Contribution to writing of paper |
| Impact | Paper submitted and accepted in Science. Picked up by 295 news outlets Blogged by 18 Tweeted by 5480 On 8 Facebook pages Referenced in 2 Wikipedia pages Reddited by 6 On 1 videos 160 readers on Mendeley |
| Start Year | 2020 |
| Description | Serological surveillance of SARS-COV-2 in Manaus and Sao Paulo |
| Organisation | Universidade de São Paulo |
| Country | Brazil |
| Sector | Academic/University |
| PI Contribution | Project lead Coordination of research teams Provided methodological input Writing of paper Epidemiological expertise Conception Data Analysis |
| Collaborator Contribution | Provision of data Analysis of data Interpretation of data Contribution to writing of paper |
| Impact | Paper submitted and accepted in Science. Picked up by 295 news outlets Blogged by 18 Tweeted by 5480 On 8 Facebook pages Referenced in 2 Wikipedia pages Reddited by 6 On 1 videos 160 readers on Mendeley |
| Start Year | 2020 |
| Description | Serological surveillance of SARS-COV-2 in Manaus and Sao Paulo |
| Organisation | University of California, San Francisco |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Project lead Coordination of research teams Provided methodological input Writing of paper Epidemiological expertise Conception Data Analysis |
| Collaborator Contribution | Provision of data Analysis of data Interpretation of data Contribution to writing of paper |
| Impact | Paper submitted and accepted in Science. Picked up by 295 news outlets Blogged by 18 Tweeted by 5480 On 8 Facebook pages Referenced in 2 Wikipedia pages Reddited by 6 On 1 videos 160 readers on Mendeley |
| Start Year | 2020 |
| Description | Serological surveillance of SARS-COV-2 in Manaus and Sao Paulo |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Project lead Coordination of research teams Provided methodological input Writing of paper Epidemiological expertise Conception Data Analysis |
| Collaborator Contribution | Provision of data Analysis of data Interpretation of data Contribution to writing of paper |
| Impact | Paper submitted and accepted in Science. Picked up by 295 news outlets Blogged by 18 Tweeted by 5480 On 8 Facebook pages Referenced in 2 Wikipedia pages Reddited by 6 On 1 videos 160 readers on Mendeley |
| Start Year | 2020 |
| Description | Set up of collaborative research partnership |
| Organisation | Clinton Health Access Initiative |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Establishment of research collaboration and negotiation of data sharing agreement/materials transfer agreement with collaborators. (Swaziland National Malaria Control Programme). |
| Collaborator Contribution | Agreement to enter into research collaboration and sharing of data for the purpose of this surveillance study. Negotiation of data transfer agreement/materials transfer agreement with collaborators. |
| Impact | None as yet. |
| Start Year | 2017 |
| Description | Set up of collaborative research partnership |
| Organisation | Government of Swaziland |
| Country | Swaziland |
| Sector | Public |
| PI Contribution | Establishment of research collaboration and negotiation of data sharing agreement/materials transfer agreement with collaborators. (Swaziland National Malaria Control Programme). |
| Collaborator Contribution | Agreement to enter into research collaboration and sharing of data for the purpose of this surveillance study. Negotiation of data transfer agreement/materials transfer agreement with collaborators. |
| Impact | None as yet. |
| Start Year | 2017 |
| Description | Short and medium term forecasts of COVID-19 deaths |
| Organisation | Imperial College London |
| Department | Department of Infectious Disease & Epidemiology |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Software development, contributed a model to this forecasting hub and guided the design of the resulting dashboard and model averaging techniques. |
| Collaborator Contribution | Collaborators contributed 2 additional models, led the project and created a dashboard and combined codebase. These are run on a weekly basis to provide updated forecasts for guiding policy and aiding outputs from the Imperial College London COVID-19 Response Team. |
| Impact | Real-time dashboard used by many for COVID-19 situational awareness and understanding transmission trends. Dashboard has been covered by several news outlets. Preprint on results at https://www.medrxiv.org/content/10.1101/2021.07.19.21260746v1 |
| Start Year | 2020 |
| Description | Spatial metrics of epidemic transmissibility |
| Organisation | Tel Aviv University |
| Country | Israel |
| Sector | Academic/University |
| PI Contribution | Joint development of new models and methods for better understanding transmissibility in spatiotemporal epidemics. First outputs are new ways of combining local reproduction numbers into larger scale metrics. |
| Collaborator Contribution | Contribution of expertise in Bayesian statistics for designing inference engines for these models and methods. |
| Impact | First preprint at: https://www.medrxiv.org/content/10.1101/2022.08.31.22279450v2 with another in preparation. |
| Start Year | 2021 |
| Description | Spatio-temporal dynamics of Enterovirus D68 in the US |
| Organisation | BioFire Diagnostics, LLC |
| Country | United States |
| Sector | Private |
| PI Contribution | Provision of data analysis and modelling expertise |
| Collaborator Contribution | Provision of data and modelling expertise |
| Impact | Park SW, Pons-Salort M, Messacar K, Cook C, Meyers L, Farrar J, Grenfell BT. Epidemiological dynamics of enterovirus D68 in the US and implications for acute flaccid myelitis. Sci Transl Med 2021;13(584):eabd2400. |
| Start Year | 2019 |
| Description | Spatio-temporal dynamics of Enterovirus D68 in the US |
| Organisation | Princeton University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Provision of data analysis and modelling expertise |
| Collaborator Contribution | Provision of data and modelling expertise |
| Impact | Park SW, Pons-Salort M, Messacar K, Cook C, Meyers L, Farrar J, Grenfell BT. Epidemiological dynamics of enterovirus D68 in the US and implications for acute flaccid myelitis. Sci Transl Med 2021;13(584):eabd2400. |
| Start Year | 2019 |
| Description | Spatio-temporal dynamics of Enterovirus D68 in the US |
| Organisation | University of Colorado |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Provision of data analysis and modelling expertise |
| Collaborator Contribution | Provision of data and modelling expertise |
| Impact | Park SW, Pons-Salort M, Messacar K, Cook C, Meyers L, Farrar J, Grenfell BT. Epidemiological dynamics of enterovirus D68 in the US and implications for acute flaccid myelitis. Sci Transl Med 2021;13(584):eabd2400. |
| Start Year | 2019 |
| Description | Spatio-temporal heterogeneities in dengue transmission in Brazil |
| Organisation | Getulio Vargas Foundation |
| Country | Brazil |
| Sector | Charity/Non Profit |
| PI Contribution | Modelling of data |
| Collaborator Contribution | Data provision Expert advice |
| Impact | Not yet recognised Paper in production |
| Start Year | 2020 |
| Description | St Georges Hospital |
| Organisation | St George's University of London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Research into the genomics of Cryptococcal meningitis. Co-supervision of MRC PhD student |
| Collaborator Contribution | Imperial College: Genomic analysis St Georges Hospital: Clinical trials, phenotypic analyses |
| Impact | See publications list |
| Description | Statistical genetics of bacterial pathogens |
| Organisation | Hannover Medical School |
| Country | Germany |
| Sector | Academic/University |
| PI Contribution | We have developed a number of different models for bacterial GWAS. I have worked on the code, worked together on conceptualising the method, generated data (simulated and real), performed analysis and written a paper on a bacterial GWAS method. We maintain the current code, and have made multiple updates. In ongoing work, we are providing supervision to a postdoc and a PhD student on two further projects, each of which should lead to a software tool and publication. |
| Collaborator Contribution | Our partners helped with initial conceptualisation, and development of statistics used in the models. They have helped with publication writing. In subsequent work, they offered insights into how the method may continue to be developed, and have contributed code and ideas for models towards this. We worked jointly on a paper and software for this method. |
| Impact | Published papers: Lees, J. A. et al. Improved Prediction of Bacterial Genotype-Phenotype Associations Using Interpretable Pangenome-Spanning Regressions. MBio 11, (2020) Lees, J. A., Galardini, M., Bentley, S. D., Weiser, J. N. & Corander, J. pyseer: a comprehensive tool for microbial pangenome-wide association studies. Bioinformatics 34, 4310-4312 (2018) Lees, J. A., Vehkala, M., Välimäki, N., Harris, S. R., Chewapreecha, C., Croucher, N. J., Corander, J. (2016). Sequence element enrichment analysis to determine the genetic basis of bacterial phenotypes. Nature Communications, 7, 12797. Published software: SEER (https://github.com/johnlees/seer) pyseer (https://github.com/mgalardini/pyseer) |
| Start Year | 2015 |
| Description | Statistical genetics of bacterial pathogens |
| Organisation | University of Helsinki |
| Department | Helsinki Institute of Life Science |
| Country | Finland |
| Sector | Academic/University |
| PI Contribution | We have developed a number of different models for bacterial GWAS. I have worked on the code, worked together on conceptualising the method, generated data (simulated and real), performed analysis and written a paper on a bacterial GWAS method. We maintain the current code, and have made multiple updates. In ongoing work, we are providing supervision to a postdoc and a PhD student on two further projects, each of which should lead to a software tool and publication. |
| Collaborator Contribution | Our partners helped with initial conceptualisation, and development of statistics used in the models. They have helped with publication writing. In subsequent work, they offered insights into how the method may continue to be developed, and have contributed code and ideas for models towards this. We worked jointly on a paper and software for this method. |
| Impact | Published papers: Lees, J. A. et al. Improved Prediction of Bacterial Genotype-Phenotype Associations Using Interpretable Pangenome-Spanning Regressions. MBio 11, (2020) Lees, J. A., Galardini, M., Bentley, S. D., Weiser, J. N. & Corander, J. pyseer: a comprehensive tool for microbial pangenome-wide association studies. Bioinformatics 34, 4310-4312 (2018) Lees, J. A., Vehkala, M., Välimäki, N., Harris, S. R., Chewapreecha, C., Croucher, N. J., Corander, J. (2016). Sequence element enrichment analysis to determine the genetic basis of bacterial phenotypes. Nature Communications, 7, 12797. Published software: SEER (https://github.com/johnlees/seer) pyseer (https://github.com/mgalardini/pyseer) |
| Start Year | 2015 |
| Description | Statistical genetics of bacterial pathogens |
| Organisation | University of Oslo |
| Country | Norway |
| Sector | Academic/University |
| PI Contribution | We have developed a number of different models for bacterial GWAS. I have worked on the code, worked together on conceptualising the method, generated data (simulated and real), performed analysis and written a paper on a bacterial GWAS method. We maintain the current code, and have made multiple updates. In ongoing work, we are providing supervision to a postdoc and a PhD student on two further projects, each of which should lead to a software tool and publication. |
| Collaborator Contribution | Our partners helped with initial conceptualisation, and development of statistics used in the models. They have helped with publication writing. In subsequent work, they offered insights into how the method may continue to be developed, and have contributed code and ideas for models towards this. We worked jointly on a paper and software for this method. |
| Impact | Published papers: Lees, J. A. et al. Improved Prediction of Bacterial Genotype-Phenotype Associations Using Interpretable Pangenome-Spanning Regressions. MBio 11, (2020) Lees, J. A., Galardini, M., Bentley, S. D., Weiser, J. N. & Corander, J. pyseer: a comprehensive tool for microbial pangenome-wide association studies. Bioinformatics 34, 4310-4312 (2018) Lees, J. A., Vehkala, M., Välimäki, N., Harris, S. R., Chewapreecha, C., Croucher, N. J., Corander, J. (2016). Sequence element enrichment analysis to determine the genetic basis of bacterial phenotypes. Nature Communications, 7, 12797. Published software: SEER (https://github.com/johnlees/seer) pyseer (https://github.com/mgalardini/pyseer) |
| Start Year | 2015 |
| Description | Stellenbosch University, South Africa / Liverpool School of Tropical Medicine |
| Organisation | University of Stellenbosch |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | Supervising meta-analysis by PhD student in Stellenbosch: does intermittent preventive treatment of malaria in pregnancy still help to protect women and children when the malaria parasite carries the 581G mutation? |
| Collaborator Contribution | The analysis is carried out by Dr Caroline Osoro in Stellenbosch University, and co-supervised by Eleanor Ochodo (SU) and Prof Feiko Ter Kuile at the Liverpool School of Tropical Medicine. |
| Impact | None yet, except the meta-analysis is registered with PROSPERO: https://www.crd.york.ac.uk/PROSPERO (registration CRD42021230110 ) Collaboration between malaria epidemiologists (myself, Prof Ter Kuile) and evidence synthesis specialists (Dr Ochodo, Dr Osoro). |
| Start Year | 2020 |
| Description | Strengthening hospitals capacities to deal with COVID-19 pandemic |
| Organisation | Imperial College London |
| Department | Imperial College Business School |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Modelling expertise Data Analysis Data Processing Contribution to report writing Lead on development of planning tools - COVID-19 elective care scheduling and Hospital Planning Tool |
| Collaborator Contribution | Contribution to report writing Health system analysis Operations research expertise |
| Impact | MRC-GIDA Report 40 MRC-GIDA Report 36 MRC-GIDA Report 29 MRC-GIDA Report 27 MRC-GIDA Report 15 |
| Start Year | 2020 |
| Description | Studies on Onchocerciasis-Associated Epilepsy |
| Organisation | Royal Veterinary College (RVC) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Participation in First International Workshop on Onchocerciasis-Associated Epilepsy (OAE), University of Antwerp, October 2017; Chairing Symposium on OAE at the American Society of Tropical Medicine & Hygiene (ASTMH) annual meeting, New Orleans, October 2018; preparation of joint manuscripts Updated February 2020: Preparation and publication of papers in Infectious Diseases of Poverty, PLoS Neglected Tropical Diseases. Mentoring of a PhD student through AIMS Cameroon from transmission dynamics modelling and collaboration on a Wellcome Trust application by the mentored student Supervision of an MRes student on modelling onchocerciasis-associated epilepsy |
| Collaborator Contribution | Convening and organisation of First International Workshop on Onchocerciasis-Associated Epilepsy (OAE); coordination of the OAE Alliance; organisation of Symposium at ASTMH; drafting of joint manuscripts; submission of Organised Session on Morbidity Management and Disability Prevention for European Congress of Tropical Medicine and International Health (ECTMIH), Liverpool, September 2019 Updated February 2020: Assisting in the implementation of a joint MSc in Epidemiology student to link onchocerciasis transmission models to epilepsy |
| Impact | Published manuscripts (e.g. in Infectious Diseases of Poverty) and manuscripts under review (e.g. in Frontiers in Neurology). Multidisciplinary collaboration: Neurologists; epidemiologists; physicians; social scientists. Paper on OAE modelling in preparation. |
| Start Year | 2017 |
| Description | Studies on Onchocerciasis-Associated Epilepsy |
| Organisation | University of Antwerp |
| Country | Belgium |
| Sector | Academic/University |
| PI Contribution | Participation in First International Workshop on Onchocerciasis-Associated Epilepsy (OAE), University of Antwerp, October 2017; Chairing Symposium on OAE at the American Society of Tropical Medicine & Hygiene (ASTMH) annual meeting, New Orleans, October 2018; preparation of joint manuscripts Updated February 2020: Preparation and publication of papers in Infectious Diseases of Poverty, PLoS Neglected Tropical Diseases. Mentoring of a PhD student through AIMS Cameroon from transmission dynamics modelling and collaboration on a Wellcome Trust application by the mentored student Supervision of an MRes student on modelling onchocerciasis-associated epilepsy |
| Collaborator Contribution | Convening and organisation of First International Workshop on Onchocerciasis-Associated Epilepsy (OAE); coordination of the OAE Alliance; organisation of Symposium at ASTMH; drafting of joint manuscripts; submission of Organised Session on Morbidity Management and Disability Prevention for European Congress of Tropical Medicine and International Health (ECTMIH), Liverpool, September 2019 Updated February 2020: Assisting in the implementation of a joint MSc in Epidemiology student to link onchocerciasis transmission models to epilepsy |
| Impact | Published manuscripts (e.g. in Infectious Diseases of Poverty) and manuscripts under review (e.g. in Frontiers in Neurology). Multidisciplinary collaboration: Neurologists; epidemiologists; physicians; social scientists. Paper on OAE modelling in preparation. |
| Start Year | 2017 |
| Description | Studies on Onchocerciasis-Associated Epilepsy |
| Organisation | University of Bern |
| Country | Switzerland |
| Sector | Academic/University |
| PI Contribution | Participation in First International Workshop on Onchocerciasis-Associated Epilepsy (OAE), University of Antwerp, October 2017; Chairing Symposium on OAE at the American Society of Tropical Medicine & Hygiene (ASTMH) annual meeting, New Orleans, October 2018; preparation of joint manuscripts Updated February 2020: Preparation and publication of papers in Infectious Diseases of Poverty, PLoS Neglected Tropical Diseases. Mentoring of a PhD student through AIMS Cameroon from transmission dynamics modelling and collaboration on a Wellcome Trust application by the mentored student Supervision of an MRes student on modelling onchocerciasis-associated epilepsy |
| Collaborator Contribution | Convening and organisation of First International Workshop on Onchocerciasis-Associated Epilepsy (OAE); coordination of the OAE Alliance; organisation of Symposium at ASTMH; drafting of joint manuscripts; submission of Organised Session on Morbidity Management and Disability Prevention for European Congress of Tropical Medicine and International Health (ECTMIH), Liverpool, September 2019 Updated February 2020: Assisting in the implementation of a joint MSc in Epidemiology student to link onchocerciasis transmission models to epilepsy |
| Impact | Published manuscripts (e.g. in Infectious Diseases of Poverty) and manuscripts under review (e.g. in Frontiers in Neurology). Multidisciplinary collaboration: Neurologists; epidemiologists; physicians; social scientists. Paper on OAE modelling in preparation. |
| Start Year | 2017 |
| Description | Studies on epidemiology, morbidity and control of Loiasis |
| Organisation | Institute of Development Research (IRD) |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Preparation of joint publications published in Trends in Parasitology and Open Forum Infectious Diseases. Supervision of a Foundation Year 2 Postgraduate Medical Training Programme physician Development of mathematical models for Loiasis transmission and control |
| Collaborator Contribution | Preparation of joint publications published in Trends in Parasitology and Open Forum Infectious Diseases. Contribution to data collation and curation |
| Impact | Publication of two papers. Presentations at the Inaugural World NTD day at the London Centre for Neglected Tropical Disease Research. Publication of a review on albendazole PD/PK in PLoS Negl Trop Dis in 2022. |
| Start Year | 2018 |
| Description | Support to COVID-19 response - Zimbabwe |
| Organisation | Medical Research Council of Zimbabwe |
| Country | Zimbabwe |
| Sector | Public |
| PI Contribution | Mathematical modelling support to guide decisions regarding the COVID-19 response Technical support on COVID surveillance Questionnaire design for national SARS-Cov 2 seroprevalence survey Grant applications to Foreign Commonwealth and Development Office |
| Collaborator Contribution | Data collection and provision Secretariat support and project management Dissemination of results |
| Impact | Policy decisions made on national lockdowns and COVID control measures |
| Start Year | 2020 |
| Description | Support to COVID-19 response - Zimbabwe |
| Organisation | Ministry of Health and Child Welfare of the Republic of Zimbabwe |
| Country | Zimbabwe |
| Sector | Public |
| PI Contribution | Mathematical modelling support to guide decisions regarding the COVID-19 response Technical support on COVID surveillance Questionnaire design for national SARS-Cov 2 seroprevalence survey Grant applications to Foreign Commonwealth and Development Office |
| Collaborator Contribution | Data collection and provision Secretariat support and project management Dissemination of results |
| Impact | Policy decisions made on national lockdowns and COVID control measures |
| Start Year | 2020 |
| Description | Support to COVID-19 response - Zimbabwe |
| Organisation | National Institute of Health Research |
| Country | Zimbabwe |
| Sector | Public |
| PI Contribution | Mathematical modelling support to guide decisions regarding the COVID-19 response Technical support on COVID surveillance Questionnaire design for national SARS-Cov 2 seroprevalence survey Grant applications to Foreign Commonwealth and Development Office |
| Collaborator Contribution | Data collection and provision Secretariat support and project management Dissemination of results |
| Impact | Policy decisions made on national lockdowns and COVID control measures |
| Start Year | 2020 |
| Description | Support to COVID-19 response in Quebec |
| Organisation | University of Bristol |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Interpretation of results and implications Critique of results |
| Collaborator Contribution | Data analysis Writing of report Dissemination of results |
| Impact | Online reports published |
| Start Year | 2020 |
| Description | Support to COVID-19 response in Quebec |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Interpretation of results and implications Critique of results |
| Collaborator Contribution | Data analysis Writing of report Dissemination of results |
| Impact | Online reports published |
| Start Year | 2020 |
| Description | Support to WHO COVID-19 modelling network |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Modelling and epidemiology expertise, contribution to writing and analysis of group paper, |
| Collaborator Contribution | Coordination of international modelling groups. |
| Impact | Early Insights from Statistical and Mathematical Modeling of Key Epidemiologic Parameters of COVID-19.; https://wwwnc.cdc.gov/eid/article/26/11/20-1074_article |
| Start Year | 2020 |
| Description | Supporting WHO COVID-19 pandemic response |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Secondment of MRC Centre staff to WHO headquarters, continued remotely |
| Collaborator Contribution | Data collection, data provision, data analysis, local expertise |
| Impact | Daily WHO sitreps |
| Start Year | 2020 |
| Description | Swab and serological testing in Vo, Italy |
| Organisation | University of Padova |
| Country | Italy |
| Sector | Academic/University |
| PI Contribution | Modelling expertise Data analysis Assistance with study design |
| Collaborator Contribution | Data collection Data provision Data analysis |
| Impact | Increased testing programme in Vo and Veneto region. Publications: https://doi.org/10.1038/s41586-020-2488-1 https://doi.org/10.1038/s41467-021-24622-7 https://doi.org/10.1186/s13073-022-01066-2 https://doi.org/10.1038/s41467-022-33460-0 https://doi.org/10.3390/v14020399 |
| Start Year | 2020 |
| Description | Teralytics - Joint Marketing Agreement (COVID-19) |
| Organisation | Teralytics |
| Country | Switzerland |
| Sector | Private |
| PI Contribution | Build the forecast models on pandemic intervention effectiveness as an input, open-source it on GitHub, and provide the outcome to the general public. COVID-19. |
| Collaborator Contribution | Provide aggregate level mobility data (the "Data Product") to be licensed to Client under the Agreement as "Licensed Data". COVID-19. |
| Impact | No outputs yet. |
| Start Year | 2020 |
| Description | Testing of Near-Infrared Spectroscopy in Africa - Brian Foy |
| Organisation | Colorado State University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | There is a clinical trial of a new systemic insecticide ivermectin in Burkina Faso designed to test whether repeated mass drug administrations can suppress the local mosquito population. RIMDAMAL II (https://clinicaltrials.gov/ct2/show/NCT03967054) is a double-blind, cluster randomized trial and we are using Near-Infrared Spectroscopy to determine whether we can detect a difference in the age of the mosquito population in the different arms of the trial. |
| Collaborator Contribution | The work is being lead by Professor Brian Foy of Colorado State University who will provide spectra from mosquitoes from different arms of the randomised control trial. Our estimates of age will be compared to other methods conducted on the same mosquitoes. |
| Impact | The project is highly multidisciplinary including epidemiologists, entomologists, clinicians and computer scientists. |
| Start Year | 2019 |
| Description | Thanzi La Onse |
| Organisation | University College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Modelling expertise and data analysis |
| Collaborator Contribution | Modelling expertise Dissemination of results Data analysis |
| Impact | Multiple publications Led to contribution of modelling expertise to support COVID-19 response in Malawi |
| Start Year | 2018 |
| Description | Thanzi La Onse |
| Organisation | University of Malawi |
| Country | Malawi |
| Sector | Academic/University |
| PI Contribution | Modelling expertise and data analysis |
| Collaborator Contribution | Modelling expertise Dissemination of results Data analysis |
| Impact | Multiple publications Led to contribution of modelling expertise to support COVID-19 response in Malawi |
| Start Year | 2018 |
| Description | Thanzi La Onse |
| Organisation | University of York |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Modelling expertise and data analysis |
| Collaborator Contribution | Modelling expertise Dissemination of results Data analysis |
| Impact | Multiple publications Led to contribution of modelling expertise to support COVID-19 response in Malawi |
| Start Year | 2018 |
| Description | The Broad Institute Genomics Collaboration |
| Organisation | Broad Institute |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Whole Genome Sequencing and Analysis |
| Collaborator Contribution | De Novo techniques for whole genome sequencing of Cryptococcus |
| Impact | Manuscripts in preparation Updated 2020: Manuscripts published in mBio and research ongoing |
| Start Year | 2014 |
| Description | The Department for Education (DfE) - Data Sharing Service Level Agreement (COVID-19) |
| Organisation | Department for Education |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | COVID-19 Data analysis and reporting |
| Collaborator Contribution | COVID-19 Data provision via Data Sharing Service Level Agreement |
| Impact | No outputs yet. |
| Start Year | 2020 |
| Description | The Global Fund - COVID-19 |
| Organisation | Global Fund to Fight AIDS, Tuberculosis and Malaria |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Public health impact estimates of the impact of The Global Fund COVID-19 investments from January 2021 - November 2022 |
| Collaborator Contribution | Provided data on spend and contributed to discussion of activities and methods. |
| Impact | Internal funder report |
| Start Year | 2022 |
| Description | The Global Fund - Malaria |
| Organisation | Global Fund to Fight AIDS, Tuberculosis and Malaria |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Modelling of malaria scenarios to support the 2019 Investment Case and subsequent strategy development targets |
| Collaborator Contribution | Provided scenarios and input data |
| Impact | Global Fund Investment Case: https://www.theglobalfund.org/en/news/2019-02-08-global-partners-commit-to-step-up-the-fight-against-aids-tb-and-malaria/ |
| Start Year | 2018 |
| Description | The Global Reference Group on Children Affected by COVID-19 |
| Organisation | Centers for Disease Control and Prevention (CDC) |
| Country | United States |
| Sector | Public |
| PI Contribution | The Global Reference Group on Children Affected by COVID-19 was established in July 2021, to produce global estimates for the numbers of children facing pandemic-associated deaths of their parents and caregivers, as well as to develop a unified strategy for evidence-based action. Our contribution was to develop methodology and estimates for the numbers of affected children |
| Collaborator Contribution | Our collaborators main contribution is to support and advocate for the integration of 'care for children' affected by second order impacts of COVID-19 into mainstream COVID-19 Emergency Response planning and action. The focus is on children experiencing pandemic-associated deaths of their parents and caregivers, along with associated poverty, violence and other social vulnerabilities. |
| Impact | 4 papers in The Lancet (https://doi.org/10.1016/S0140-6736(21)01253-8), Pediatrics (https://doi.org/10.1542/peds.2021-053760), The Lancet Child and Adolescent Health (https://doi.org/10.1016/S2352-4642(22)00005-0) and JAMA Peds (https://doi.org/10.1001/jamapediatrics.2022.3157). |
| Start Year | 2021 |
| Description | The Global Reference Group on Children Affected by COVID-19 |
| Organisation | Harvard University |
| Department | Harvard Medical School |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | The Global Reference Group on Children Affected by COVID-19 was established in July 2021, to produce global estimates for the numbers of children facing pandemic-associated deaths of their parents and caregivers, as well as to develop a unified strategy for evidence-based action. Our contribution was to develop methodology and estimates for the numbers of affected children |
| Collaborator Contribution | Our collaborators main contribution is to support and advocate for the integration of 'care for children' affected by second order impacts of COVID-19 into mainstream COVID-19 Emergency Response planning and action. The focus is on children experiencing pandemic-associated deaths of their parents and caregivers, along with associated poverty, violence and other social vulnerabilities. |
| Impact | 4 papers in The Lancet (https://doi.org/10.1016/S0140-6736(21)01253-8), Pediatrics (https://doi.org/10.1542/peds.2021-053760), The Lancet Child and Adolescent Health (https://doi.org/10.1016/S2352-4642(22)00005-0) and JAMA Peds (https://doi.org/10.1001/jamapediatrics.2022.3157). |
| Start Year | 2021 |
| Description | The Global Reference Group on Children Affected by COVID-19 |
| Organisation | Maestral International |
| Country | United States |
| Sector | Private |
| PI Contribution | The Global Reference Group on Children Affected by COVID-19 was established in July 2021, to produce global estimates for the numbers of children facing pandemic-associated deaths of their parents and caregivers, as well as to develop a unified strategy for evidence-based action. Our contribution was to develop methodology and estimates for the numbers of affected children |
| Collaborator Contribution | Our collaborators main contribution is to support and advocate for the integration of 'care for children' affected by second order impacts of COVID-19 into mainstream COVID-19 Emergency Response planning and action. The focus is on children experiencing pandemic-associated deaths of their parents and caregivers, along with associated poverty, violence and other social vulnerabilities. |
| Impact | 4 papers in The Lancet (https://doi.org/10.1016/S0140-6736(21)01253-8), Pediatrics (https://doi.org/10.1542/peds.2021-053760), The Lancet Child and Adolescent Health (https://doi.org/10.1016/S2352-4642(22)00005-0) and JAMA Peds (https://doi.org/10.1001/jamapediatrics.2022.3157). |
| Start Year | 2021 |
| Description | The Global Reference Group on Children Affected by COVID-19 |
| Organisation | United States Agency for International Development |
| Country | United States |
| Sector | Public |
| PI Contribution | The Global Reference Group on Children Affected by COVID-19 was established in July 2021, to produce global estimates for the numbers of children facing pandemic-associated deaths of their parents and caregivers, as well as to develop a unified strategy for evidence-based action. Our contribution was to develop methodology and estimates for the numbers of affected children |
| Collaborator Contribution | Our collaborators main contribution is to support and advocate for the integration of 'care for children' affected by second order impacts of COVID-19 into mainstream COVID-19 Emergency Response planning and action. The focus is on children experiencing pandemic-associated deaths of their parents and caregivers, along with associated poverty, violence and other social vulnerabilities. |
| Impact | 4 papers in The Lancet (https://doi.org/10.1016/S0140-6736(21)01253-8), Pediatrics (https://doi.org/10.1542/peds.2021-053760), The Lancet Child and Adolescent Health (https://doi.org/10.1016/S2352-4642(22)00005-0) and JAMA Peds (https://doi.org/10.1001/jamapediatrics.2022.3157). |
| Start Year | 2021 |
| Description | The Global Reference Group on Children Affected by COVID-19 |
| Organisation | University College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | The Global Reference Group on Children Affected by COVID-19 was established in July 2021, to produce global estimates for the numbers of children facing pandemic-associated deaths of their parents and caregivers, as well as to develop a unified strategy for evidence-based action. Our contribution was to develop methodology and estimates for the numbers of affected children |
| Collaborator Contribution | Our collaborators main contribution is to support and advocate for the integration of 'care for children' affected by second order impacts of COVID-19 into mainstream COVID-19 Emergency Response planning and action. The focus is on children experiencing pandemic-associated deaths of their parents and caregivers, along with associated poverty, violence and other social vulnerabilities. |
| Impact | 4 papers in The Lancet (https://doi.org/10.1016/S0140-6736(21)01253-8), Pediatrics (https://doi.org/10.1542/peds.2021-053760), The Lancet Child and Adolescent Health (https://doi.org/10.1016/S2352-4642(22)00005-0) and JAMA Peds (https://doi.org/10.1001/jamapediatrics.2022.3157). |
| Start Year | 2021 |
| Description | The Global Reference Group on Children Affected by COVID-19 |
| Organisation | University of KwaZulu-Natal |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | The Global Reference Group on Children Affected by COVID-19 was established in July 2021, to produce global estimates for the numbers of children facing pandemic-associated deaths of their parents and caregivers, as well as to develop a unified strategy for evidence-based action. Our contribution was to develop methodology and estimates for the numbers of affected children |
| Collaborator Contribution | Our collaborators main contribution is to support and advocate for the integration of 'care for children' affected by second order impacts of COVID-19 into mainstream COVID-19 Emergency Response planning and action. The focus is on children experiencing pandemic-associated deaths of their parents and caregivers, along with associated poverty, violence and other social vulnerabilities. |
| Impact | 4 papers in The Lancet (https://doi.org/10.1016/S0140-6736(21)01253-8), Pediatrics (https://doi.org/10.1542/peds.2021-053760), The Lancet Child and Adolescent Health (https://doi.org/10.1016/S2352-4642(22)00005-0) and JAMA Peds (https://doi.org/10.1001/jamapediatrics.2022.3157). |
| Start Year | 2021 |
| Description | The Global Reference Group on Children Affected by COVID-19 |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | The Global Reference Group on Children Affected by COVID-19 was established in July 2021, to produce global estimates for the numbers of children facing pandemic-associated deaths of their parents and caregivers, as well as to develop a unified strategy for evidence-based action. Our contribution was to develop methodology and estimates for the numbers of affected children |
| Collaborator Contribution | Our collaborators main contribution is to support and advocate for the integration of 'care for children' affected by second order impacts of COVID-19 into mainstream COVID-19 Emergency Response planning and action. The focus is on children experiencing pandemic-associated deaths of their parents and caregivers, along with associated poverty, violence and other social vulnerabilities. |
| Impact | 4 papers in The Lancet (https://doi.org/10.1016/S0140-6736(21)01253-8), Pediatrics (https://doi.org/10.1542/peds.2021-053760), The Lancet Child and Adolescent Health (https://doi.org/10.1016/S2352-4642(22)00005-0) and JAMA Peds (https://doi.org/10.1001/jamapediatrics.2022.3157). |
| Start Year | 2021 |
| Description | The Global Reference Group on Children Affected by COVID-19 |
| Organisation | World Bank Group |
| Country | United States |
| Sector | Public |
| PI Contribution | The Global Reference Group on Children Affected by COVID-19 was established in July 2021, to produce global estimates for the numbers of children facing pandemic-associated deaths of their parents and caregivers, as well as to develop a unified strategy for evidence-based action. Our contribution was to develop methodology and estimates for the numbers of affected children |
| Collaborator Contribution | Our collaborators main contribution is to support and advocate for the integration of 'care for children' affected by second order impacts of COVID-19 into mainstream COVID-19 Emergency Response planning and action. The focus is on children experiencing pandemic-associated deaths of their parents and caregivers, along with associated poverty, violence and other social vulnerabilities. |
| Impact | 4 papers in The Lancet (https://doi.org/10.1016/S0140-6736(21)01253-8), Pediatrics (https://doi.org/10.1542/peds.2021-053760), The Lancet Child and Adolescent Health (https://doi.org/10.1016/S2352-4642(22)00005-0) and JAMA Peds (https://doi.org/10.1001/jamapediatrics.2022.3157). |
| Start Year | 2021 |
| Description | The Global Reference Group on Children Affected by COVID-19 |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | The Global Reference Group on Children Affected by COVID-19 was established in July 2021, to produce global estimates for the numbers of children facing pandemic-associated deaths of their parents and caregivers, as well as to develop a unified strategy for evidence-based action. Our contribution was to develop methodology and estimates for the numbers of affected children |
| Collaborator Contribution | Our collaborators main contribution is to support and advocate for the integration of 'care for children' affected by second order impacts of COVID-19 into mainstream COVID-19 Emergency Response planning and action. The focus is on children experiencing pandemic-associated deaths of their parents and caregivers, along with associated poverty, violence and other social vulnerabilities. |
| Impact | 4 papers in The Lancet (https://doi.org/10.1016/S0140-6736(21)01253-8), Pediatrics (https://doi.org/10.1542/peds.2021-053760), The Lancet Child and Adolescent Health (https://doi.org/10.1016/S2352-4642(22)00005-0) and JAMA Peds (https://doi.org/10.1001/jamapediatrics.2022.3157). |
| Start Year | 2021 |
| Description | The Global Reference Group on Children Affected by COVID-19 |
| Organisation | World Without Orphans |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | The Global Reference Group on Children Affected by COVID-19 was established in July 2021, to produce global estimates for the numbers of children facing pandemic-associated deaths of their parents and caregivers, as well as to develop a unified strategy for evidence-based action. Our contribution was to develop methodology and estimates for the numbers of affected children |
| Collaborator Contribution | Our collaborators main contribution is to support and advocate for the integration of 'care for children' affected by second order impacts of COVID-19 into mainstream COVID-19 Emergency Response planning and action. The focus is on children experiencing pandemic-associated deaths of their parents and caregivers, along with associated poverty, violence and other social vulnerabilities. |
| Impact | 4 papers in The Lancet (https://doi.org/10.1016/S0140-6736(21)01253-8), Pediatrics (https://doi.org/10.1542/peds.2021-053760), The Lancet Child and Adolescent Health (https://doi.org/10.1016/S2352-4642(22)00005-0) and JAMA Peds (https://doi.org/10.1001/jamapediatrics.2022.3157). |
| Start Year | 2021 |
| Description | The Impact of Peri-partum Treatment in Burkina Faso |
| Organisation | Aix-Marseille University |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Expertise in undertaking this kind of analysis and supervisory support of the researcher (PhD student) undertaking the analysis. |
| Collaborator Contribution | Data, knowledge and the funding for the PhD student. |
| Impact | PhD thesis in preparation; other publications forthcoming |
| Start Year | 2019 |
| Description | The Jameel Institute - Kenneth C Griffin Initiative for the Economics of Pandemic Preparedness (EPPI) |
| Organisation | National Centre for Infectious Diseases |
| Country | Singapore |
| Sector | Hospitals |
| PI Contribution | 'The Jameel Institute - Kenneth C Griffin Initiative for the Economics of Pandemic Preparedness' was founded in September 2022, to help us prepare for future pandemics. The Imperial team, in collaboration with the partners, will develop and apply integrated economic-epidemiological modelling to inform public health decision related to pandemic preparedness and disease outbreaks around the world. |
| Collaborator Contribution | Community Jameel and Kenneth C Griffin provide funding; Umea University contributes to the scientific program of work; WHO supports partnerships of the initiative with policymakers across the world. |
| Impact | None yet |
| Start Year | 2022 |
| Description | The Jameel Institute - Kenneth C Griffin Initiative for the Economics of Pandemic Preparedness (EPPI) |
| Organisation | Umea University |
| Department | Umea School of Business, Economics and Statistics (USBE) |
| Country | Sweden |
| Sector | Academic/University |
| PI Contribution | 'The Jameel Institute - Kenneth C Griffin Initiative for the Economics of Pandemic Preparedness' was founded in September 2022, to help us prepare for future pandemics. The Imperial team, in collaboration with the partners, will develop and apply integrated economic-epidemiological modelling to inform public health decision related to pandemic preparedness and disease outbreaks around the world. |
| Collaborator Contribution | Community Jameel and Kenneth C Griffin provide funding; Umea University contributes to the scientific program of work; WHO supports partnerships of the initiative with policymakers across the world. |
| Impact | None yet |
| Start Year | 2022 |
| Description | The Jameel Institute - Kenneth C Griffin Initiative for the Economics of Pandemic Preparedness (EPPI) |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | 'The Jameel Institute - Kenneth C Griffin Initiative for the Economics of Pandemic Preparedness' was founded in September 2022, to help us prepare for future pandemics. The Imperial team, in collaboration with the partners, will develop and apply integrated economic-epidemiological modelling to inform public health decision related to pandemic preparedness and disease outbreaks around the world. |
| Collaborator Contribution | Community Jameel and Kenneth C Griffin provide funding; Umea University contributes to the scientific program of work; WHO supports partnerships of the initiative with policymakers across the world. |
| Impact | None yet |
| Start Year | 2022 |
| Description | The RAFT consortium |
| Organisation | Center for Infectious Disease Research |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Data analysis and mathematical modelling expertise |
| Collaborator Contribution | Provision of data Technical Expertise Local knowledge |
| Impact | Not yet |
| Start Year | 2020 |
| Description | The RAFT consortium |
| Organisation | Foreign Commonwealth and Development Office (FCDO) |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Data analysis and mathematical modelling expertise |
| Collaborator Contribution | Provision of data Technical Expertise Local knowledge |
| Impact | Not yet |
| Start Year | 2020 |
| Description | The RAFT consortium |
| Organisation | Institut Pierre Richet (IPR) |
| Country | Cote d'Ivoire |
| Sector | Academic/University |
| PI Contribution | Data analysis and mathematical modelling expertise |
| Collaborator Contribution | Provision of data Technical Expertise Local knowledge |
| Impact | Not yet |
| Start Year | 2020 |
| Description | The RAFT consortium |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Data analysis and mathematical modelling expertise |
| Collaborator Contribution | Provision of data Technical Expertise Local knowledge |
| Impact | Not yet |
| Start Year | 2020 |
| Description | The RAFT consortium |
| Organisation | Malaria Consortium |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | Data analysis and mathematical modelling expertise |
| Collaborator Contribution | Provision of data Technical Expertise Local knowledge |
| Impact | Not yet |
| Start Year | 2020 |
| Description | The RAFT consortium |
| Organisation | National Institute for Medical Research, Tanzania |
| Country | Tanzania, United Republic of |
| Sector | Public |
| PI Contribution | Data analysis and mathematical modelling expertise |
| Collaborator Contribution | Provision of data Technical Expertise Local knowledge |
| Impact | Not yet |
| Start Year | 2020 |
| Description | The economic analysis of the HPTN071/PopART trials |
| Organisation | London School of Economics and Political Science (University of London) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Leadership on economic analysis |
| Collaborator Contribution | Data collection and data analysis Modelling |
| Impact | Paper to be published in 2021 Papers published in AIDs and presented at AIDs conference in Mexico, 2019 |
| Start Year | 2018 |
| Description | The economic analysis of the HPTN071/PopART trials |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Leadership on economic analysis |
| Collaborator Contribution | Data collection and data analysis Modelling |
| Impact | Paper to be published in 2021 Papers published in AIDs and presented at AIDs conference in Mexico, 2019 |
| Start Year | 2018 |
| Description | The economic analysis of the HPTN071/PopART trials |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Leadership on economic analysis |
| Collaborator Contribution | Data collection and data analysis Modelling |
| Impact | Paper to be published in 2021 Papers published in AIDs and presented at AIDs conference in Mexico, 2019 |
| Start Year | 2018 |
| Description | The economic analysis of the HPTN071/PopART trials |
| Organisation | University of Stellenbosch |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | Leadership on economic analysis |
| Collaborator Contribution | Data collection and data analysis Modelling |
| Impact | Paper to be published in 2021 Papers published in AIDs and presented at AIDs conference in Mexico, 2019 |
| Start Year | 2018 |
| Description | The economic analysis of the HPTN071/PopART trials |
| Organisation | University of Zambia |
| Country | Zambia |
| Sector | Academic/University |
| PI Contribution | Leadership on economic analysis |
| Collaborator Contribution | Data collection and data analysis Modelling |
| Impact | Paper to be published in 2021 Papers published in AIDs and presented at AIDs conference in Mexico, 2019 |
| Start Year | 2018 |
| Description | The farm environment: an overlooked reservoir of Mycobacterium bovis? |
| Organisation | University of Warwick |
| Department | University of Warwick Research Students Skills Programme |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Advising on sampling, analysis and interpretation of data, drafting manuscripts and reports |
| Collaborator Contribution | Collecting samples, processing in the laboratory including control samples, drafting manuscripts and reports |
| Impact | Conference presentations |
| Start Year | 2016 |
| Description | The population dynamics of malaria within the mosquito and how this is influenced by temperature |
| Organisation | Penn State University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Provided Modelling expertise and data analysis |
| Collaborator Contribution | Provided raw data from experimental infections of mosquitoes |
| Impact | Manuscript accepted in Nature Ecology and Evolution Data provided by collaborator forms the basis of a PhD chapter. |
| Start Year | 2019 |
| Description | Tools for the detection of AMR Pathogens |
| Organisation | Christian Medical College, Vellore |
| Country | India |
| Sector | Academic/University |
| PI Contribution | Project Management Assistance with procurement Grant writing Primer design Laboratory testing of samples |
| Collaborator Contribution | LSHTM - Bioinformatics expertise KNUST - Provision of data and samples CMC Vellore - Provision of data and samples |
| Impact | No outputs yet |
| Start Year | 2022 |
| Description | Tools for the detection of AMR Pathogens |
| Organisation | Kwame Nkrumah University of Science and Technology (KNUST) |
| Country | Ghana |
| Sector | Academic/University |
| PI Contribution | Project Management Assistance with procurement Grant writing Primer design Laboratory testing of samples |
| Collaborator Contribution | LSHTM - Bioinformatics expertise KNUST - Provision of data and samples CMC Vellore - Provision of data and samples |
| Impact | No outputs yet |
| Start Year | 2022 |
| Description | Tools for the detection of AMR Pathogens |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Project Management Assistance with procurement Grant writing Primer design Laboratory testing of samples |
| Collaborator Contribution | LSHTM - Bioinformatics expertise KNUST - Provision of data and samples CMC Vellore - Provision of data and samples |
| Impact | No outputs yet |
| Start Year | 2022 |
| Description | Transmission Studies of Human Onchocerciasis in the Amazonian Focus |
| Organisation | Central University of Venezuela |
| Country | Venezuela, Bolivarian Republic of |
| Sector | Academic/University |
| PI Contribution | Data analysis and preparation of joint publications |
| Collaborator Contribution | Sharing of epidemiological, parasitological, and entomological data for the analysis of transmission and control studies of onchocerciasis in the Amazonian focus between Venezuela and Brazil |
| Impact | We have published at least 14 papers in peer-review journals, a book chapter in Advances in Parasitology (2009), a book chapter in Encyclopaedia of Environmental Health (2011, 2013, 2019) |
| Description | Typhoid Environmental Surveillance in Fiji |
| Organisation | International Vaccine Institute (IVI) |
| Country | Korea, Republic of |
| Sector | Charity/Non Profit |
| PI Contribution | Environmental site selection and GIS analysis Provision of laboratory and field protocols |
| Collaborator Contribution | Provision of GIS data |
| Impact | Not yet recognised |
| Start Year | 2021 |
| Description | Typhoid environmental surveillance |
| Organisation | Christian Medical College, Vellore |
| Country | India |
| Sector | Academic/University |
| PI Contribution | environmental site selection and GIS data analysis Development of protocol Writing of paper Training of laboratories Data analysis |
| Collaborator Contribution | Sample collection and testing and analysis Data analysis Methods development |
| Impact | Paper on medrXiv Methodology shared with other groups in Fiji, Nigeria and Indonesia and will be used to support environmental surveillance for disease burden |
| Start Year | 2019 |
| Description | Typhoid environmental surveillance |
| Organisation | Kwame Nkrumah University of Science and Technology (KNUST) |
| Country | Ghana |
| Sector | Academic/University |
| PI Contribution | environmental site selection and GIS data analysis Development of protocol Writing of paper Training of laboratories Data analysis |
| Collaborator Contribution | Sample collection and testing and analysis Data analysis Methods development |
| Impact | Paper on medrXiv Methodology shared with other groups in Fiji, Nigeria and Indonesia and will be used to support environmental surveillance for disease burden |
| Start Year | 2019 |
| Description | Typhoid environmental surveillance |
| Organisation | Liverpool School of Tropical Medicine |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | environmental site selection and GIS data analysis Development of protocol Writing of paper Training of laboratories Data analysis |
| Collaborator Contribution | Sample collection and testing and analysis Data analysis Methods development |
| Impact | Paper on medrXiv Methodology shared with other groups in Fiji, Nigeria and Indonesia and will be used to support environmental surveillance for disease burden |
| Start Year | 2019 |
| Description | Typhoid environmental surveillance |
| Organisation | University of Washington |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | environmental site selection and GIS data analysis Development of protocol Writing of paper Training of laboratories Data analysis |
| Collaborator Contribution | Sample collection and testing and analysis Data analysis Methods development |
| Impact | Paper on medrXiv Methodology shared with other groups in Fiji, Nigeria and Indonesia and will be used to support environmental surveillance for disease burden |
| Start Year | 2019 |
| Description | UCL-Lancet Countdown Climate Change and Health. |
| Organisation | University College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Indicator lead - infectious diseases |
| Collaborator Contribution | 26 international partner organisations. |
| Impact | Annual Lancet publications Annual regional reports see: http://www.lancetcountdown.org/resources/ Update 2021: Paper published in BMJ with focus on infectious disease/climate change Update 2022: Multiple papers published and full report published in the Lancet |
| Start Year | 2016 |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | Avenir Health |
| Country | United States |
| Sector | Private |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | Centers for Disease Control and Prevention (CDC) |
| Department | Division of Global HIV/AIDS |
| Country | United States |
| Sector | Public |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | European Centre for Disease Prevention and Control (ECDC) |
| Country | Sweden |
| Sector | Public |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | Global Fund to Fight AIDS, Tuberculosis and Malaria |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | Government of the United States of America |
| Department | U.S. Census Bureau |
| Country | United States |
| Sector | Public |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | International Epidemiologic Databases to Evaluate AIDS (IeDEA) |
| Country | Global |
| Sector | Charity/Non Profit |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | Joint United Nations Programme on HIV/AIDS (UNAIDS) |
| Country | Global |
| Sector | Public |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Department | Alpha Network |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | UNICEF |
| Country | United States |
| Sector | Public |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | United Nations (UN) |
| Department | UN Population Division |
| Country | United States |
| Sector | Public |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | United States President's Emergency Plan for AIDS Relief |
| Country | United States |
| Sector | Public |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | University of Cape Town |
| Department | Centre for Infectious Disease Epidemiology and Research |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | University of Stellenbosch |
| Department | South African Centre for Epidemiological Modelling and Analysis |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | Understanding clinical pathways for COVID-19 hospitalised patients |
| Organisation | Imperial College School of Medicine |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Statistical modelling Clinical expertise Leadership of project |
| Collaborator Contribution | Statistical modelling Data collection |
| Impact | Reports 17 Report 29 |
| Start Year | 2020 |
| Description | Understanding how a mosquito interacts with a bednet |
| Organisation | Liverpool School of Tropical Medicine |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Provided expertise in data analysis and modelling |
| Collaborator Contribution | Provision of laboratory data and field experiments. |
| Impact | Joint publication in Nature Microbiology Joint application for field research funding |
| Start Year | 2019 |
| Description | Understanding the role of complementary medicine in influencing the uptake and effectiveness of HIV prevention and treatment methods and services |
| Organisation | Biomedical Research and Training Institute (BRTI) |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | Development of study protocol Preparation of submissions to ethics committees |
| Collaborator Contribution | Data collection and provision Local expertise and research infrastructure Preparation of submissions to ethics committees |
| Impact | Not yet recognised |
| Start Year | 2020 |
| Description | Understanding the role of complementary medicine in influencing the uptake and effectiveness of HIV prevention and treatment methods and services |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Development of study protocol Preparation of submissions to ethics committees |
| Collaborator Contribution | Data collection and provision Local expertise and research infrastructure Preparation of submissions to ethics committees |
| Impact | Not yet recognised |
| Start Year | 2020 |
| Description | Understanding the role of complementary medicine in influencing the uptake and effectiveness of HIV prevention and treatment methods and services |
| Organisation | Ohio State University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Development of study protocol Preparation of submissions to ethics committees |
| Collaborator Contribution | Data collection and provision Local expertise and research infrastructure Preparation of submissions to ethics committees |
| Impact | Not yet recognised |
| Start Year | 2020 |
| Description | Understanding the role of complementary medicine in influencing the uptake and effectiveness of HIV prevention and treatment methods and services |
| Organisation | Roehampton University |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Development of study protocol Preparation of submissions to ethics committees |
| Collaborator Contribution | Data collection and provision Local expertise and research infrastructure Preparation of submissions to ethics committees |
| Impact | Not yet recognised |
| Start Year | 2020 |
| Description | University of Hong Kong |
| Organisation | University of Hong Kong |
| Country | Hong Kong |
| Sector | Academic/University |
| PI Contribution | Collaboration on fieldwork and analysis |
| Collaborator Contribution | Helped to win grants and publish papers |
| Impact | Numerous publications with Cowling or Kwok as co authors. |
| Start Year | 2010 |
| Description | Using data analysis and mathematical modelling to shed light on guidelines for start mass drug administration (onchocerciasis elimination mapping) and stop MDA |
| Organisation | Centers for Disease Control and Prevention (CDC) |
| Country | United States |
| Sector | Public |
| PI Contribution | PhD student at Imperial College is providing mathematical modelling expertise and analysing data |
| Collaborator Contribution | Provision of data sets Engagement with collectors of data sets in Africa to pursue publications of primary data Possibility of conducting fieldwork |
| Impact | No impact yet |
| Start Year | 2021 |
| Description | Using machine learning to predict the infecting dengue serotype from antibody titre data |
| Organisation | University of Florida |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Data analysis Modelling expertise Paper writing |
| Collaborator Contribution | Data provision Modelling expertise Interpretation of results |
| Impact | Paper in development |
| Start Year | 2021 |
| Description | Using machine learning to predict the infecting dengue serotype from antibody titre data |
| Organisation | Upstate Medical University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Data analysis Modelling expertise Paper writing |
| Collaborator Contribution | Data provision Modelling expertise Interpretation of results |
| Impact | Paper in development |
| Start Year | 2021 |
| Description | Using seroprevalence age profiles to identify changes in incidence and interruption of transmission of filarial infections in Mali |
| Organisation | University of Bamako |
| Country | Mali |
| Sector | Academic/University |
| PI Contribution | Hosting of 3 month International Society of Infectious Diseases fellowship Joint preparation of manuscript under review in Clinical Infectious Diseases |
| Collaborator Contribution | Collection and analysis of field data and joint preparation of manuscript under review in Clinical Infectious Diseases |
| Impact | Hosting of the fellowship and submission of manuscript currently under review Update 2022 - paper published in 2021 in Clinical Infectious Diseases. Implication of publication of the paper has resulted in collaboration with CDC and Taskforce for Global Health to revise together the guidelines for serological monitoring. Datasets are being looked at for additional countries |
| Start Year | 2019 |
| Description | VIMC Working Group on COVID-19 Impact on Vaccine Preventable Disease |
| Organisation | Bill and Melinda Gates Foundation |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Vaccine impact modelling Processing of model estimates Secretariat coordination Writing of journal articles |
| Collaborator Contribution | Vaccine impact modelling Compiling coverage estimates Writing of journal articles |
| Impact | Paper in pre-print Policy impact - prioritising measles vaccine campaign |
| Start Year | 2020 |
| Description | VIMC Working Group on COVID-19 Impact on Vaccine Preventable Disease |
| Organisation | Gavi |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Vaccine impact modelling Processing of model estimates Secretariat coordination Writing of journal articles |
| Collaborator Contribution | Vaccine impact modelling Compiling coverage estimates Writing of journal articles |
| Impact | Paper in pre-print Policy impact - prioritising measles vaccine campaign |
| Start Year | 2020 |
| Description | VIMC Working Group on COVID-19 Impact on Vaccine Preventable Disease |
| Organisation | Kaiser Permanente |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Vaccine impact modelling Processing of model estimates Secretariat coordination Writing of journal articles |
| Collaborator Contribution | Vaccine impact modelling Compiling coverage estimates Writing of journal articles |
| Impact | Paper in pre-print Policy impact - prioritising measles vaccine campaign |
| Start Year | 2020 |
| Description | VIMC Working Group on COVID-19 Impact on Vaccine Preventable Disease |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Vaccine impact modelling Processing of model estimates Secretariat coordination Writing of journal articles |
| Collaborator Contribution | Vaccine impact modelling Compiling coverage estimates Writing of journal articles |
| Impact | Paper in pre-print Policy impact - prioritising measles vaccine campaign |
| Start Year | 2020 |
| Description | VIMC Working Group on COVID-19 Impact on Vaccine Preventable Disease |
| Organisation | UNICEF |
| Country | United States |
| Sector | Public |
| PI Contribution | Vaccine impact modelling Processing of model estimates Secretariat coordination Writing of journal articles |
| Collaborator Contribution | Vaccine impact modelling Compiling coverage estimates Writing of journal articles |
| Impact | Paper in pre-print Policy impact - prioritising measles vaccine campaign |
| Start Year | 2020 |
| Description | VIMC Working Group on COVID-19 Impact on Vaccine Preventable Disease |
| Organisation | University of Cambridge |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Vaccine impact modelling Processing of model estimates Secretariat coordination Writing of journal articles |
| Collaborator Contribution | Vaccine impact modelling Compiling coverage estimates Writing of journal articles |
| Impact | Paper in pre-print Policy impact - prioritising measles vaccine campaign |
| Start Year | 2020 |
| Description | VIMC Working Group on COVID-19 Impact on Vaccine Preventable Disease |
| Organisation | University of Notre Dame |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Vaccine impact modelling Processing of model estimates Secretariat coordination Writing of journal articles |
| Collaborator Contribution | Vaccine impact modelling Compiling coverage estimates Writing of journal articles |
| Impact | Paper in pre-print Policy impact - prioritising measles vaccine campaign |
| Start Year | 2020 |
| Description | VIMC Working Group on COVID-19 Impact on Vaccine Preventable Disease |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Vaccine impact modelling Processing of model estimates Secretariat coordination Writing of journal articles |
| Collaborator Contribution | Vaccine impact modelling Compiling coverage estimates Writing of journal articles |
| Impact | Paper in pre-print Policy impact - prioritising measles vaccine campaign |
| Start Year | 2020 |
| Description | Vaccine design using ecological models |
| Organisation | Simon Fraser University |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Data analysis and models |
| Collaborator Contribution | Provided machine learning techniques and vaccine design |
| Impact | Patent and publication under preparation |
| Start Year | 2017 |
| Description | Vaccine immune responses |
| Organisation | Antigen Discovery Inc |
| Country | United States |
| Sector | Private |
| PI Contribution | Data analysis and designed an assay |
| Collaborator Contribution | Data provision |
| Impact | Multiple publications and data released on vaccine trial |
| Start Year | 2014 |
| Description | WHO - Assessing spread of pyrethorid resistance across Africa |
| Organisation | World Health Organization (WHO) |
| Department | Global Malaria Programme |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Collaboration with the World Health Organisation (WHO) Global Malaria Programme to understand the spread of pyrethroid resistant mosquitoes across Africa and how this influences the effectiveness of insecticide treated bednets used to control malaria. |
| Collaborator Contribution | Provided data on impact of insecticide on wild caught mosquitoes. |
| Impact | The work was presented in a WHO document (World Malaria Report 2019, Global report on insecticide resistance in malaria vectors: 2010-2016, accessed https://www.who.int/malaria/publications/atoz/9789241514057/en/ ) and on a live WHO webinar (https://apps.who.int/iris/bitstream/handle/10665/274556/WHO-CDS-GMP-2018.17-eng.pdf?ua=1). This work has supported the development of online threat maps for insecticide resistance status (https://www.who.int/malaria/maps/threats-about/en/). Attended WHO meetings resulting in policy recommendations and guideline changes. Meetings attended: (1) WHO consultation meeting, 15-18 December 2020 - WHO consultation to review results of the multi-centre study on determination of insecticide discriminating concentrations for monitoring of resistance in mosquitoes (2) Revision of Test procedures for IR monitoring in malaria vectors https://www.who.int/malaria/publications/atoz/9789241511575/en/ |
| Start Year | 2018 |
| Description | WHO - COVID-19 ESFT |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Supported the continued update of COVID-19 country-specific scenarios to feed directly into the WHO Essential Supplies Forecasting Tool. |
| Collaborator Contribution | Developed and maintained the WHO ESFT tool. |
| Impact | https://www.who.int/publications/i/item/WHO-2019-nCoV-Tools-Essential_forecasting-2022.1 |
| Start Year | 2022 |
| Description | WHO - Global Influenza programme |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Coordinate network of scientists and provide analysis |
| Collaborator Contribution | Provide policy questions and improve data access |
| Impact | Teleconference calls between modelling group country, epidemiologists and WHO |
| Start Year | 2017 |
| Description | WHO - Vaccination against STI |
| Organisation | World Health Organization (WHO) |
| Department | South Sudan World Health Organization |
| Country | Global |
| Sector | Public |
| PI Contribution | Expertise in Mathematical Modelling WHO efforts for the elimination of cervical cancer globally. We collaborate on another project on HSV 2 disease burden and vaccination impact to inform WHO business case for the development of a new vaccine. |
| Collaborator Contribution | They partially fund some of the research and the provide scientific input. |
| Impact | Multiple publications, workshops and we contribute to inform global strategy |
| Start Year | 2017 |
| Description | WHO - Vaccines for public health emergencies (FWC/IVB/IVR/IMR) |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Work is still on-going. To produce a WHO blueprint, statistical and epidemiological design and analysis plan. |
| Collaborator Contribution | Contributions to the design and plan for analysis of vaccine studies during public health emergencies. |
| Impact | Two papers submitted for WHO- Vaccines for public health emergencies Natalie E. Dean1*, Pierre-Stéphane Gsell2, Ron Brookmeyer3, Victor De Gruttola4, Christl A. Donnelly5, M. Elizabeth Halloran6,7, Momodou Jasseh8, Martha Nason9, Ximena Riveros2, Conall Watson10, Ana Maria Henao-Restrepo2, Ira M. Longini, Jr.1* Considerations for the design of vaccine efficacy trials during public health emergencies. In press (Science Translational Medicine) Natalie E. Dean1*, Ira M. Longini, Jr1, Ron Brookmeyer2, Christl A. Donnelly3, M. Elizabeth Halloran4,5, Pierre-Stéphane Gsell6, Peter W. Horby7, Martha C. Nason8, Victor De Gruttola9* Combining evidence from randomized clinical trials across outbreaks. Under review with Clinical Infectious Diseases. |
| Start Year | 2016 |
| Description | WHO - modelling to support an update of the malaria global technical strategy |
| Organisation | World Health Organization (WHO) |
| Department | Global Malaria Programme |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Modelling to support a number of global malaria scenario projections that will be used to inform future work aimed at updating the global technical strategy for malaria. |
| Collaborator Contribution | Partners at the Global Malaria Programme lead this work and have set aims and objectives as well as providing expertise and data to inform modelling. |
| Impact | Modelled scenario estimates detailing global projections. |
| Start Year | 2020 |
| Description | WHO Berlin hub collaboration on pandemic preparedness and epidemic response |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Literature review on epidemic models and parameters for priority pathogens Co-organising of a workshop on how modelling informed policy during the pandemic - leading from the modelling side |
| Collaborator Contribution | Bringing together experts to expand the literature review on models and parameters, and collaboratively think about how to turn this into a dynamic database which can be useful in practice in future epidemics Co-organising of a workshop on how modelling informed policy during the pandemic - leading from the policy side |
| Impact | No concrete outputs yet |
| Start Year | 2022 |
| Description | WHO COVID-19 analytics team |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Senior data scientist - advise on methodology and data pipeline infrastructure |
| Collaborator Contribution | Project management Data provision Dissemination of results |
| Impact | Not yet recognised |
| Start Year | 2021 |
| Description | WHO COVID-19 analytics team (Thibaut Jombart) |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Senior data scientist - advise on methodology and data pipeline infrastructure |
| Collaborator Contribution | Project management Data provision Dissemination of results |
| Impact | Not yet recognised |
| Start Year | 2021 |
| Description | WHO EYE strategy risk analysis working group |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | I am a member of the risk analysis working group and have contributed analysis in this capacity. |
| Collaborator Contribution | The WHO EYE strategy is an initiative to eliminate yellow fever epidemics. They have commissioned work in this capacity. |
| Impact | Only internal reports and mention in the annual partners meeting. |
| Start Year | 2019 |
| Description | WHO Global Influenza |
| Organisation | World Health Organization (WHO) |
| Department | Global Influenza Programme |
| Country | Switzerland |
| Sector | Public |
| PI Contribution | Helped to set up an international analytics working group to analyse seasonal influenza data reported by Member states to WHO. Continue to be involved in organising fortnightly teleconferences and assist in meetings. |
| Collaborator Contribution | Curation of data for analysis, platform for fortnightly calls, organisation of international meetings. |
| Impact | Influenza Public Health Research Agenda, Pandemic Influenza Severity Assessment Analytics white paper, draft opinion piece prepared for submission to peer-reviewed journal. |
| Start Year | 2017 |
| Description | WHO Global Malaria Programme |
| Organisation | World Health Organization (WHO) |
| Department | Global Malaria Programme |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Collaboration on modelling to inform policy across a range of areas, including new products and economics. |
| Collaborator Contribution | Intellectual partners, developing questions relevant to support public health policy. |
| Impact | PMID: 29242750 PMID: 28588994 PMID: 28566213 PMID: 28837020 PMID: 30961603 PMID: 33253211 PMID: 34789253 PMID: 36400084 |
| Start Year | 2011 |
| Description | WHO IVR Dengue |
| Organisation | World Health Organization (WHO) |
| Department | Initiative for Vaccine Research |
| Country | Switzerland |
| Sector | Public |
| PI Contribution | Technical assistance regarding serosurvey design for targeting the dengue vaccine. |
| Collaborator Contribution | Expertise, external collaborators, platform for public reports. |
| Impact | Public report, publication in peer-reviewed journal "Considerations for Serosurvey Design", PLoS One/ |
| Start Year | 2016 |
| Description | WHO Outbreak Analysis |
| Organisation | World Health Organization (WHO) |
| Department | Department of Pandemic and Epidemic Diseases |
| Country | Global |
| Sector | Public |
| PI Contribution | We continue to be a WHO Collaborating Centre for Infectious Disease Modelling and as part of the Terms of Reference contributed rapid analysis of outbreaks and epidemics. We rapidly evaluate the epidemiology and transmission dynamics of emerging and re-emerging threats. 2018 - 2019 has included analysis of the Ebola outbreak(s) in the Democratic Republic of the Congo, providing >15 reports for WHO and the Ministry of Health. |
| Collaborator Contribution | Data for analysis, collaborations with country MoH. |
| Impact | Over 20 reports for internal use at WHO and Country level. Publication in peer-reviewed journal. |
| Start Year | 2010 |
| Description | WHO insecticide treated bednet (ITN) data |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Samir Bhatt's group provided the ITN data for use in the world malaria report 2020. His group also provided prevalence estimates. |
| Collaborator Contribution | Technical expertise in data preparation and were the data provider |
| Impact | Publication of the world malaria report Updated 2021: Publication of WHO Malaria COVID report Publication in Lancet Infectious Diseases Submission to Nature Communications Submission to PLoS Computational Biology |
| Start Year | 2015 |
| Description | WHO polio collaborating institute for data analysis and modelling |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | epidemiological analysis and reports Assessing effectiveness of nOPV2 (new polio oral vaccine) during rollout |
| Collaborator Contribution | provision of data and requests for participation in advisory groups |
| Impact | several publications including New England Journal of Medicine and Lancet Infectious Diseases |
| Description | WWARN |
| Organisation | Worldwide Antimalarial Resistance Network |
| Country | Global |
| Sector | Charity/Non Profit |
| PI Contribution | We set up a study group in 2013 in collaboration with WWARN to conduct an analysis on the prophylactic protection given by the antimalarial amodiaquine. In 2016 we set up a further study group with WWARN to conduct analysis of multiple clinical trials of the antimalarial mefloquine. |
| Collaborator Contribution | WWARN contributed data and guidance. |
| Impact | Published artesunate-amodiaquine results in BMC Medicine 2020. |
| Start Year | 2013 |
| Description | Wellcome Trust Investigator Award |
| Organisation | Chinese University of Hong Kong |
| Country | Hong Kong |
| Sector | Academic/University |
| PI Contribution | Project Management Lead on data analysis Support on data collection Contribution of infectious disease dynamics expertise |
| Collaborator Contribution | Data collection Support data analysis |
| Impact | Multiple papers published Code developed (serosolver code) Update 2022 - extension granted Outputs on REACT study linked to work completed on this grant - supports the UKHSA response (link to REACT website) PLoS Pathogens paper |
| Start Year | 2015 |
| Description | Wildlife disease |
| Organisation | Zoological Society of London |
| Department | Institute of Zoology |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | Research grants won and commenced Publications in leading journals (Science) Genomic epidemiology and experimental analysis |
| Collaborator Contribution | Shared research staff and resources |
| Impact | Research publications, grants, conferences and training |
| Description | YZ-UHP! |
| Organisation | Biomedical Research and Training Institute (BRTI) |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | Project leadership, securing funding, research design (including drafting of study questionnaires and research and intervention tools), organising data collection, data processing systems development and implementation, support with staff training, statistical data analysis, mathematical modelling, and report writing. |
| Collaborator Contribution | BRTI - provision of a local institutional research base for the study; intellectual inputs to funding proposal development and research design, data collection and data processing systems, and scientific reports; local consultations on draft research tools; translation of research tools into the local language; obtained local IRB approvals; conducting data collection including implementation of behavioural economics interventions; local supervision of the local partner (DOMCCP) responsible for implementing the community psychology intervention; quality assurance for field-based HIV diagnostics. LSE - intellectual leadership on the design and oversight of behavioural economics interventions and associated research and intervention tools. University of Copenhagen - intellectual leadership on the design and oversight of the community psychology intervention and the qualitative research components of the study and of the associated research and intervention tools. ZMOHCC and PSI - support with establishing PrEP and VMMC services in the study areas. DOMCCP - implementation of the community psychology intervention. AiBST - laboratory diagnostics for detection of PrEP in dried blood spot specimens. AHISA Alliance - as a result of this project, Dr Constance Nyamukapa (Research Associate), Dr Owen Mugurungi (Director of the AIDS and TB Department in ZMOHCC) and myself were invited and were successful in becoming members of the NIH-supported Adolescent HIV Prevention and Treatment Implementation Science Alliance |
| Impact | No outputs as yet Collaboration is multi-disciplinary - epidemiology, behavioural economics, demography, community psychology, laboratory diagnostics, public health UPDATE 2021 - publication in 'Trials' UPDATE 2022 - results presented at International Union of Scientific Study of Populations conference in 2021 UPDATE 2023 -Publication 2022 in PLoS ONE, https://doi.org/10.1371/journal.pone.0273776. Status of the HIV epidemic in Manicaland, east Zimbabwe prior to the outbreak of the COVID-19 pandemic. -Publication 2022 in BMC Women's Health, How gender norms and 'good girl' notions prevent adolescent girls and young women from engaging with PrEP: qualitative insights from Zimbabwe. -Publication 2022 in BMC Infectious Diseases - Improving access to pre-exposure prophylaxis for adolescent girls and young women: recommendations from healthcare providers in eastern Zimbabwe |
| Start Year | 2017 |
| Description | YZ-UHP! |
| Organisation | Diocese of Mutare Community Care Programme |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | Project leadership, securing funding, research design (including drafting of study questionnaires and research and intervention tools), organising data collection, data processing systems development and implementation, support with staff training, statistical data analysis, mathematical modelling, and report writing. |
| Collaborator Contribution | BRTI - provision of a local institutional research base for the study; intellectual inputs to funding proposal development and research design, data collection and data processing systems, and scientific reports; local consultations on draft research tools; translation of research tools into the local language; obtained local IRB approvals; conducting data collection including implementation of behavioural economics interventions; local supervision of the local partner (DOMCCP) responsible for implementing the community psychology intervention; quality assurance for field-based HIV diagnostics. LSE - intellectual leadership on the design and oversight of behavioural economics interventions and associated research and intervention tools. University of Copenhagen - intellectual leadership on the design and oversight of the community psychology intervention and the qualitative research components of the study and of the associated research and intervention tools. ZMOHCC and PSI - support with establishing PrEP and VMMC services in the study areas. DOMCCP - implementation of the community psychology intervention. AiBST - laboratory diagnostics for detection of PrEP in dried blood spot specimens. AHISA Alliance - as a result of this project, Dr Constance Nyamukapa (Research Associate), Dr Owen Mugurungi (Director of the AIDS and TB Department in ZMOHCC) and myself were invited and were successful in becoming members of the NIH-supported Adolescent HIV Prevention and Treatment Implementation Science Alliance |
| Impact | No outputs as yet Collaboration is multi-disciplinary - epidemiology, behavioural economics, demography, community psychology, laboratory diagnostics, public health UPDATE 2021 - publication in 'Trials' UPDATE 2022 - results presented at International Union of Scientific Study of Populations conference in 2021 UPDATE 2023 -Publication 2022 in PLoS ONE, https://doi.org/10.1371/journal.pone.0273776. Status of the HIV epidemic in Manicaland, east Zimbabwe prior to the outbreak of the COVID-19 pandemic. -Publication 2022 in BMC Women's Health, How gender norms and 'good girl' notions prevent adolescent girls and young women from engaging with PrEP: qualitative insights from Zimbabwe. -Publication 2022 in BMC Infectious Diseases - Improving access to pre-exposure prophylaxis for adolescent girls and young women: recommendations from healthcare providers in eastern Zimbabwe |
| Start Year | 2017 |
| Description | YZ-UHP! |
| Organisation | London School of Economics and Political Science (University of London) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Project leadership, securing funding, research design (including drafting of study questionnaires and research and intervention tools), organising data collection, data processing systems development and implementation, support with staff training, statistical data analysis, mathematical modelling, and report writing. |
| Collaborator Contribution | BRTI - provision of a local institutional research base for the study; intellectual inputs to funding proposal development and research design, data collection and data processing systems, and scientific reports; local consultations on draft research tools; translation of research tools into the local language; obtained local IRB approvals; conducting data collection including implementation of behavioural economics interventions; local supervision of the local partner (DOMCCP) responsible for implementing the community psychology intervention; quality assurance for field-based HIV diagnostics. LSE - intellectual leadership on the design and oversight of behavioural economics interventions and associated research and intervention tools. University of Copenhagen - intellectual leadership on the design and oversight of the community psychology intervention and the qualitative research components of the study and of the associated research and intervention tools. ZMOHCC and PSI - support with establishing PrEP and VMMC services in the study areas. DOMCCP - implementation of the community psychology intervention. AiBST - laboratory diagnostics for detection of PrEP in dried blood spot specimens. AHISA Alliance - as a result of this project, Dr Constance Nyamukapa (Research Associate), Dr Owen Mugurungi (Director of the AIDS and TB Department in ZMOHCC) and myself were invited and were successful in becoming members of the NIH-supported Adolescent HIV Prevention and Treatment Implementation Science Alliance |
| Impact | No outputs as yet Collaboration is multi-disciplinary - epidemiology, behavioural economics, demography, community psychology, laboratory diagnostics, public health UPDATE 2021 - publication in 'Trials' UPDATE 2022 - results presented at International Union of Scientific Study of Populations conference in 2021 UPDATE 2023 -Publication 2022 in PLoS ONE, https://doi.org/10.1371/journal.pone.0273776. Status of the HIV epidemic in Manicaland, east Zimbabwe prior to the outbreak of the COVID-19 pandemic. -Publication 2022 in BMC Women's Health, How gender norms and 'good girl' notions prevent adolescent girls and young women from engaging with PrEP: qualitative insights from Zimbabwe. -Publication 2022 in BMC Infectious Diseases - Improving access to pre-exposure prophylaxis for adolescent girls and young women: recommendations from healthcare providers in eastern Zimbabwe |
| Start Year | 2017 |
| Description | YZ-UHP! |
| Organisation | Ministry of Health and Child Welfare of the Republic of Zimbabwe |
| Country | Zimbabwe |
| Sector | Public |
| PI Contribution | Project leadership, securing funding, research design (including drafting of study questionnaires and research and intervention tools), organising data collection, data processing systems development and implementation, support with staff training, statistical data analysis, mathematical modelling, and report writing. |
| Collaborator Contribution | BRTI - provision of a local institutional research base for the study; intellectual inputs to funding proposal development and research design, data collection and data processing systems, and scientific reports; local consultations on draft research tools; translation of research tools into the local language; obtained local IRB approvals; conducting data collection including implementation of behavioural economics interventions; local supervision of the local partner (DOMCCP) responsible for implementing the community psychology intervention; quality assurance for field-based HIV diagnostics. LSE - intellectual leadership on the design and oversight of behavioural economics interventions and associated research and intervention tools. University of Copenhagen - intellectual leadership on the design and oversight of the community psychology intervention and the qualitative research components of the study and of the associated research and intervention tools. ZMOHCC and PSI - support with establishing PrEP and VMMC services in the study areas. DOMCCP - implementation of the community psychology intervention. AiBST - laboratory diagnostics for detection of PrEP in dried blood spot specimens. AHISA Alliance - as a result of this project, Dr Constance Nyamukapa (Research Associate), Dr Owen Mugurungi (Director of the AIDS and TB Department in ZMOHCC) and myself were invited and were successful in becoming members of the NIH-supported Adolescent HIV Prevention and Treatment Implementation Science Alliance |
| Impact | No outputs as yet Collaboration is multi-disciplinary - epidemiology, behavioural economics, demography, community psychology, laboratory diagnostics, public health UPDATE 2021 - publication in 'Trials' UPDATE 2022 - results presented at International Union of Scientific Study of Populations conference in 2021 UPDATE 2023 -Publication 2022 in PLoS ONE, https://doi.org/10.1371/journal.pone.0273776. Status of the HIV epidemic in Manicaland, east Zimbabwe prior to the outbreak of the COVID-19 pandemic. -Publication 2022 in BMC Women's Health, How gender norms and 'good girl' notions prevent adolescent girls and young women from engaging with PrEP: qualitative insights from Zimbabwe. -Publication 2022 in BMC Infectious Diseases - Improving access to pre-exposure prophylaxis for adolescent girls and young women: recommendations from healthcare providers in eastern Zimbabwe |
| Start Year | 2017 |
| Description | YZ-UHP! |
| Organisation | Population Services International |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Project leadership, securing funding, research design (including drafting of study questionnaires and research and intervention tools), organising data collection, data processing systems development and implementation, support with staff training, statistical data analysis, mathematical modelling, and report writing. |
| Collaborator Contribution | BRTI - provision of a local institutional research base for the study; intellectual inputs to funding proposal development and research design, data collection and data processing systems, and scientific reports; local consultations on draft research tools; translation of research tools into the local language; obtained local IRB approvals; conducting data collection including implementation of behavioural economics interventions; local supervision of the local partner (DOMCCP) responsible for implementing the community psychology intervention; quality assurance for field-based HIV diagnostics. LSE - intellectual leadership on the design and oversight of behavioural economics interventions and associated research and intervention tools. University of Copenhagen - intellectual leadership on the design and oversight of the community psychology intervention and the qualitative research components of the study and of the associated research and intervention tools. ZMOHCC and PSI - support with establishing PrEP and VMMC services in the study areas. DOMCCP - implementation of the community psychology intervention. AiBST - laboratory diagnostics for detection of PrEP in dried blood spot specimens. AHISA Alliance - as a result of this project, Dr Constance Nyamukapa (Research Associate), Dr Owen Mugurungi (Director of the AIDS and TB Department in ZMOHCC) and myself were invited and were successful in becoming members of the NIH-supported Adolescent HIV Prevention and Treatment Implementation Science Alliance |
| Impact | No outputs as yet Collaboration is multi-disciplinary - epidemiology, behavioural economics, demography, community psychology, laboratory diagnostics, public health UPDATE 2021 - publication in 'Trials' UPDATE 2022 - results presented at International Union of Scientific Study of Populations conference in 2021 UPDATE 2023 -Publication 2022 in PLoS ONE, https://doi.org/10.1371/journal.pone.0273776. Status of the HIV epidemic in Manicaland, east Zimbabwe prior to the outbreak of the COVID-19 pandemic. -Publication 2022 in BMC Women's Health, How gender norms and 'good girl' notions prevent adolescent girls and young women from engaging with PrEP: qualitative insights from Zimbabwe. -Publication 2022 in BMC Infectious Diseases - Improving access to pre-exposure prophylaxis for adolescent girls and young women: recommendations from healthcare providers in eastern Zimbabwe |
| Start Year | 2017 |
| Description | YZ-UHP! |
| Organisation | The African Institute of Biomedical Science and Technology |
| Country | Zimbabwe |
| Sector | Academic/University |
| PI Contribution | Project leadership, securing funding, research design (including drafting of study questionnaires and research and intervention tools), organising data collection, data processing systems development and implementation, support with staff training, statistical data analysis, mathematical modelling, and report writing. |
| Collaborator Contribution | BRTI - provision of a local institutional research base for the study; intellectual inputs to funding proposal development and research design, data collection and data processing systems, and scientific reports; local consultations on draft research tools; translation of research tools into the local language; obtained local IRB approvals; conducting data collection including implementation of behavioural economics interventions; local supervision of the local partner (DOMCCP) responsible for implementing the community psychology intervention; quality assurance for field-based HIV diagnostics. LSE - intellectual leadership on the design and oversight of behavioural economics interventions and associated research and intervention tools. University of Copenhagen - intellectual leadership on the design and oversight of the community psychology intervention and the qualitative research components of the study and of the associated research and intervention tools. ZMOHCC and PSI - support with establishing PrEP and VMMC services in the study areas. DOMCCP - implementation of the community psychology intervention. AiBST - laboratory diagnostics for detection of PrEP in dried blood spot specimens. AHISA Alliance - as a result of this project, Dr Constance Nyamukapa (Research Associate), Dr Owen Mugurungi (Director of the AIDS and TB Department in ZMOHCC) and myself were invited and were successful in becoming members of the NIH-supported Adolescent HIV Prevention and Treatment Implementation Science Alliance |
| Impact | No outputs as yet Collaboration is multi-disciplinary - epidemiology, behavioural economics, demography, community psychology, laboratory diagnostics, public health UPDATE 2021 - publication in 'Trials' UPDATE 2022 - results presented at International Union of Scientific Study of Populations conference in 2021 UPDATE 2023 -Publication 2022 in PLoS ONE, https://doi.org/10.1371/journal.pone.0273776. Status of the HIV epidemic in Manicaland, east Zimbabwe prior to the outbreak of the COVID-19 pandemic. -Publication 2022 in BMC Women's Health, How gender norms and 'good girl' notions prevent adolescent girls and young women from engaging with PrEP: qualitative insights from Zimbabwe. -Publication 2022 in BMC Infectious Diseases - Improving access to pre-exposure prophylaxis for adolescent girls and young women: recommendations from healthcare providers in eastern Zimbabwe |
| Start Year | 2017 |
| Description | YZ-UHP! |
| Organisation | University of Copenhagen |
| Country | Denmark |
| Sector | Academic/University |
| PI Contribution | Project leadership, securing funding, research design (including drafting of study questionnaires and research and intervention tools), organising data collection, data processing systems development and implementation, support with staff training, statistical data analysis, mathematical modelling, and report writing. |
| Collaborator Contribution | BRTI - provision of a local institutional research base for the study; intellectual inputs to funding proposal development and research design, data collection and data processing systems, and scientific reports; local consultations on draft research tools; translation of research tools into the local language; obtained local IRB approvals; conducting data collection including implementation of behavioural economics interventions; local supervision of the local partner (DOMCCP) responsible for implementing the community psychology intervention; quality assurance for field-based HIV diagnostics. LSE - intellectual leadership on the design and oversight of behavioural economics interventions and associated research and intervention tools. University of Copenhagen - intellectual leadership on the design and oversight of the community psychology intervention and the qualitative research components of the study and of the associated research and intervention tools. ZMOHCC and PSI - support with establishing PrEP and VMMC services in the study areas. DOMCCP - implementation of the community psychology intervention. AiBST - laboratory diagnostics for detection of PrEP in dried blood spot specimens. AHISA Alliance - as a result of this project, Dr Constance Nyamukapa (Research Associate), Dr Owen Mugurungi (Director of the AIDS and TB Department in ZMOHCC) and myself were invited and were successful in becoming members of the NIH-supported Adolescent HIV Prevention and Treatment Implementation Science Alliance |
| Impact | No outputs as yet Collaboration is multi-disciplinary - epidemiology, behavioural economics, demography, community psychology, laboratory diagnostics, public health UPDATE 2021 - publication in 'Trials' UPDATE 2022 - results presented at International Union of Scientific Study of Populations conference in 2021 UPDATE 2023 -Publication 2022 in PLoS ONE, https://doi.org/10.1371/journal.pone.0273776. Status of the HIV epidemic in Manicaland, east Zimbabwe prior to the outbreak of the COVID-19 pandemic. -Publication 2022 in BMC Women's Health, How gender norms and 'good girl' notions prevent adolescent girls and young women from engaging with PrEP: qualitative insights from Zimbabwe. -Publication 2022 in BMC Infectious Diseases - Improving access to pre-exposure prophylaxis for adolescent girls and young women: recommendations from healthcare providers in eastern Zimbabwe |
| Start Year | 2017 |
| Description | Zambia Pertussis RSV Infant Mortality Estimation study (which was expanded to include covid-specific mortuary-based surveillance in all ages) |
| Organisation | University of Zambia |
| Country | Zambia |
| Sector | Academic/University |
| PI Contribution | Mathematical modelling and analytic expertise |
| Collaborator Contribution | Provision of data on prevalence of COVID positive samples collected from post-mortem samples within the main morgue of Lusaka, Zambia |
| Impact | Not yet recognised |
| Start Year | 2020 |
| Description | Zika - Institut Pasteur |
| Organisation | Pasteur Institute, Paris |
| Country | France |
| Sector | Charity/Non Profit |
| PI Contribution | Investigators from the MRC Centre for Outbreak Analysis and Modelling designed the collaboration and are now overseeing it. |
| Collaborator Contribution | Training of lab techniques and provision of reagents. |
| Impact | None yet but we are working on publications |
| Start Year | 2016 |
| Description | Zika - University of Wisconsin (still active) |
| Organisation | University of Wisconsin-Madison |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Investigators designed the collaboration and are now overseeing it. |
| Collaborator Contribution | Serological surveys, fieldwork, and testing. |
| Impact | None yet but we are working on publications |
| Start Year | 2016 |
| Title | BE - PrEP |
| Description | Tablet-based game to improve HIV risk perception, provide information on pre-exposure prophylaxis for HIV prevention (PrEP), and offer referrals to local PrEP services. The intervention is currently being pre-tested in a longitudinal population-based survey in Manicaland, east Zimbabwe. Update 2023: Pretesting of the intervention is now complete. |
| Type | Preventative Intervention - Behavioural risk modification |
| Current Stage Of Development | Early clinical assessment |
| Year Development Stage Completed | 2018 |
| Development Status | Under active development/distribution |
| Impact | NA |
| Title | BE - PrEP adherence |
| Description | SMS text reminders to women who have taken up pre-exposure prophylaxis (PrEP) to strengthen their adherence to PrEP. The intervention is currently being pre-tested in a longitudinal population-based survey in Manicaland, east Zimbabwe. Update 2023: Intervention has to be cancelled due to small number of cases. |
| Type | Preventative Intervention - Behavioural risk modification |
| Current Stage Of Development | Early clinical assessment |
| Year Development Stage Completed | 2018 |
| Development Status | Under active development/distribution |
| Impact | NA |
| Title | BE - VMMC |
| Description | Behavioural economics theory-based game to improve HIV risk perception, provide information on voluntary medical male circumcision, and offer referrals to local VMMC services with a financial incentive to take up VMMC. Participants are randomised to receive a fixed or a lottery-based incentive. The intervention is currently being pre-tested in a longitudinal population-based survey in Manicaland, east Zimbabwe. Update 2023: Pretesting of the intervention is now complete. |
| Type | Preventative Intervention - Behavioural risk modification |
| Current Stage Of Development | Early clinical assessment |
| Year Development Stage Completed | 2018 |
| Development Status | Under active development/distribution |
| Impact | NA |
| Title | Clinical Trial Simulator |
| Description | Clinical trial simulator - improves efficiency in the designs of very expensive Phase III clinical trials |
| Type | Support Tool - For Medical Intervention |
| Current Stage Of Development | Initial development |
| Year Development Stage Completed | 2019 |
| Development Status | Under active development/distribution |
| Impact | Scientific papers in the Lancet Funding from industry and MRC Generating open access software Intervention improved the ability to assess clinical trial design of important new therapies - economic and practical benefits to the pharmaceutical industry. |
| Title | Community conversations |
| Description | Community conversations to build support from key family members, peers and the wider community for adolescent girls and young women (AGYW) to use HIV prevention methods to protect themselves from HIV infection. Modest funding is provided to community groups to help them implement activities to identify and address social and practical barriers to use of HIV prevention methods by AGYW and their male partners. The intervention is currently being pre-tested in a longitudinal population-based survey in Manicaland, east Zimbabwe, as an intervention to complement the individual-level behavioural economics PrEP and VMMC interventions described elsewhere. Update 2023: Pretesting of the intervention is now complete. |
| Type | Preventative Intervention - Behavioural risk modification |
| Current Stage Of Development | Early clinical assessment |
| Year Development Stage Completed | 2018 |
| Development Status | Under active development/distribution |
| Impact | NA |
| Title | Dengue Vaccine Development |
| Description | Dengue vaccine developed by Sanofi Pasteur. Vaccine is licensed, only recommended in humans with previous exposure to Dengue. |
| Type | Therapeutic Intervention - Vaccines |
| Current Stage Of Development | Refinement. Clinical |
| Year Development Stage Completed | 2017 |
| Development Status | On hold |
| Clinical Trial? | Yes |
| Impact | Refinement of population that would benefit from vaccination. |
| URL | https://www.ncbi.nlm.nih.gov/pubmed/27701113 |
| Title | Development of Dengue Anti-viral |
| Description | Dengue anti-viral drug Assessment of the impact of the drug on dengue replication within host. Currently in animal testing phase Update 2022 - 2 papers under clearance |
| Type | Therapeutic Intervention - Drug |
| Current Stage Of Development | Refinement. Non-clinical |
| Year Development Stage Completed | 2018 |
| Development Status | Under active development/distribution |
| Impact | Not yet recognised |
| Title | Insecticide treated bednet against malaria containing 2 insecticides |
| Description | Support the design of two randomised control trials of a bednet with pyrethroid and chlorfenapyr insecticide in Tanzania and Benin. Trial started in 2019. |
| Type | Preventative Intervention - Physical/Biological risk modification |
| Current Stage Of Development | Late clinical evaluation |
| Year Development Stage Completed | 2020 |
| Development Status | Under active development/distribution |
| Clinical Trial? | Yes |
| UKCRN/ISCTN Identifier | TBC |
| Impact | Not yet recognised. |
| Title | Phase IV community trial of moxidectin vs ivermectin in African settings |
| Description | Phase II and Phase III clinical trials completed; FDA approved. Participation in the design and analysis of Phase IV community trials Modelling conducted to explore the epidemiological impact of moxidectin based on Phase II clinical trial Modelling ongoing to explore the epidemiological impact based on Phase III clinical trial |
| Type | Therapeutic Intervention - Drug |
| Current Stage Of Development | Refinement. Clinical |
| Year Development Stage Completed | 2018 |
| Development Status | Under active development/distribution |
| Clinical Trial? | Yes |
| Impact | Impacts on other conditions such as Scabies, soil transmitted Helminths, including Strongyloidiasis to be assessed. |
| URL | https://www.medicinesdevelopment.com/development-programs.htm |
| Title | TR-LAMP molecular diagnostic for Aspergillus fungus |
| Description | New CMOS-based lab-on-a-chip diagnostic for fungal antimicrobial resistance |
| Type | Diagnostic Tool - Non-Imaging |
| Current Stage Of Development | Initial development |
| Year Development Stage Completed | 2020 |
| Development Status | Actively seeking support |
| Impact | n/a |
| Title | AMIMA |
| Description | AMR determination from genome data for Streptococcus pneumoniae |
| Type Of Technology | Webtool/Application |
| Year Produced | 2022 |
| Open Source License? | Yes |
| Impact | Led on to further development and integration with other tools |
| URL | https://amima.poppunk.net/ |
| Title | APEestim model selection |
| Description | Two repositories of Matlab code used to generate results for the preprints: "Adaptive Estimation for Epidemic Renewal and Phylogenetic Skyline Models" and "Optimising Renewal Models for Real-Time Epidemic Prediction and Estimation". These code-sets allow the choice of model complexity when investigating inference problems pertaining to effective reproduction number or effective population size of an infectious disease. |
| Type Of Technology | Software |
| Year Produced | 2019 |
| Open Source License? | Yes |
| Impact | Forms part of the modelling hub used by Imperial College London's COVID-19 response team for forecasting deaths. |
| URL | https://mrc-ide.github.io/covid19-short-term-forecasts/index.html |
| Title | BacQuerya |
| Description | A search engine for bacterial metadata, which synthesises and presents information from multiple sources |
| Type Of Technology | Webtool/Application |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | None yet |
| URL | http://www.bacquerya.com |
| Title | BeeBOP - online surveillance tool |
| Description | Online surveillance tool for pathogen genomic epidemiology. |
| Type Of Technology | Webtool/Application |
| Year Produced | 2022 |
| Impact | Tool used globally for surveillance of pneumococcal disease. |
| URL | https://beebop.dide.ic.ac.uk/ |
| Title | BenchmarkDR |
| Description | Benchmarking tool for drug resistance prediction |
| Type Of Technology | Software |
| Year Produced | 2022 |
| Open Source License? | Yes |
| Impact | Presented at MGML conference in 2022 |
| URL | https://github.com/WGS-TB/BenchmarkDR |
| Title | COVID infection fatality rate estimation |
| Description | R package to estimate COVID fatality rates by age from seroprevalence data. |
| Type Of Technology | Software |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | Publication |
| URL | https://www.nature.com/articles/s43856-022-00106-7 |
| Title | COVID-19 NAT-RDT |
| Description | Background Although nucleic acid tests (NAT) have been widely used in testing for COVID-19, they are not always readily available. NAT tests usually require laboratory capacity, as well as trained personnel, and can also be prohibitively costly when conducting large numbers of tests, e.g. when testing for COVID-19 in the community. Recently emerging, antigen-detection rapid diagnostic tests (Ag-RDTs) could help to address these challenges, by offering cheap, easy-to-use tools that could be deployed at the point of care. However, they typically have lower performance than NAT. To decide testing strategy In any local setting, it is important to properly weigh the pros and cons of both NAT and Ag-RDTs, in order to identify optimal diagnostic strategies. This webtool offers a resource to aid in these evaluations. Comparing different testing strategies An 'Ag-RDT-led' strategy is one in which Ag-RDT is used as the first test, but could be followed by NAT for confirmation. There are three such strategies: confirming Ag-RDT-positive results with NAT; confirming Ag-RDT-negative results with NAT; and using an Ag-RDT alone, i.e. without need for NAT confirmation. A 'NAT-based' strategy uses NAT wherever it is available to provide results in time for clinical decisions; otherwise, it is assumed that a patient would be managed through clinical judgement on whether a patient has COVID-19. This webtool compares these two strategies, to identify when an Ag-RDT-led strategy would be preferred over a NAT-based one. The approach is to assume fixed characteristics for an Ag-RDT (sensitivity, specificity and cost), and to examine a wide range of values for other parameters, for example the availability of NAT, and the performance of clinical judgement in the absence of NAT. Under this wide range of scenarios, this webtool examines the probability that an Ag-RDT-led strategy would be simultaneously more impactful, and more cost-effective, than a NAT-based strategy. Please click on the 'Run Model' heading, where you can interact with the webtool. |
| Type Of Technology | Webtool/Application |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | No impacts yet |
| URL | https://covid-ag-rdt.shinyapps.io/model/ |
| Title | COVID-19 Scenario Analysis Tool (covidsim) |
| Description | The COVID-19 Scenario Analysis Tool enables users quickly and easily to generate calibrated forward scenarios of the COVID-19 epidemic in low- and middle-income countries in order to facilitate health planning. The latest release allows the user to explore the introduction of vaccination and how this can be used to help relax other non-pharmaceutical interventions. This tool allows the user to make projections of the prevalence of infections each day and the expected number of people requiring hospitalisation and critical care facilities. The relative benefits of different scenarios can be compared with metrics including health system capacity (maximum number of beds and critical care beds needed compared to those available), the peak of the epidemic, and the total projected deaths up to 1st February 2021. The model is automatically re-calibrated weekly to the cumulative COVID-19 deaths reported, obtained from the COVID-19 Data Repository by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. For countries not included in that data repository we use data from Worldometers. |
| Type Of Technology | Webtool/Application |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | Open to the public to view projections of infections. Approximately 100 visitors per day globally |
| URL | https://covidsim.org/v4.20210216/?place=gb |
| Title | COVID-19 Scenario Analysis Tool covidsim.org (user-friendly interface to a COVID-19 transmission model incorporating the impact of vaccines). Published May 21, 2020. |
| Description | Ghani A, Hogan A, FitzJohn R, et al. COVID-19 Scenario Analysis Tool covidsim.org (user-friendly interface to a COVID-19 transmission model incorporating the impact of vaccines). Published May 21, 2020. |
| Type Of Technology | Webtool/Application |
| Year Produced | 2020 |
| Impact | https://www.covidsim.org/ |
| URL | https://www.covidsim.org/ |
| Title | COVID-19 UK |
| Description | This site gives estimates of the reproduction number of COVID-19 and projections of cases by Local Authority in the UK based on testing data and mortality data. In addition the tool provides a map of hotspots for England, wales, Scotland and Northern Ireland. |
| Type Of Technology | Webtool/Application |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | Ongoing |
| URL | https://imperialcollegelondon.github.io/covid19local/#details |
| Title | COVID-HIV study portal |
| Description | Portal to provide information for the survey management as access to real time results from the survey |
| Type Of Technology | Webtool/Application |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | Enabled research team to provide monthly reports on COVID and how COVID was preventing HIV risks and preventions to the Government of Zimbabwe on a real time basis |
| URL | http://www.manicalandhivproject.org/resources.html |
| Title | Code for EPIONCHO-IBM, individual based (stochastic model) for the tranmission dynamics, control and elimination of onchocerciasis |
| Description | R code for EPIONCHO-IBM describing the number of Onchocerca volvulus in humans and vectors and the impact and effects of interventions on infection levels of onchocerciasis in Africa. |
| Type Of Technology | Software |
| Year Produced | 2019 |
| Open Source License? | Yes |
| Impact | This software is now being used for in-silico testing of hypothetical macrofilaricides, test and treat interventions and evaluation of moxidectin. |
| URL | https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0007557 |
| Title | CovidSim |
| Description | Laydon D, Ferguson N, Nedjati-Gilani G, Hinsley W. CovidSim. Published online April 22, 2020. This is the COVID-19 CovidSim microsimulation model developed by the MRC Centre for Global Infectious Disease Analysis hosted at Imperial College, London. |
| Type Of Technology | Webtool/Application |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | CovidSim models the transmission dynamics and severity of COVID-19 infections throughout a spatially and socially structured population over time. It enables modelling of how intervention policies and healthcare provision affect the spread of COVID-19. It is used to inform health policy by making quantitative forecasts of (for example) cases, deaths and hospitalisations, and how these will vary depending on which specific interventions, such as social distancing, are enacted. With parameter changes, it can be used to model other respiratory viruses, such as influenza. |
| URL | https://github.com/mrc-ide/covid-sim |
| Title | DAEDALUS software on GitHub |
| Description | Software allows for estimation of model to determine both the health and economic impacts of COVID-19 pandemic and optimise closure of the economy by different economic sectors |
| Type Of Technology | Software |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | Software has been used to inform COVID response in countries, and optimal pandemic mitigation strategies, and return on investment for pandemic preparedness Software has been used to support work for WHO - work is ongoing |
| Title | DAEDALUS: A model to optimize social and economic activity while containing SARS-CoV-2 transmission |
| Description | Optimizing social and economic activity while containing SARS-CoV-2 transmission |
| Type Of Technology | Software |
| Year Produced | 2022 |
| Open Source License? | Yes |
| Impact | Advancing the science of integrated economic-epidemiological modeling |
| URL | https://www.nature.com/articles/s43588-022-00233-0#citeas |
| Title | DUST |
| Description | An Engine for simulation of stochastic models. Includes support for running stochastic models in parallel, either with shared or varying parameters. Simulations are run efficiently in compiled code and can be run with a fraction of simulated states returned to R, allowing control over memory usage. Support is provided for building bootstrap particle filter for performing Sequential Monte Carlo (e.g., Gordon et al. 1993 ). The core of the simulation engine is the 'xoshiro256**' algorithm (Blackman and Vigna ), and the package is further described in FitzJohn et al 2021 . |
| Type Of Technology | Software |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | Software development has powered the COVID-19 real time response |
| Title | Dashboard for COVID-19 in Dhaka sewage and clinical data |
| Description | Dashboard to visualise spatial and temporal COVID-19 clinical and sewage data for public health institutes |
| Type Of Technology | Webtool/Application |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | No impacts yet |
| Title | Detect Population Structure Within Phylogenetic Trees |
| Description | Algorithms for detecting population structure from the history of coalescent events recorded in phylogenetic trees. This method classifies each tip and internal node of a tree into disjoint sets characterized by similar coalescent patterns |
| Type Of Technology | Software |
| Year Produced | 2017 |
| Open Source License? | Yes |
| Impact | We have demonstrated the role ofhuman demography and transmission patterns in shaping the evolution ofHIV-1, and our method has shown distinct outbreaks of HIV-1 in speci?c groups de?ned by age, race, and behaviour. Package updated in May 2020 Paper published in Systematic Biology |
| URL | https://cran.r-project.org/web/packages/treestructure/index.html |
| Title | EPIFLOW R Package |
| Description | Open Source Code for estimating the risk of international disease spread due to air travel |
| Type Of Technology | Software |
| Year Produced | 2019 |
| Impact | Development of model used to inform air travel restrictions |
| URL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738191/ |
| Title | EpiEstim |
| Description | Package for the R statistical software to estimate reproduction number during an epidemic. We created an updated version of a software we initially developed in 2013, with more flexibility in the method and a user friendly interface |
| Type Of Technology | Software |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | Two papers published (Cori et al. AJE 2013, Thompson et al. Epidemics 2019). The method gained tremendous attention during the covid-19 pandemic, as it was found to be the most accurate in a review of methods to estimate Rt (Gostik et al., PLoS Comp Biol 2020). EpiEstim is being used routinely by the following national or local governmental and public health agencies worldwide to monitor their Covid-19 epidemics, who publish estimates of Rt obtained using EpiEstim on their websites on a daily or weekly basis: • National Institute of Health in France • Federal Public Service for Public Health, Food Chain Safety and Environment of Belgium • Swiss national COVID-19 Science Task force • National center for epidemiology in Spain • Austrian Agency for Health and Food Safety • Quebec's national institute for public health • Public Health Ontario • Ottawa public health • Department of health of the state of New Jersey • City of St Louis, USA • Ministry of health of Bermuda • Ministry of Health of Brazil The Welsh government has estimated the impact of the firebreaker introduced in Wales in October 2020 using EpiEstim . WHO PAHO (Pan American Health Organization) has developed an interface to help country estimate the rate of transmission of COVID-19 using EpiEstim, and has included EpiEstim training as part of their early response to COVID-19 in Argentina and Barbados. EpiEstim also appears as the recommended software to estimate the reproduction number in documents produced by the World Health Organisation (WHO) • on criteria to adjust public health and social measures in the context of COVID-19 • on equitable allocation of COVID-19 health products UPDATE 2022: In 2021 EpiEstim was extended to track the transmissibility of novel variants in real time. Was used to characterise the transmissibility of Delta and Omicron variants. Paper under review - A generic method and software to estimate the transmission advantage of pathogen variants in real-time : SARS-CoV-2 as a case-study https://www.medrxiv.org/content/10.1101/2021.11.26.21266899v1 |
| URL | https://github.com/jstockwin/EpiEstimApp |
| Title | EpiFilter |
| Description | Provides improved estimates of the end of an epidemic and the likelihood of resurgence via specialised reproduction numbers and elimination probabilities. Available in both R and Matlab and widely usable with incidence data. Applies smoothing algorithms from control engineering that provide more reliable inference especially when incidence is small (hence its use for detecting elimination or resurgence). |
| Type Of Technology | Software |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | Several dashboards have been improved with this tool and I have been contacted on its use from various researchers. See collaborations for links to relevant dashboards. |
| Title | Epiflows |
| Description | Epiflows is an R package for risk assessment of travel-related spread of disease. It produces estimates of the expected number of symptomatic and/or asymptomatic infections that could be introduced to other locations from the source of infection. |
| Type Of Technology | Software |
| Year Produced | 2018 |
| Open Source License? | Yes |
| Impact | Publication: https://f1000research.com/articles/7-1374/v1 |
| URL | https://github.com/reconhub/epiflows |
| Title | Epistem |
| Description | A tool to estimate time varying instantaneous reproduction number during epidemics |
| Type Of Technology | Webtool/Application |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | No impacts yet |
| URL | https://github.com/mrc-ide/EpiEstim |
| Title | Estimating excess non-COVID deaths in England & Wales from ONS data (Katharina Hauck) |
| Description | Weekly updates of deaths in England and Wales using publicly available data on the provisional number of deaths registered in the past week from the Office of National Statistics (see Data). We show the number of registered all-cause deaths, and the deaths registered as COVID-19 deaths as provided by the ONS for every week beginning in March 2020. We compare the all-cause deaths with the number of deaths we would have expected to see being registered in this week had there been no pandemic, based on numbers of deaths in corresponding weeks of previous years, and determine the number of excess deaths as the difference. We then compare the excess deaths with the recorded COVID-19 deaths, which gives an estimate of excess deaths that were not associated with COVID-19 according to official registers. These estimates of excess non-COVID-19 deaths inform whether the pandemic led to unexpected deaths that were higher (or lower) than what we would have expected in that week. It is possible that all or almost all excess deaths comprise of registered COVID-19 deaths, in that situation there are no excess non-COVID-19 deaths. It is also possible that excess non-COVID-19 deaths are actually lower than expected deaths, once registered COVID-19 deaths are subtracted from excess deaths. We also present total cumulative deaths across all categories. This is the sum of registered all-cause deaths, COVID-19 deaths, expected deaths and excess non-COVID-19 deaths from the week ending 6 March 2020 to 05 November 2021 Hauck K, Ferguson N. ONS excess deaths (Weekly estimates of expected deaths and excess non-COVID-19 deaths during the pandemic in England and Wales). Published August 6, 2020. https://j-idea.github.io/ONSdeaths/ |
| Type Of Technology | Software |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | Informed policy relating to COVID-19 mitigation strategies Paper in preparation |
| Title | GRINCH - Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2 |
| Description | The software tool grinch (global report investigating novel coronavirus haplotypes) tracks the international spread of lineages of concern with automated daily reports. Further, it is linked to a custom tracking website (cov-lineages.org/global_report.html) which hosts this daily report and will continue to include novel SARS-CoV-2 lineages of concern as they are detected. |
| Type Of Technology | Webtool/Application |
| Year Produced | 2022 |
| Open Source License? | Yes |
| Impact | GRINCH has been used widely across the globe to track SARS-CoV-2 variants of concern. |
| URL | http://cov-lineages.org/global_report.html |
| Title | GroupTesting |
| Description | Group testing for COVID-19 - a modular platform |
| Type Of Technology | Software |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | Publication on the arXiv, currently under review |
| URL | https://github.com/WGS-TB/GroupTesting |
| Title | Gubbins |
| Description | Since the introduction of high-throughput, second-generation DNA sequencing technologies, there has been an enormous increase in the size of datasets being used for estimating bacterial population phylodynamics. Although many phylogenetic techniques are scalable to hundreds of bacterial genomes, methods which have been used for mitigating the effect of horizontal sequence transfer on phylogenetic reconstructions cannot cope with these new datasets. Gubbins (Genealogies Unbiased By recomBinations In Nucleotide Sequences) is an algorithm that iteratively identifies loci containing elevated densities of base substitutions while concurrently constructing a phylogeny based on the putative point mutations outside of these regions. Simulations demonstrate the algorithm generates highly accurate reconstructions under realistic models of short-term bacterial evolution, and can be run in only a few hours on alignments of hundreds of bacterial genome sequences. |
| Type Of Technology | Webtool/Application |
| Year Produced | 2022 |
| Open Source License? | Yes |
| Impact | gubbins has been cited in over 1000 publications for genomic epidemiology of bacterial pathogens by other research group globally |
| Title | HPCs-portal |
| Description | Portal to track progress with implementing data collection and individual-level intervention procedures for a study measuring and interpreting HIV prevention cascades and investigating multilevel factors influencing why adolescent girls and young women don't use efficacious HIV prevention methods in east Zimbabwe. |
| Type Of Technology | Webtool/Application |
| Year Produced | 2018 |
| Open Source License? | Yes |
| Impact | Improved oversight, management and implementation of the survey and intervention procedures including real-time monitoring of progress against targets and data quality for key aspects of the study. |
| URL | https://portal.yzuhp.co.zw |
| Title | INGOT-DR |
| Description | INGOT-DR: an interpretable classification method for predicting drug resistance in M. tuberculosis. Algorithms for Molecular Biology, Volume 16, Issue 1 (2021). PubMed ID 34376217. |
| Type Of Technology | Software |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | Used to predict mutations associated with drug resistance in a data driven manner |
| Title | LRCN-DR |
| Description | Software predicts drug resistance phenotype from genetic data |
| Type Of Technology | Software |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | Not yet recognised |
| Title | MALECOT - R package for inferring population structure from genetic data |
| Description | Although many programs exist for detecting structure in genetic data, these are not geared up for the types of poly-clonal data common in malaria application, in which a single individual may harbor multiple different strains of parasite. The MALECOT software solves this problem by building on previous modelling work to address poly-clonality directly within a Bayesian statistical framework. |
| Type Of Technology | Software |
| Year Produced | 2018 |
| Open Source License? | Yes |
| Impact | This software has been utilised by researchers in several institutions, including (that I am aware of) the University of North Carolina at Chapel Hill and the London School of Hygeine and Tropical Medicine. In both cases I have received good feedback that the program performed well and aided in their research goals. |
| URL | https://bobverity.github.io/MALECOT/ |
| Title | MCState |
| Description | Implements Monte Carlo methods for state-space models such as 'SIR' models in epidemiology using Particle MCMC (pmcmc) and SMC2 methods. |
| Type Of Technology | Software |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | Used to support the COVID-19 response |
| Title | MINT - Malaria Intervention Tool |
| Description | Tool to guide malaria control decision making |
| Type Of Technology | Webtool/Application |
| Year Produced | 2021 |
| Impact | Been used to support planning of national malaria control programmes in multiple African countries including Ghana and Cameroon |
| Title | MIPanalyzer - R package for analysing molecular inversion probe data |
| Description | Molecular Inversion Probe (MIP) data is a form of targetted amplicon genetic data that is increasingly used in malaria genetic analyses. As with any sequencing approach, MIP data requires its own custom filtering and analysis tools to get the most out of the data. The MIPanalyzer program makes it straightfoward to analyze MIP data and to visualise results. |
| Type Of Technology | Software |
| Year Produced | 2019 |
| Open Source License? | Yes |
| Impact | This software package was used in our Nature Communications paper based on MIP data (https://doi.org/10.1038/s41467-020-15779-8) and continues to be an important part of the suite of analysis tools used by researchers at the University of North Caroline at Chapel Hill. |
| URL | https://mrc-ide.github.io/MIPanalyzer/index.html |
| Title | Malariaverse |
| Description | A suite of software packages to support context-specific modelling using the malariasimulation model |
| Type Of Technology | Software |
| Year Produced | 2022 |
| Open Source License? | Yes |
| Impact | Open-access tools enable a wider user base to access context specific modelling using the malariasimulation model |
| Title | Modelling ICU capacity under different epidemiological scenarios of the COVID-19 pandemic in three western European countries. |
| Description | Software developed to assist in modelling ICU capacity under different epidemiological scenarios in 3 western European countries. |
| Type Of Technology | Software |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | Publication of report Data for MRC/J-IDEA COVID-19 Report 36: Modelling ICU capacity under different epidemiological scenarios of the COVID-19 pandemic in three western European countries. [16:21] Hauck, Katharina D McCabe R, Kont M, Schmit N, Whittaker C, Lochen A, Baguelin M, Knock E, Whittles L, Lees J, Brazeau N, Walker P, Ghani A, Ferguson N, White P, Donnelly C, Hauck K, Watson Oet al., 2021, Modelling ICU capacity under different epidemiological scenarios of the COVID-19 pandemic in three western European countries, International Journal of Epidemiology, Vol: 50, Pages: 753-767, ISSN: 0300-5771 Publications - Professor Katharina Hauck |
| Title | Modelling the relationship between mobility and COVID-19 transmissibility |
| Description | Code to carry out analyses modelling the link between human mobility and COVID-19 transmission |
| Type Of Technology | Software |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | Paper published - Reduction in mobility and COVID-19 transmission | Nature Communications |
| Title | Montagu |
| Description | The Consortium secretariat leads the development of "Montagu", a web-based delivery platform used to streamline the process of data exchange between the modelling groups and the funders. Specifically, Montagu enables easy access to the standardised input data used by the modelling groups and subsequently generated outputs used by the funders. Montagu also hosts documentation of the models, raw results, and data inputs, and will eventually provide new tools for data visualisation and analyses. Montagu aims to improve consistency between the Consortium models and offer greater accuracy through testing of uploaded vaccine impact estimates for completeness and broad numerical quality. It enhances general security and communication within the Consortium as it provides a centralised upload and download point. Overall, the software will bring a higher level of automation to the estimates generation process and reduce workloads for the modelling groups while offering greater assurances and transparency to the funders. Montagu development commenced in early 2017 as an open source project using Agile methods with the code stored here. Access to Montagu is currently restricted to the Consortium members and funders only. |
| Type Of Technology | Webtool/Application |
| Year Produced | 2018 |
| Open Source License? | Yes |
| Impact | Essential to the VIMC collaboration - entry point for the data contributions by external modelling groups and result disseminations to external stakeholders (WHO, GAVI, Gates) and to the public through data visualisation tool Used to inform multiple published papers |
| URL | http://www.vaccineimpact.org |
| Title | Naomi |
| Description | Mathematical model and web-interface for developing district-level estimates of people living with HIV, antiretroviral treatment coverage, and new HIV infections in sub-Saharan Africa. |
| Type Of Technology | Software |
| Year Produced | 2019 |
| Open Source License? | Yes |
| Impact | - Used to develop official district-level estimates for US Government PEPFAR planning and budget allocation in 2020. - Estimates to be publicly released by UNAIDS in June 2020. |
| URL | http://naomi.unaids.org |
| Title | Odin - updated 2021 (created 2016) |
| Description | odin implements a high-level language for describing and implementing ordinary differential equations in R. It provides a "domain specific language" (DSL) which looks like R but is compiled directly to C. The actual solution of the differential equations is done with the deSolve package, giving access to the excellent Livermore solvers (lsoda, lsode, etc), or with dde for use with delay differential equations. The DSL is declarative reflecting the mathematical nature of the equations (typically ordinary differential equations are simple mathematical relationships, so the order should not matter). It includes support for equations that involve vectors, matrices and higher dimensional arrays (up to 8!), including a high-level array indexing notation that removes the need for explicit looping. Delay differential equations are supported, including when the delayed quantities are arbitrarily complicated expressions of variables. Interpolation functions can be used to include time-varying quantities into the model (piecewise constant, linear and spline interpolation is supported, using cinterpolate. The equations are analysed before compilation so that parts that do not depend on time are not included in the final derivative calculations. Supports user-supplied parameters for any part of the system. Supports a large number of mathematical functions (see the functions vignette) for a complete list. In addition, the same machinery can be used to generate discrete-time models that proceed over a set of steps (rather than through continuous time). These may be stochastic and make use of any of R's random number functions. odin works using code generation; the nice thing about this approach is that it never gets bored. So if the generated code has lots of tedious repetitive bits, they're at least likely to be correct (compared with implementing yourself). |
| Type Of Technology | Software |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | Used to support multiple workstreams within the department (malaria, covid, stochastic) and has led to multiple publications and influences on international health policies |
| Title | Omega statistic for prior checking |
| Description | An information theoretic metric for diagnosing if skyline plots (widely used for estimating dynamics of infectious diseases or even species) are overly dependent on hidden assumptions. |
| Type Of Technology | New/Improved Technique/Technology |
| Year Produced | 2021 |
| Impact | Paper pointing out potential problems in popular approaches to estimating effective infected population sizes in Systematic Biology at https://academic.oup.com/sysbio/article/71/1/121/6275766?login=true The product is under a GNU license and open access at https://datadryad.org/stash/dataset/doi:10.5061/dryad.1jwstqjs2 |
| URL | https://academic.oup.com/sysbio/article/71/1/121/6275766?login=true |
| Title | Online mitigation calculator |
| Description | Calculator to estimate the effectiveness of NPIs against COVID-19 |
| Type Of Technology | Webtool/Application |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | Utilised several times by researchers globally to support COVID-19 research and response |
| URL | http://epidemicforecasting.org/calc |
| Title | Orderly - updated 2021 (first created 2017) |
| Description | orderly is a package designed to help make analysis more reproducible. Its principal aim is to automate a series of basic steps in the process of writing analyses, making it easy to: track all inputs into an analysis (packages, code, and data resources) store multiple versions of an analysis where it is repeated track outputs of an analysis create analyses that depend on the outputs of previous analyses With orderly we have two main hopes: analysts can write code that will straightforwardly run on someone else's machine (or a remote machine) when an analysis that is run several times starts behaving differently it will be easy to see when the outputs started changing, and what inputs started changing at the same time orderly requires a few conventions around organisation of a project, and after that tries to keep out of your way. However, these requirements are designed to make collaborative development with git easier by minimising conflicts and making backup easier by using an append-only storage system. |
| Type Of Technology | Software |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | Used to assist with Ebola, COVID-19 outbreak responses within the department. Has been used to support HIV modelling at Imperial Use of Orderly has led to multiple publications and reports and has resulted in multiple influences on policy |
| URL | https://www.vaccineimpact.org/orderly/articles/orderly.html |
| Title | Outbreaks |
| Description | This package compiles a series of publicly available disease outbreak data. Data can be provided as R objects (loaded automatically when loading the package), text files distributed alongside the package, or functions generating a dataset. |
| Type Of Technology | Software |
| Year Produced | 2016 |
| Open Source License? | Yes |
| Impact | Several publications, including: https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006554 |
| URL | https://github.com/reconhub/outbreaks |
| Title | PIRANHA |
| Description | Piranha is a tool developed to help standardise and streamline sequencing of poliovirus. It's been developed by members of the Rambaut group at the University of Edinburgh as part of the Poliovirus Sequencing Consortium. Piranha runs an end-to-end read-to-report analysis that produces distributable, interactive reports alongside analysed consensus data. B |
| Type Of Technology | Software |
| Year Produced | 2022 |
| Open Source License? | Yes |
| Impact | Used to support direct detection nanopore sequencing of poliovirus in National Labs |
| Title | PhyDyn |
| Description | Phylogenetic and Phylodynamic Inference |
| Type Of Technology | Software |
| Year Produced | 2018 |
| Open Source License? | Yes |
| Impact | PhyDyn - First public release |
| URL | https://github.com/mrc-ide/PhyDyn |
| Title | PopPUNK |
| Description | It is a bacterial genomic epidemiology software |
| Type Of Technology | Software |
| Year Produced | 2018 |
| Open Source License? | Yes |
| Impact | Publication and development of a new typing scheme for pneumococcus - https://poppunk.readthedocs.io/en/latest Update 2022 - is now in use by UKHSA and US CDC for local and global comparisons of pneumiciccus |
| URL | https://www.mdpi.com/2073-4425/10/9/687 |
| Title | PopPUNK |
| Description | Modular genomic epidemiology software, consisting of three components: pp-sketchlib (https://github.com/johnlees/pp-sketchlib) High performance genome sketching and comparison methods, scalable to millions of genomes PopPUNK (https://github.com/johnlees/PopPUNK) Machine learning and network analysis methods which link sketches to clustering and evolutionary analysis PopPIPE (https://github.com/johnlees/PopPIPE) Subclustering pipeline for detailed strain analysis |
| Type Of Technology | Software |
| Year Produced | 2018 |
| Open Source License? | Yes |
| Impact | We have in the region of 50-100 users who have used these software packages to analyse their data. They underpin the analysis methods of at least two large global genomics collaborations. |
| URL | https://www.poppunk.net |
| Title | PopPUNK web |
| Description | This browser tool assists with genomic epidemiology using user input genome data. Visualisations and analysis are returned, and results from larger studies and databases are incorporated. Unlike similar tools, all data is kept private to the user by using in-browser computation and genome sketching. |
| Type Of Technology | Webtool/Application |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | Members of the GPS collaboration (which is large and global) will use this to replace some of their bioinformatic requirements |
| URL | https://web.poppunk.net/ |
| Title | Publication relating to the software epiflows which is published in F1000Research |
| Description | Publication relating to the software epiflows which is published in F1000Research https://f1000research.com/articles/7-1374/v1 |
| Type Of Technology | Software |
| Year Produced | 2018 |
| Open Source License? | Yes |
| Impact | Not yet known |
| URL | https://f1000research.com/articles/7-1374/v1 |
| Title | Quantifying the noise in epidemic data |
| Description | Method for computing the information within an epidemic data stream given estimates of delays and under-reporting. |
| Type Of Technology | Software |
| Year Produced | 2022 |
| Open Source License? | Yes |
| Impact | News and views article on this work in Nature Computational Science at https://www.nature.com/articles/s43588-022-00319-9 |
| URL | https://www.nature.com/articles/s43588-022-00313-1#Bib1 |
| Title | R Package - mlesky : Maximum likelihood inference of effective population size through time using GMRF-skygrid approach |
| Description | This package is related to previous Bayesian implementations of the Bayesian skygrid model with the following notable differences: The GMRF process takes place on the 2nd-order difference of log(Ne), which is more similar to the skygrowth model of Volz & Didelot When computing the GMRF likelihood, the smoothing parameter (ie the precision of random walk) is fixed We use a novel cross-validation approach for selecting the smoothing parameter |
| Type Of Technology | Software |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | Has been used to support research - has led to papers under development |
| Title | R package "Markovid" for estimating COVID-19 within-hospital progression parameters |
| Description | As part of our continual analysis of COVID-19 data on patients in hospital we required estimates of progression paramaters such as the probability of requiring ICU treatment. Although the datasets themselves were higly sensitive and could not be publicly released, we opted to make the analysis software itself open source. The Markovid package also includes simulation functions for checking the workings of the algorithms on dummy data. The released software will aid in the transparency of our wor |
| Type Of Technology | Software |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | So far this software has only been used directly by members of our own group, although this may be due in part to the fact that the associated publication is still in review and so it is only advertised via the preprint. Variations of the same estimation methods continue to be developed and applied to other COVID-19 datasets from international collaborators. |
| Title | RDTs-Smartphone camera app |
| Description | Smartphone camera application developed by our collaborators on the study on HIV misclassification errors (Global Solutions for Infectious Diseases) to collect and transmit images of the outputs from HIV rapid tests used in routine health services - thereby enabling evaluation by external experts of the quality of outputs from these tests and the accuracy of interpretation of these outputs by local clinic staff. |
| Type Of Technology | Software |
| Year Produced | 2016 |
| Open Source License? | Yes |
| Impact | The tool has enabled us to establish that approximately 50% of false-negative HIV test results occurring in routine health services in Zimbabwe could be due to errors by local clinic staff in reading or recording the outputs from HIV rapid tests. |
| Title | Risk averse reproduction number |
| Description | Algorithm for computing a global measure of transmissibility from local reproduction numbers. Code in Matlab and R. |
| Type Of Technology | Software |
| Year Produced | 2022 |
| Open Source License? | Yes |
| Impact | Preprint at https://www.medrxiv.org/content/10.1101/2022.08.31.22279450v2 with another in preparation. |
| URL | https://www.medrxiv.org/content/10.1101/2022.08.31.22279450v2 |
| Title | Shiny90 |
| Description | Mathematical model and web-tool for estimating knowledge of HIV status amongst people living with HIV in sub-Sharan Africa |
| Type Of Technology | Software |
| Year Produced | 2018 |
| Open Source License? | Yes |
| Impact | - Tool used for national and global estimates of progress towards the UNAIDS 90-90-90 HIV testing and treatment targets. |
| URL | http://shiny90.unaids.org |
| Title | Skygrowth |
| Description | Phylodynamic Inference |
| Type Of Technology | Software |
| Year Produced | 2018 |
| Open Source License? | Yes |
| Impact | Skygrowth- 1 publication in Systematic Biology New version released |
| URL | https://github.com/mrc-ide/skygrowth |
| Title | SplitStrains |
| Description | SplitStrains, a tool to identify and separate mixed M. tuberculosis infections from WGS data. Microbial Genomics, Volume 7, Issue 6 (2021). PubMed ID 34165419. |
| Type Of Technology | Software |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | External researchers have used software to support data processing and analysis |
| URL | https://github.com/WGS-TB/SplitStrains |
| Title | TB Simulator for public health planners in India |
| Description | Simulator was developed on request of Govt of India, for state-level health planners to examine different possible scenarios for TB interventions in their own state. |
| Type Of Technology | Webtool/Application |
| Year Produced | 2022 |
| Impact | The simulator was officially launched by the Indian Secretary for Health in November 2022. It is now being rolled out to individual States, through training workshops. |
| Title | The epoch sampling skyline plot |
| Description | Released package for phylodynamic estimation in the software BEAST 2: https://github.com/laduplessis/besp This is a new method for estimating population size (e.g. the number of infected in an epidemic) from genetic sequence data and is based on information theory. |
| Type Of Technology | Software |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | This released package should improve inference in a popular software (BEAST 2), and from various presentations on this work it seems that initial reception has been positive. |
| URL | https://academic.oup.com/mbe/advance-article/doi/10.1093/molbev/msaa016/5719057 |
| Title | Treedater |
| Description | Phylogenetics |
| Type Of Technology | Software |
| Year Produced | 2018 |
| Open Source License? | Yes |
| Impact | Treedater- 1 pub in Virus Evolution New version released |
| URL | https://github.com/emvolz/treedater |
| Title | Unitig/graph software |
| Description | This is a suite of packages for analysing bacterial genomic variation in a graph-based manner, suitable for analysis of pangenomes. unitig-caller: https://github.com/johnlees/unitig-caller unitig-counter: https://github.com/johnlees/unitig-counter Determining genomic variation in collections of bacterial genomic data gg-caller: https://github.com/samhorsfield96/ggCaller Calling genes in bacterial pangenome graphs |
| Type Of Technology | Software |
| Year Produced | 2019 |
| Open Source License? | Yes |
| Impact | Used in GWAS analysis, and subsequent research papers |
| Title | VIMC Data Visualisation Tool |
| Description | Visualisation tool to show data associated with Lancet paper |
| Type Of Technology | Webtool/Application |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | Publication of high impact Lancet paper - Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study |
| URL | https://montagu.vaccineimpact.org/2020/visualisation/ |
| Title | drjacoby - Flexible Markov chain monte carlo via reparameterization |
| Description | drjacoby is a package for running flexible Markov chain Monte Carlo (MCMC). The likelihood and the priors that go into the model can be written as either R or C++ functions, with the latter typically being much faster. Outputs are produced in a standardised format, and can be explored using a range of built in diagnostic plots and statistics. |
| Type Of Technology | Software |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | This software was used in a highly-cited paper providing early estimates of COVID-19 severity, published in the Lancet Infectious Diseases. |
| URL | https://mrc-ide.github.io/drjacoby/ |
| Title | eigen1 |
| Description | Fitsjohn R. eigen1. Published online February 12, 2021. https://github.com/mrc-ide/eigen1 |
| Type Of Technology | Webtool/Application |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | Fitsjohn R. eigen1. Published online February 12, 2021. https://github.com/mrc-ide/eigen1 |
| Title | epidemia |
| Description | Software developed by Sam Bhatt and research team for COVID modelling. Scott J, Gandy A, Mishra S, Unwin J, Flaxman S, Bhatt S. epidemia. Published online July 16, 2020. |
| Type Of Technology | Software |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | Software has been used extensively by Scottish government to model COVID-19 transmission as well as, many researchers. Modelling has been used to inform decisions regarding national lockdowns and restrictions |
| URL | https://github.com/ImperialCollegeLondon/epidemia |
| Title | individual |
| Description | An R package for specifying and simulating individual-based models. This package is designed to: encourage clear and testable components for defining your individual-based models, and provide memory efficient, fast code for executing your model |
| Type Of Technology | Software |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | Used by other researchers outside Imperial to develop individual based models |
| Title | malariasimulation |
| Description | Imperial College London's next malaria simulation. The main goals are make an extensible, maintainable and fast simulation to evaluate and report on malaria intervention strategies |
| Type Of Technology | Software |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | Not yet recognised |
| Title | mandrake |
| Description | Visualisation for microbial population structure |
| Type Of Technology | Software |
| Year Produced | 2022 |
| Open Source License? | Yes |
| Impact | Used in other software packages Used to make outreach videos |
| URL | https://mandrake.readthedocs.io/en/latest/ |
| Title | mapping-vgsc-allele-frequencies |
| Description | Contains code for running geo-spatial modelling analyses to predict VGSC allele frequencies in mosquito vectors of malaria |
| Type Of Technology | Software |
| Year Produced | 2022 |
| Open Source License? | Yes |
| Impact | Not yet recognised |
| Title | mlesky |
| Description | This is software for maximum likelihood inference of an epidemic history from pathogen sequence data. |
| Type Of Technology | Software |
| Year Produced | 2022 |
| Open Source License? | Yes |
| Impact | This software has facilitated evaluation of SAR-CoV-2 variants (BA.4/BA.5 and XBB 1.5) in situations where standard surveillance data is sparse or missing. |
| Title | mpoxspam |
| Description | This software implements a stochastic pair approximation simulation for an mpox epidemic through a sexual network. |
| Type Of Technology | Software |
| Year Produced | 2022 |
| Open Source License? | Yes |
| Impact | This software is currently being used to project future outcomes of the mpox epidemic in Euro-region men who have sex with men and to investigate vaccination thresholds and behavioural interventions. This model has been utilised by WHO, ECDC, and UKHSA. |
| Title | nimue |
| Description | Nimue is built on the shoulders of squire and sircovid. The squire website is the best initial reference to refer to for base model structure and parameterisation details. Winskill P, Watson O, Barnsley G, FitzJohn R, Whittaker C. nimue. Published online October 1, 2020. |
| Type Of Technology | Webtool/Application |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | No impacts yet |
| URL | https://github.com/mrc-ide/nimue |
| Title | orderly |
| Description | Lightweight Reproducible Reporting for R Fitzjohn R, Ashton R, Hill A, et al. orderly. Published online December 20, 2020. |
| Type Of Technology | Webtool/Application |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | No Impacts yet |
| URL | https://github.com/vimc/orderly |
| Title | progressionEstimation |
| Description | This package uses Bayesian models implemented in stan to estimate the rates at which microbes progress from carriage to disease using case and carrier data. |
| Type Of Technology | Software |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | Not yet recognised |
| Title | pyseer |
| Description | A suite of statistical genetics methods (primarily genome-wide association studies) for microbes |
| Type Of Technology | Software |
| Year Produced | 2018 |
| Open Source License? | Yes |
| Impact | We have a community of users of this tool, and know of it being used for the analysis in tens of publications. |
| URL | http://pyseer.readthedocs.io/ |
| Title | rdhs: API Client and Dataset Management for the Demographic and Health Survey (DHS) Data |
| Description | Provides a client for (1) querying the DHS API for survey indicators and metadata (), (2) identifying surveys and datasets for analysis, (3) downloading survey datasets from the DHS website, (4) loading datasets and associate metadata into R, and (5) extracting variables and combining datasets for pooled analysis. |
| Type Of Technology | Software |
| Year Produced | 2019 |
| Open Source License? | Yes |
| Impact | - Published and maintained rOpenSci foundation |
| URL | https://ropensci.github.io/rdhs/ |
| Title | reactidd - R Package |
| Description | R Package for REACT study |
| Type Of Technology | Webtool/Application |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | Provides code and data at same time REACT studies are published |
| Title | safir |
| Description | Simulation of COVID-19 vaccine impact |
| Type Of Technology | Software |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | Has been used to generate results presented at WHO-SAGE meetings directly informing a change to guidance on vaccine delivery in 2021 and 2022. |
| Title | sircovid |
| Description | Dynamic transmission model of COVID-19 in the UK FitzJohn R, Jomaba M, Knock E. sircovid2. Published online September 25, 2020. |
| Type Of Technology | Software |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | We have used sircovid every week since April 2020 to provide forecasts of future COVID-19 cases, hospitalisations and deaths in the UK to SPI-M. These have been used to inform SAGE, and in turn presented as evidence to the UK government. |
| URL | https://mrc-ide.github.io/sircovid |
| Title | sircovid, odin, dust, mcstate, |
| Description | Dynamic transmission model of COVID-19 in the UK |
| Type Of Technology | Software |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | We have used sircovid every week since April 2020 to provide forecasts of future COVID-19 cases, hospitalisations and deaths in the UK to SPI-M. These have been used to inform SAGE, and in turn presented as evidence to the UK government. Papers published which describe the software development, and real world applications: Reproducible parallel inference and simulation of stochastic state space models using odin, dust, and mcstate [version 2; peer review: 1 approved, 1 approved with reservations] Wellcome Open Research, 5:288 The 2020 SARS-CoV-2 epidemic in England: key epidemiological drivers and impact of interventions, Science Translational Medicine 13(602) Non-pharmaceutical interventions, vaccination and the Delta variant: epidemiological insights from modelling England's COVID-19 roadmap out of lockdown - a mathematical modelling study The Lancet 398(10313): 1825-35 https://github.com/mrc-ide/odin https://github.com/mrc-ide/dust https://github.com/mrc-ide/mcstate |
| URL | https://mrc-ide.github.io/sircovid |
| Title | skygrowth |
| Description | Phylodynamic inference of effective population size for time-scaled phylogenies. Inference makes use of Bayesian Gibbs-within-Metropolis MCMC and fast maximum a posteriori algorithms. The growth rate of effective population size is modeled as a simple Brownian motion process. This package includes functions for incorporating time-varying covariates into phylodynamic inference. This is appropriate if the covariate is expected to alter the growth rate of effective population size computing the reproduction number (expected number of offspring) through time given prior information about the generation interval |
| Type Of Technology | Software |
| Year Produced | 2018 |
| Open Source License? | Yes |
| Impact | Publication is Systematic Biology |
| URL | https://github.com/mrc-ide/skygrowth |
| Title | squire |
| Description | SEIR transmission model of COVID-19 |
| Type Of Technology | Webtool/Application |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | No impacts yet |
| URL | https://github.com/mrc-ide/squire |
| Title | tfpscanner |
| Description | This is software for the automation of scanning large sequence databases for variants showing unusual growth patterns or unusual evolutionary rates. |
| Type Of Technology | Software |
| Year Produced | 2022 |
| Open Source License? | Yes |
| Impact | This software is currently used by UKHSA and WHO to facilitate variant surveillance of SARS-CoV-2. |
| Title | treedater |
| Description | treedater fits a strict or relaxed molecular clock to a phylogenetic tree and estimates evolutionary rates and times of common ancestry. The calendar time of each sample must be specified (possibly with bounds of uncertainty) and the length of the sequences used to estimate the tree. treedater uses heuristic search to optimise the TMRCAs of a phylogeny and the substitution rate. An uncorrelated relaxed molecular clock accounts for rate variation between lineages of the phylogeny which is parameterised using a Gamma-Poisson mixture model. |
| Type Of Technology | Software |
| Year Produced | 2017 |
| Open Source License? | Yes |
| Impact | Publication in Viral Evolution |
| URL | https://github.com/emvolz/treedater |
| Title | vimes |
| Description | Package for the R statistical software to detect outbreak clusters |
| Type Of Technology | Software |
| Year Produced | 2018 |
| Open Source License? | Yes |
| Impact | One article: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312344/ Starting a collaboration with Public Health England and one with Santé Publique France to implement software on their surveillance data |
| URL | https://github.com/reconhub/vimes |
| Company Name | R Epidemics Consortium |
| Description | The R Epidemics Consortium (RECON) is international not-for-profit, non-governmental organisation gathering experts in data science, modelling methodology, public health, and software development to create the next generation of analytics tools for informing the response to disease outbreaks, health emergencies and humanitarian crises, using the R software and other free, open-source resources. This includes packages specifically designed for handling, visualising, and analysing outbreak data using cutting-edge statistical methods, as well as more general-purpose tools for data cleaning, versioning, and encryption, and system infrastructure. |
| Year Established | 2018 |
| Impact | Training - short courses and hackathons Release of open-source projects and packages |
| Website | https://www.repidemicsconsortium.org/ |
| Description | A glass of wine and some evidence synthesis (Christl Donnelly) |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | Article for Royal Society's policy blog |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://blogs.royalsociety.org/in-verba/2018/06/22/evidencesynthesis/ |
| Description | A open access webinar for the International Decision Support Initiative (iDSI) introducing the types of models used in economic evaluations, iDSI WEBINAR - Dr Hugo Turner |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Participation in webinar to discuss the types of models used in economic evaluations to raise awareness of evidence based decision making |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.youtube.com/watch?v=x1yya-mUrk0&ab_channel=MRCCentreforGlobalInfectiousDiseaseAnalysis |
| Description | ASTMH 2018 |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | Poster presentation on dengue transmission intensity in Colombia, American Society of Tropical Medicine and Hygiene Conference 2018. |
| Year(s) Of Engagement Activity | 2018 |
| Description | An Innovative Research Collaboration: Selected Research Highlights 2019 |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | LCNTDR's new research booklet 'An Innovative Research Collaboration: Selected Research Highlights 2019' (PDF 6MB) contains 16 articles in which the researchers provide a non-technical introduction to their research. Each article outlines the background, need and impact of the research project. |
| Year(s) Of Engagement Activity | 2019 |
| URL | https://www.londonntd.org/news/an-innovative-research-collaboration-selected-research-highlights-201... |
| Description | Andrew Marr Show (Neil Ferguson, 18-Jul-21) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Andrew Marr Show (Neil Ferguson, 18-Jul-21) |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.bbc.co.uk/iplayer/episodes/b0080bbs/the-andrew-marr-show |
| Description | Appearance on BBC 2 documentary on COVID-19 (Thibaut Jombart) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Appearance in BBC 2 documentary - Was the scientific advice for lockdown flawed? |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.bbc.co.uk/news/health-54976192 |
| Description | Article for Biomedical Science Journal for Teens |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Schools |
| Results and Impact | Worked with Science Journal for Kids to produce an accessible article with assessment questions and teachers' key aimed at a teenage audience |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://www.sciencejournalforkids.org/search-articles/category/ebola |
| Description | Article in science journal for teens |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Schools |
| Results and Impact | We published a children-friendly version of a recent paper using mathematical modelling to understand the impact of delaying the second COVID-19 vaccine dose in England |
| Year(s) Of Engagement Activity | 2023 |
| URL | https://www.sciencejournalforkids.org/wp-content/uploads/2023/02/delay_article.pdf |
| Description | BBC Coronavirus Podcast |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Participation in BBC Coronavirus podcast on 4/2/2020 to discuss origin of virus, speed of transmissibility, and death rate. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.bbc.co.uk/programmes/p085nmt6 |
| Description | BBC Horizons COVID-19 special series (Kris Murray) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Interview with Dr Kris Murray for BBC Horizons COVID-19 series to raise awareness of current progress in reducing transmission of COVID-19 and pandemic origins. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.bbc.co.uk/programmes/m000jbhj |
| Description | BBC Horizons programme on COVID-19 - part 3 - vaccinations and post-pandemic future |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Interview given to BBC Horizons programme. Sparked debates and questions on social media |
| Year(s) Of Engagement Activity | 2020,2021 |
| Description | BBC Interview - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | BBC Web Article Interview - Covid-19 (17 Jan 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | BBC Interview COVID-19 - (Katharina Hauck) |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Media interview on hospital capacity by Dr Katharina Hauck - COVID-19 |
| Year(s) Of Engagement Activity | 2021 |
| Description | BBC Interview for News Article - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | BBC Interview for News Article - Covid-19 (8 Feb 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | BBC News Interview with Huw Edwards - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | BBC News Interview with Huw Edwards - Covid-19 (25 Feb 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | BBC News at 5 - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | BBC News at 5 Live in Studio - Covid-19 (26 Feb 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | BBC Newsnight - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | BBC Newsnight Prec-recorded Interview - Covid-19 (10 Feb 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | BBC Podcast: Newscast Baselines & Basslines (Marc Baguelin) (23-Feb-21) |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | BBC Podcast: Newscast Baselines & Basslines (Marc Baguelin) (23-02-2021) |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.bbc.co.uk/sounds/play/p097vglg |
| Description | BBC Radio 2 - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | BBC Radio 2 Interviews - Covid-19 (23 Jan 2020, 11 Feb 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | BBC Radio 2 Jeremy Vine Show - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | BBC Radio 2 Jeremy Vine Show Interview - Covid-19 (26 Feb 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | BBC Radio 4 - The Life Scientific (22-Sep-22) |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | BBC Radio 4 - The Life Scientific Neil Ferguson on modelling Covid-19 22-Sep-20 |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.bbc.co.uk/programmes/m000mt0h |
| Description | BBC Radio 4 - the Today show (Samir Bhatt) |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Interview on BBC Radio 4 Today show regarding results published in Report 13 - Europe in Lockdown |
| Year(s) Of Engagement Activity | 2020 |
| Description | BBC Radio 4 Today Programme - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | BBC Radio 4 Today Programme Interview in Studio - Covid-19 (25 Feb 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | BBC Radio 4 Today Programme Interviews - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | BBC Radio 4 Today Programme Interviews - Covid-19 (Feb & March 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | BBC World News - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | BBC World News Pre-recorded Interview - Covid-19 (24 Feb 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | BBC World Service Radio - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | BBC World Service Radio - pre-recorded on phone, with Pascale Harter - Covid-19 (26 Feb 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | BBC World Service Radio Science in Action - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | BBC World Service Radio Science in Action Online Telephone Interview - Covid-19 |
| Year(s) Of Engagement Activity | 2020 |
| Description | BBC World at One Interview - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | TV Film interview with BBC World at One (23 Jan 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | Best buys in NCDs podcast and article in BMJ |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Podcast to discuss the launch of new book which addressed the issues of prioritising interventions for investment in health |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.bmj.com/content/bmj/368/bmj.m141.full.pdf |
| Description | Big Questions podcast - Covid 19 |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | Guest on Big Questions podcast episode 'What does my family want to know about coronavirus?' |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.oxfordsparks.ox.ac.uk/content/what-does-my-family-want-know-about-coronavirus |
| Description | Big Questions podcast - Covid 19 (Christl Donnelly) |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | Guest on Big Questions podcast episode 'What does my family want to know about coronavirus?' |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.oxfordsparks.ox.ac.uk/content/what-does-my-family-want-know-about-coronavirus |
| Description | Bioinformatics podcast |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | A podcast host/curator on bioinformatics/computational biology research contacted me upon viewing one of the preprints generated as a result of this award. He asked me to do one of his podcast episodes, in which we discussed epidemic modelling from the ground up before touching specifically on my work. The aim was to educate and inform a general audience on how epidemics are mathematically described and on some pitfalls related to these descriptions. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://bioinformatics.chat/epidemics |
| Description | Business Insider - Comment in news article and interview regarding human-animal transmission of COVID-19 (Kris Murray) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Comment in article - Bats are still on the menu and for sale at markets in Indonesia, despite their link to COVID-19. Sparked discussion on human-animal transmission and origins of viruses with pandemic potential https://www.youtube.com/watch?app=desktop&v=IZpiUSU4VOI&t=175s |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.businessinsider.com/bat-meat-food-market-indonesia-2020-12?r=US&IR=T |
| Description | CBS News TV - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | CBS News TV Interview - Covid-19 (10 Feb 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | CNN TV Interview - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | CNN TV Interview, USA - Covid-19 (23 Jan 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | COVID vaccine talk series |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | I gave a series of talks to care home staff and Directors of care homes through the Hampshire Care Home Alliance, on the topic of covid vaccine development and safety. Over 60 people attended the initial talks. Subsequently the talk was put on youtube and additional groups have reached out for me to talk to their organisations. Attendees confirmed that the talk made them feel much more confident about taking the covid vaccine. |
| Year(s) Of Engagement Activity | 2020,2021 |
| URL | https://www.youtube.com/watch?v=T9NlXgNUcWQ |
| Description | COVID19 Updates Episode 10: COVID19 - Health Systems and Economics with Prof Katharina Hauck (26-06-2020).; 2020. |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | COVID19 Updates Episode 10: COVID19 - Health Systems and Economics with Prof Katharina Hauck (26-06-2020).; 2020. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/bm6sxDC7qvo |
| Description | COVID19 Updates Episode 11: COVID-19 - Emergency Preparedness with Ms Janetta Skarp (29-06-2020).; 2020. |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | COVID19 Updates Episode 11: COVID-19 - Emergency Preparedness with Ms Janetta Skarp (29-06-2020).; 2020. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/XfJ8cjC5LFY |
| Description | COVID19 Updates Episode 12: COVID-19 - Financing Epidemic Responses with Adrian Gheorghe (01-07-2020).; 2020. |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | https://youtu.be/GOt30diV9Yw |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/GOt30diV9Yw |
| Description | COVID19 Updates Episode 13: COVID-19 -Governments Response to Pandemics with Prof Tony Travers (06-07-2020).; 2020. |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | https://youtu.be/PhynEUyyVIg |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/PhynEUyyVIg |
| Description | COVID19 Updates Episode 14: COVID-19 - Indirect Impacts with Prof Timothy Hallett (13-07-2020).; 2020. |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | https://youtu.be/xNBEcPdxTJA |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/xNBEcPdxTJA |
| Description | COVID19 Updates Episode 15: INSIGHTS in COVID-19 and Community Engagement with Professor Helen Ward (27-07-2020).; 2020. |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | https://youtu.be/HawQvcBk5nY |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/HawQvcBk5nY |
| Description | COVID19 Updates Episode 16: INSIGHTS in COVID-19 Mis-Information with Professor Helen Ward (27-07-2020).; 2020. |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | https://youtu.be/l8-OCDx0-20 |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/l8-OCDx0-20 |
| Description | COVID19 Updates Episode 17: COVID-19 - Community Transmission with Prof Steven Riley & Prof Graham Cooke (25-08-2020).; 2020. |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | https://youtu.be/lXquvsJ09nY |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/lXquvsJ09nY |
| Description | COVID19 Updates Episode 1: Professor Neil Ferguson on the Current 2019-NCoV Coronavirus Outbreak (05-02-2020).; 2020. |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | COVID19 Updates Episode 1: Professor Neil Ferguson on the Current 2019-NCoV Coronavirus Outbreak (05-02-2020).; 2020. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/ALQTdCYGISw |
| Description | COVID19 Updates Episode 2: INSIGHTS Mathematical Modelling COVID19 Response Prof Nim Pathy & Prof Steven Riley (10-02-2020).; 2020. |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | COVID19 Updates Episode 2: INSIGHTS Mathematical Modelling COVID19 Response Prof Nim Pathy & Prof Steven Riley (10-02-2020).; 2020. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/gYpoyb1W2OQ |
| Description | COVID19 Updates Episode 3: Update COVID-19 Outbreak with Prof Neil Ferguson, Dr Ilaria Dorigatti & Dr Lucy Okell (15-02-2020).; 2020. |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | COVID19 Updates Episode 3: Update COVID-19 Outbreak with Prof Neil Ferguson, Dr Ilaria Dorigatti & Dr Lucy Okell (15-02-2020).; 2020. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/ZKMdX1SPiFk |
| Description | COVID19 Updates Episode 4: Update on COVID-19 Outbreak with Professor Neil Ferguson and Dr Erik Volz (20-02-2020).; 2020. |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | COVID19 Updates Episode 4: Update on COVID-19 Outbreak with Professor Neil Ferguson and Dr Erik Volz (20-02-2020).; 2020. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/UgK3Wz0iVRI |
| Description | COVID19 Updates Episode 5: Update on COVID-19 Outbreak with Professor Neil Ferguson and Professor Christl Donnelly (28-02-2020).; 2020. |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | COVID19 Updates Episode 5: Update on COVID-19 Outbreak with Professor Neil Ferguson and Professor Christl Donnelly (28-02-2020).; 2020. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/4g7Qpvhh5m4 |
| Description | COVID19 Updates Episode 6: Update on COVID-19 Outbreak with Professor Neil Ferguson (11-03-2020).; 2020. |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | COVID19 Updates Episode 6: Update on COVID-19 Outbreak with Professor Neil Ferguson (11-03-2020).; 2020. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/0PbRV2Md8Ew |
| Description | COVID19 Updates Episode 7?: Update on COVID-19 with Professor Steven Riley (24-03-2020).; 2020. |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | COVID19 Updates Episode 7 : Update on COVID-19 with Professor Steven Riley (24-03-2020).; 2020. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/87PaliteOJw |
| Description | COVID19 Updates Episode 8: UPDATE on COVID 19 with Prof Samir Bhatt (06-04-2020).; 2020. |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | COVID19 Updates Episode 8: UPDATE on COVID 19 with Prof Samir Bhatt (06-04-2020).; 2020. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/Xc_udVeLHjQ |
| Description | COVID19 Updates Episode 9: UPDATE on COVID 19 with Professor Steven Riley (08-04-2020). |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | COVID19 Updates Episode 9: UPDATE on COVID 19 with Professor Steven Riley (08-04-2020). |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/GsRTDUxfwqk |
| Description | Capacity building Ethiopia |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Introduction of the new collaborative project with goals for the next 5 years for partners and policy makers. |
| Year(s) Of Engagement Activity | 2018 |
| Description | Channel 4 News - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Channel 4 News Live TV Interview - Covid-19 (22 Jan 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | Channel 4 news interview with John Snow |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Channel 4 news interview with John Snow at 7 pm to discuss the epidemiology of COVID-19 on 11 Feb 2020. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.channel4.com/news/here-we-would-expect-to-see-some-small-clusters-of-cases-prof-steven-r... |
| Description | China Global Television Network (CGTN) - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | China Global Television Network (CGTN) Press Briefing and Interview (22 Jan 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | Cleptocrazia Arts & Science festival - Villa Romana, Florence, Italy |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Public/other audiences |
| Results and Impact | Participation in festival - session on Pandemics and Epidemics. Sparked questions from the public |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://estatefiorentina.it/eventi/cleptocrazia-a-lecture-series-video-projections-a-cura-di-valeria... |
| Description | Co-lead of the Data technologies to combat AMR working group |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | the expected outcome of this activity is a policy paper to describe current and future trends on using Data technologies to Combat AMR. The finalising of the report in progress. |
| Year(s) Of Engagement Activity | 2021,2022 |
| Description | Co-organiser of Department Seminar Series |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Other audiences |
| Results and Impact | I co-organised a weekly seminar series for the Department of Infectious Disease Epidemiology at Imperial College London which was attended by academic staff and students. Seminars sparked questions and networking during post-seminar social events. |
| Year(s) Of Engagement Activity | 2022 |
| Description | Comment for Financial Times - The next pandemic: where is it coming from and how do we stop it? (Kris Murray) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Comment for financial times articles highlighting the impact of zoonotic transmission on human health. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.ft.com/content/2a80e4a2-7fb9-4e2c-9769-bc0d98382a5c |
| Description | Commentary on the state of the mpox epidemic in Science magazine (2022) |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Provided information about likely drivers underlying decline of mpox in the United Kingdom in 2022. |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.science.org/doi/pdf/10.1126/science.adf4961 |
| Description | Conference workshop on mathematical modelling for physicians in India |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Introductory workshop on modelling of infectious diseases for public health professionals held as part of a national medical conference in India (Amritacon) |
| Year(s) Of Engagement Activity | 2021 |
| Description | Contributor to the speakers for schools national programme |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Schools |
| Results and Impact | Giving lectures in schools who teach disadvantaged students about careers in science. Reach is national. Sparked discussion regarding variety of careers in science Encouraged students to pursue careers in scientific sectors |
| Year(s) Of Engagement Activity | 2010,2011,2012,2013,2014,2015,2016,2017,2018,2019,2020 |
| URL | https://www.speakers4schools.org/speakers/sir-roy-anderson/ |
| Description | Coordinator of the Imperial Malaria Network |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Other audiences |
| Results and Impact | I act as the coordinator of the Malaria Network at Imperial, and am organising workshops that reach 100+ academics from several university departments. |
| Year(s) Of Engagement Activity | 2022 |
| Description | Coronavirus explained |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | Public facing website to ensure that science behind COVID-19 was accessible to members of the public |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://coronavirusexplained.ukri.org/en/ |
| Description | Coursera: Science Matters: Let's Talk About COVID-19. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Science Matters: Let's Talk About COVID-19. Welcome to 'Science Matters: Let's Talk about COVID-19', from the Abdul Latif Jameel Institute for Disease and Emergency Analytics (J-IDEA) at Imperial College London. This was the most popular course launched on Coursera in 2020 during Europe's first lockdown. The outbreak of the Novel Coronavirus Disease (COVID-19) is the most significant public health emergency of the 21st century so far. As the epidemic spreads, people around the world want to understand the science behind the most pressing questions: how many people have been infected? |
| Year(s) Of Engagement Activity | 2020,2021 |
| URL | https://www.coursera.org/learn/covid-19 |
| Description | CystiTeam - Formal working group on epidemiology and modelling of Taenia solium taeniasis/cysticercosis |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Formation of a collaboration, CystiTeam, which aims to tackle the population biology, transmission dynamics, epidemiology and control of T. solium through mathematical modelling approaches. Publication in Bulletin of the World Health Organisation and Gates Open Research |
| Year(s) Of Engagement Activity | 2019,2020 |
| Description | Dedicated COVID-19 page hosted on Imperial College Website |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Dedicated webpage to communicate all COVID-19 research. Has been visited extensively by researchers and general public globally. Contents has been used to inform and engage general public and also to rapidly disseminate results. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/ |
| Description | Developed an educational tool 'An infectious way to teach students about outbreaks' |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | The study of infectious disease outbreaks is required to train today's epidemiologists. A typical way to introduce and explain key epidemiological concepts is through the analysis of a historical outbreak. There are, however, few training options that explicitly utilise real-time simulated stochastic outbreaks where the participants themselves comprise the dataset they subsequently analyse. In our activity, we presented a teaching exercise in which an infectious disease outbreak is simulated over a five-day period and subsequently analysed. We iteratively developed the teaching exercise to offer additional insight into analysing an outbreak. An R package for visualisation, analysis and simulation of the outbreak data was developed to accompany the practical to reinforce learning outcomes. Computer simulations of the outbreak revealed deviations from observed dynamics, highlighting how simplifying assumptions conventionally made in mathematical models often differ from reality. Our activity provides a pedagogical tool for others to use and adapt in their own settings. |
| Year(s) Of Engagement Activity | 2016,2017,2018 |
| URL | https://www.sciencedirect.com/science/article/pii/S1755436517300920?via%3Dihub |
| Description | Development of 'Science Journal for Kids [Teens]' article on the impact of COVID-19 on major endemic diseases. |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | A 'Science Journal for Kids [Teens]' article was developed to explain to general (School-aged) audience, our research which looked at the impact of the COVID-19 pandemic on other diseases (specifically, HIV, Tb and malaria). |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.sciencejournalforkids.org/articles/what-is-the-impact-of-covid-19-on-other-diseases/ |
| Description | Discussion group at the Royal Society |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | We presented our paper Semi-Mechanistic Bayesian modeling of COVID-19 with Renewal Processes at the royal society as part of a discussion group for the Journal JRSSA |
| Year(s) Of Engagement Activity | 2022 |
| Description | Dr Leonid Chindelevitch - interview on Radio Liberty on mathematical modelling of infectious diseases (including COVID-19) |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Dr Chindelevitch participated in a radio broadcast on Radio Liberty (Russia) to discuss mathematical modelling of infectious diseases, including COVID-19. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.svoboda.org/a/leonid-chindelevitch-modelirovanie-epidemii/31387899.html |
| Description | E 58 Science in context video - Preventing HIV in the US by Kate Mitchell (team member) |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | To diffuse the results of the study to a wider audience https://twitter.com/MRC_Outbreak/status/1616422992807972864?s=20&t=YyHLA1yFXVDW-JxILsjbrg https://www.youtube.com/watch?v=-nNiB2a_v2U |
| Year(s) Of Engagement Activity | 2023 |
| URL | https://www.imperial.ac.uk/news/242631/long-acting-prep-injections-could-help-reduce/ |
| Description | Economics of pandemic preparedness |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | 10 November 2022 Jameel Institute Annual Symposium - Preparing for the next pandemic: economics, behaviour & equity Session 1 on economics of pandemic preparedness Moderator: Professor Katharina Hauck, Deputy Director of the Jameel Institute |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.youtube.com/watch?v=smfyBC3xBOw&t=2s |
| Description | Edinburgh Science Festival |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Ticketed event at the Edinburgh Science Festival, public presentation + panel discussion. Generated public discussion, debate, education, awareness. |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://www.sciencefestival.co.uk/ |
| Description | Eo 49 - Science in context- HPV& HIV |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Youtube: https://youtu.be/07Dx0ti7SMQ 26K views Twitter: https://twitter.com/MRC_Outbreak/status/1580545247515332609?s=20&t=EhDR9qKqw1va5zNOPAoPYg >= 8,471 impressions, 131 engagements and 756 views |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.youtube.com/watch?v=-nNiB2a_v2U |
| Description | Epirecipes (Thibaut Jombart) |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | This was a three day meeting to bring together researchers to implement as many different epidemiological models as possible. The meeting was held at The Alan Turing Institute on Monday 1st October 2018 |
| Year(s) Of Engagement Activity | 2018 |
| URL | http://epirecip.es/ |
| Description | Evidence Synthesis Policy work - article in Blog (22/06/2018) |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Royal Society and the Academy of Medical Sciences publication Donnelly C and Kreitmair M. A glass of wine and some evidence synthesis - In Verba Royal Society blog. https://blogs.royalsociety.org/in-verba/2018/06/22/evidencesynthesis/ https://royalsociety.org/topics-policy/projects/evidence-synthesis/ |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://blogs.royalsociety.org/in-verba/2018/06/22/evidencesynthesis/ |
| Description | Financial Times - Covid-19 |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Financia Times Web Article Interview - Covid-19 (18 Jan 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | Flu Frenzy |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | We ran a influenza epidemic simulation for school children 15 - 17 years old through a 1/2 day workshop. The aims were to familiarise students with the concept of epidemiology, our research and career, and infectious disease parameters. |
| Year(s) Of Engagement Activity | 2018 |
| Description | Foreign Correspondents Club of China - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Foreign Correspondents Club of China Zoom Meeting - Covid-19 (24 Feb 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | GOARN (Global outbreak alert response network) UK partners day |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | GOARN is a network which coordinates human and technical resources for rapid identification, confirmation and response to outbreaks of international importance. This meeting allowed all UK GOARN members to meet and discuss the new GOARN strategy. |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://goarn.who.int |
| Description | Great Exhibition Road Festival |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Public/other audiences |
| Results and Impact | Participation in Great Exhibition Road Festival. Outreach workshops and activities for general public including families to raise awareness fo basic epidemiological concepts and work of the MRC centre. |
| Year(s) Of Engagement Activity | 2019 |
| Description | Great Exhibition Road Festival |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | The Great Exhibition Road Festival is a yearly science fair held in South Kensington that covers all aspects of science and technology. I was part of the planning and also manned the stalls in the Department of Infectious Disease Epidemiology display on epidemics. This included active engagement with students, parents and some experts on infectious disease. The aim was to inform the general public about zoonoses, vaccination and models in epidemiology. Engagement was through a series of epidemic based games and simulations. |
| Year(s) Of Engagement Activity | 2019 |
| Description | Great exhibition road festival |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Public/other audiences |
| Results and Impact | Stall on infectious diseases with multiple activities for public of all ages to learn about infectious diseases and modelling. Hundreds of visitors. Feedback extremely positive showing that visitors of all ages enjoyed the stall and learnt a lot |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.greatexhibitionroadfestival.co.uk |
| Description | Guest Speaker (co-author) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Lancet Countdown Climate Change and Health annual report launch 2017- Canadian Brief Launch, Ottowa Children's Hospital, Ottowa, Canada 2018 - EU Policy Brief Launch, Health and Environment Alliance (HEAL), Brussels, Belgium. 171 citations so far (since Nov 2018) 2019 - Press conference and Germany Policy Brief Launch, Hertie School, Berlin, Germany engagement with 5,500 health professionals 11 regional policy briefs 35 launch events globally in 2019 2200 media pieces globally 131 media articles related to German press release and policy launch 2.5 million 'impressions' (social media) Shared by public figures and celebrities (including Hilary Clinton, Leonardo di Caprio, Jeremy Corbyn, Director-General WHO Tedros Ghebreyesus, UNDP Administrator Achim Steiner, Green Party MP Caroline Lucas etc.) 21 citations so far (since Nov 2019) extensive reach across multiple sectors/stakeholders (media, policy makers, politicians, general public Copied from Exec Director email Nick Watts (for 2019 report impacts): Media: In 2019 we've tripled our record for total global reach, with over 10,000 outlets covering the launch. There were strong unique pieces in the New York Times, TIME, CBBC, The Economist, New Scientist, The Guardian, Daily Mail, The Telegraph, BBC, CNN, USA Today, Sky News, Daily Mirror (front page), New Scientist, Financial Times, CNBC, El Pais, The Independent, Times of India, Vox, Wired, 7 News, The Globe and Mail, NBC News, AP News, Le Monde, France 24, China Global Television Network, Clarin, Al Jazeera, Reuters, Evening Standard, South China Morning Post, Yahoo, Deutsche Welle, Huffpost, Scientific American, El Espectador Report and Data: The report actually made it online (which is a success in and of itself), and we managed to launch our new Data Platform, which is designed to be flexible and grow over time as strengthen our data, methods, and ability to visualise our indicators. Policy Engagement: All 11 of the policy briefs went out (for the UK, China, US, Canada, Global, India, Brazil, Australia, France, Germany, EU, Chile), partnering with core medical associations around the world. This and the rest of our work has led to requests to brief Ministries of Health in Italy, the UK, China, and Australia; formal partnership requests to set up 'official' monitoring initiatives on behalf of the European Environment Agency and a request for an MoU to do the same with the WHO; declarations of a "climate emergencies" from the RCEM, ACEM, and RACP; and public statements of support from the three main UK political parties and from the heads of the WHO, UNDP, UNEP, and UNFCCC. Events: By the end of 2019, we'll have run 38 events in almost as many countries, coordinated by our own partners and health associations and ministries around the world. Social Media: An enormous spike in social media engagement, and over 25 million impressions around the launch day. |
| Year(s) Of Engagement Activity | 2017,2018,2019 |
| URL | http://www.lancetcountdown.org/ |
| Description | Guest lecturer at University of North Carolina - Epidemiology Masters |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Postgraduate students |
| Results and Impact | Guest lecture to Masters student in their Infectious Disease Modelling Epi course Introducing postgrads to HIV epidemiology ad modelling - sparked discussions from cohort |
| Year(s) Of Engagement Activity | 2021 |
| Description | HPCs-stakeholders meeting |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Presentation and discussion of proposed integrated formulations for HIV prevention cascades for use in evaluating and strengthening implementation of HIV prevention methods. The presentations sparked discussion and ideas for simplification and improvements to the proposed formulations. |
| Year(s) Of Engagement Activity | 2017 |
| Description | HPCs-workshop |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Workshop to produce improved formulations of HIV prevention cascades that meet the needs of policymakers and practitioners engaged in HIV prevention at international, national and local levels. The formulations developed at the workshop were subsequently presented at an international stakeholders meeting organised by UNAIDS in Geneva and were used in the development of international guidelines that have ow been drafted by UNAIDS for use by countries in sub-Saharan Africa. |
| Year(s) Of Engagement Activity | 2017 |
| Description | Hackfest (Thibaut Jomnbart) |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Hackfest 1, London 2017, Making outbreak analysis easier and prettier Hackfest 2, London 2017, Mapping epidemics Hackfest 3, Malta 2018, SitReps and Case Studies; 2 day interactive workshop where participants can bring their data, problems and questions, and go back home with a customised case study or sitrep, using state-of-the art analysis tools. |
| Year(s) Of Engagement Activity | 2017,2018 |
| Description | Harvard Summer School's Pre-College Program, "The Coronavirus Pandemic: The Fight to Save the World" |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | I spoke about how scientists navigated the challenges in modelling in the COVID-19 pandemic |
| Year(s) Of Engagement Activity | 2022 |
| Description | How to eliminate rabies: why vaccinating man's best friend is man's best hope (06/12/2018) |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Article written by C. Donnelly |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://www.londonntd.org/news/how-to-eliminate-rabies-why-vaccinating-man%E2%80%99s-best-friend-is-... |
| Description | How to eliminate rabies: why vaccinating man's best friend is man's best hope (Christl Donnelly) |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | Article on Imperial Medicine Blog as part of World Rabies Day in 2017, new version published on London Centre for Neglected Tropical Diseases Research news website |
| Year(s) Of Engagement Activity | 2017,2018 |
| URL | https://wwwf.imperial.ac.uk/blog/imperial-medicine/2017/09/28/world-rabies-day-why-vaccinating-mans-... |
| Description | Imperial Podcast - World Polio day 2021 |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Professor Nicholas Grassly and Dr Laura Cooper took part in the Imperial College podcast, to mark World Polio day and the progress made on polio eradication, and the challenges the health community faces to declare COVID as eradicated. This was well received on social media channels. |
| Year(s) Of Engagement Activity | 2021 |
| Description | Insights: In Conversation: RT Hon Tony Blair and Professor Neil Ferguson about the Challenges of COVID-19 (04-11-2020).; 2020. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Insights: In Conversation: RT Hon Tony Blair and Professor Neil Ferguson about the Challenges of COVID-19 (04-11-2020).; 2020. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/d4Qsx836Txc |
| Description | Insights: Real Time Modelling of COVID-19 (23-12-2020).; 2020. https://youtu.be/d4Qsx836Txc |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Insights: Real Time Modelling of COVID-19 (23-12-2020).; 2020. https://youtu.be/d4Qsx836Txc |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/d4Qsx836Txc |
| Description | Insights: Symposium Highlights of Shaping the Post-COVID-19 World (24-11-2020).; 2020. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Insights: Symposium Highlights of Shaping the Post-COVID-19 World (24-11-2020).; 2020. https://youtu.be/2dtIohODFNw |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/mA3EBLEnXZk |
| Description | Insights: Symposium Shaping the Post-COVID-19 World (24-11-2020).; 2020. |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Shaping the post-COVID-19 world. This symposium marks the one year anniversary of the Abdul Latif Jameel Institute for Disease and Emergency Analytics launched in October 2019. Join world leading experts in health, science and economics to discuss the post-COVID-19 world. Speakers include bankers, Nobel laureates, epidemiologists, public health policy makers and a former Prime Minister. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/2dtIohODFNw |
| Description | Insights: Tutorial COVID-19 Scenario Analysis Tool | Https://Www.Covidsim.Org (17-02-2021).; 2021. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Insights: Tutorial COVID-19 Scenario Analysis Tool | Https://Www.Covidsim.Org (17-02-2021).; 2021. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://youtu.be/v3-rQU2qf00 |
| Description | Insights: Tutorial J-IDEA Pandemic Hospital Planner (07-05-2020).; 2020. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Insights: Tutorial J-IDEA Pandemic Hospital Planner (07-05-2020).; 2020. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/QLTl4dIL5o4 |
| Description | Insights: Tutorial J-IDEA Pandemic Hospital Planner (07-05-2020).; 2020. |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Insights: Tutorial J-IDEA Pandemic Hospital Planner (07-05-2020).; 2020. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/QLTl4dIL5o4 |
| Description | Insights: Webinar Day 1 Panel Discussion - Insights into COVID-19 Modelling & Evidence-Based Policy Making (07-09-2020).; 2020. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Webinar Series Day 1 - Insights into COVID-19 modelling & evidence based policy making https://youtu.be/zKSgVjb_baw |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.youtube.com/playlist?list=PLNzrUckV9eSJAybOPMPxPulI0bciy8HXf |
| Description | Insights: Webinar Day 1 Professor Azra Ghani - Insights into COVID-19 Modelling & Evidence-Based Policy Making (07-09-2020).; 2020. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Insights: Webinar Day 1 Professor Azra Ghani - Insights into COVID-19 Modelling & Evidence-Based Policy Making (07-09-2020).; 2020. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/wzPGyplCmtE |
| Description | Insights: Webinar Day 1 Professor Gabriel Leung - Insights into COVID-19 Modelling & Evidence-Based Policy Making (07-09-2020).; 2020. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Insights: Webinar Day 1 Professor Gabriel Leung - Insights into COVID-19 Modelling & Evidence-Based Policy Making (07-09-2020).; 2020. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/Q9Im1TU4zsY |
| Description | Insights: Webinar Day 1 Professor Neil Ferguson - Insights into COVID-19 Modelling & Evidence-Based Policy Making (07-09-2020).; 2020. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Insights: Webinar Day 1 Professor Neil Ferguson - Insights into COVID-19 Modelling & Evidence-Based Policy Making (07-09-2020).; 2020. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/r3no1M4Ifnk |
| Description | Insights: Webinar Day 2 Dr Anne Cori - Insights into COVID-19 Modelling & Evidence-Based Policy Making (08-09-2020).; 2020. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Insights: Webinar Day 2 Dr Anne Cori - Insights into COVID-19 Modelling & Evidence-Based Policy Making (08-09-2020).; 2020. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/wv3BecZD5DU |
| Description | Insights: Webinar Day 2 Dr Sheetal Silal - Insights into COVID-19 Modelling & Evidence-Based Policy Making (08-09-2020).; 2020. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Insights: Webinar Day 2 Dr Sheetal Silal - Insights into COVID-19 Modelling & Evidence-Based Policy Making (08-09-2020).; 2020. https://youtu.be/mGdhibi29_Y |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/mGdhibi29_Y |
| Description | Insights: Webinar Day 2 Panel Discussion - Insights into COVID-19 Modelling & Evidence-Based Policy Making (08-09-2020).; 2020. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Insights: Webinar Day 2 Panel Discussion - Insights into COVID-19 Modelling & Evidence-Based Policy Making (08-09-2020).; 2020. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/1jfdklQQFQo |
| Description | Insights: Webinar Day 2 Professor Hsien-Ho Lin - Insights into COVID-19 Modelling & Evidence-Based Policy Making (08-09-2020).; 2020. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Insights: Webinar Day 2 Professor Hsien-Ho Lin - Insights into COVID-19 Modelling & Evidence-Based Policy Making (08-09-2020).; 2020. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/WLX7rZXPils |
| Description | Integrated economic-epidemiological modelling during the COVID-19 response and future applications |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | This joint webinar of the World Health Organization, the Jameel Institute and MRC Centre for Global Infectious Disease Analysis of Imperial College London focused on recent developments in integrated econ-epi modelling. The objectives were to give an overview of the unique features of integrated econ-epi models, reflect how they have been used in the response to the COVID-19 pandemic, discuss existing shortcomings and areas where improvements are needed, and lastly, future applications of econ-epi models to support the pandemic preparedness agenda. |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.who.int/news/item/31-08-2020-health-systems-governance-and-financing-webinar-series |
| Description | Interview for Greenpeace - Breaking down the Amazon: how deforestation could drive the next pandemic (Kris Murray) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Interview with Greenpeace to raise awareness of link between planetary and human health. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://unearthed.greenpeace.org/2020/04/24/deforestation-amazon-next-pandemic-covid-coronavirus/ |
| Description | Interview for International News - Science News |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Response to enquiry for Science - Polio returns in rich countries, but big outbreaks are unlikely This was to in response to the outbreak of Polio in New York, to comment on the possibility of wide-spread outbreaks. |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.science.org/content/article/polio-back-rich-countries-it-poses-far-bigger-threat-develop... |
| Description | Interview for detailed methods article in Wall Street journal "Numbers" Section |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Spent ~ 2 hours on the phone with journalist Jo McGinty from the Wall Street Journal to explain exactly how we estimated R0 for the Wuhan COVID-19 outbreak. This resulted in an article published in Wall Street Journal which provided clarity for the general public as to how mathematical modelling can be used to predict outbreaks and support containment efforts. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.wsj.com/articles/how-many-people-might-one-person-with-coronavirus-infect-11581676200 |
| Description | Interview for national News - El Espectador |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Policymakers/politicians |
| Results and Impact | This was one of the first pieces alerting about preparedness for COVID-19 pandemic in Latin America |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.elespectador.com/noticias/salud/la-pregunta-es-si-estamos-preparados-para-la-llegada-del... |
| Description | Interview on Radio - BBC World Service on the latest World Malaria Report |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Professor Tom Churcher spoke on BBC World Service re the latest World Malaria Report to discuss the latest numbers of malaria cases and future directions for the control of the disease. Contacted by members of the public to clarify points made |
| Year(s) Of Engagement Activity | 2021 |
| Description | Interview on Radio 4, More or Less - COVID-19 (Lucy Okell) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | I was interviewed for the Radio 4 programme More or Less, about our work on the COVID-19 fatality risks. |
| Year(s) Of Engagement Activity | 2020 |
| Description | Interview regarding open letter - Radio 4 Today programme |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Open letter shared in Guardian and Daily Mail - subsequent invitation to speak on BBC Radio 4 today programme Changed the view of the public on the way in which science was used to inform decision making |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.theguardian.com/uk-news/2020/may/09/uk-scientists-letter-scientific-basis-for-lockdown-n... |
| Description | Interview regarding publication about HIV treatment cascade in MSM in Africa |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | Interview in a Reuter newspaper regarding a recent publication. Was picked up by other newspapers and news outlets and was discussed extensively on social media Was picked up by UNAIDs to inform report for World AIDs days. Increased awareness of HIV transmission and prevention gaps in MSM in Africa. |
| Year(s) Of Engagement Activity | 2019 |
| URL | http://news.trust.org/item/20191007220346-g5l6y/ |
| Description | Interview with BBC news - 13th July 2021 about the consequences of fully opening up society on cases and hospitalisations of people with Coronavirus |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Interview about the consequences of fully opening up society on cases and hospitalisations of people with Coronavirus which sparked questions from interviewers on behalf of the general public and questions from other journalists/ colleagues/ members of the public |
| Year(s) Of Engagement Activity | 2021 |
| Description | Interview with Financial Times (Nuno Faria) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Interview in Financial Times with Anna Gross - Brazil virus variant found to evade natural immunity. Dr Nuno Faria contributed to raising awareness of viral mutations and the challenges they pose to COVID-19 response |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.ft.com/content/51cf718d-e701-4292-a9dd-dd36c1b1c5ea?sharetype=blocked |
| Description | Interview with New Scientist |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Interview with New scientist to discuss new threats from infectious diseases Sparked multiple global enquiries from media outlets and policy makers |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.newscientist.com/article/2248423-how-the-covid-19-pandemic-is-making-malaria-and-hiv-mor... |
| Description | Interview with New Scientist - COVID-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | I gave an interview to the New Scientist for a piece they were writing about the COVID fatality risks by age and was quoted in the article. |
| Year(s) Of Engagement Activity | 2020 |
| Description | Interview with Robert Peston (Neil Ferguson) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Interview with Robert Peston (ITV) on the new variants, easing restrictions to raise awareness of ongoing pandemic. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://twitter.com/itvpeston/status/1364717072085889025 |
| Description | Interview with Science News Magazine regarding COVID-19 outbreak |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Interview with Science News magazine re the COVID-19 outbreak |
| Year(s) Of Engagement Activity | 2020 |
| Description | Interview with Tom Clarke (ITV) (Azra Ghani) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Interview with science editor Tom Clarke and Azra Ghani - What the future holds after the UK emerges from coronavirus lockdown |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.youtube.com/watch?v=TlapS08KQvM |
| Description | Interview with the BBC about COVID-19 Modelling Work |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Interview with BBC journalist about our work modelling SARS-CoV-2 transmission and estimates of potential COVID-19 mortality and global burden of disease. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.bbc.co.uk/news/health-52055546 |
| Description | Interviews given following launch of Global funding investment case |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Multiple media interviews given |
| Year(s) Of Engagement Activity | 2022 |
| Description | Interviews in French media on Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Early assessment of the threat posed by Covid-19 and current scientific knowledge on the new pathogen. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://tinyurl.com/rtlkaap |
| Description | Interviews in UK media on COVID-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Multiple outreach events - Radio, Instagram Live, contribution to Imperial News Articles |
| Year(s) Of Engagement Activity | 2010,2020,2021,2022 |
| Description | Interviews in UK media on Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Description of work projecting the potential impact of lockdown lifting strategies on the COVID-19 epidemic in the UK |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://tinyurl.com/y3cbcq5v |
| Description | Introduction to Infectious Disease Modelling, Johannesburg, South Africa (Thibaut Jombart) |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Three-day workshop, 21-23 May 2018 |
| Year(s) Of Engagement Activity | 2018 |
| Description | Introduction to R for surveillance and outbreak analysis, Sofia, Bulgaria (Thibaut Jombart) |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Four-day short course, to provide an introduction to surveillance and outbreak analysis using the R software at SoHo workspace in Sofia Bulgaria, 8-11 October 2018. Participants will get an introduction and overview of conducting epidemiological analyses in R and gain practical experience of new packages for outbreak analysis developed by RECON, including descriptive approaches (epicurves), single- and multi-variable analyses (in the context of outbreak investigations) and depending on participant feedback phylogenetic analyses using R, short-term forecasting or automated sitrep generation. |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://recon-sofia-2018.netlify.com/ |
| Description | Introduction to outbreak analysis using R, Malta (Thibaut Jombart) |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Two-day short course to provide an introduction to outbreak analysis using the R software in the Mater Dei Hospital Malta, 19-20 November 2018, as a satellite event to the ESCAIDE conference. The workshop was aimed at people currently undertaking, or having recently completed, a field-epidemiology training programme (FETP), with some interest in epidemics analysis using R. Participants will get an overview and gain practical experience of new packages for outbreak analysis developed by RECON, including descriptive approaches (epicurves), short-term forecasting, or automated sitrep generation. |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://recon-malta-2018.netlify.com/ |
| Description | Introduction to outbreak response analytics using R with WHO Afro (Thibaut Jombart) |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Third sector organisations |
| Results and Impact | Workshop in Cotonou, Benin |
| Year(s) Of Engagement Activity | 2018 |
| Description | Invited oral presentation at the ASTMH annual meeting |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | Up to 200 online attendees for my invited oral presentation at the annual meeting of the ASTMH, which sparked questions and discussion afterwards. |
| Year(s) Of Engagement Activity | 2021 |
| Description | Invited oral presentation at the PAMCA annual meeting |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | I gave an oral presentation at the annual meeting of the Pan-African Mosquito Control Association, an international group of public health researchers and policy makers interested in mosquito-borne disease control. My talk initiated several questions and requests for contact. |
| Year(s) Of Engagement Activity | 2022 |
| Description | Invited oral presentation at the bieinnal meeting on the Genomic Epidemiology of Malaria |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | I gave an invited oral presentation on new results regarding geospatial modelling of genetic markers of insecticide resistance in African malaria vector species. The meeting was fully online and around 50 people attended. My talk triggered questions and potential for future collaborations. |
| Year(s) Of Engagement Activity | 2021 |
| Description | Invited panelist for the UK Govt Office for Science Women's Network |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | Invited panelist to discuss career highlights, barriers to women progressing in academia, advice for Go Science, and women supporting other women in the workplace |
| Year(s) Of Engagement Activity | 2021 |
| Description | Invited talk at STD Prevention Conference (Erik Volz) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | The purpose of the talk was to describe the molecular epidemiology of HIV |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://www.cdc.gov/stdconference/default.htm |
| Description | It all adds up: Maths conference for girls (Christl Donnelly) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Schools |
| Results and Impact | Three day conference in maths for girls (typically only accommodating state schools) with the aim of inspiring girls to continue maths, and hearing about and engaging in all things maths alongside other girls. |
| Year(s) Of Engagement Activity | 2017,2018,2019 |
| URL | https://www.maths.ox.ac.uk/study-here/undergraduate-study/outreach/it-all-adds |
| Description | LA Times - Covid-19 |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | LA Times Interview - Covid-19 (10 Feb 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | LBC News - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | LBC News Interview - Covid-19 (10 Feb 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | LGBTQ+ STEM day |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | I was part of a panel of LGBTQ+ scientists from Imperial College who each gave a talk on LGBTQ+ STEM day, which was attended by >100 people. There was a discussion afterwards. The aim was to raise visibility of LGBTQ+ scientists, showcase their work, improve working culture and understanding of LGBTQ+ issues. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.imperial.ac.uk/events/126380/lgbtq-stem-day-celebration/ |
| Description | Lancet Countdown - European Launch event |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Hosted presenter + panel discussion for 2018 Lancet Countdown report on Climate Change and Health, held at Health and Environment Alliance in Brussels. Launch event attended by politicians (e.g., DG Sante), media, public, policymakers. |
| Year(s) Of Engagement Activity | 2018 |
| URL | http://www.lancetcountdown.org/media/1420/2018-lancet-countdown-policy-brief-eu.pdf |
| Description | Lockdown lessons: Modelling COVID-19 (Steven Riley) (18-Jun-20) |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Imperial COVID-19 Lockdown Lessons. Lesson 4: Modelling the Spread of the Virus. Prof Steven Riley is an epidemiologist who uses computer modelling to predict the spread of infectious disease. He worked with the group of scientists whose models predicted that 250K people could die of COVID-19 in the UK if the lockdown was delayed, providing the Government with scientific evidence to endorse a lockdown. He will be joined by members of his team, Dr Kylie Ainslie, Dr Lucy Okell and Daniel Lydon to talk about their research on COVID-19. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.youtube.com/watch?v=DFanDIPTt4Q&feature=youtu.be |
| Description | London Centre NTD Research Anniversary Event |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | Annual Anniversary Research Symposium with key note speakers, research presentations and networking opportunities. |
| Year(s) Of Engagement Activity | 2018,2019 |
| URL | https://www.londonntd.org/news/beyond-2020-presentation-highlights |
| Description | Malaria no more campaign |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Public health campaign related to eradication of malaria. Starring David Beckham and other high profile celebrities |
| Year(s) Of Engagement Activity | 2007,2020 |
| URL | https://malarianomore.org.uk/ |
| Description | Mathematical Modelling Workshop to Brazil Public Health Practitioners |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Alongside others from the department, I helped deliver a series of workshops and lectures to Brazilian public health professionals from the Ministry of Health and various regional public health bodies. The course was focussed on building quantitative skills and enabling policymakers to embed mathematical modelling directly into their public health decision making. Discussion following the course has led to the prospect of several collaborations focussed on modelling arboviral disease dynammics. |
| Year(s) Of Engagement Activity | 2022 |
| Description | Mathematical Modelling Workshop to Public Health Practitioners from The Gambia and surrounding countries |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Mathematical modelling workshop delivered to approximately 35 researchers and policymakers from The Gambia and Senegal, including a number of employees of the countries' National Malaria Control Programme. The workshop was focussed on the utilisation of mathematical modelling to support public-health decision making, especially as related to malaria control. |
| Year(s) Of Engagement Activity | 2023 |
| Description | Mathematics and statistics of genomic epidemiology |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Talk given at workshop titled 'Interpretable machine learning methods for predicting drug resistance' Sparked questions from researchers and postgraduate students on the application of methods in current healthcare systems |
| Year(s) Of Engagement Activity | 2020 |
| URL | http://www.birs.ca/events/2020/5-day-workshops/20w5222 |
| Description | Media Interview - WIRED - Climate change is fuelling the spread of deadly tropical diseases |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Media interview on the consequences of climate change of tropical diseases to increase awareness amongst public |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.wired.co.uk/article/climate-change-tropical-disease-spread |
| Description | Media engagement for COVID-19 (not including REACT) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | I gave numerous interviews on the disease dynamics of COVID-19 from January 2020 to October 2021. This entry does not relate to the REACT study. I also gave many interviews essentially about situational awareness. Interviews included Channel 4 News, the Today Program, CNN International (>300 million audience), Bloomberg, plus many print media. During early February 2020, it became apparent that there was an intense need for clear evidence-based situational awareness. I would call out my Bloomberg slots in particular. After the global market turmoil in mid-february 2020 it was apparent that financial markets were reacting to many different extreme opinions. |
| Year(s) Of Engagement Activity | 2020,2021 |
| URL | https://www.bloomberg.com/news/audio/2020-03-26/riley-evidence-of-the-severity-of-pandemic-is-there |
| Description | Media engagement for REACT-1 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | We conducted numerous press and broadcast interviews to disseminate the results from REACT-1, including all major UK TV news, the Today Program, all major newspapers. We gave a Science Media Centre briefing at which often the full top tier UK health press group attended. We were often the top BBC website news story on the morning of the release and we sometimes stayed as the top story through the morning and into the afternoon. Mail online sometimes reproduced all key charts in the newpaper, as presented in the preprint. |
| Year(s) Of Engagement Activity | 2020,2021 |
| URL | https://www.google.com/search?q=react+study+bbc&rlz=1C1GCEU_en-GBGB898GB898&sxsrf=AJOqlzWze9-RJdR55x... |
| Description | Media interview (Katy Gaythorpe VIMC) with VOANews about the impact of vaccination |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Interview given regarding the impact of vaccinations. No impacts recognised |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://twitter.com/MRC_Outbreak/status/1421122393326690308?s=20&t=uIe90MUa2DBQNidMxau1eQ |
| Description | Media interview - Al Jazeera (Thibaut Jombart) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Media interview with Al Jazeera to discuss the COVID-19 pandemic (early stages) Approximately 64,000 views |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.youtube.com/watch?app=desktop&v=jfPKfIADQf8 |
| Description | Media interview in The Daily Telegraph to discuss 'Catalogue of Tuberculosis Mutations' |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Dr Chindelevitch was interviewed by the Daily Telegraph to discuss his work on the development of 'Catalogue of Tuberculosis Mutations'. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.telegraph.co.uk/global-health/science-and-disease/worlds-largest-catalogue-tuberculosis-... |
| Description | Media interview with RAI, Sky News, Manifesto, Espress, Il Sole 24 ore |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Multiple interviews with media outlets (TV, Radio, Newspaper reporting on the results of reports regarding spread of COVID-19 Raised public awareness of epidemiology of virus https://video.sky.it/news/mondo/virus-cinese-a-sky-tg24-parla-ricercatrice-imperial-college/v569418.vid https://www.raiplayradio.it/audio/2020/01/RADIO3-SCIENZA-del-20012020---Un-virus-emergente-del-20012020-b9a91e1e-bda8-4f84-b6ba-8a68efff7717.html |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://video.sky.it/news/mondo/virus-cinese-a-sky-tg24-parla-ricercatrice-imperial-college/v569418.... |
| Description | Media interview with The Lancet regarding HCV |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Media interview and article written about paper published in The Lancet. Article was widely reported in other news sources. |
| Year(s) Of Engagement Activity | 2019 |
| URL | https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(19)30073-8/fulltext |
| Description | Media interviews providing update on COVID-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Interview posted on social media to provide updates on estimated number of undetected cases. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.youtube.com/watch?v=4g7Qpvhh5m4 |
| Description | Modelling Training at Indian Council of Medical Research |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Purpose: To start capacity building in modelling at ICMR. Outcomes and impacts: partneship building, resulting in joint publications and continued support for workshop attendees, resulting in sustained capacity building |
| Year(s) Of Engagement Activity | 2020 |
| Description | Modelling workshop in Blantyre, Malawi |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | We delivered a week-long workshop on malaria modelling to a group of students, policymakers and scientists at the Malawi-Liverpool Wellcome Trust in Blantyre. We also presented to the National Malaria programme about how to use modelling to guide development of a National Strategic Plan for malaria control. As evidenced by the link, feedback was overwhelmingly positive and collaboration between institutions remains ongoing. |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.mlw.mw/news_and_events/the-infectious-disease-epidemiology-group-holds-a-modelling-works... |
| Description | Multiple Youtube videos to prove insight into epidemiological response to COVID-19 |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Creation of multiple Youtube videos to inform general public of the current infection and transmission rate of COVID-19 and how modelling expertise can be used to effectively support government response. Multiple videos have been posted to this channel and have been widely shared on social media. Audiences have reported changes in their views and opinions, multiple organisations have requested further information and support. |
| Year(s) Of Engagement Activity | 2020,2021 |
| URL | https://www.youtube.com/channel/UCkdhXtZA1NV9o_o0hQRtPIA |
| Description | Multiple appearances on BBC Briefing Room (Radio 4) |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Professor Ghani made multiple appearances on Radio 4 to discuss current COVID-19 situation in the UK. This included questions from members of the public and was widely circulated on social media. |
| Year(s) Of Engagement Activity | 2021,2022 |
| Description | Multiple media engagement activities relating to release of report regarding Malaria/COVID |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | NTV Uganda Interview https://www.youtube.com/watch?v=189azUvjrh0 BBC Africa live radio interview https://www.bbc.co.uk/programmes/w172x1gmpck7ppb Summary piece in Science https://www.sciencemag.org/news/2020/08/scientists-worried-pandemic-would-cause-malaria-deaths-soar-so-far-it-hasnt-happened Piece in the Telegraph https://www.telegraph.co.uk/global-health/science-and-disease/prompt-distribution-bed-nets-could-prevent-hundreds-thousands/ |
| Year(s) Of Engagement Activity | 2020 |
| Description | Multiple press releases - Science Media Centre (Anne Cori and Marc Bagelin) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | 3x Press briefings to Science Media Centre on: Roadmap out of modelling - https://www.sciencemediacentre.org/roadmap-modelling-hear-from-the-modellers/ Roadmap out of modelling - https://www.sciencemediacentre.org/roadmap-modelling-hear-from-the-modellers-2/ Modelling vaccination of most vulnerable - https://www.sciencemediacentre.org/roadmap-modelling-hear-from-the-modellers/ This sparked discussions and requests for further information |
| Year(s) Of Engagement Activity | 2021 |
| Description | Nature press briefing: Report 13 - Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe (Samir Bhatt) (Jun-20) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Nature press briefing: Report 13 - Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe (Samir Bhatt) (Jun-20) |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.nature.com/articles/s41586-020-2405-7 |
| Description | New York Times - Covid-19 |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | New York Times Interview - Covid-19 (10 Feb 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | New York Times front page interview |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | 'A Mysterious Infection, Spanning the Globe in a Climate of Secrecy' Widely syndicated 4-page NYT article featuring research by Fisher Lab |
| Year(s) Of Engagement Activity | 2019 |
| URL | https://www.nytimes.com/2019/04/06/health/drug-resistant-candida-auris.html?action=click&module=Rela... |
| Description | News item - Imperial website - Why do children need polio vaccine boosters - Q and A |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Interview for Imperial College news - Q and A with Dr Isobel Blake and Nick Grassly re the need for polio booster campaigns in London |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.imperial.ac.uk/news/240691/why-children-need-polio-vaccine-boosters/ |
| Description | News standard - request for quotes - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | News standard requested quotes, UK - Covid-19 (22 Jan 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | Newspaper article |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | I wrote two articles for The Guardian about SARS-CoV-2 genomic activities https://www.theguardian.com/commentisfree/2021/dec/22/omicron-scientists-variant-virus-lab-public-health https://www.theguardian.com/commentisfree/2021/may/22/how-genetic-sequencing-is-helping-scientists-find-the-next-covid-variant |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.theguardian.com/profile/manon-ragonnet-croni |
| Description | Nigeria HIV/AIDS Indicator and Impact Survey technical review consultation |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Participated in international technical review meeting and briefing to Minister of Health, Nigeria on the methods and findings of new national HIV survey completed in January 2019. |
| Year(s) Of Engagement Activity | 2019 |
| Description | Nuffield student placement |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | Two high school students spent two months working in my lab over the summer |
| Year(s) Of Engagement Activity | 2019 |
| Description | Old wine in new bottle and new wine in old bottles - Changes in antimalarial use - Keynote speech |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Samir Bhatt gave the keynote speech on his Lancet Commission on malaria eradication paper |
| Year(s) Of Engagement Activity | 2019 |
| URL | https://malariaworld.org/blog/event-global-excellence-research-symposium-ii-%E2%80%9Cnew-wine-old-bo... |
| Description | Op-ed for Financial Times Agonising choices in ICUs should be made by society, not individual (Katharina) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Op-ed published in Financial Times - Agonising choices in ICUs should be made by society, not individual Engagement with genral public on FT website - sparked questions and discussions about content |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://on.ft.com/32xBccX |
| Description | Outbreak analytics as a tool to inform the response to Ebola |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Symposium in Goma, DRC to discuss Ebola outbreak response. Helped shape the four strategic response planning (SRP 4) |
| Year(s) Of Engagement Activity | 2019 |
| Description | Outreach lesson on microbes in St Michaels Primary School, London |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | ran a workshop with Year 5 children on infectious diseases and the microbes that cause them. sparked interest in scientific careers. |
| Year(s) Of Engagement Activity | 2019 |
| Description | Oxford - Mathematical Institute (09/01/2019) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Schools |
| Results and Impact | Presentation on the use of statistics in understanding the spread and control of infectious diseases: state funded, girls-only school audience. |
| Year(s) Of Engagement Activity | 2019 |
| Description | Oxford Sparks Animation - Covid 19 (Christl Donnelly) |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Contributed to animated video on YouTube on topic of 'Understanding COVID-19 transmission, informing control' |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.oxfordsparks.ox.ac.uk/content/understanding-covid-19-transmission-informing-control |
| Description | PRESS RELEASE Imperial website COVID-19 local hotspots in England and Wales (03-09-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Imperial website COVID-19 local hotspots in England and Wales (03-09-2020). Published online September 3, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Lancet Publication England Roadmap (27-10-2021). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Lancet Publication England Roadmap (27-10-2021). Published online October 27, 2021. |
| Year(s) Of Engagement Activity | 2021 |
| Description | PRESS RELEASE Lancet Publication Global Vaccine Impact (23-06-2022). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Lancet Publication Global Vaccine Impact (23-06-2022). Published online June 23, 2022. |
| Year(s) Of Engagement Activity | 2022 |
| Description | PRESS RELEASE Lancet Publication Omicron severity compared with Delta (17-03-2022). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S, Quenault A. PRESS RELEASE Lancet Publication Omicron severity compared with Delta (17-03-2022). Published online March 17, 2022. |
| Year(s) Of Engagement Activity | 2022 |
| Description | PRESS RELEASE Lancet Publication Test and trace (18-08-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Lancet Publication Test and trace (18-08-2020). Published online August 18, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Nature Publication Italy (30-06-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Nature Publication Italy (30-06-2020). Published online June 30, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 10 Population survey on COVID19 behaviour (20-03-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 10 Population survey on COVID19 behaviour (20-03-2020). Published online March 20, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 11 China exiting social distancing COVID0-19 (24-03-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 11 China exiting social distancing COVID0-19 (24-03-2020). Published online March 24, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 12 Global burden of COVID-19 (26-03-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 12 Global burden of COVID-19 (26-03-2020). Published online March 26, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 13 European COVID-19 infections & NPI impact (30-03-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 13 European COVID-19 infections & NPI impact (30-03-2020). Published online March 30, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 14 Online Community Involvement in COVID-19 (03-04-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 14 Online Community Involvement in COVID-19 (03-04-2020). Published online April 3, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 15 Strengthening hospital capacity for the COVID-19 pandemic (17-04-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 15 Strengthening hospital capacity for the COVID-19 pandemic (17-04-2020). Published online April 17, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 16 Role of testing in COVID-19 control (23-04-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 16 Role of testing in COVID-19 control (23-04-2020). Published online April 23, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 17 Clinical outcome (30-04-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 17 Clinical outcome (30-04-2020). Published online April 30, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 18 and 19 The impact of COVID19 epidemic on HIV, TB and Malaria (01-05-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 18 and 19 The impact of COVID19 epidemic on HIV, TB and Malaria (01-05-2020). Published online May 1, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 20 COVID19 transmission in Italy (04-05-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 20 COVID19 transmission in Italy (04-05-2020). Published online May 4, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 21 Impact of COVID-19 interventions in Brazil (08-05-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 21 Impact of COVID-19 interventions in Brazil (08-05-2020). Published online May 8, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 22 COVID-19 pandemic will disproportionately impact world's most disadvantaged and vulnerable populations in low- and middle-income countries (11-05-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 22 COVID-19 pandemic will disproportionately impact world's most disadvantaged and vulnerable populations in low- and middle-income countries (11-05-2020). Published online May 11, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 23 Impact of COVID-19 State-level tracking of COVID-19 in the United States (21-05-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 23 Impact of COVID-19 State-level tracking of COVID-19 in the United States (21-05-2020). Published online May 21, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 24 Mobility data in the United Kingdom (29-05-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 24 Mobility data in the United Kingdom (29-05-2020). Published online May 29, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 25 South Korea COVID19 response and lifting interventions (29-05-2020) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 25 South Korea COVID19 response and lifting interventions (29-05-2020). Published online May 29, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 26 Reduction in mobility and COVID-19 transmission (08-06-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 26 Reduction in mobility and COVID-19 transmission (08-06-2020). Published online June 8, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 27 Hospital Capacity (15-06-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 27 Hospital Capacity (15-06-2020). Published online June 15, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 28 Excess non-COVID-19 deaths (18-06-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 28 Excess non-COVID-19 deaths (18-06-2020). Published online June 18, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 29 Impact of COVID-19 on emergency department attendance (01-07-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 29 Impact of COVID-19 on emergency department attendance (01-07-2020). Published online July 1, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 30 COVID-19 trends and control measures in China (03-07-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 30 COVID-19 trends and control measures in China (03-07-2020). Published online July 3, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 31 Majority of COVID-19 deaths in Damascus, Syria are unreported (15-09-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 31 Majority of COVID-19 deaths in Damascus, Syria are unreported (15-09-2020). Published online September 15, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 32 US COVID-19 transmission driven by ages 20-49, extra measures needed to control spread as schools re-open (17-09-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 32 US COVID-19 transmission driven by ages 20-49, extra measures needed to control spread as schools re-open (17-09-2020). Published online September 17, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 33: Allocation and impact of COVID-19 vaccine (25-09-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 33: Allocation and impact of COVID-19 vaccine (25-09-2020). Published online September 25, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 34 Infection fatality ratio - estimates from seroprevalence (29-10-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 34 Infection fatality ratio - estimates from seroprevalence (29-10-2020). Published online October 29, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 35 UK can protect economy, schools and hospitals through more targeted virus restrictions (16-11-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 35 UK can protect economy, schools and hospitals through more targeted virus restrictions (16-11-2020). Published online November 16, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 36 Modelling ICU capacity under different epidemiological scenarios of the COVID-19 pandemic in three western European countries (16-11-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 36 Modelling ICU capacity under different epidemiological scenarios of the COVID-19 pandemic in three western European countries (16-11-2020). Published online November 16, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 37 Children's role in the COVID-19 pandemic: a systematic review of early surveillance data on susceptibility, severity, and transmissibility (25-11-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 37 Children's role in the COVID-19 pandemic: a systematic review of early surveillance data on susceptibility, severity, and transmissibility (25-11-2020). Published online November 25, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 38 SARS-CoV-2 setting-specific transmission rates: a systematic review and meta-analysis (27-11-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 38 SARS-CoV-2 setting-specific transmission rates: a systematic review and meta-analysis (27-11-2020). Published online November 27, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 39 Vast majority of COVID-19 deaths in Sudan capital are undetected (01-12-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 39 Vast majority of COVID-19 deaths in Sudan capital are undetected (01-12-2020). Published online December 1, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 4 Severity 2019-nCoV (10-02-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 4 Severity 2019-nCoV (10-02-2020). Published online February 10, 2020 |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 40 Optimal scheduling rules for elective care to minimize years of life lost during the SARS-CoV-2 pandemic: an application to England (10-12-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 40 Optimal scheduling rules for elective care to minimize years of life lost during the SARS-CoV-2 pandemic: an application to England (10-12-2020). Published online December 10, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 41 The 2020 SARS-CoV-2 epidemic in England: key epidemiological drivers and impact of interventions (22-12-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 41 The 2020 SARS-CoV-2 epidemic in England: key epidemiological drivers and impact of interventions (22-12-2020). Published online December 22, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 42 Transmission of SARS-CoV-2 Lineage B.1.1.7: new variant growing rapidly in England epidemiological and genetic data show (31-12-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 42 Transmission of SARS-CoV-2 Lineage B.1.1.7: new variant growing rapidly in England epidemiological and genetic data show (31-12-2020). Published online December 31, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 43 The impact of vaccine hesitancy (24-03-2021). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 43 The impact of vaccine hesitancy (24-03-2021). Published online March 24, 2021. |
| Year(s) Of Engagement Activity | 2021 |
| Description | PRESS RELEASE Report 48 Booster vaccines and global impact of Omicron (16-12-2021). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 48 Booster vaccines and global impact of Omicron (16-12-2021). Published online December 16, 2021. |
| Year(s) Of Engagement Activity | 2021 |
| Description | PRESS RELEASE Report 49 Growth, population distribution and immune escape of Omicron in England (16-12-2021). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 49 Growth, population distribution and immune escape of Omicron in England (16-12-2021). Published online December 16, 2021. |
| Year(s) Of Engagement Activity | 2021 |
| Description | PRESS RELEASE Report 50 Moderate reduction in hospitalisation risk from Omicron variant in England (22-12-2021). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 50 Moderate reduction in hospitalisation risk from Omicron variant in England (22-12-2021). Published online December 22, 2021. |
| Year(s) Of Engagement Activity | 2021 |
| Description | PRESS RELEASE Report 51 Economic and social benefits of booster vaccinations in Indonesia (14-02-2022). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 51 Economic and social benefits of booster vaccinations in Indonesia (14-02-2022). Published online February 14, 2022. |
| Year(s) Of Engagement Activity | 2021 |
| Description | PRESS RELEASE Report 6 Sensitivity of international surveillance COVID-19 (21-02-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 6 Sensitivity of international surveillance COVID-19 (21-02-2020). Published online February 21, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Report 9 Public health interventions COVID0-19 (16-03-2020). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 9 Public health interventions COVID0-19 (16-03-2020). Published online March 16, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Science publication Brazil (08-12-2020) - Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic. |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Science publication Brazil (08-12-2020) - Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic. Published online December 8, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Science publication Brazil (23-07-2020) - COVID-19 in Brazil: Genomic and epidemiological data shed unique light on the different phases of the SARS-CoV-2 epidemic in Brazil, researchers say. |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Science publication Brazil (23-07-2020) - COVID-19 in Brazil: Genomic and epidemiological data shed unique light on the different phases of the SARS-CoV-2 epidemic in Brazil, researchers say. Published online July 23, 2020. |
| Year(s) Of Engagement Activity | 2020 |
| Description | PRESS RELEASE Science publication US age groups (02-02-2021) - Age groups that sustain resurging COVID-19 epidemics in the United States. |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Science publication US age groups (02-02-2021) - Age groups that sustain resurging COVID-19 epidemics in the United States. Published online February 2, 2021. |
| Year(s) Of Engagement Activity | 2021 |
| Description | Panel discussion, eRotary Club DUE MONDI |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Invited talk given to members of the Rotary club. Talk given was on mathematical modelling and the gender gap Sparked discussions from audience members |
| Year(s) Of Engagement Activity | 2021 |
| Description | Paper of the week : HPV vaccine in PLHIV |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Our paper was selected by the International Papillomavirus Society (IPVS), "Social Media Task Force" : Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis. It was featured on their social media channels with a the link to the article, and accompanied by a short audio description (2 minutes) from us. |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://twitter.com/IPVSociety/status/1583361298540032000?s=20 |
| Description | Participation in Science Media Centre Interview |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | 25/2/2020 Participation in Science Media Centre interview - briefing session to discuss transmission, surveillance, effectiveness, case fatality rate of COVID-19. Reuters, Swiss Radio, BBC News, BBC Radio 4 Today Programme, Bloomber, Channel 4 News, daily mail, Economist, Evening Standard, Financial Times, ITV News, Sky News, The Sun, The Telegraph, The Times, Yahoo News, BBC Radio 4, The Mirror, Press Association |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.sciencemediacentre.org/coronavirus-panel-of-experts-to-answer-your-questions/ |
| Description | Participation and delivery of modelling workshop in Lusaka, Zambia |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Richard Sheppard, a researcher supported by the grant, helped to deliver a workshop to researchers and policymakers on the use of infectious disease modelling and how this influences policy. This workshop has lead to ongoing collaborations with Zambian researchers and policymakers culminating in a current paper under peer view quantifying the impact of COVID-19 in Lusaka and current work with the Zambian National Public Health Insititute (ZNPHI). |
| Year(s) Of Engagement Activity | 2023 |
| Description | Participation in Instagram Live with Epidummology - outreach to general public |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Participation in Instagram Live with Epidummology twitter account - outreach to general public (mostly youth) on Modelling the UK roadmap out of lockdown. This sparked many questions from audience members from multiple countries |
| Year(s) Of Engagement Activity | 2021 |
| Description | Participation in formal working group to assess the impact of releasing genetically modified mosquitoes on malaria burden across different regions of Africa (Penny Hancock) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Participation in working group to assess the impact of releasing genetically modified mosquitoes on malaria burden across different regions of Africa. Working group established in response to malaria burden, to explore the potential of novel technologies involving genetically modified mosquitoes. |
| Year(s) Of Engagement Activity | 2021 |
| Description | Participation in open day at ICL - Imperial Malaria network (Penny Hancock) |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | Participation in Imperial College open day - networking opportunity with wider college structures and research teams for collaborative working. |
| Year(s) Of Engagement Activity | 2021 |
| Description | Participation in series 'I'm a Scientist get me out of here' - Pandemic Zone and MRC Medical Research Zone |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Schools |
| Results and Impact | Live chat forum for students to to ask questions regarding COVId-19 pandemic, scientific careers, general advice. This provided an avenue for students to interact with scientific researchers who they would otherwise not encounter in their daily lives. Pandemic Prevention Zone reached 1112 students Medical Research Zone reached ~1000 students Dr Imai was voted as the 'Scientist of the Week' by the students who participated |
| Year(s) Of Engagement Activity | 2021 |
| Description | Participation in videos posted on social media to raise provide update on the status of COVID-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Interview posted on social media to provide update on spread of COVID-19 and how data is used to assess transmissibility. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.youtube.com/watch?v=ZKMdX1SPiFk&t=17s |
| Description | Participation in webinar use of mathematical modelling to support COVID response at University of Montreal (Marie-Claude Boily) |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Postgraduate students |
| Results and Impact | Webinar at University of Montreal to outline how mathematical modelling is used to support the COVID-19 response. Questions sparked from the audience and requests for further information |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.youtube.com/watch?v=ZI6VbLHr05c |
| Description | Participation on channel 4 Big Lockdown Debate with Krishnan Guru Murphy (Steven Riley) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Participation from Prof Steven Riley in Channel 4 Lockdown Debate. Intended purpose was to communicate the underlying science of the epidemic in England and the scientific rationale for non pharmaceutical interventions. Sparked questions and debates and further requests for information |
| Year(s) Of Engagement Activity | 2020 |
| Description | Pneumococcal genomic surveillance workshop |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Describe the development of a new genomic epidemiology tool, demonstrate its intended capabilities, and ask for feedback for future development. |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://isppd.kenes.com/workshops-2022/ |
| Description | Podcast Interview for Center for Compassion and Global Health |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Interview given to highlight the role of epidemiological modelling in compassion for global health No tracked outcomes or impacts |
| Year(s) Of Engagement Activity | 2019 |
| URL | http://ccagh.org/maria-gloria-basanez-on-compassion-and-epidemiological-modelling/ |
| Description | Podcast in The Guardian |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | Podcast with Ian Sample from The Guardian to find out how worried we should be about poliovirus detection in London sewage and what it means for the global effort to eradicate polio. |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.theguardian.com/science/audio/2022/jun/30/is-polio-in-our-sewage-as-worrying-as-it-sound... |
| Description | Podcast on COVID-19 models |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Participated in a live podcast to inform COVID-19 awareness at the community level in Trinidad and Tobago. Led to many interesting questions. |
| Year(s) Of Engagement Activity | 2020 |
| Description | Podcast on monkeypox |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Following the global raise in monkeypox cases, we recorded a podcast to give information on monkeypox and the ongoing epidemic |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.youtube.com/watch?v=J9iSle32TrM |
| Description | Podcast with Jack Blanchard (Politico) - Life after the coronavirus pandemic (Neil Ferguson) (12-Feb-21) |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Podcast interview with Jack Blanchard (Politico) to discuss the future months of pandemic response (12-Feb-21) |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.politico.eu/podcast/meet-prof-neil-ferguson-life-after-the-coronavirus-pandemic/ |
| Description | Podcast with The Economist |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Coronavirus surveillance and effectiveness. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://podcasts.apple.com/us/podcast/babbage-going-viral-going-global/id151230264?i=1000466772268 |
| Description | Podcast: BBC HARDtalk (Neil Ferguson) (6-Jan-21) |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Neil Ferguson: Did the UK get its Covid strategy wrong? Stephen Sackur speaks to British epidemiologist Professor Neil Ferguson, whose early modelling of Covid-19 made him an influential advocate of the lockdown strategy. The UK is back in lockdown and infections are surging. What has gone wrong, and why have other countries done better? |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.bbc.co.uk/programmes/w3cszc7j |
| Description | Podcast: BBC Inside Health (Neil Ferguson) (6-Jan-21) |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Covid in 2021: James Gallagher talks to Neil Ferguson |
| Year(s) Of Engagement Activity | 2021 |
| URL | http://www.bbc.co.uk/programmes/m000qx10 |
| Description | Podcast: BBC Inside Science (Christl Donnelly) (2-Apr-20) |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Coronavirus: Models & being 'led by the science'; Unpicking the models and graphs informing government strategy. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.bbc.co.uk/programmes/m000gvcp |
| Description | Podcast: BBC political thinking (Neil Ferguson) (26-Jun-20) |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Political Thinking with Nick Robinson. The Neil Ferguson One |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.bbc.co.uk/programmes/p08j3kcg |
| Description | Podcast: Bloomberg Surveillance (Steven Riley) (13-Oct-20) |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | High Covid Levels Lessen Contact Tracing Impact: ICL's Riley. Imperial College London Professor of Infectious Disease Dynamics Steven Riley discusses the effectiveness of virus tracing and lockdowns amid a resurgence of Covid-19 cases across Europe and looks at what Asia did different from the rest of the world in handling the virus. He speaks on "Bloomberg Surveillance." |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.youtube.com/watch?v=zzzWqwNs5Kg |
| Description | Podcast: Bloomberg Surveillance (Steven Riley) (28-Feb-20) |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Coronavirus vs. Seasonal Flu: Impact on Patients, Health Services. Steven Riley, professor of infectious disease dynamics at Imperial College London, discusses the severity of the coronavirus, the impact on local health services, and how a virus migrates from urban to rural areas. He speaks on "Bloomberg Surveillance." |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.youtube.com/watch?v=0VAPilSBU78 |
| Description | Podcast: Crunching the numbers (Azra Ghani) (13-Mar-20) |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Crunching the numbers for coronavirus |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.imperial.ac.uk/news/196137/crunching-numbers-coronavirus/ |
| Description | Podcast: Get the bugs (Richard Fitzjohn) (11-Jun-20) |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Get the bugs! How research software engineers help fighting infectious diseases like the coronavirus. What challenges do they face? |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://us-rse.org/rse-stories/2020/richard-fitzjohn/ |
| Description | Podcast: IMF (Azra Ghani, Neil Ferguson) (15-Apr-20) |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Epidemiologists Help Steer Economy Through COVID-19. For the first time, the IMF is seeking guidance from epidemiologists for its macroeconomic projections. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.imf.org/en/News/Podcasts/All-Podcasts/2020/04/23/MD-Epidemiologists |
| Description | Presentation from VIMC team members (Gaythorpe, Katy Xiang Li, Keith Fraser, Anna-Maria Hartner, Jaspreet Toor) at EPIDEMICS |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Talks given at EPIDEMICS by VIMC members on published papers (https://elifesciences.org/articles/67635), coverage clusterinsubnational heterogeneity in in vaccine coverage (work with Susuy Echeverria-Londono), impact of COVID disruption on routine immunisation Sparked questions and discussions from audience members, including discussions on recent publication and requests for further collaborations |
| Year(s) Of Engagement Activity | 2014,2021 |
| URL | https://www.imperial.ac.uk/news/225353/vaccines-given-last-20-years-could/ |
| Description | Presentation to the United Nations Development Programme About COVID-19 Modelling Work |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | COVID-19 modelling work presented to practitioners from the United Nations Development Programme. |
| Year(s) Of Engagement Activity | 2020 |
| Description | Presentations and guidance to the ACTA Cryptococcal meningitis trial group |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Study participants or study members |
| Results and Impact | Updating the ACTA African clinical trials group on data produced by our MRC research |
| Year(s) Of Engagement Activity | 2017 |
| Description | Press Release relating to pre-print: Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil (Nuno Faria) (2-Mar-21) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Well attended press release at Science Media Centre relating to preprint which showed Cases of SARS-CoV-2 infection in Manaus, Brazil, resurged in late 2020, despite high levels of previous infection there. Sparked extensive discussion and questions and was widely cited on all media channels (BBC, Guardian, Telegraph, Twitter) - 495k impressions on Twitter |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.sciencemediacentre.org/the-brazil-sars-cov-2-variant-lineage-p-1-what-we-know-so-far/ |
| Description | Press release and interview(s) regarding publication of report on Vaccines prevented 37 million deaths in LMICs in the last 20 years |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Media interviews regarding release of Lancet paper 'Vaccines prevented 37 million deaths in LMICs in the last 20 years' Widely discussed on social media channels and in press - many articles in media (Independent, Times of India, Telegraph, Forbes) [14:35] Gaythorpe, Katy News mentions: Imperial College Vaccines prevented 37 million deaths in LMICs in the last 20 years Globo Estudo internacional evidencia a importância da vacinação para salvar milhões de vidas LSHTM Vaccines against 10 diseases prevented 37 million deaths in low- and middle-income countries in last Yahoo Deaths among under-fives would be 45% higher in less developed countries without just 10 vaccines, study suggests Medical Express Without vaccination against 10 diseases, mortality in children would be 45% higher: study The Irish News Millions of children's lives saved by vaccinations against 10 diseases - study Salute Vaccini: efficacia vaccinazione The Print Vaccination averted 45% deaths due to 10 pathogens between 2000 & 2019 - Lancet study EurekAlert The Lancet: Study estimates that, without vaccination against 10 diseases, mortality in children under five would be 45% higher in low-income and middle-income countries Vaccines prevented 37 million deaths in LMICs in the last 20 years | Imperial News | Imperial College LondonVACCINE SUCCESS - Vaccine programmes in low- and middle-income countries have prevented 37 million deaths in the last 20 years alone - 36 million in children under 5.www.imperial.ac.uk https://www.forbes.com/sites/anuradhavaranasi/2021/01/30/from-2000-to-2019-vaccinations-against-10-pathogens-have-prevented-37-million-deaths-in-98-developing-countries-lancet-study/ https://timesofindia.indiatimes.com/city/mumbai/vaccines-could-prevent-69mn-deaths-before-2030/articleshow/80593112.cms |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.imperial.ac.uk/news/213373/vaccines-prevented-37-million-deaths-lmics/ |
| Description | Press release regarding How COVID disruptions can affect global TB burden |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Press Release with Stop TB Partnership - widely cited in media including Forbes magazine and Telegraph https://www.telegraph.co.uk/global-health/science-and-disease/coronavirus-lockdown-could-lead-nearly-15-million-extra-tb-deaths/ https://www.forbes.com/sites/madhukarpai/2020/05/11/aids-tb-and-malaria-set-to-get-deadlier-due-to-coronavirus/?sh=53fb5a02d2fc |
| Year(s) Of Engagement Activity | 2020 |
| Description | Press release relating to publication 'Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world' |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Press release relating to publication was mentioned in The Telegraph. No impacts recognised |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.telegraph.co.uk/global-health/science-and-disease/pandemic-triggers-worst-disruption-chi... |
| Description | Profile of work on COVID-19 in Brazil in New York Times - Carl Zimmer (Nuno Faria) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Article written by Carl Zimmer featuring the work of Dr Nuno Faria (Reader, Imperial College London, MRC Centre for Global Infectious Disease Analysis). Highly cited on social media, with requests for further information |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.nytimes.com/2021/03/01/health/covid-19-coronavirus-brazil-variant.html?smid=fb-nytimes&s... |
| Description | Public Lecture for World AIDS Day at SACEMA, University of Stellenbosch |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | Public lecture for World AIDS Day (1 December) hosted by the South African Centre for Epidemiologic Modelling and Analysis at University of Stellenbosch, South Africa |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.youtube.com/watch?v=0wZ05Fuow_o |
| Description | Public Lecture, Emerging Fungal Infections, Sydney |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Public/other audiences |
| Results and Impact | Public lecture, Fungal emerging disease, Sydney |
| Year(s) Of Engagement Activity | 2018 |
| Description | Public online talk: Imperial COVID-19 Lockdown Lessons |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Schools |
| Results and Impact | I talked as part of a panel for the COVID-19 Lockdown Lessons run by Imperial. These are primarily for schools and students but also open to the general public. We answered questions from the audience. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.imperial.ac.uk/be-inspired/student-recruitment-and-outreach/schools-and-colleges/student... |
| Description | Public paper and code review |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | I maintain a blog detailing my own research, summarising other people's research, and also more general issues such as programming and computer maintenance informed by my research. I post around 4-5 times a year, and each post typically receives around 100-300 unique views (helped by cross-posting on social media). I usually receive a few direct comments or discussions due to these posts, some from other scientists, some from members of more general interest groups. |
| Year(s) Of Engagement Activity | 2015,2016,2017,2018,2019,2020,2021 |
| URL | http://www.johnlees.me/blog-posts/ |
| Description | Public webinar - HIV ESTIMATES AT DISTRICT LEVEL for South Africa |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Webinar to provide update on ESTIMATES AT DISTRICT LEVEL of HIV in South Africa. Data has been extensively to support HIV policy and planning by additional organisations in South Africa |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.facebook.com/SANationalAIDSCouncil/videos/hiv-estimates-in-south-africa-thembisa-naomi-m... |
| Description | Publication of articles in newspapers |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Publication in Provincial newspaper regarding the use of mathematical modelling predictions to support the government COVID response and the need for social distancing measures to combat transmission of COVID-19 and defence of use of mathematical modelling to support COVID response https://www.lesoleil.com/opinions/covid-19-pourquoi-les-mesures-deloignement-social-sont-presentement-necessaires-5ad0a3d2c381ba8d517834c93322b3c2 https://plus.lapresse.ca/screens/1c7478c0-ddee-4328-8a71-fbaa688a31eb__7C___0.html https://www.ledevoir.com/opinion/libre-opinion/580446/le-coupable-est-il-le-modele-ou-un-nouveau-virus https://theconversation.com/covid-19-voici-pourquoi-les-mesures-deloignement-social-sont-necessaires-133748 |
| Year(s) Of Engagement Activity | 2020 |
| Description | Publication of research paper adapted for children in Science Journal for Kids |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Schools |
| Results and Impact | Adapted version of research paper published in Journals for Kids. JfK is an American company that re-writes scientific papers into accessible reading for children and young adults. The purpose is to make scientific literature accessible to children and young adults. |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://www.sciencejournalforkids.org/search-articles/how-deadly-is-ebola |
| Description | Q and A - Expert Insight: Nick Grassly's comments on poliovirus detection in the UK |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Interview for Imperial College website - Q and A to inform the public about different types of poliovirus and the impacts of detection within London on healthcare workers and vaccination campaigns |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.imperial.ac.uk/news/238351/expert-insight-nick-grasslys-comments-poliovirus/ |
| Description | Q&A Imperial experts in conversation with Alice Gast (Steven Riley) (28-Jan-21) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | Global Imperial: Expert Insights on COVID-19, After an unpredictable and extraordinary 2020, COVID-19 continues to affect our daily lives as we begin a new year. We are at a pivotal moment worldwide with news of the approval of various vaccines and our understanding of the infectious disease substantially improved. In conversation with Professors Wendy Barclay, Peter Openshaw, and Steven Riley, President Alice Gast explores the big questions the world is now asking about COVID-19 in this Global Imperial event on 28 January 2021. |
| Year(s) Of Engagement Activity | 2021 |
| URL | http://www.youtube.com/watch?v=pEPAz5mMXXk |
| Description | Quarterly newsletter for VIMC members |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | Newsletter to VIMC members to provide updates on progress and future plans for work |
| Year(s) Of Engagement Activity | 2017,2018,2019,2020,2021 |
| URL | https://www.vaccineimpact.org/newsletters/ |
| Description | Quote in 'The Guardian' - Does warm weather mean you are less likely to catch Covid? |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Quoted in The Guardian - Does warm weather mean you are less likely to catch Covid? No impact knows |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.theguardian.com/world/2021/jul/20/does-warm-weather-mean-you-are-less-likely-to-catch-co... |
| Description | RDTs-ZMOHCC |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | Presentation of interim results showing levels and possible causes of errors in HIV test results obtained in national programmes in Zimbabwe to senior staff in the Zimbabwe Ministry of Health and Child Care. The results also showed high levels of HIV-negative laboratory tests for people living with HIV infection who were already stable on antiretroviral treatment. Requested to conduct further laboratory tests to establish the true HIV infection status of the study subjects. |
| Year(s) Of Engagement Activity | 2018 |
| Description | RECON Gathering (Thibaut Jombart) |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Challenges and Opportunities in Outbreak Response Analytics; this event held in London includes a one-day symposium followed by a day of workshops with 2 parallel sessions: i) a discussion of analytic resources for field epidemiology training, and ii) a community-driven hackathon. |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://recon-gathering-march2018.netlify.com/ |
| Description | Radio 4 - More or Less - Professor Christl Donnelly |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Professor Christl Donnelly spoke on Radio 4 to discuss the survey - Statistical numeracy in MPs following a press release from the Royal Statistical Society |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.nationalworld.com/news/politics/mps-statistics-maths-problem-3564209 |
| Description | Radio 4 podcast - Covid 19 |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | Guest on Radio 4 podcast More or Less: Behind the Stats - episode 'Mitigation or Suppression: what's best to tackle Coronavirus?' |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.bbc.co.uk/programmes/p08766m3 |
| Description | Radio 4 podcast - Covid 19 (Christl Donnelly) |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | Guest on Radio 4 podcast More or Less: Behind the Stats - episode 'Mitigation or Suppression: what's best to tackle Coronavirus?' |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.bbc.co.uk/programmes/p08766m3 |
| Description | Radio 4 today programme to discuss COVID-19 testing (Nick Grassly) |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Interview given on Radio 4 Today Programme (August 2020) to discuss COVID-19 testing (in response to paper published). |
| Year(s) Of Engagement Activity | 2020 |
| Description | Results dissemination workshop |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Dissemination of results from research on HIV prevention cascades and progress with implementing 'treat-all' ART programme in Zimbabwe to national policy makers. |
| Year(s) Of Engagement Activity | 2019 |
| Description | Results dissemination workshop |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Other audiences |
| Results and Impact | Dissemination of results on HIV prevention cascade and local implementation of the national 'treat-all' ART programme. |
| Year(s) Of Engagement Activity | 2019 |
| Description | Reuters Next (Neil Ferguson) (13-Jan-21) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Rethink, rebuild, recover. The discussion we must have today to shape a better tomorrow. Led by Reuters editors, this four-day event has been carefully curated to address the most critical global issues of the day. Live sessions and panel discussions will be broadcast into 3 different time zones: SGT, GMT and EST. Radical RedesignManaging the Masses and Politicians Through the Fog of Covid. COVID-19 has laid bare many failings in the public health system. What lessons are there to learn around the world and what are the biggest challenges beyond COVID? |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://reutersevents.com/events/next/conference-agenda.php |
| Description | Reuters Quoted - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Quoted by Reuters re Covid-19 |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.reuters.com/article/us-china-health-transmission/coronavirus-contagion-rate-makes-it-har... |
| Description | Round Table on Infectious Diseases for the Imperial College Society of Infectious Diseases in 2022 |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Undergraduate students |
| Results and Impact | Round Table (online) with Imperial College Infectious Disease Society to discuss Neglected Tropical Diseases, March 202, that was followed by a panel discussion. Other panelists included Doctors Without Borders and Clinical Infectious Disease Research at Imperial. |
| Year(s) Of Engagement Activity | 2022 |
| Description | Round Table on Neglected Tropical Diseases and Global Health for NTD World Day with Royal Academy of Medicine of Spain |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Fourth Dialogue on Social Medicine, Global Health and Neglected Tropical Diseases on NTD World Day for the Royal Academy of Medicine of Spain. The intended purpose was to have a debate as to how best tackle NTDs globally, from scientific, political, R&D, NGOs and financial perspectives. |
| Year(s) Of Engagement Activity | 2023 |
| URL | https://www.ranm.tv/index.php/channel/44/sesiones-y-actos-2023/ |
| Description | Royal Society Diversity Conference (Christl Donnelly) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Other audiences |
| Results and Impact | Chaired Round Table discussion on achieving diverse leadership in a research environment |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://royalsociety.org/science-events-and-lectures/2018/11/annual-diversity-conference-2018/ |
| Description | Royal Society Diversity Conference: Achieving diverse leadership in a research environment (01/11/2018) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Public/other audiences |
| Results and Impact | The panel brought high-profile speakers from STEM academia and industry to share their expertise in creating inclusive leadership teams and overcoming barriers to success. The conference was of particular interest to the research community, scientists, diversity practitioners, learned academies and societies, professional bodies and policy-makers. |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://royalsociety.org/science-events-and-lectures/2018/11/annual-diversity-conference-2018/ |
| Description | Royal Statistical Society Special topic meeting on R/local R/transmission of Covid-19 |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Contributed to series of position papers, talks and critical discussions on the strengths and weaknesses of popular metrics used to characterise COVID-19 spread. Resulting paper (with entire series including rebuttals to discussions to appear in the Journal of the Royal Statistical Society A): https://rss.org.uk/RSS/media/File-library/News/2021/ParagThompsonDonnelly.pdf |
| Year(s) Of Engagement Activity | 2021,2022 |
| URL | https://rss.org.uk/news-publication/news-publications/2021/member-callouts/special-topic-meeting-on-... |
| Description | S. PRESS RELEASE Report 46 Pandemic healthcare pressure linked to large number of COVID-19 deaths in Brazil (06-10-2021). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | MRC Centre for Global Infectious Disease Analsysis, van Elsland S. PRESS RELEASE Report 46 Pandemic healthcare pressure linked to large number of COVID-19 deaths in Brazil (06-10-2021). Published online October 6, 2021. |
| Year(s) Of Engagement Activity | 2021 |
| Description | SMC D Press Briefing: Eigenschaften und Verbreitung der SARS-CoV-2-Variante B.1.617.2 (26-02-2021). Press briefing presented at: Science Media Centre |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Ferguson N, Gupta R. SMC D Press Briefing: Eigenschaften und Verbreitung der SARS-CoV-2-Variante B.1.617.2 (26-02-2021). Press briefing presented at: Science Media Centre; February 26, 2021. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.sciencemediacenter.de/alle-angebote/press-briefing/details/news/eigenschaften-und-verbre... |
| Description | SMC Press Briefing - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | SMC Press Briefing (Global) - Covid-19 |
| Year(s) Of Engagement Activity | 2020 |
| Description | SMC Press Briefing: Imperial modelling on omicron, immune escape and boosters - Report 49 (17-12-2021). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Ghani A, Ferguson N. SMC Press Briefing: Imperial modelling on omicron, immune escape and boosters - Report 49 (17-12-2021). Press briefing presented at: Science Media Centre; December 17, 2021. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.sciencemediacentre.org/imperial-modelling-on-omicron-immune-escape-and-boosters/ |
| Description | SMC Press Briefing: Latest interim results from the REACT-1 study on COVID-19 prevalence across England (08-07-2021). Press briefing presented at: Science Media Centre; July 8, 2021. |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Riley S, Elliot P. SMC Press Briefing: Latest interim results from the REACT-1 study on COVID-19 prevalence across England (08-07-2021). Press briefing presented at: Science Media Centre; July 8, 2021. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.sciencemediacentre.org/latest-interim-results-from-the-react-1-study-on-covid-19-prevale... |
| Description | SMC Press Briefing: Latest results from the REACT-1 study on COVID-19 prevalence across England (04-08-2021). Press briefing presented at: Science Media Centre; August 4, 2021. |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Riley S, Elliot P. SMC Press Briefing: Latest results from the REACT-1 study on COVID-19 prevalence across England (04-08-2021). Press briefing presented at: Science Media Centre; August 4, 2021. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.sciencemediacentre.org/latest-results-from-the-react-1-study-on-covid-19-prevalence-acro... |
| Description | SMC Press Briefing: Latest results from the REACT-1 study on COVID-19 prevalence across England (08-04-2021). Press briefing presented at: Science Media Centre; April 8, 2021. |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Riley S, Elliot P. SMC Press Briefing: Latest results from the REACT-1 study on COVID-19 prevalence across England (08-04-2021). Press briefing presented at: Science Media Centre; April 8, 2021. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.sciencemediacentre.org/latest-results-from-the-react-1-study-on-covid-19-prevalence-acro... |
| Description | SMC Press Briefing: Latest results from the REACT-1 study on COVID-19 prevalence across England (13-05-2021). Press briefing presented at: Science Media Centre; May 13, 2021. |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Riley S, Elliot P. SMC Press Briefing: Latest results from the REACT-1 study on COVID-19 prevalence across England (13-05-2021). Press briefing presented at: Science Media Centre; May 13, 2021. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.sciencemediacentre.org/latest-results-from-the-react-1-study-on-covid-19-prevalence-acro... |
| Description | SMC Press Briefing: Latest results from the REACT-1 study on COVID-19 prevalence across England (14-10-2021). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Donnelly C, Elliot P. SMC Press Briefing: Latest results from the REACT-1 study on COVID-19 prevalence across England (14-10-2021). Press briefing presented at: Science Media Centre; October 14, 2021. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.sciencemediacentre.org/latest-results-from-the-react-1-study-on-covid-19-prevalence-acro... |
| Description | SMC Press Briefing: Latest results from the REACT-1 study on COVID-19 prevalence across England (17-06-2021). Press briefing presented at: Science Media Centre; June 17, 2021. |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Riley S, Elliot P. SMC Press Briefing: Latest results from the REACT-1 study on COVID-19 prevalence across England (17-06-2021). Press briefing presented at: Science Media Centre; June 17, 2021. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.sciencemediacentre.org/latest-results-from-the-react-1-study-on-covid-19-prevalence-acro... |
| Description | SMC Press Briefing: Latest results from the REACT-1 study on COVID-19 prevalence across England (26-01-2022). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Donnelly C, Elliot P. SMC Press Briefing: Latest results from the REACT-1 study on COVID-19 prevalence across England (26-01-2022). Press briefing presented at: Science Media Centre; January 26, 2022. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.sciencemediacentre.org/latest-results-from-the-react-1-study-on-covid-19-prevalence-acro... |
| Description | SMC Press Briefing: Latest results from the REACT-1 study on COVID-19 prevalence across England - round 15 final report (18-11-2021). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Donnelly C, Elliot P. SMC Press Briefing: Latest results from the REACT-1 study on COVID-19 prevalence across England - round 15 final report (18-11-2021). Press briefing presented at: Science Media Centre; November 18, 2021. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.sciencemediacentre.org/latest-results-from-the-react-1-study-on-covid-19-prevalence-acro... |
| Description | SMC Press Briefing: New modelling from Imperial: hospitalisation risk for Omicron cases in England - Report 50 (22-12-2021). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Ghani A, Ferguson N. SMC Press Briefing: New modelling from Imperial: hospitalisation risk for Omicron cases in England - Report 50 (22-12-2021). Press briefing presented at: Science Media Centre; December 22, 2021. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.sciencemediacentre.org/new-modelling-from-imperial-hospitalisation-risk-for-omicron-case... |
| Description | SMC Press Briefing: Q&A on the B.1.617.2 delta variant: what do and don't we know? (09-06-2021). Press briefing presented at: Science Media Centre; June 9, 2021. |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Ferguson N, Barclay W, Barrett J. SMC Press Briefing: Q&A on the B.1.617.2 delta variant: what do and don't we know? (09-06-2021). Press briefing presented at: Science Media Centre; June 9, 2021. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.sciencemediacentre.org/qa-on-the-b-1-617-2-delta-variant-what-do-and-dont-we-know/ |
| Description | SMC Press Briefing: Response to No.10 press conference & MRC Centre for Global Infectious Disease Analysis Report 9 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Ghani A, Ferguson N, Hunter P. SMC Press Briefing: Response to No.10 press conference & MRC Centre for Global Infectious Disease Analysis Report 9 (17-03-2020). Press briefing presented at: Science Media Centre; March 17, 2020 |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.sciencemediacentre.org/response-to-no-10-press-conference-mrc-centre-for-global-infectio... |
| Description | SMC Press Briefing: Study on household transmission of SARS-CoV-2, looking at variant type and vaccination status (28-10-2021). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Ferguson N, Singanayagam A, Zambon M, Lalvani A. SMC Press Briefing: Study on household transmission of SARS-CoV-2, looking at variant type and vaccination status (28-10-2021). Press briefing presented at: Science Media Centre; October 28, 2021. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.sciencemediacentre.org/study-on-household-transmission-of-sars-cov-2-looking-at-variant-... |
| Description | STARmed videos - public engagement on the impacts of falsified medicine |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | National competition in Indonesia for general public to discuss the impacts of falsified medicine and raise awareness of the issue. Competition was won by a school student and sparked discussion amongst members of the public |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://starmeds.id/en/blog/activities/capacity-building-and-public-engagement/ |
| Description | STEM for Britain |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Selected as a finalist for the STEM for Britain event, producing a poster on minimal models for epidemics. This was presented to a mixture of politicians and scientists with the aim of improving cross-insights between these groups. Led to several interesting discussions and even informed one MP about modelling and what it can do. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://stemforbritain.org.uk/ |
| Description | School Visit (Birmingham) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | Dr Patrick Walker spoke to high school children in a deprived area (age 14-16) on the following: Use of mathematics to understand the control of infectious diseases Benefits of going to university Careers in Academia This sparked questions and debates about the impact of the modelling of policy decisions during the COVID-19 pandemic, and the benefits of going to university |
| Year(s) Of Engagement Activity | 2021 |
| Description | School activity (Menorca, Spain) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Schools |
| Results and Impact | Activity with 10-yo pupils around the topic of the International Day of Women and Girls in Science. |
| Year(s) Of Engagement Activity | 2023 |
| Description | School of Public Health COVID-19 Showcase |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Postgraduate students |
| Results and Impact | Presented on behalf of the Department of Infectious Disease Epidemiology (DIDE) as part of the Shool of Public Health (SPH) showcase 2020. Estimated >200 participants from throughout the school listened in on a zoom call. Spoke about my recent statistical analysis of COVID data, and received positive feedback after the event that my talk was clear and engageable for non-technical members of the audience. |
| Year(s) Of Engagement Activity | 2020 |
| Description | School pupil placement |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Schools |
| Results and Impact | A 15 year old school pupil from France came for a 2-week work placement with me. She learnt about modelling infectious diseases, met with academics at various career stages, helped with preparation for a science festival and with the stall on the day. She also performed a research project using mathematics to design a winning strategy for one of the games showcased at our stall at the festival; she summarised her findings as a poster. |
| Year(s) Of Engagement Activity | 2022 |
| Description | School visit - Il Volta incontra - Liceo Scientifico Alessandro Volta, Milano, Italy |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | Event to talk about my work to high school students who are choosing university career Sparked discussion from students who were interested in studying mathematics and biology |
| Year(s) Of Engagement Activity | 2022 |
| Description | School visit at Henry Box school in Witney |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | School assembly visit to sixth form students to talk about the novel Coronavirus and epidemiology Sparked questions and discussion and improved understanding of outbreak response |
| Year(s) Of Engagement Activity | 2020 |
| Description | Science Journal for Teens Article: How can we stop the COVID-19 pandemic? (Report 9) (Apr-20) |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | How can we help stop the COVID-19 pandemic? The new coronavirus has already claimed the lives of hundreds of thousands of people. Different countries are taking different measures in the fight against this new threat. Many people are staying at home. But is it worth it? That's what we wanted to find out. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://sciencejournalforkids.org/articles/how-can-we-help-stop-the-covid-19-pandemic/ |
| Description | Science Journal for Teens Article: What is the impact of COVID-19 on other diseases? (Report 19) (Jul-20) |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | What is the impact of COVID-19 on other diseases? The new coronavirus has spread almost everywhere on our planet. Governments have taken various measures to try and control the disease - many of us are in lockdown, and lots of schools and businesses are closed. Some people have lost their jobs. These (and other) measures have consequences for other diseases as well. We wanted to assess what impact the coronavirus epidemic would have on three other current epidemics: HIV, tuberculosis (TB) and malaria. These three diseases are a major threat, especially in poorer countries. (Report 19) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://sciencejournalforkids.org/articles/what-is-the-impact-of-covid-19-on-other-diseases/ |
| Description | Science Media Centre Press Briefing - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Covid-19 Press Briefing by the Science Media Centre (22 Jan 2020) to multiple news and media outlets, scientific journals etc.: ABC (Australia), BBC, Conde Nast, Swiss Radio, Associated Press (USA), British Medical Journal (BMJ), The Daily Mail, The Economist, Evening Standard, The Express, Finnacial Times, The Guardian, ITN, ITV, Mail on Sunday, Mail Online, Mirror, Nature, Press Association, Reuters, The Sun, The Telegraph, Times, Yahoo News, AFP (France), Associated Press (UK), New Scientist, ZDF (Germany) |
| Year(s) Of Engagement Activity | 2020 |
| Description | Science Media Centre press briefing: Latest results from the REACT-2 study on coronavirus antibody prevalence in England (Helen Ward) (25-Feb-2021) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Science Media Centre press briefing: Latest results from the REACT-2 study on coronavirus antibody prevalence in England (Helen Ward) (25-Feb-2021) |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.sciencemediacentre.org/latest-results-from-the-react-2-study-on-coronavirus-antibody-pre... |
| Description | Science Media Centre press briefing: Latest interim results from the REACT-1 study on COVID-19 prevalence across England (Steven Riley) (18-Feb-21) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Science Media Centre press briefing: Latest interim results from the REACT-1 study on COVID-19 prevalence across England (Steven Riley) (18-Feb-21) |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.sciencemediacentre.org/latest-interim-results-from-the-react-1-study-on-covid-19-prevale... |
| Description | Science Media Centre press briefing: Latest interim results from the REACT-1 study on COVID-19 prevalence across England (Steven Riley) (21-Jan-21) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Schools |
| Results and Impact | Science Media Centre press briefing: Latest interim results from the REACT-1 study on COVID-19 prevalence across England (Steven Riley) (21-Jan-21) |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.sciencemediacentre.org/latest-interim-results-from-the-react-1-study-on-covid-19-prevale... |
| Description | Science Media Centre press briefing: Latest interim results from the REACT-1 study on COVID-19 prevalence across England (Steven Riley) (30-Nov-20) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Science Media Centre press briefing: Latest interim results from the REACT-1 study on COVID-19 prevalence across England (Steven Riley) (30-Nov-20) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.sciencemediacentre.org/latest-interim-results-from-the-react-1-study-on-covid-19-prevale... |
| Description | Science Media Centre press briefing: Latest interim results from the REACT-1 study on COVID-19 spread across England (Steven Riley) (1-Oct-20) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Science Media Centre press briefing: Latest interim results from the REACT-1 study on COVID-19 spread across England (Steven Riley) (1-Oct-20) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.sciencemediacentre.org/latest-interim-results-from-the-react-1-study-on-covid-19-spread-... |
| Description | Science Media Centre press briefing: Latest interim results from the REACT-1 study on COVID-19 spread across England (Steven Riley) (29-Oct-20) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Science Media Centre press briefing: Latest interim results from the REACT-1 study on COVID-19 spread across England (Steven Riley) (29-Oct-20) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.sciencemediacentre.org/latest-interim-results-from-the-react-1-study-on-covid-19-spread-... |
| Description | Science Media Centre press briefing: NERVTAG Q&A on the new variant (Neil Ferguson) (21-Dec-20) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Science Media Centre press briefing: NERVTAG Q&A on the new variant (Neil Ferguson) (21-Dec-20) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.sciencemediacentre.org/nervtag-qa-on-the-new-variant/ |
| Description | Science Media Centre press briefing: REACT-2 study on COVID-19 home antibody test surveillance (Helen Ward) (13-Aug-20) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Science Media Centre press briefing: REACT-2 study on COVID-19 home antibody test surveillance (Helen Ward) (13-Aug-20) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.sciencemediacentre.org/react-2-study-on-covid-19-home-antibody-test-surveillance/ |
| Description | Science Media Centre press briefing: Top tips and a tool for interpreting mathematical models on COVID-19 (Azra Ghani) (8-Feb-21) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Science Media Centre press briefing: Top tips and a tool for interpreting mathematical models on COVID-19 (Azra Ghani) (8-Feb-21) |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.sciencemediacentre.org/top-tips-and-a-tool-for-interpreting-mathematical-models-on-covid... |
| Description | Science Media Centre press briefing: Updated latest results from the REACT-1 study on COVID-19 prevalence across England (Steven Riley (28-Jan-21) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Science Media Centre press briefing: Updated latest results from the REACT-1 study on COVID-19 prevalence across England (Steven Riley (28-Jan-21) |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.sciencemediacentre.org/updated-latest-results-from-the-react-1-study-on-covid-19-prevale... |
| Description | Science Media Centre press briefing: Updated latest results from the REACT-1 study on COVID-19 prevalence across England (Steven Riley) (15-Dec-20) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Science Media Centre press briefing: Updated latest results from the REACT-1 study on COVID-19 prevalence across England (Steven Riley) (15-Dec-20) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.sciencemediacentre.org/updated-latest-results-from-the-react-1-study-on-covid-19-prevale... |
| Description | Science Media Centre press briefing: Updated latest results from the REACT-1 study on COVID-19 spread across England (Steven Riley (12-Nov-20) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Science Media Centre press briefing: Updated latest results from the REACT-1 study on COVID-19 spread across England (Steven Riley (12-Nov-20) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.sciencemediacentre.org/updated-latest-results-from-the-react-1-study-on-covid-19-spread-... |
| Description | Science Media Centre press briefing: Updated latest results from the REACT-1 study on COVID-19 spread across England (Steven Riley) (9-Oct-20) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Science Media Centre press briefing: Updated latest results from the REACT-1 study on COVID-19 spread across England (Steven Riley) (9-Oct-20) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.sciencemediacentre.org/updated-latest-results-from-the-react-1-study-on-covid-19-spread-... |
| Description | Science Media Centre press briefing: Why vaccination of the most vulnerable does not guarantee an early end to the pandemic (Anne Cori & Marc Baguelin) (21-Jan-21) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Science Media Centre press briefing: Why vaccination of the most vulnerable does not guarantee an early end to the pandemic (Anne Cori & Marc Baguelin) (21-Jan-21) |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.sciencemediacentre.org/why-vaccination-of-the-most-vulnerable-does-not-guarantee-an-earl... |
| Description | Science Media Centre press briefing: Wuhan coronavirus outbreak (Neil Ferguson) (22-Jan-20) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Science Media Centre press briefing: Wuhan coronavirus outbreak (Neil Ferguson) (22-Jan-20) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.sciencemediacentre.org/wuhan-coronavirus-outbreak/ |
| Description | Science Media Centre press briefing: coronavirus - panel of experts to answer journalists questions (Christl Donnelly) (25-Feb-20). |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Science Media Centre press briefing: coronavirus - panel of experts to answer journalists questions (Christl Donnelly) (25-Feb-20). |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.sciencemediacentre.org/coronavirus-panel-of-experts-to-answer-your-questions/ |
| Description | Science Media Centre press briefing: hear from scientists who've done the new REACT-1 study on coronavirus spread across the country (Steven Riley) (15-Jul-20) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Science Media Centre press briefing: hear from scientists who've done the new REACT-1 study on coronavirus spread across the country (Steven Riley) (15-Jul-20) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.sciencemediacentre.org/hear-from-scientists-whove-done-the-new-react-1-study-on-coronavi... |
| Description | Science Media Centre press briefing: https://www.sciencemediacentre.org/updated-latest-results-from-the-react-1-study-on-covid-19-prevalence-across-england-3/ (Steven Riley (4-Mar-21) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Science Media Centre press briefing: https://www.sciencemediacentre.org/updated-latest-results-from-the-react-1-study-on-covid-19-prevalence-across-england-3/ (Steven Riley (4-Mar-21) |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.sciencemediacentre.org/updated-latest-results-from-the-react-1-study-on-covid-19-prevale... |
| Description | Science Media Centre press briefing: latest results from the REACT-1 study on coronavirus spread across the country (Steven Riley) (11-Sep-20) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Science Media Centre press briefing: latest results from the REACT-1 study on coronavirus spread across the country (Steven Riley) (11-Sep-20) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.sciencemediacentre.org/latest-results-from-the-react-1-study-on-coronavirus-spread-acros... |
| Description | Science Media Centre press briefing: latest results from the REACT-2 study on coronavirus antibody prevalence in England (Helen Ward) (27-Oct-20) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Science Media Centre press briefing: latest results from the REACT-2 study on coronavirus antibody prevalence in England (Helen Ward) (27-Oct-20) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.sciencemediacentre.org/latest-results-from-the-react-2-study-on-coronavirus-antibody-pre... |
| Description | Science Media Centre press briefing: part 2 of the REACT-1 study on coronavirus spread across the country - hear from the scientist leading the research (Steven Riley) (6-Aug-20) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Science Media Centre press briefing: part 2 of the REACT-1 study on coronavirus spread across the country - hear from the scientist leading the research (Steven Riley) (6-Aug-20) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.sciencemediacentre.org/part-2-of-the-react-1-study-on-coronavirus-spread-across-the-coun... |
| Description | Science Media Centre press briefing: response to No.10 press conference & MRC GIDA Report 9 (Azra Ghani, Neil Ferguson) (17-Mar-20) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Science Media Centre press briefing: response to No.10 press conference & MRC GIDA Report 9 (Azra Ghani, Neil Ferguson) (17-Mar-20) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.sciencemediacentre.org/response-to-no-10-press-conference-mrc-centre-for-global-infectio... |
| Description | Science Media Centre press briefing: what does winter hold for COVID-19 and UK health? (Azra Ghani) *14-Jul-20) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Science Media Centre press briefing: what does winter hold for COVID-19 and UK health? (Azra Ghani) *14-Jul-20) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.sciencemediacentre.org/what-does-winter-hold-for-covid-19-and-uk-health/ |
| Description | Science in Context Video - Polio in UK Sewage |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Science in context short video with Prof Nick Grassly to discuss the consequences of detection of poliovirus in UK sewage |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.youtube.com/watch?v=Bm1ywZrHyHw&feature=youtu.be |
| Description | Science in Context interview |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | Not known |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.youtube.com/watch?v=1ZBvdSDGt2g |
| Description | Science in context video - Polio booster campaign |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Dr Blake participated in a Q and A short video regarding the polio booster rollout in the UK, ahead of World Polio Day to raise awareness of the justification for the campaign. Following the interview, a member of the public contacted Dr Blake to request further information about the polio vaccine and expressed hesitancy regarding vaccinating their child. Following discussions with Dr Blake, the individual decided to proceed with vaccination. |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.youtube.com/watch?v=XhgWWlGB6do&feature=youtu.be |
| Description | Seminar BSL4ZNet COVID-19 (Neil Ferguson) (19-Aug-20) |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | BSL4ZNET COVID-19 Internaytional Symposium. Contributing scientific knowledge towards the global control of SARS-COV-2. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.csi-sci.ca/_Library/_documents/Poster_BSL4ZNet_-_COVID-19_Symposium_poster_Final.pdf |
| Description | Seminar Series COVID-19 (Day 2) (8-Sep-20) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Webinar Series Day 2 - Insights into COVID-19 modelling & evidence based policy making |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.youtube.com/playlist?list=PLNzrUckV9eSJIF41YCUaUWHOg_CTxmc99 |
| Description | Seminars at Vienna University and Drexel University |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Participation in invited seminars to postgraduate students to discuss applications of genomic epidemiology tools and models. This sparked discussions and questions from audience members and positive feedback was received from participants and organisers |
| Year(s) Of Engagement Activity | 2021 |
| Description | Several media interviews regarding COVID-19 outbreak |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Media interviews with London Broadcasting Corporation (LBC Radio), Yomiuri newspaper in Japan, Nippon TV in Japan, TBS TV in Japan and Asahi TV in Japan, Bunshun magazine in Japan regarding COVID-19 outbreak to inform public of recent activities within Imperial to support epidemiological analysis. |
| Year(s) Of Engagement Activity | 2020 |
| Description | Short film: COVID-19 R&P: Research Meets Performance | Episode 2, Report 10 |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Imperial College partnered with the Burnt OrangeTheatre Company. Each group created a short film incorporating some of their personal experiences during the pandemic, and elements of the COVID-19 research report their group was assigned. The research stimulus for this video was Report 10 -Public response to UK Government recommendations on COVID-19: population survey, 17-18 March 2020, produced by MRC GIDA (https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-10-population-survey-covid-19/) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/vfzBgYnZg2o |
| Description | Short film: COVID-19 R&P: Research Meets Performance | Episode 1, Report 1 |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Imperial College partnered with the Burnt OrangeTheatre Company. Each group created a short film incorporating some of their personal experiences during the pandemic, and elements of the COVID-19 research report their group was assigned. The research stimulus for this video was Report 1 -Estimating the potential total number of novel Coronavirus (2019-nCoV) cases in Wuhan City, China, produced by MRC GIDA (https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-1-case-estimates-of-covid-19/). |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/H6Zifam_wng |
| Description | Short film: COVID-19 R&P: Research Meets Performance | Episode 3, Report 13 |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Imperial College partnered with the Burnt OrangeTheatre Company. Each group created a short film incorporating some of their personal experiences during the pandemic, and elements of the COVID-19 research report their group was assigned. The research stimulus for this video was Report 13 -Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries, produced by MRC GIDA (https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-13-europe-npi-impact/) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/xjKQt6Qc6d0 |
| Description | Short film: COVID-19 R&P: Research Meets Performance | Episode 4, Report 22 |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Imperial College partnered with the Burnt OrangeTheatre Company. Each group created a short film incorporating some of their personal experiences during the pandemic, and elements of the COVID-19 research report their group was assigned. The research stimulus for this video was Report 22 -Equity in response to the COVID-19 pandemic: an assessment of the direct and indirect impacts of disadvantaged and vulnerable populations in low-and lower middle-income countries, produced by MRC GIDA (https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-22-equity/) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/5A22gWcL98Y |
| Description | Short film: COVID-19 R&P: Research Meets Performance | Episode 5, Report 24 |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Schools |
| Results and Impact | Imperial College partnered with the Burnt OrangeTheatre Company. Each group created a short film incorporating some of their personal experiences during the pandemic, and elements of the COVID-19 research report their group was assigned. The research stimulus for this video was Report 24 -Anonymised & aggregated crowd level mobility data from mobile phones suggests initial compliance with COVID-19 social distancing interventions was high & geographically consistent across UK, produced by MRC GIDA (https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-24-uk-mobility/) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://youtu.be/UB3zpV5T67I |
| Description | Short talk to research software engineers |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Industry/Business |
| Results and Impact | I gave a short talk at the RSELondonSouthEast conference for Research Software Engineers, which was a based on a broad programming outcome of my scientific research experience. The talk was of a general nature, and I also uploaded the talk and slides freely after the event. |
| Year(s) Of Engagement Activity | 2020 |
| Description | Sky News Breakfast Programme - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Sky News Breakfast Programme TV Interview - Covid-19 (22 Jan 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | Societal engagement award for combatting HIV stigma |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Public/other audiences |
| Results and Impact | Combatting HIV stigma |
| Year(s) Of Engagement Activity | 2018 |
| Description | Symposium at Icasa conference |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Symposium at Icasa conference to discuss the role of key populations in HIV transmission in Africa and prevention needs. Engagement and discussion with symposium attendants and plans to organise a webinar to reach a larger audience |
| Year(s) Of Engagement Activity | 2019 |
| URL | https://www.icasa2019rwanda.org/conferenceprogramme/icasa-2019-online.html |
| Description | TAILOR-MADE VACCINES COULD ALMOST HALVE RATES OF SERIOUS BACTERIAL DISEASE |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Press release to raise awareness of issues regarding vaccine design. Widely reported on news outlets (e.g. BBC, Daily Mail). Comments on websites showed engagement with the public. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.sciencefocus.com/news/vaccines-tailored-to-age-group-could-reduce-disease-spread-by-almo... |
| Description | Talk at Northampton High School: University and career paths, Caroline Chisholm school |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | Talk |
| Year(s) Of Engagement Activity | 2018 |
| Description | Talk at The London Academy of Excellence Stratford |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | This was an invited talk to The London Academy of Excellence Stratford where i outlined the benefits and challenges of a career in science. The goal was to inspire the students to persue a life in science but also understand some of the pros and cons |
| Year(s) Of Engagement Activity | 2021 |
| Description | Talk at Wellcome Trust: Antimicrobial Resistance - Genomes, Big Data and Emerging Technologies |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Talk given at conference. Sparked discussion and questions afterwards with requests for further information. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://coursesandconferences.wellcomegenomecampus.org/our-events/ntimicrobial-resistance-2020/ |
| Description | Talk given at COG-consortium relating to mutations in transmissibility of COVID-19 (Erik Volz) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Talk given relating to Kent variant of COVID-19. Talk was picked up by media and received press attention. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.cogconsortium.uk/news_item/upcoming-cog-uk-showcase-event-16th-dec-2020/ |
| Description | Talk given at Caroline Chisham school on Science in Higher Education |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | Talk given at school on studying science in higher education. Sparked discussion as to the varying fields of study available. Raised awareness of scientific careers |
| Year(s) Of Engagement Activity | 2014,2019 |
| Description | Talk given on River Blindness in April 2018 and April 2019 |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | Talk given in 2018 for Wives fellowship and in 2019 to raise awareness amongst active and retired healthcare professionals of River Blindness. Sparked questions and discussions afterwards. |
| Year(s) Of Engagement Activity | 2018,2019 |
| Description | Talk given to Boston Consulting Group |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Talk given to BCG - informing business on the impact of vaccination and what is still unknown regarding the epidemiology of COVID-19 Request by BCG to publish summary of talk given within BCG Circular to executives |
| Year(s) Of Engagement Activity | 2021 |
| Description | Talk given to British Pharmaceutical Society on the epidemiology of COVID |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Informed participants on the epidemiology of COVID, with a focus on gaps in knowledge Request from Royal Society to publish an article in 'Interface' |
| Year(s) Of Engagement Activity | 2022 |
| Description | Talk given to London Academy of Excellence (Tottenham) and Highgate School |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | 60 pupils attended careers talk for medical research. Sparked questions and discussions afterwards. Professor Grassly has also mentored school pupils to seek careers in medical research. |
| Year(s) Of Engagement Activity | 2021 |
| Description | Talk on 'Modelling clinical trials of Sanofi Pasteur dengue vaccine' at Vaccine Network |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Talk on 'Modelling clinical trials of Sanofi Pasteur dengue vaccine' at Vaccine Network Sparked questions and discussions afterwards regarding applications of similar methods in different contexts. |
| Year(s) Of Engagement Activity | 2019 |
| Description | Teach in Wallands Community Primary School, Lewes, East Sussex |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | Teach in Wallands Community Primary School, Lewes, East Sussex Teaching children aged 7-8 about science and disease - session was well recieved. |
| Year(s) Of Engagement Activity | 2019,2020,2022 |
| Description | Ted Talk on epidemic dynamics and on the power of individual actions in the control of COVID-19 (Ilaria Dorigatti) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Invited Ted talk to discuss infectious disease dynamics. Raised awareness of importance on NPIs to control COVID-19 epidemic |
| Year(s) Of Engagement Activity | 2020 |
| Description | The Economics of HIV |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | "Understanding the Economics of Microbial Threats", Working Group, lecture and expert member, National Academies of Sciences, Engineering, and Medicine, Washington (D.C.), June |
| Year(s) Of Engagement Activity | 2018 |
| URL | http://www.nationalacademies.org/hmd/Activities/PublicHealth/microbialthreats/2018-JUN-12/Videos/S1/... |
| Description | The Economist - Contribute to reports - Covid-19 |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | The Economist - Provided images & data for reports - Covid-19 (26 Feb 2020 & 28 Feb 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | The Economist radio podcast - Covid 19 |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | Participant in The Economist weekly podcast: 'Going viral, going global-what can countries do to prepare for covid-19?' |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.economist.com/podcasts/2020/02/26/going-viral-going-global-what-can-countries-do-to-prep... |
| Description | The Economist radio podcast - Covid 19 (Christl Donnelly) |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | Participant in The Economist weekly podcast: 'Going viral, going global-what can countries do to prepare for covid-19?' |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.economist.com/podcasts/2020/02/26/going-viral-going-global-what-can-countries-do-to-prep... |
| Description | The Guardian Interview - Covid-19 |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | The Guardian - Newspaper interviews - Covid-19 (Jan 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | The Independent - What happens after Omicron wave? (9-Feb-22) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | After 2 years of living through a global pandemic, many scientists and policymakers are trying to answer what happens next. |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.independent.co.ug/what-happens-after-omicron-wave/ |
| Description | The Telegraph Interview - Covid-19 |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | The Telegraph newspaper interview via Skype - Covid-19 (21 Jan 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | The Telegraph Interviews - Covid-19 |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | The Telegraph Interviews - Covid-19 (Feb 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | The Times: Falling deaths suggest pandemic's second wave is over (23-Mar-21) |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Professor Neil Ferguson, director of the MRC Centre for Global Infectious Disease Analysis at Imperial College London, said: "The new ONS data on deaths is encouraging in suggesting the second devastating wave of the pandemic is behind us. But calling epidemics 'waves' can be misleading, in implying a phenomenon that has reached a natural end. That is not the case here. The rapid decline in deaths we've thankfully seen is entirely because of the lockdown and the rapid roll-out of vaccines. So while I'm optimistic that this we will be able to return to something more like normal in the next few months, we need to remain vigilant and cautious in the pace with which social distancing is relaxed - particularly given the threat still posed by new variants of the virus." |
| Year(s) Of Engagement Activity | 2021 |
| Description | The Times: The women in science staging a quiet revolution (Azra Ghani, Christl Donnelly) (6-Mar-21) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Professor Azra Ghani and Professor Christl Donnelly are featured in an article highlighting 17 female role models in science. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.thetimes.co.uk/article/the-women-in-science-staging-a-quiet-revolution-s3whkrvhs |
| Description | The Year Britain Stopped, Channel 4 (24-May-21) |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | A fascinating portrait of Britain on the brink, with Covid stories across society - from frontline workers to scientists, and Boris Johnson and the nurse who helped save his life |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.channel4.com/programmes/the-year-britain-stopped |
| Description | The return on investment to pandemic preparedness |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Presentation of advisory research support to the Center for Global Development on the Return on Investment of Pandemic Preparedness for the G20 High Level Independent Panel on Financing the Global Commons for Pandemic Preparedness and Response |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.cgdev.org/event/what-return-investment-pandemic-preparedness |
| Description | Training modelling workshop with ICMR India |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Led residential modelling workshop held at ICMR headquarters as part of capacity building initiative in modelling at ICMR |
| Year(s) Of Engagement Activity | 2020 |
| Description | UNAIDS Reference Group on Estimates Modelling and Projections |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Coordinated and chaired technical expert meetings to provide scientific guidance to UNAIDS and partners on the data and methods used to produce global HIV/AIDS estimates and projections. Each meeting convenes 30-50 technical experts and results in a public report and recommendations implemented in annual global HIV estimates published by UNAIDS. |
| Year(s) Of Engagement Activity | 2008,2009,2010,2011,2012,2013,2014,2015,2016,2017,2018,2019,2020 |
| URL | http://www.epidem.org |
| Description | Voice of America - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Voice of America Interview - Covid-19 (13 Feb 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | WHO - Global Malaria Programme |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Gave evidence for a policy recommendation for a new type of bed net for malaria control. |
| Year(s) Of Engagement Activity | 2018 |
| Description | WHO - Global Malaria Programme - Insecticide resistance management |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Third sector organisations |
| Results and Impact | A webminar where we discussed changes in the level of insecticide resistant mosquitoes in Africa |
| Year(s) Of Engagement Activity | 2018 |
| Description | WHO Hepatitis day event - COVID-19 (Tim Hallett) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Contributed to a speech on the impact of COVID on Hepatitis |
| Year(s) Of Engagement Activity | 2020 |
| Description | WHO Regional Greenlight committee for SE Asia region - expert panel committee member |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Purpose - to support country TB programmes in the SE Asian region in their control of drug resistant TB Impacts and outcomes - provided technical support to India and Indonesia for their strategic planning Interest led to a multi-country workshop to support capacity building amongst policymakers and professional practitioners |
| Year(s) Of Engagement Activity | 2018,2019,2020 |
| Description | WHO STAG-IH meeting (strategic advisory group on infectious hazards) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | The Strategic and Technical Advisory Group on Infectious Hazards with Pandemic and Epidemic Potential (STAG-IH) provides independent advice and analysis to WHO on the infectious hazards that may pose a potential threat to global health security. I presented recent work of our group, as a WHO collaborating centre, and contributed to discussions around the future of pandemic and epidemic surveillance. |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.who.int/news-room/events/detail/2022/10/24/default-calendar/strategic-technical-advisory... |
| Description | WILDLIFE DISEASES ON THE INCREASE: A MAJOR THREAT FOR EUROPE'S BIODIVERSITY |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | IUCN policy brief to the European Parliament Change to incoming EU 'Animal Health' Law |
| Year(s) Of Engagement Activity | 2013 |
| URL | http://www.biodiversa.org/552 |
| Description | Wallstreet Journal - Covid-19 |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Wallstreet Journal, Japan, Interview - Covid-19 (13 Jan 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | Washington Post article |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Washington Post article featuring front-page Science article 'Exotic pet trade linked to invasive fungus that's killing frogs globally' |
| Year(s) Of Engagement Activity | 2018 |
| URL | https://www.washingtonpost.com/news/speaking-of-science/wp/2018/05/10/exotic-pet-trade-linked-to-inv... |
| Description | We do STEM! - Istituto Degasperi, Borgo Valsugana, Italy |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Schools |
| Results and Impact | Participated to interview and video created by high school students to talk about the role of women in science and gender gap |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://youtu.be/z9dLy53HvKU |
| Description | Webinar - Insights into COVID-19 modelling and evidence based policy making |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Participation in a webinar: Insights into COVID-19 modelling and evidence based policy making Outcomes - request for further information from other academics/ media/ members of the public |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.youtube.com/watch?v=1jfdklQQFQo |
| Description | Webinar Pandemic Briefing (Azra Ghani) (1-Jul-20) |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Webinar: Weekly COVID-19 Pandemic Briefing - Mathematical Modelling and Response Decisions |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.chathamhouse.org/events/all/members-event/webinar-weekly-covid-19-pandemic-briefing-math... |
| Description | Webinar on Covid-19 modelling and evidence-based policy making |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Webinar as a replacement of Short course on infectious disease modelling. I talked about methods for estimating the reproduction number and applications to COVID-19 |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.youtube.com/watch?v=wv3BecZD5DU&feature=youtu.be |
| Description | Webinar: Bowman Lecture (Christl Donnelly) (10-Dec-20) |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Understanding infectious disease transmission and control: a view from the coalface |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://echo360.org.uk/media/1cd5126a-d2e0-423d-b76d-bbd2729915fc/public |
| Description | Webinar: COVID-19 planning (Azra Ghani) (11-Aug-20) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | AHSC COVID-19 Seminar Series, Planning next phase of the pandemic |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.youtube.com/watch?v=6AE61VX7Blg |
| Description | Webinar: Hospital Planner (Katharina Hauck) (7-May-20) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | J-IDEA Pandemic Hopsital Planner. How can you plan for extreme surges in demand with a limited supply of hospital care in the midst of a pandemic? |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.youtube.com/watch?v=Y-rlUoylR9c |
| Description | Webinar: Q&A Webinar: Modelling COVID-19 (24-Jun-20) |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Let's talk about COVID-19, Q&A: Modelling COVID-19. Since the start of the new coronavirus outbreak, our researchers have been working hard to understand the epidemic. From research on the spread of the virus and number of people infected to the impact of measures taken to prevent the spread of the disease, the task is huge. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.youtube.com/watch?v=HUKC8Wq2a0k |
| Description | Webinar: Q&A antibody testing (22-Jul-20) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Let's talk about COVID-19, Q&A COVID-19 Antibody Testing. As we ease out of lockdown, understanding how the COVID-19 pandemic is progressing across England has been essential. How many people have been infected and where? How does our body fight the virus? |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.youtube.com/watch?v=WNF_zEX7OKw |
| Description | Webinar: Real-Time analysis COVID-19 (Christl Donnelly) (30-Jun-20) |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Real-time analysis of COVID-19: epidemiology, statistics and modelling in action |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.lshtm.ac.uk/newsevents/events/real-time-analysis-covid-19-epidemiology-statistics-and-mo... |
| Description | Webinar: World Economic Forum (WEF) the bigger picture (Neil Ferguson) (18-Feb-20) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | World Economic Forum Webinar: The Bigger Picture on Coronavirus and Rapid Response Healthcare featuring professor Neil Ferguson.. |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.youtube.com/watch?v=XNbfRRkJVLE |
| Description | Webinars series on 'KNOWLEDGE EXCHANGE IN THE TIME OF COVID-19 USING EVIDENCE TO ADDRESS HEALTH CARE CHALLENGES IN LOW- AND MIDDLE-INCOME COUNTRIES' |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Webinar series aimed at policy makers to address healthcare challenges - resource allocation and health technology assessment during COVID-19 pandemic Impacts not yet recognised |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://adphealth.org/hitap-webinar/ |
| Description | Where the earth meets the sky |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | I gave a key note talk large physics conference called where the earth meets the sky. My talk was about the interdisciplinary nature of science |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://indico.nbi.ku.dk/event/1330/ |
| Description | Workshop on 'Mathematics and statistics of genomic epidemiology' (Erik Volz) |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | All videos posted online to widen access to participation |
| Year(s) Of Engagement Activity | 2020 |
| URL | http://www.birs.ca/events/2020/5-day-workshops/20w5222 |
| Description | Workshop to report on results of a linkage project in South Africa |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Workshop was held to present he results of a study and obtain input from the community and local researchers. Raised awareness of study outcomes and provided attendees with knowledge of research methodologies. |
| Year(s) Of Engagement Activity | 2018 |
| Description | World Bank COVID-19 (Azra Ghani, Patrick Walker) (4-Apr-20) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Understanding the Epidemiology of COVID-19 |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.worldbank.org/en/news/video/2020/04/14/understanding-the-epidemiology-of-covid-19 |
| Description | Xinhua (China) Interview - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Xinhua (China) Newspaper Interview via Skype - Covid-19 (23 Jan 2020) |
| Year(s) Of Engagement Activity | 2020 |
| Description | YZ-UHP! Youth Advisory Board |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Study participants or study members |
| Results and Impact | Briefing and consultation on plans for and experience of research procedures for study on use of HIV prevention methods by young people in the research study area. |
| Year(s) Of Engagement Activity | 2019 |
| Description | Yahoo News Quoted - Covid-19 |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Quoted by Yahoo News re Covid-19 |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://news.yahoo.com/coronavirus-all-your-questions-answered-155238631.html |
| Description | Youtube series - COVID19 Science in Context series |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Web series COVID-19 in context to provide answers to questions from the public (submitted on Twitter). Has sparked questions and discussions and further involvement from the public on social media Science in Context Episode 1: COVID19 with Prof Neil Ferguson (25-02-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1364986643644571658?s=20 Science in Context Episode 2: COVID19 with Dr Anne Cori (04-03-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1367492879443234816?s=20 Science in Context Episode 3 Science in Context: COVID19 with Prof Steven Riley (11-03-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1370030767619907588?s=20 Science in Context Episode 4 Science in Context: COVID-19 with Prof Azra Ghani (18-03-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1372566399013556225?s=20 Science in Context Episode 5 Science in Context: COVID-19 with Prof Neil Ferguson (25-03-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1375111435169230849?s=20 Science in Context Episode 6 Science in Context: COVID-19 with Dr Anne Cori (02-04-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1378028590802014210 Science in Context Episode 7 Science in Context: COVID-19 with Dr Nuno Faria (08-04-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1380224263567900682 Science in Context Episode 8 Science in Context: COVID-19 with Prof Steven Riley (16-04-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1382992265258409987 Science in Context Episode 9 Science in Context: COVID-19 with Prof Neil Ferguson (23-04-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1385488412849938432 Science in Context Episode 10: COVID-19 with Dr Anne Cori (30-04-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1388130123107422212 Science in Context Episode 11: COVID-19 with Prof Azra Ghani (14-05-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1393186932608446467 Science in Context Episode 12: COVID-19 with Prof Steven Riley (20-05-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1395318648932380673 Science in Context Episode 13: COVID-19 with Dr Anne Cori (11-06-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1403294976054902786 Science in Context Episode 14: COVID-19 with Prof Neil Ferguson (25-06-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1408328891438149633 Science in Context Episode 15: COVID-19 with Prof Katharina Hauck (09-07-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1425730599734718468 Science in Context Episode 16: COVID-19 with Prof Steven Riley (12-08-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1425730599734718468 Science in Context Episode 17: COVID-19 with Dr Anne Cori (26-08-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1430806754493935619 Science in Context Episode 18: COVID-19 with Prof Neil Ferguson (23-09-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1440952965989388288?s=20 Science in Context Episode 19: COVID-19 with Prof Christl Donnelly (14-10-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1449009362228416523?s=20 Science in Context Episode 20: COVID19 with Dr Marc Baguelin & Dr Pablo Perez Guzman (22-10-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1451585747983769604?s=20 Science in Context Episode 21: COVID-19 with Dr Anne Cori & Dr Marc Baguelin (27-10-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1453494113840533505?s=20 Science in Context Episode 22: COVID-19 with Prof Christl Donnelly (25-11-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1463930748864507905?s=20&t=QrmNDBYKCKVhP_c2BqyiRg Science in Context Episode 23: COVID-19 with Prof Neil Ferguson (02-12-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1466446374292144129?s=20&t=QrmNDBYKCKVhP_c2BqyiRg Science in Context Episode 24: COVID-19 with Prof Azra Ghani (10-12-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1469307967057145865?s=20&t=QrmNDBYKCKVhP_c2BqyiRg Science in Context Episode 25: COVID-19 with Dr Anne Cori (17-12-2021).; 2021. https://twitter.com/MRC_Outbreak/status/1471760311162216449?s=20&t=QrmNDBYKCKVhP_c2BqyiRg Science in Context Episode 26: COVID-19 with Dr Juliette Unwin (25-02-2022).; 2022. https://twitter.com/MRC_Outbreak/status/1497179369990729729?s=20&t=QrmNDBYKCKVhP_c2BqyiRg Science in Context Episode 27: COVID-19 with Dr Rob Johnson (28-02-2022).; 2022. https://twitter.com/MRC_Outbreak/status/1498339540993548290?s=20&t=QrmNDBYKCKVhP_c2BqyiRg |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://twitter.com/MRC_Outbreak |
| Description | Youtube videos |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Released youtube videos summarising research papers. Roughly hundreds of views each at this time. |
| Year(s) Of Engagement Activity | 2021,2022 |
| URL | http://www.johnlees.me/presentations/ |
| Description | societal engagement seed fund on HIV stigma |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Undergraduate students |
| Results and Impact | 3 workshops of 3 hours with a HIV patient group, undergraduate or postgraduate level students in physical theatre/contemporary circus. |
| Year(s) Of Engagement Activity | 2019 |
| Description | work experience students (multiple) visited department to conduct short research projects and learn about scientific careers |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | pupils from various London secondary schools including deprived boroughs visited department and conducted a research project to improve their CVs and give them an experience of medical research |
| Year(s) Of Engagement Activity | 2019,2020 |
| Description | work experience students for one week practicals in the lab + one lady who did a three month placement after her A levels |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | Three groups of work experience students for one week practicals in the lab and one lady who did a three month placement with us after her A levels. |
| Year(s) Of Engagement Activity | 2018 |